pmid,doi,title,journal,year,abstract_length,methods_length,intro_length,existing_tool_count,novel_tool_count,total_tool_count,existing_tools,novel_tools,tool_metadata,tool_sources,is_gff
10215625,10.1101/gad.13.8.978,Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein.,Genes Dev,1999,790,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Specific mutations in some tumor suppressor genes such as p53 can act in a dominant fashion. We tested whether this mechanism may also apply for the neurofibromatosis type-2 gene (NF"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10339466,,Myeloid malignancies induced by alkylating agents in Nf1 mice.,Blood,1999,1152,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""c syndrome (t-AML and MDS) are severe late complications of treatment with genotoxic chemotherapeutic agents. Children with neurofibromatosis type 1 (NF1) are predisposed to malignant myeloid disorders that are associated with inactivation of the NF1 tumor suppressor gene in the leukemic clone. Recent "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Therapy-related acute myeloid leukemia and myelodysplastic syndrome (t-AML and MDS) are severe late complications of treatment with genotoxic chemotherape"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10383727,10.1046/j.1523-1747.1999.00609.x,"The Nf1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation, and collagen deposited by fibroblasts.",J Invest Dermatol,1999,1339,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""gen matrix produced by fibroblasts. Trauma has been proposed to trigger neurofibroma formation. To test if loss of the neurofibromatosis type 1 gene (Nf1) compromises fibroblast function in vivo following trauma, skin wounding was performed in Nf1 knockout mice. The pattern and amount of collagen-rich "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""med in Nf1 knockout mice. The pattern and amount of collagen-rich granulation bed tissue, manufactured by fibroblasts, was grossly abnormal in 60% of Nf1+/- wounds. Nf1 mutant fibroblasts showed cell autonomous abnormalities in collagen deposition in vitro that were not mimicked by Ras activation in fibro"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 patients develop peripheral nerve tumors (neurofibromas) composed mainly of Schwann cells and fibroblasts, in an abundant collage"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10433955,10.1016/S0002-9440(10)65158-9,Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.,Am J Pathol,1999,1511,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Ependymal tumors are heterogeneous with regard to morphology, localization, age at first clinical manifestation, and prognosis. Several molecular alterations have be"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10567424,10.1074/jbc.274.48.34438,Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.,J Biol Chem,1999,1428,15631,0,1,2,3,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Plasmids,\nCloning, and Mutagenesis Synthetic genes\nencoding for human merlin FERM (P35240; amino acids 22\u2013312)\nand radixin FERM (P352"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "" coefficient\nwas found to be around 1 for all experiments. All measurements were\nperformed at least in triplicates. Cell Culture and Pull-Down\nAssays HEK293 cells (Sigma:85120602)\nwere cultured using Dulbecco\u2019s modified Eagle medium (Gibco)\nsupplemented with 10% fetal bovine serum and NEAA (Gibco) in a hu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""abeled peptide was added to each\nsample. After mixing, the FP signals were recorded using SpectraMax\niD5 (Molecular Devices). Data were analyzed with GraphPad Prism version\n7.0.0 for MacOS (GraphPad Software, San Diego, California USA). A\nquadratic equation for equilibrium binding  was used to fit the obtained da"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
10591653,10.1126/science.286.5447.2176,Mouse tumor model for neurofibromatosis type 1.,Science,1999,636,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by increased incidence of benign and malignant tumors of neural crest origin. Mutations that activat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characterized by increased incidence of benign and malignant tumors of neural crest origi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10595919,10.1016/S0002-9440(10)65508-3,Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.,Am J Pathol,1999,1393,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""There is little information regarding the status of cell cycle regulators in malignant peripheral nerve sheath tumors (MPNSTs) and neurofibromas (NFs). In"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10620616,10.1084/jem.191.1.181,Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.,J Exp Med,2000,1916,5444,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Animals. \n Nf1 +/\u2212 mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6.129 background, and were backcr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""ozygous inactivation of Nf1 are largely unknown. Recently neurofibromin, the protein encoded by NF1, was shown to negatively regulate Ras activity in Nf1-/- murine myeloid hematopoietic cells in vitro through the c-kit receptor tyrosine kinase (dominant white spotting, W). Since the W and Nf1 locus appear"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods Animals. \n Nf1 +/\u2212 mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA) in a C57BL/6."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
10627474,,Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.,Blood,2000,1851,9212,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""BWA"", ""R"", ""STAR"", ""NanoDrop"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods and materials CD34 enrichment Cryopreserved UCB-derived mononuclear cells were thawed in RPMI 1640 (Gibco) with 20% heat-inactivated fetal bovine serum (Millip"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""(catalog no. 300-18), interleukin-6 (catalog no. 200-06), and Flt3 (catalog no. 300-19), as previously published. 18 In vitro knockout (KO) of human  NF1  gene in UCB HSPCs We designed 3 guide RNAs targeting the exon 2 of the human  NF1  gene from Synthego, (single guide RNA[sgRNA]_1: AGUCAGUACUGAGCACA"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""rence (STAR). Mapping quality was ensured, and alignment coverage was visually inspected in Partek Flow. Gene expression levels were quantified using featureCounts and normalized using transcripts per million (TPM). Differential analyses were performed on Partek Flow v12.3 software using DESeq2 package. Principa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""e adapter contamination, low-quality bases, and Ns. Filtered reads were aligned to the reference genome (b37/hg19/hg38) using Burrow-Wheeler Aligner (BWA) and sorted using Sambamba. Novogene\u2019s CRISPR-specific pipeline summarized all observed edits per guide RNA. To confirm on-target events and identify"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""nducted using Partek Flow software, v12.3.  Reads were aligned to the whole human genome (GRCh38) using Spliced Transcripts Alignment to a Reference (STAR). Mapping quality was ensured, and alignment coverage was visually inspected in Partek Flow. Gene expression levels were quantified using featureCoun"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": "" the QIAGEN RNeasy Kit, RNA was extracted according to the manufacturer\u2019s instructions (Novogene). The RNA quality and quantity were assessed using a NanoDrop spectrophotometer (Thermo Fisher Scientific) and a Bioanalyzer (Agilent Technologies), ensuring that RNA integrity number values were \u22658.0 for high-q"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""fied using featureCounts and normalized using transcripts per million (TPM). Differential analyses were performed on Partek Flow v12.3 software using DESeq2 package. Principal component analysis (PCA) and hierarchical clustering were performed on normalized counts to visualize expression patterns. Differe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:DESeq2"": [""methods""]}",False
10633134,10.1136/jmg.37.1.44,A search for evidence of somatic mutations in the NF1 gene.,J Med Genet,2000,1368,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disorder affecting 1 in 3000 people. The NF1 gene is located on chromosome 17q11.2, spans 350 kb of genomic DNA, and contai"", ""confidence"": 0.75, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disorder affecting 1 in 3000 people. The NF1 gene is located on chromosome 17q11.2, spans 350 kb o"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10669747,10.1128/MCB.20.5.1699-1712.2000,"Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.",Mol Cell Biol,2000,1372,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 (NF2) protein, known as schwannomin or merlin, is a tumor suppressor involved in NF2-associated and sporadic schwannomas and meni"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10678181,10.1016/s1097-2765(00)80415-3,Nf1 and Gmcsf interact in myeloid leukemogenesis.,Mol Cell,2000,862,6356,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""(Proteome Profiler Mouse XL Cytokine Array, R&D Systems, Minneapolis, MN, USA). In brief, protein lysates were prepared from the paraspinal tumors of Nf1 f/f ; DhhCre mouse neurofibromas, which exhibited a global deletion of either GM-CSFR-\u03b1 or GM-CSFR-\u03b2c. The arrays were conducted according to the ins"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""ose cultures. We generated hematopoietic cells deficient in both Nf1 and Gmcsf to test whether GM-CSF is required to drive excessive proliferation of Nf1-/- cells in vivo. Here we show that GM-CSF play a central role in establishing and maintaining the MPD and that recipients engrafted with Nf1-/- Gmcsf-/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Mice GM-CSFR-\u03b1 and the GM-CSFR \u03b2 c  knockout mice on a C57BL/6 background were a kind gift from Bruce C. Trapnell (CCHMC). Mouse"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""multiple comparisons as appropriate. A  p -value < 0.05 is considered significant. Generation of graphs and statistical analyses were performed using GraphPad Prism v.10."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""d and dorsal root ganglia (DRG) in 7-month-old mice. Image snapshots of dissected spinal cords with the attached nerves were taken and analyzed using ImageJ. (V.1.53k). A DRG with a diameter >1 mm, measured parallel to the spinal axis, was defined as a tumor. 2.3. Immunofluorescence (IF) and Immunohistoch"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""2, Biolegend), and several others. Samples were analyzed with the Aurora cell multiparametric flow analyzer (Cytek Biosciences, Fremont, CA, USA) and FlowJO_V10 or SpectroFlo 3.3.0 software. 2.5. Mouse Cytokine Array Analysis Mouse cytokine protein expressions were quantified using a mouse cytokine array "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
10684924,10.1093/nar/28.6.1307,Cold shock induces the insertion of a cryptic exon in the neurofibromatosis type 1 (NF1) mRNA.,Nucleic Acids Res,2000,1234,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ssion based on the flexibility in the selection of splice sites. In this manuscript we present the characterisation of an alternative splicing of the NF1 pre-mRNA induced by cold-shock conditions. We demonstrate that the accuracy of the splicing mechanism was perturbed after keeping samples for a short"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Alternative splicing is a regulatory process of gene expression based on the flexibility in the selection of splice sites. In this manuscript we present th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10705390,10.5858/2000-124-0382-AUMFMA,A unique method for mutation analysis of tumor suppressor genes in colorectal carcinomas using a crypt isolation technique.,Arch Pathol Lab Med,2000,1035,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Contamination of nontumor tissue makes genetic analysis difficult. For this reason, it is important to obtain pure tumor tissue to ensure accura"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10712203,10.1086/302812,Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.,Am J Hum Genet,2000,1677,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Despite intense study of the neurofibromatosis type 2 (NF2) tumor-suppressor protein merlin, the biological properties and tumor-suppressor functions of merlin are still largely unkno"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
10844550,10.1046/j.1523-1747.2000.00994.x,The neurofibromatosis type 1 (Nf1) tumor suppressor is a modifier of carcinogen-induced pigmentation and papilloma formation in C57BL/6 mice.,J Invest Dermatol,2000,1645,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""There is increasing evidence implicating the human NF1 gene in epithelial carcinogenesis. To test if NF1 can play a part in skin tumor formation, we analyzed effects of the skin cancer initiator dimethylb"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""ancer initiator dimethylbenz-anthracene and/or the tumor promoter 12-O-tetradecanoyl-13-acetylphorbol on mice heterozygous for null mutations in Nf1 (Nf1+/-). Mice were on the C57BL/6 background, noted for resistance to chemical carcinogens. Nf1+/- mice (18 of 24) developed papillomas after treatment with"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""There is increasing evidence implicating the human NF1 gene in epithelial carcinogenesis. To test if NF1 can play a part in skin tumor formation, we analy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
10900196,10.1074/jbc.M001702200,Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts.,J Biol Chem,2000,1426,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by multiple neurofibromas, peripheral nerve tumors containing mainly Schwann cells and fibroblasts. The N"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by multiple neurofibromas, peripheral nerve tumors containing mainly Schwann cel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11080503,10.1074/jbc.M009202200,Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.,J Biol Chem,2001,1241,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ntal cellular processes by cycling between an active GTP-bound conformation and an inactive GDP-bound form. Neurofibromin, the protein product of the NF1 tumor suppressor gene, and p120GAP are GTPase-activating proteins (GAPs) for p21(Ras) (Ras) and negatively regulate output by accelerating GTP hydrol"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Members of the Ras superfamily of signaling proteins modulate fundamental cellular processes by cycling between an active GTP-bound conformation and an inac"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11106646,10.1074/jbc.M006708200,Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.,J Biol Chem,2001,1306,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis 2 tumor suppressor gene product merlin has strong sequence identity to the ezrin-radixin-moesin (ERM) family over its approximately 300-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11159187,10.1016/S0002-9440(10)63992-2,Tumorigenic properties of neurofibromin-deficient neurofibroma Schwann cells.,Am J Pathol,2001,1713,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Dermal and plexiform neurofibromas are peripheral nerve sheath tumors that arise frequently in neurofibromatosis type 1. The goal of the present study wa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11316791,10.1101/gad.189601,"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44.",Genes Dev,2001,767,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis-2 (NF2) gene encodes merlin, an ezrin-radixin-moesin-(ERM)-related protein that functions as a tumor suppressor. We found that merlin me"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11356864,10.1523/JNEUROSCI.21-11-03764.2001,Bipartite interaction between neurofibromatosis type I protein (neurofibromin) and syndecan transmembrane heparan sulfate proteoglycans.,J Neurosci,2001,1258,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The neurofibromatosis type 1 (NF1) gene encodes a large tumor suppressor protein (neurofibromin). Although it is known to possess Ras GTPase-activating protein (GAP) activity, the cel"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatosis type 1 (NF1) gene encodes a large tumor suppressor protein (neurofibromin). Although it is known to possess Ras GTPase-activating protei"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11368764,10.1042/0264-6021:3560377,"The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.",Biochem J,2001,1516,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis 2 protein product merlin, named for its relatedness to the ezrin, radixin and moesin (ERM) family of proteins, is a tumour suppressor wh"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11380622,10.1046/j.1365-2443.2001.00432.x,Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma.,Genes Cells,2001,1333,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Although mutational inactivation and allelic loss in the NF2 gene appear to be causal events in the majority of vestibular schwannomas, involvem"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""ate NF2 expression. Luciferase assay and site-directed mutagenesis demonstrated that a 70-base pair (bp) region (-591 to -522 bp from the translation start site) was essential for the basic expression of the NF2 gene. A gel mobility shift assay indicated recognition by nuclear protein of the unusually l"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
11404331,10.1093/genetics/158.2.667,A systematic screen for dominant second-site modifiers of Merlin/NF2 phenotypes reveals an interaction with blistered/DSRF and scribbler.,Genetics,2001,1243,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin, the Drosophila homologue of the human tumor suppressor gene Neurofibromatosis 2 (NF2), is required for the regulation of cell proliferation and d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11432873,10.1074/jbc.M105792200,Schwannomin isoform-1 interacts with syntenin via PDZ domains.,J Biol Chem,2001,1407,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 gene (NF2) is involved in the pathogenesis of benign tumors of the human nervous system. The NF2 protein, called schwannomin or m"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11433044,10.1093/nar/29.13.e68,Quantification of splice variants using real-time PCR.,Nucleic Acids Res,2001,1063,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""of real-time PCR have made this technique attractive to study its application in quantification of splice isoforms. We use skipping of exon 37 in the NF1 gene as a model to compare and evaluate the different strategies for quantitating splice variants using real-time PCR. An overview of three different"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A reliable and robust method for measuring the expression of alternatively spliced transcripts is an important step in investigating the significance of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11435472,10.1084/jem.194.1.57,"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.",J Exp Med,2001,1731,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type I (NF1), a disease characterized by the formation of cutaneous neurofibromas infiltrated with a hi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Mutations in the NF1 tumor suppressor gene cause neurofibromatosis type I (NF1), a disease characterized by the formation of cutaneous neurofibromas infiltrated with a high den"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11533205,10.1128/JVI.75.19.9427-9434.2001,Retroviral integration at the Epi1 locus cooperates with Nf1 gene loss in the progression to acute myeloid leukemia.,J Virol,2001,1432,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ouse model of JMML through reconstitution of lethally irradiated mice with hematopoietic stem cells homozygous for a loss-of-function mutation in the Nf1 gene (D. L. Largaespada, C. I. Brannan, N. A. Jenkins, and N. G. Copeland, Nat. Genet. 12:137-143, 1996). In the course of these experiments, we foun"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Juvenile myelomonocytic leukemia (JMML) is a disease that occurs in young children and is associated with a high mortality rate. In most patients, JMML has a progressive course leading to death by virtue of infect"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11535133,10.1042/0264-6021:3580727,Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.,Biochem J,2001,1456,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The mechanism underlying the tumour-suppressor activity of the neurofibromatosis type 2 (NF2) gene product, merlin, is largely undefined but there is evidence that the b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11544276,10.1172/JCI12758,Quantitative effects of Nf1 inactivation on in vivo hematopoiesis.,J Clin Invest,2001,1084,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The NF1 tumor-suppressor gene is frequently inactivated in juvenile myelomonocytic leukemia, and Nf1 mutant mice model this myeloproliferative disorder (MPD)"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The NF1 tumor-suppressor gene is frequently inactivated in juvenile myelomonocytic leukemia, and Nf1 mutant mice model this myeloproliferative disorder (MPD). Comp"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11703924,10.1016/s1534-5807(01)00009-0,"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling.",Dev Cell,2001,972,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations in the neurofibromatosis type II (NF2) tumor suppressor predispose humans and mice to tumor development. The study of Nf2+/- mice has demonstrated an additional "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11719502,10.1074/jbc.C100553200,p21-activated kinase links Rac/Cdc42 signaling to merlin.,J Biol Chem,2002,1289,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 tumor suppressor gene, NF2, is mutated in the germ line of NF2 patients and predisposes affected individuals to intracranial and "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11727199,10.1086/337952,"C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.",Am J Hum Genet,2002,1793,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termination of the edited mRNA. Previous stud"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""C-->U RNA editing of neurofibromatosis 1 (NF1) mRNA changes an arginine (CGA) to a UGA translational stop codon, predicted to result in translational termina"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11756419,10.1074/jbc.M109979200,Structural basis for neurofibromatosis type 2. Crystal structure of the merlin FERM domain.,J Biol Chem,2002,730,21958,0,1,4,5,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Drosophila  stocks and genetics Drosophila melanogaster  (RRID:NCBITaxon_7227) crosses and staging were done at 25 \u00b0C. The following "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""idoma Bank, DCAD2, RRID:AB_528120, 1:100), anti-Cut (Developmental Studies Hybridoma Bank, 2B10, RRID:AB_528186, 1:100). For immunostaining of NF2 in HEK293T and MDCK cells, cells cultured in chamber slides were fixed in 4% formaldehyde for 15 min, followed by permeabilization in PBST. Fixed cells were th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""heat block overnight before imaging on a Leica M205 FA microscope. Wing sizes were measured using ImageJ and statistical analysis was performed using Graphpad Prism software. The wing size of  nub - Gal4  flies was used as a reference. Immunofluorescence and western blot Drosophila  third instar larval wing discs"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" on glass slides. Slides were then dried on a 50 \u00b0C heat block overnight before imaging on a Leica M205 FA microscope. Wing sizes were measured using ImageJ and statistical analysis was performed using Graphpad Prism software. The wing size of  nub - Gal4  flies was used as a reference. Immunofluorescence"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""iscs, heat shocks were carried out 2\u20134 days after egg-laying in a 37 \u00b0C water bath for 1 hour before returning the larvae to 25 \u00b0C. Wandering third instar larvae were dissected for immunostaining. For clonal induction in adult ovaries, heat shocks were carried out 2 days after eclosion in a 37 \u00b0C incuba"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
11784085,10.1006/dbio.2001.0504,Allele-specific non-CpG methylation of the Nf1 gene during early mouse development.,Dev Biol,2001,998,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Recent reports of cytosine methylation occurring at CpA and CpT dinucleotides in murine ES cells as well as in Drosophila have renewed interest in meth"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11809806,10.1128/MCB.22.4.1150-1157.2002,"The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human Schwannoma cells.",Mol Cell Biol,2002,1664,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannoma tumors, which occur sporadically and in patients with neurofibromatosis, account for 8% of intracranial tumors and can only be treated by surgical removal."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
11896214,10.1038/labinvest.3780429,NF1 tumor suppressor mRNA is targeted to the cell-cell contact zone in Ca(2+)-induced keratinocyte differentiation.,Lab Invest,2002,1348,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have previously shown that NF1 (type 1 neurofibromatosis) p21ras GTPase-activating tumor suppressor protein undergoes major relocalization during the formation of cell-cell junctio"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have previously shown that NF1 (type 1 neurofibromatosis) p21ras GTPase-activating tumor suppressor protein undergoes major relocalization during the formati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
11996670,10.1042/BJ20020060,The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteins.,Biochem J,2002,1374,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The Protein 4.1 family contains at least two members that function as tumour suppressors, the neurofibromatosis 2 gene product merlin and the recently ident"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12000789,10.1101/gad.226302,Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse.,Genes Dev,2002,699,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Biallelic NF2 gene inactivation is common in sporadic and in neurofibromatosis type 2 (NF2)-related meningiomas. We show that, beginning at four months of age, thirty percent of mice with arachnoidal"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,BMC Genomics,2002,1280,4325,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""e (Invitrogen) and random hexamers (Amersham Biosciences). RT-PCR library formation and PCR analysis Primers used for the amplification of the total  NF1  cDNA in 5 overlapping fragments were as described [ 17 ]. Reactions were performed as described [ 13 ]. The PCR products were cloned in the pCR2.1-T"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods RNA isolation and cDNA preparation RNA was isolated from fresh blood leukocytes from two normal individuals using TRIzol LS Reagent ("", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""transcripts In order to clearly describing the identity (ID) of the transcripts, following nomenclature was used: \u2022 The ID of all transcript variants start with 'NF1' followed by '-'. \u2022 Sequence changes are all described at the RNA level, with 1 = first base of methionine (ATG) at the start. Numbering s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods"", ""abstract""]}",False
12077339,10.1128/MCB.22.14.5100-5113.2002,Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation.,Mol Cell Biol,2002,1503,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1flox/flox"": ""d2dec4d7-24be-4218-b7b5-63349158aa15""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a critical growth regul"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1flox/flox"": {""context"": ""lly expressed in astrocytes by embryonic day 14.5. Successive intercrossing with mice bearing a conditional Nf1 allele (Nf1flox) resulted in GFAP-Cre Nf1flox/flox (Nf1(GFAP)CKO) animals. No astrocytoma formation or neurological impairment was observed in Nf1(GFAP)CKO mice after 20 months, but increased numbers "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1) inherited tumor syndrome develop low-grade gliomas (astrocytomas) at an increased frequency, suggesting that the NF1 gene is a c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1flox/flox"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12082543,10.1038/sj.neo.7900249,Mouse models of neurofibromatosis 1 and 2.,Neoplasia,2002,826,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""matoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatosis 1 (NF1) are prone to the development of astrocytomas and peripheral nerve sheath tumors whereas those affected with neurofibromatosis 2 (NF2) develop schwan"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatoses represent two of the most common inherited tumor predisposition syndromes affecting the nervous system. Individuals with neurofibromatos"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12095621,10.1016/s0014-5793(02)02887-9,Quantification of NF1 transcripts reveals novel highly expressed splice variants.,FEBS Lett,2002,629,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Previously, we have shown that the NF1 gene gives rise to multiple novel splice variants. In the present study, nine NF1 variants were quantified by real-time PCR in various human tissues."", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Previously, we have shown that the NF1 gene gives rise to multiple novel splice variants. In the present study, nine NF1 variants were quantified by rea"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12124168,10.1016/s1535-6108(02)00078-8,Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment.,Cancer Cell,2002,155,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Deletion of both copies of the Nf1 gene in Schwann cells combined with Nf1 heterozygosity in the tumor environment promotes neurofibroma formation in mice."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Deletion of both copies of the Nf1 gene in Schwann cells combined with Nf1 heterozygosity in the tumor environment promotes neurofibroma formation in mice."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12130630,10.1074/jbc.C200125200,Mutant products of the NF2 tumor suppressor gene are degraded by the ubiquitin-proteasome pathway.,J Biol Chem,2002,1162,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2), a syndrome associated with multiple tumors of the nervous system, mostly schwannomas, is caused by mutations in the NF2 tu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12191989,10.1074/jbc.C200434200,The motor protein kinesin-1 links neurofibromin and merlin in a common cellular pathway of neurofibromatosis.,J Biol Chem,2002,988,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations in either of the two tumor suppressor genes NF1 (neurofibromin) and NF2 (merlin) result in Neurofibromatosis, a condition predisposing individuals to developing a variety of benign and malignant tu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Mutations in either of the two tumor suppressor genes NF1 (neurofibromin) and NF2 (merlin) result in Neurofibromatosis, a condition predisposing individuals to developin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12199909,10.1186/1471-5945-2-10,Functional expression of NF1 tumor suppressor protein: association with keratin intermediate filaments during the early development of human epidermis.,BMC Dermatol,2002,1702,9093,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""A68"": ""328fd785-453d-4a09-be93-b7da67d9d33e""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods The expression of NF1 protein was studied in developing human epidermis using western transfer analysis, indirect immunofluorescence, confocal laser scanning microscopy, i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The expression of NF1 protein was studied in developing human epidermis using western transfer analysis, indirect immunofluorescence, confocal laser scanning "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:A68"": {""context"": ""nd \u03b1-tubulin (T-9026) from Sigma Chemical Company, St. Louis, MO; \u03b24 integrin (12088-019, Gibco BRL Life Technologies Inc.); and syndecan-1 (CD138, MCA681H, Serotec, Kidlington, UK). Western transfer analysis Cultured keratinocytes, adult epidermal and fetal skin samples were homogenized in RIPA buffer"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:A68"": [""methods""]}",False
12243339,,Inhibition of ras-mediated activator protein 1 activity and cell growth by merlin.,Mol Cells,2002,918,14946,0,1,3,4,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. Our study examined male and female animals, and similar findings are reported for both sexes. Generation of Nf2-cKO mice. The animals were main"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""mental Table 2 . For lentivirus packaging, the second-generation packaging plasmids (psPAX2 and pMD2.G) and lentivirus vector were cotransfected into HEK293T cells (3101HUMGNHu17, BMCR) using the Lipofectamine 8000 transfection reagent (Beyotime, C0533) following manufacturer\u2019s instructions as described ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s, 1-way or 2-way ANOVA was performed. A  P  value less than 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 9 (GraphPad Software). Study approval. All the animal experiments were approved by the animal committee of Zhejiang Sci-Tech University (201911001). "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" embryo collection. EdU staining was performed based on the BeyoClick EdU-594 (C0078S, Beyotime). The Edu +  osteoprogenitor cells were counted using ImageJ (NIH) for data analysis. EdU +  cells were calculated from 3 samples using ImageJ. Apoptosis assay. The apoptosis was determined by TUNEL labeling as"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
12393498,10.1182/blood-2002-08-2635,Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.,Blood,2003,1008,8797,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""FlowJo"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Animals Protocols were approved by Institutional Animal Care and Use Committee at Augusta University.  Nf1 +/\u2013 mice were obtained from Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA) and backcrossed 13 generations into the C57BL/6\u00a0J stra"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""tivated in juvenile myelomonocytic leukemia (JMML). Other patients with JMML acquire activating RAS gene mutations. Recipient mice reconstituted with Nf1-/- fetal hematopoietic cells develop a myeloproliferative disease (MPD) that models the human disease. JMML arises from clonal expansion of a hematopoie"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and methods Animals Protocols were approved by Institutional Animal Care and Use Committee at Augusta University.  Nf1 +/\u2013 mice were obtained fro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""a area and I/M ratio analysis was assessed by 1-way and 2-way ANOVA with Tukey\u2019s post-hoc test for multiple comparisons. Analysis was performed using GraphPad Prism version 5.0d.  P \u2009<\u20090.05 were considered significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""d laser. At least 100,000 events were collected for samples. Data were collected uncompensated and analyzed using FlowJo software version 8.7.3 (Tree Star). Isolation of bone marrow-derived neutrophils and characterization Murine bone marrow\u2013derived neutrophils were generated from 6- to 8-week-old WT an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""er, 488-nm blue laser, and 633-nm red laser. At least 100,000 events were collected for samples. Data were collected uncompensated and analyzed using FlowJo software version 8.7.3 (Tree Star). Isolation of bone marrow-derived neutrophils and characterization Murine bone marrow\u2013derived neutrophils were gen"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
12469121,10.1038/ng1059,Nf1 has an essential role in endothelial cells.,Nat Genet,2003,1176,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) or von Recklinghausen neurofibromatosis is a genetic disorder that occurs in 1 of 4000 births and is characterized by benign and malignant tumors. C"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) or von Recklinghausen neurofibromatosis is a genetic disorder that occurs in 1 of 4000 births and is characterized by benig"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12471027,10.1074/jbc.M210639200,Isolation and characterization of an aggresome determinant in the NF2 tumor suppressor.,J Biol Chem,2003,1211,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomin (Sch) is the product of the NF2 tumor suppressor gene. The NF2 gene is mutated in patients affected by neurofibromatosis type 2, a syndrome associated with multiple "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12600938,10.1101/gad.1054703,Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.,Genes Dev,2003,1166,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations in the NF1 tumor suppressor underlie the familial tumor predisposition syndrome neurofibromatosis type I. Although its encoded protein, neurofibromin, functions"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Mutations in the NF1 tumor suppressor underlie the familial tumor predisposition syndrome neurofibromatosis type I. Although its encoded protein, neurofibromin, functions as a "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12612091,10.1128/MCB.23.6.2213-2224.2003,Brain lipid binding protein in axon-Schwann cell interactions and peripheral nerve tumorigenesis.,Mol Cell Biol,2003,1423,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {""Nf1:p53"": ""8500990a-8848-413c-9c5b-7697d697fa2e""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Loss of axonal contact characterizes Schwann cells in benign and malignant peripheral nerve sheath tumors (MPNST) from neurofibromatosis type 1 (NF1) patients. Tumor Schwann cells demonstrate NF1 mutations, elevated Ras activity, and aberrant epidermal growth factor receptor (EGFR) expression. Usi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:XF"": {""context"": ""roarrays, we found that brain lipid binding protein (BLBP) is elevated in an EGFR-positive subpopulation of Nf1 mutant mouse Schwann cells (Nf1(-/-) TXF) that grows away from axons; BLBP expression was not affected by farnesyltransferase inhibitor, an inhibitor of H-Ras. BLBP was also detected in EGFR"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1:p53"": {""context"": "" expression was not affected by farnesyltransferase inhibitor, an inhibitor of H-Ras. BLBP was also detected in EGFR-positive cell lines derived from Nf1:p53 double mutant mice and human MPNST. BLBP expression was induced in normal Schwann cells following transfection with EGFR but not H-Ras12V. Furthermor"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Loss of axonal contact characterizes Schwann cells in benign and malignant peripheral nerve sheath tumors (MPNST) from neurofibromatosis type 1 (NF1) patients. Tumor Schwann cel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:XF"": [""abstract""], ""animal_models:Nf1:p53"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12673723,10.1002/cncr.11275,Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.,Cancer,2003,1892,10380,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""limma"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell lines, cell culture, and transfection The LNCaP, VCaP, C4-2, DU145, PC-3, 22Rv1, and 293\u2009T cell lines were purchased from the Ce"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ated Hospital of Zhengzhou University, Zhengzhou, China (2023-KY-0636-001). Statistical analysis All data were analyzed using the following software: GraphPad Prism 8.0 (GraphPad, San Diego, CA, USA), R-4.3.1 (R Core Team,  https://www.r-project.org/ ), and SPSS v. 25.0 (IBM, Chicago, IL, USA). We employed a  t  "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""n, Shanghai, China). The gene transcripts of interest were quantitated using the QuantStudio Three Real-Time PCR System (Thermo Fisher) using the NovoStart\u00ae SYBR qPCR SuperMix Plus (Novoprotein), with ACTB as an internal control. The primer sequence used during our quantitative real-time polymerase chai"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": "" ) dataset [ 36 ]. Based on these datasets, we analyzed differentially expressed genes of prostate cancer tissue and normal prostate tissue using the limma R package. As a supplement, The University of Alabama at Birmingham CANcer data analysis Portal [ 37 ] (UALCAN;  https://ualcan.path.uab.edu/index.ht"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""re analyzed using the following software: GraphPad Prism 8.0 (GraphPad, San Diego, CA, USA), R-4.3.1 (R Core Team,  https://www.r-project.org/ ), and SPSS v. 25.0 (IBM, Chicago, IL, USA). We employed a  t  test or ANOVA to assess statistical significance unless stated otherwise. Each experiment was cond"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
12679023,10.1016/s0969-2126(03)00052-2,PDZ tandem of human syntenin: crystal structure and functional properties.,Structure,2003,814,20694,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Computational Design of New Probes The crystal structure coordinates of MDA-9/Syntenin were extracted from the Protein Databank "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": "", URD001, NGI03, and NVS125. The energy calculations were performed with the default parameter settings (igb = 5 and saltcon = 0.1), by employing the Python version of the MMGBSA module from AmberTools18. The protocol presented in the amber-MMGBSA tutorial was followed for each calculation (refer to:  htt"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Python"": [""methods""]}",False
12695331,10.1101/gad.1054603,NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.,Genes Dev,2003,1029,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutation of the Neurofibromatosis 2 (NF2) tumor suppressor gene leads to cancer development in humans and mice. Recent studies suggest that Nf2 loss also contributes to t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12730209,10.1074/jbc.M209413200,Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.,J Biol Chem,2003,1387,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin, the neurofibromatosis type 1 (NF1) gene product, contains a central domain homologous to a family of proteins known as Ras-GTPase-activating proteins (Ras-GAPs), which function as neg"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin, the neurofibromatosis type 1 (NF1) gene product, contains a central domain homologous to a family of proteins known as Ras-GTPase-activatin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12896975,10.1074/jbc.M306149200,Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A.,J Biol Chem,2003,1485,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The cAMP-protein kinase A (PKA) pathway, important in neuronal signaling, is regulated by molecules that bind and target PKA regulatory subunits. Of four regulat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
12904481,10.1523/JNEUROSCI.23-18-07207.2003,Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants.,J Neurosci,2003,1543,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c"", ""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to learning disabilities, macrocephaly, and brain tumors as well as abnormalities on magnetic resonance imaging that are po"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""y, and brain tumors as well as abnormalities on magnetic resonance imaging that are postulated to result from abnormal myelination. Here we show that Nf1+/- spinal cords in adult mice have more than twofold-increased numbers of NG2+ progenitor cells. Nf1-/- embryonic spinal cords have increased numbers of"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""ult from abnormal myelination. Here we show that Nf1+/- spinal cords in adult mice have more than twofold-increased numbers of NG2+ progenitor cells. Nf1-/- embryonic spinal cords have increased numbers of Olig2+ progenitors. Also, cultures from Nf1 mutant embryos with hemizygous and biallelic Nf1 mutatio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to learning disabilities, macrocephaly, and brain tumors as well as abnormalities on magnetic reso"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
12946024,10.1111/j.1750-3639.2003.tb00034.x,Pathological adhesion of primary human schwannoma cells is dependent on altered expression of integrins.,Brain Pathol,2003,1114,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations in the tumor suppressor gene coding for merlin cause Neurofibromatosis type 2 (NF2), all spontaneous schwannomas, and a majority of meningiomas. Merlin links tran"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1358802,10.1016/s0888-7543(05)80228-9,The gene for a novel epidermal antigen maps near the neurofibromatosis 1 gene.,Genomics,1992,986,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""role in cell adhesion, was mapped to chromosome bands 17q11-q12, placing it in the vicinity of the gene for the genetic disorder neurofibromatosis 1 (NF1). The pleomorphic cutaneous lesions of NF1 and the precedent for other genes being embedded within the NF1 gene prompted us to investigate whether th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Recently the M17S1 gene, encoding an epidermal antigen thought to play a role in cell adhesion, was mapped to chromosome bands 17q11-q12, placing it in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
1362901,10.1091/mbc.3.12.1437,The role of Gln61 and Glu63 of Ras GTPases in their activation by NF1 and Ras GAP.,Mol Biol Cell,1992,1523,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Two distinct GAPs of 120 and 235 kDa called GAP1 and NF1 serve as attenuators of Ras, a member of GTP-dependent signal transducers, by stimulating its intrinsic guanosine triphosphatase (GTPase) activity. T"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Two distinct GAPs of 120 and 235 kDa called GAP1 and NF1 serve as attenuators of Ras, a member of GTP-dependent signal transducers, by stimulating its intrinsic guanosine triphosphatase (GTPase) activity. The G"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
1376554,,Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.,Am J Pathol,1992,799,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""A large number of eukaryotic proteins have been shown to be anchored to the cell membrane by glycosylphosphatidylinositol (GPI). This glycolipid anchor can"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1376775,10.1523/JNEUROSCI.12-06-02177.1992,SAG: a Schwann cell membrane glycoprotein.,J Neurosci,1992,838,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We report on characterization of a 170,000 Da glycoprotein found exclusively in the PNS. We refer to this protein as the Schwann cell membrane glycoprotei"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1427886,10.1016/s0888-7543(05)80154-5,A radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 locus.,Genomics,1992,1162,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We describe a high-resolution radiation hybrid map of the region on human chromosome 22 containing the neurofibromatosis type 2 (NF2) gene. Eighty-five hamste"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
14523097,10.1523/JNEUROSCI.23-26-08949.2003,The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.,J Neurosci,2003,1557,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1)-inherited tumor predisposition syndrome develop low-grade astrocytomas. The NF1 tumor suppressor gene product neurofibromin exhibits GTPase-activati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""neration in response to PACAP and attenuated calcium influx and Rap1 activation. Based on the differential effects of forskolin and dibutyryl-cAMP on Nf1-/- astrocytes, neurofibromin likely functions at the level of adenylyl cyclase activation. Last, the reintroduction of a fragment of neurofibromin conta"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with the neurofibromatosis 1 (NF1)-inherited tumor predisposition syndrome develop low-grade astrocytomas. The NF1 tumor suppressor gene product neurofibromin exhi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
14580336,10.1016/s1097-2765(03)00382-4,"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1.",Mol Cell,2003,795,26186,0,0,10,10,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""TopHat"", ""monocle"", ""STAR"", ""Seurat"", ""clusterProfiler"", ""HTSeq"", ""Monocle3"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. For experiments involving human pancreatic tissues, the sex of organ donors is reported in  Supplemental Table 1  and was not considered as a b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""encing analysis using the Illumina HiSeq 3000 or NovaSeq 6000 System. Raw sequencing data were aligned to the reference genome GRCh38 or GRCm38 using TopHat 2.1.1. Gene expression reads were quantified using HTSeq 0.11.1. For tumor tissue samples, in order to separate human and mouse transcripts, the raw "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""scores of a list of gene signatures were calculated using the \u201cAddModuleScore\u201d command in Seurat. Single-cell trajectory analysis was performed using Monocle3 v.1.3.4 in R software with the default setting. The Seurat object containing all organoid cells were passed into Monocle3 to infer their cell-type t"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""PTN cells were cultured in CM for 4 days to allow organoid formation. On day 4, the organoids were exposed to low-nutrient medium for 1 day to induce starvation responses. A control group was maintained in fresh complete nutrient medium. Half of the medium (~200 \u03bcL) from each well was collected, and FIT"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""le with the sample preparation protocol. The reference genomes GRCh38 and GRCm38 were used for alignment. The subsequent analysis was performed using Seurat v.5.0.1 in R software. A quality control step was performed to remove low-quality cells, including possible cell debris (nFeature <200), cell doublet"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""core of the transformed/normalized read count as indicated in each figure. Overrepresentation analysis for the lists of genes was performed using the clusterProfiler 4.4.4 package in R with default settings. A significant enrichment was considered with a multiple test\u2013adjusted  P  value of less than 0.05. scRNA-Se"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:HTSeq"": {""context"": ""000 System. Raw sequencing data were aligned to the reference genome GRCh38 or GRCm38 using TopHat 2.1.1. Gene expression reads were quantified using HTSeq 0.11.1. For tumor tissue samples, in order to separate human and mouse transcripts, the raw reads were aligned to a concatenated human and mouse geno"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Monocle3"": {""context"": ""scores of a list of gene signatures were calculated using the \u201cAddModuleScore\u201d command in Seurat. Single-cell trajectory analysis was performed using Monocle3 v.1.3.4 in R software with the default setting. The Seurat object containing all organoid cells were passed into Monocle3 to infer their cell-type tr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""gned to both the human and mouse genome ( 56 ). Differential expression analysis of the read counts from aligned RNA-Seq data was performed using the DESeq2 1.36.0 package in R software. A prefiltering process was applied for each analysis to remove genes with a low read count, i.e., we only retained gene"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" were captured using a Leica DMI6000 B microscope and compatible software (Leica Microsystems). Fluorescence signal intensities were quantified using ImageJ v1.5g software (NIH). The following primary and secondary antibodies were used: mouse anti\u2013human STEM121 (Takara Bio, Y40410, dilution 1:200); mouse "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:HTSeq"": [""methods""], ""computational_tools:Monocle3"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
14627667,10.1136/jmg.40.11.802,Identification of recurrent regions of chromosome loss and gain in vestibular schwannomas using comparative genomic hybridisation.,J Med Genet,2003,1538,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Schwannomas are benign tumours of the nervous system that are usually sporadic but also occur in the inherited disorder neurofibromatosis type 2"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
14679174,10.1172/JCI20503,It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.,J Clin Invest,2003,636,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""their role in tumor pathogenesis has been enigmatic. In an elegant set of experiments using cells derived from a murine model of neurofibromatosis 1 (NF1), Yang et al. dissect the molecular pathways involved in mast cell migration to neurofibromin-deficient Schwann cells. These results set the stage fo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromas are benign tumors comprised primarily of Schwann cells and fibroblasts. Mast cell infiltration is a well-known phenomenon; however, their ro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
14679180,10.1172/JCI19195,Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.,J Clin Invest,2003,1341,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c"", ""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The NF1 tumor suppressor gene encodes a GTPase-activating protein called neurofibromin that negatively regulates Ras signaling. Mutations in NF1 cause neurof"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""fibroma formation. Neurofibromas occur with high penetrance in mice in which Nf1 is ablated in Schwann cells in the context of a heterozygous mutant (Nf1+/-) microenvironment. Mast cells infiltrate neurofibromas, where they secrete proteins that can remodel the ECM and initiate angiogenesis. Thus, identif"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""tumor microenvironments is important for understanding tumorigenesis and for designing potential therapies. Here, we show that homozygous Nf1 mutant (Nf1-/-) Schwann cells secrete Kit ligand (KitL), which stimulates mast cell migration, and that Nf1+/- mast cells are hypermotile in response to KitL. Furth"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The NF1 tumor suppressor gene encodes a GTPase-activating protein called neurofibromin that negatively regulates Ras signaling. Mutations in NF1 cause neurofibroma"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
14679203,10.1074/jbc.M305526200,Merlin neutralizes the inhibitory effect of Mdm2 on p53.,J Biol Chem,2004,1151,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The stability of p53 tumor suppressor is regulated by Mdm2 via the ubiquitination and proteasome-mediated proteolysis pathway. The c-Abl and PTEN tumor suppressors are known to"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""el activity. This study also showed that overexpression of merlin-induced apoptosis of cells depending preferentially on p53 in response to the serum starvation or a chemotherapeutic agent. These results suggest that merlin could be a positive regulator of p53 in terms of tumor suppressor activity, and "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
14741381,10.1016/s0014-5793(03)01507-2,"PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin.",FEBS Lett,2004,0,17383,0,3,4,7,"{""animal_models"": {}, ""antibodies"": {""Neurofibromin antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b""}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""GATK"", ""BWA"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Cell lines : ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace . To create an isogenic  28 NF1  null cell line, we utilized CRISPR Cas9 targeting of  NF1 exon 2  to create inactivating indels in  46 NF1  on both alleles  (Supplemental Fig.\u00a01 ) "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""cDNA (WT) and variant tagged m Nf1  (G848R, R1276Q, R1809C, and delM992) in  NF1 null ipn97.4 human Schwann cells. Using previously generated data in HEK293 cells, we used empty vector (EV) controls to filter out non-specific PPIs . All lists from each individual pull down were compiled ( 29 Supplemental "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Neurofibromin antibody"": {""context"": "" 2\u00a0h. The gels were transferred onto a polyvinylidene difluoride (PVDF) membrane at 85\u00a0V for 2\u00a0h. Blots were probed overnight at 4\u00a0\u00b0C with either the neurofibromin antibody (Cell Signaling Technologies Cat. #: 14623\u00a0S; Danvers, MA, USA), or one of the selected antibodies for validation (details in  Supplemental Table 22 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied to get more accurate base quality scores, which will in turn impro"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""s ToolKit (version 4.6.0) following their Best Practices Guidelines . In brief, BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""mmed sequence reads were further analyzed using Broad\u2019s Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines . In brief, BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Pic"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell lines : ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace . To create an isogenic  28 NF1  null cell lin"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""antibodies:Neurofibromin antibody"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:R"": [""methods""]}",False
1496981,,Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors.,Am J Hum Genet,1992,1679,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 (NF2) gene has been hypothesized to be a recessive tumor suppressor, with mutations at the same locus on chromosome 22 that lead "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
14988005,10.1016/S0014-5793(04)00078-X,Neurofibromin is actively transported to the nucleus.,FEBS Lett,2004,760,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations in the neurofibromatosis type 1 (NF1) tumor suppressor gene predispose individuals to a variety of benign and malignant tumors. Many tumor suppressors 'shuttle' between the nucleus and t"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Mutations in the neurofibromatosis type 1 (NF1) tumor suppressor gene predispose individuals to a variety of benign and malignant tumors. Many tumor suppressors 'shuttle' "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
14991710,10.1002/dvdy.20002,Characterization of chicken Nf2/merlin indicates regulatory roles in cell proliferation and migration.,Dev Dyn,2004,1618,19658,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""FlowJo"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Ethics statement All procedures executed in chickens were approved by the Institutional Animal Care and Use Committee (IACUC) of Jili"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""as mean \u00b1 SEM and bars with superscript symbols that indicate the significant difference compared with control groups at **  P  < 0.01, *  P  < 0.05. GraphPad Prism version 8 (GraphPad Prism, CA, USA) was applied to form statistical graphs based on the results. Appendix Supplementary materials \n \n Supplementary I"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""GCCATAGTCA 281 MYC KU981087.1 F: ATCAGCAACAACCGAAAATG R: GTCACGCAGGGCAAAGAAAC 132 GDF9 AY566700.2 F: CTATTGCTGCATTCACTGGC R: CCTTGGTGGCGTACATCTTA 269 STAR NM_204686.2 F: GTCCCTCGCAGACCAAGT R: TCCCTACTGTTAGCCCTGA 196 CYP11A1 NM_001001756.1 F: GTGGACACGACTTCCATGACT R: GAGAGTCTCCTTGATGGCGG 174 BCL-2 NM_205"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ic cells comprises the number of cells in the right upper quadrant (Q1-UR) and number of cells in the right lower quadrant (Q1-LR) and analyzed using FlowJo v7.6 software (Stanford University, Stanford, CA, USA). Each experiment was carried out at least three times. ROS detection Reactive Oxygen Species A"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""CTAGTCAGCTGAAGACTTTAAT-3\u2032, which was synthesized by Genepharma (Shanghai, China). Statistical analysis Statistical analysis was carried out using the SPSS12.0 software package. The data were collected and analyzed with a one-way ANOVA followed by Tukey\u2019s multiple-comparison test when more than two group"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
15039234,10.1016/S0002-9440(10)63233-6,Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.,Am J Pathol,2004,1393,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nic p21(ras) decreases surface Fas antigen expression and renders fibroblasts resistant to Fas mediated apoptosis. Neurofibromin, which is encoded by NF1, is a GTPase activating protein that negatively regulates p21(ras) activity. NF1 loss leads to deregulation of p21(ras)-effector pathways, which cont"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Genetic loss of surface Fas antigen expression leads to reduced apoptosis of myeloid and lymphoid progenitor cells, and a propensity to develop autoimmunity and myeloid "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15123692,10.1074/jbc.M312083200,"Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity.",J Biol Chem,2004,1452,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 gene-encoded protein, merlin, is related to the ERM (ezrin, radixin, and moesin) family of membrane-cytoskeleton-associated prote"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1519665,,Nonradioactive in situ hybridization using digoxigenin-labeled oligonucleotides. Applications to musculoskeletal tissues.,Am J Pathol,1992,1257,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We have optimized a technique for in situ localization of specific mRNAs using digoxigenin-11-dUTP-labeled oligonucleotide probes. DNA probes were synthesized for type I and type II c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
15206577,10.2131/jts.29.91,Gene expression analysis of the lung following paraquat administration in rats using DNA microarray.,J Toxicol Sci,2004,1551,9416,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Ethics Statement The ethical approval for this study was obtained from the Animal Ethics Committee, Universiti Sains Malaysia (U"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""The TyrH-positive neurons were identified by dense cytoplasmic immunolabeling. 2.6. Statistical Analysis Statistical analysis was performed using IBM SPSS software version 22.0 (Armonk, NY, USA). Data that were normally distributed are presented as the mean (standard deviation). The differences among th"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""s and water ad libitum unless otherwise stated. All rats were acclimatized to the animal room conditions for at least one week before the experiments started. 2.2. Tualang Honey The Tualang honey (AgroMas\u00ae) used in this study was supplied by the Federal Agricultural Marketing Authority (FAMA), Kedah, Ma"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,J Biomed Biotechnol,2004,910,11426,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Animals Mice with severe combined immunodeficiency (SCID) were\nused as recipients of human neurofibroma\nxenotransplants.  SCID mice h"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",Mol Cancer,2004,1718,7120,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Patients and Samples Samples of 14 plexiform neurofibromas and 9 MPNSTs were obtained by surgical excision from patients with NF1 at Henri Mondor hospital (Creteil, France). The plexiform neurofibromas (deep lesions involving a plexus of nerves) were large, had a nodular aspect,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Patients and Samples Samples of 14 plexiform neurofibromas and 9 MPNSTs were obtained by surgical excision from patients with NF1 at Henri Mondor hospital (Creteil, France). The plexiform neuro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" amplification of the PCR product is first detected, rather than the amount of PCR product accumulated after a fixed number of cycles. The larger the starting quantity of the target molecule, the earlier a significant increase in fluorescence is observed. The parameter C t  (threshold cycle) is defined "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
15446585,10.1111/j.1750-3639.2004.tb00067.x,Gene expression profiling reveals unique molecular subtypes of Neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors.,Brain Pathol,2004,1582,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nt peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) and respond poorly to current therapeutic regimens. To better understand the molecular heterogeneity of these tumors, we performed gene expression p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive Schwann cell neoplasms that are frequently associated with Type I Neurofibromatosis (NF1) a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15570216,,Targeted gene expression in the chicken eye by in ovo electroporation.,Mol Vis,2004,2411,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""PURPOSE: The chicken embryo lens is a classical model system for developmental and cell biology studies. To understand the molecular mechanisms that unde"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
15598747,10.1073/pnas.0405971102,Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.,Proc Natl Acad Sci U S A,2004,860,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis 2 (NF2) is a tumor suppressor, although the molecular mechanism accounting for this effect remains unknown. Here, we show that merlin ex"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
15623944,10.1155/2004/406591,DNA ploidy and chromosome (FISH) pattern analysis of peripheral nerve sheath tumors.,Cell Oncol,2004,1766,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND AND METHODS: 44 peripheral nerve sheath tumors (PNST) (27 schwannomas, 9 neurofibromas and 8 malignant peripheral nerve sheath tumors (MPNST)) we"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
15647118,10.1186/1477-7525-3-3,Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.,Health Qual Life Outcomes,2005,0,43239,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" manuals, coding algorithms and scoring systems, as well as background information about the conceptual and measurement properties of the instrument. NF1-CTD: A case study Recently there has been interest in using measures of FHS and HRQL to evaluate treatment alternatives for NF1-CTD. NF1 is one of th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: a framework for orthopedic applications This section identifies specific study design and measurement instrument factors that should be considered in sele"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
15652750,10.1016/j.ccr.2004.10.016,Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.,Cancer Cell,2005,859,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""of neurofibromatosis type 1. The epidermal growth factor receptor is not expressed by normal Schwann cells, yet is overexpressed in subpopulations of Nf1 mutant Schwann cells. We evaluated the role of EGFR in Schwann cell tumorigenesis. Expression of EGFR in transgenic mouse Schwann cells elicited feat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Benign neurofibromas and malignant peripheral nerve sheath tumors are serious complications of neurofibromatosis type 1. The epidermal growth factor receptor is "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15659388,10.1074/jbc.M414154200,Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.,J Biol Chem,2005,1444,11280,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Mouse Procedures and Genotyping All mouse experiments were performed in compliance with national and institutional animal welfar"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""mined by averaging all events recorded from each NMJ [ 43 ]. 2.6. Statistical Analysis Statistical analyses and graph generation were performed using GraphPad Prism 10 (GraphPad Software, San Diego, USA). Outliers were identified by Prism and excluded from the dataset and corresponding graphs. Unless otherwise sp"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""mbined with 11 mg para-hydroxy-cumarinic acid (Sigma Aldrich) in 10 mL DMSO. Western blot results were quantified by densitometric analysis using the Fiji image processing package [ 42 ]. X-ray films were scanned with an Epson Expression 1600 Pro Scanner (Epson Deutschland GmbH, D\u00fcsseldorf, Germany) at "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
15681480,10.1016/S1525-1578(10)60014-1,Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.,J Mol Diagn,2005,1763,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutation detection in the neurofibromatosis type 2 (NF2) gene is challenging because when combining mutation detection methods such as single-strand conformational polymorphism and"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
15767669,10.1128/MCB.25.7.2632-2643.2005,TATA-binding protein (TBP)-like factor (TLF) is a functional regulator of transcription: reciprocal regulation of the neurofibromatosis type 1 and c-fos genes by TLF/TRF2 and TBP.,Mol Cell Biol,2005,1026,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ere we report that human TLF (also called TBP-related factor 2 [TRF2]) activates a number of different genes, including the neurofibromatosis type 1 (NF1) gene. The overexpression of TLF increases the amount of NF1 mRNA in cells. In vivo, TLF binds to and upregulates transcription from a fragment of th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The lack of direct targets for TATA-binding protein (TBP)-like factors (TLFs) confounds the understanding of their role in gene expression. Here we report that human"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15832546,10.1017/s0012162205000460,Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.,Dev Med Child Neurol,2005,1582,10424,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""Python"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The objective of this study was to explore the behaviour, including sleep patterns, of children with neurofibromatosis type 1 (NF1). For this purpose we designed a cross-sectional descriptive survey conducted by postal enquiry with telephone follow-up. Simonds and Parraga's sleep"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cells used in this study were previously describ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cells used"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cell"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""yence, Neu-Isenburg, Germany). Data analysis, statistics, and bioinformatic database analysis NGS data analysis and heat map creation were done using GraphPad Prism software (GraphPad Software, Boston, USA) version 9.5.0. Tests for the presence of a circadian rhythm were performed by Cosinor analysis based on est"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ere incubated for another 24\u00a0h. Then, a serum shock was induced with 10% FBS-containing medium. After that the cells were lysed at six-hour intervals starting at zero and ending at 48\u00a0h ( Figure 1 ). For sample collection, cells were washed two times with 1\u2009mL of 4\u00b0C cold Phosphate Buffered Saline (PBS,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""reely available online tool ( 44 https://cosinor.online/app/cosinor.php ). In addition, numerical and graphical analysis was done using the CosinorPy Python package.  To determine the most suitable period length, a \u201cgrid-search\u201d approach is employed, where the parameter T is systematically varied between "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
15849434,10.1271/bbb.69.861,Identification of Rab GTPase-activating protein-like protein (RabGAPLP) as a novel Alix/AIP1-interacting protein.,Biosci Biotechnol Biochem,2005,926,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Alix/AIP1 is a multifunctional adaptor protein involved in endocytosis, cell adhesion, and cell death. By yeast two-hybrid screening we identified a novel Alix/AIP1-interacting protein nam"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1587809,,Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue.,J Biol Chem,1992,651,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""A small catalytic domain from the neurofibromatosis type 1 gene, NF1-333, consisting of 333 amino acids between residues 1197 and 1528, including an additional N-terminal methionine, was expressed in Escherichia coli a"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A small catalytic domain from the neurofibromatosis type 1 gene, NF1-333, consisting of 333 amino acids between residues 1197 and 1528, including an additional N-terminal methio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15937108,10.1073/pnas.0503224102,The NF1 tumor suppressor critically regulates TSC2 and mTOR.,Proc Natl Acad Sci U S A,2005,1547,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Loss-of-function mutations in the NF1 tumor suppressor gene underlie the familial cancer syndrome neurofibromatosis type I (NF1). The NF1-encoded protein, neurofibromin, functions as a Ra"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Loss-of-function mutations in the NF1 tumor suppressor gene underlie the familial cancer syndrome neurofibromatosis type I (NF1). The NF1-encoded protein, neurofibromin, functions as a Ras-GTPa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
15988004,10.1128/MCB.25.14.5869-5879.2005,Transcriptional repression of the Neurofibromatosis-1 tumor suppressor by the t(8;21) fusion protein.,Mol Cell Biol,2005,1256,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Von Recklinghausen's disease is a relatively common familial genetic disorder characterized by inactivating mutations of the Neurofibromatosis-1 (NF1) gene that predisposes these patients to malignancies, including an increased risk for juvenile myelomonocytic leukemia. However, NF1 mutations are n"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Von Recklinghausen's disease is a relatively common familial genetic disorder characterized by inactivating mutations of the Neurofibromatosis-1 (NF1) gene"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16033085,,Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.,Anticancer Res,2005,2790,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""UNLABELLED: Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve sheath tumors (MPNST), usually arising from PNF, and this is the major cause of p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""UNLABELLED: Plexiform neurofibroma (PNF) is a typical feature of neurofibromatosis 1 (NF1). About 10% of patients with NF1 develop malignant peripheral nerve sheath tumor"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16036108,10.1593/neo.04637,Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.,Neoplasia,2005,1554,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neuroectodermal tumor cells, like neural crest (NC) cells, are pluripotent, proliferative, and migratory. We tested the hypothesis that genetic programs e"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
1605307,,Adrenal medullary tumors and iris proliferation in a transgenic mouse model of neurofibromatosis.,Am J Pathol,1992,1218,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The expression of the human T-cell lymphotropic virus type 1 (HTLV-1) tax gene in transgenic mice has been shown to result in the development of neurofibromas"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16061561,10.1136/jmg.2004.027953,Age related shift in the mutation spectra of germline and somatic NF2 mutations: hypothetical role of DNA repair mechanisms.,J Med Genet,2005,1476,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""It has been suggested that somatic mutations that accumulate due to an age related decline in the efficiency of DNA repair mechanisms might contribute to the increased incidence of cancer in older people. However, there is lit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16082189,10.4161/cbt.4.9.1911,Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistance.,Cancer Biol Ther,2005,1158,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""PAK1, a Rac/CDC42-dependent Ser/Thr kinase, is required for both neurofibromatosis (NF) and RAS transformation in vivo. FK228, a histone deacetylase (HDAC) inh"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16093333,10.1152/jn.00489.2005,Sensory neurons from Nf1 haploinsufficient mice exhibit increased excitability.,J Neurophysiol,2005,1681,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by tumor formation. People with NF1 also can experience more intense painful responses to stimuli, such a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""excitability of capsaicin-sensitive sensory neurons isolated from the dorsal root ganglia of adult mice with a heterozygous mutation of the Nf1 gene (Nf1+/-), analogous to the human mutation, in comparison to wildtype sensory neurons. Sensory neurons from adult Nf1+/- mice generated a more than twofold hi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder characterized by tumor formation. People with NF1 also can experience more intense painful res"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16098465,10.1016/j.ccr.2005.07.004,Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma.,Cancer Cell,2005,852,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""arbors mutations that inactivate p53 and activate Ras signaling. We have generated mouse strains that lack p53 and harbor a conditional allele of the NF1 tumor suppressor that negatively regulates Ras signaling. The mice develop malignant astrocytomas with complete penetrance. The majority of tumors di"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant astrocytoma, the most prevalent primary brain tumor, is resistant to all known therapies and frequently harbors mutations that inactivate p53 and activate"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16116616,10.1002/humu.20228,Palindromic AT-rich repeat in the NF1 gene is hypervariable in humans and evolutionarily conserved in primates.,Hum Mutat,2005,1752,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""oli strain, and RNA polymerases in sequencing. Using these methods, we analyzed a palindromic AT-rich repeat (PATRR) in the neurofibromatosis type 1 (NF1) gene on chromosome 17 (17PATRR). The 17PATRR manifests a size polymorphism due to a highly variable length of (AT)(n) dinucleotide repeats within th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Palindromic sequences are dispersed in the human genome and may cause chromosomal translocations in humans. They constitute unsequenced gaps in the human gen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16169856,10.1074/jbc.M503707200,The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway.,J Biol Chem,2005,1605,8074,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""pheatmap"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin is a neurofibromatosis type 1 (NF1) tumor suppressor gene product with a domain that acts as a GTPase-activating protein and functions, in part, as a negative regulator of Ras. Loss of"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Eight AD brain tissues datasets and three blood datasets were obtained. Consensus clustering was utilized as a method to discern the various subtypes of AD. Then"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""lgorithms using a reference set [ 28 , 29 ]. The results of the immune cell infiltration were visualized using the R language packages \u2018ggplots\u2019 and \u2018pheatmap\u2019. 2.7 eQTL datasets Blood eQTL comprises a comprehensive collection of data reflecting the cis-eQTLs for a total of 16,987 genes. This dataset was ge"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:pheatmap"": [""methods""]}",False
16226702,10.1016/j.ccr.2005.09.015,A mouse model for studying therapy-induced cancers.,Cancer Cell,2005,682,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""uced second malignant neoplasms (SMNs) have become a major concern. In this issue of Cancer Cell, Chao et al. report that mice carrying a mutation in Nf1, the gene responsible for neurofibromatosis type 1, treated with radiation and/or cyclophosphamide, developed tumors similar to human SMNs at a signi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""As more pediatric cancer patients survive for longer periods following treatment with cytotoxic agents, therapy-induced second malignant neoplasms (SMNs) ha"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16226708,10.1016/j.ccr.2005.08.011,Therapy-induced malignant neoplasms in Nf1 mutant mice.,Cancer Cell,2005,0,2741,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" promotes neoplastic progression of PNs and reduces overall survival, we administered spinal irradiation (SI) to conditional knockout mouse models of NF1-associated PNs in 2 germline contexts:  Nf1 fllfl ; PostnCre  and  + Nf1 fl/- ; PostnCre . Both genotypes develop extensive  + Nf1  null spinal PNs, "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods To test whether radiotherapy promotes neoplastic progression of PNs and reduces overall survival, we administered spinal irradiation (SI) to conditional knockout mou"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
16267393,,The Phosphorylation status of merlin is important for regulating the Ras-ERK pathway.,Mol Cells,2005,1323,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type2 (NF2) tumor suppressor gene product, merlin, is structurally related to the ezrin-radixin-moesin (ERM) family of proteins that anc"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16314489,10.1242/dev.02162,Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.,Development,2005,1259,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The gene responsible for neurofibromatosis type 1 (NF1) encodes a tumor suppressor that functions as a negative regulator of the Ras proto-oncogene. Individuals with germline mutations in NF1 are predispo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The gene responsible for neurofibromatosis type 1 (NF1) encodes a tumor suppressor that functions as a negative regulator of the Ras proto-oncogene. Individuals"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16324214,10.1186/1471-2148-5-69,"Evolution and origin of merlin, the product of the Neurofibromatosis type 2 (NF2) tumor-suppressor gene.",BMC Evol Biol,2005,2736,1738,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods BLAST search Initial sequences of genes and proteins of interest from various organisms were identified from the National Center for Biotechnology Information ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
16340004,10.1093/nar/gni189,New approaches to the analysis of palindromic sequences from the human genome: evolution and polymorphism of an intronic site at the NF1 locus.,Nucleic Acids Res,2005,1162,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""n cloning and propagation in Saccharomyces cerevisiae. With this approach we have investigated an intronic sequence in the human Neurofibromatosis 1 (NF1) locus that is represented by multiple conflicting versions in GenBank. We find that the site is highly polymorphic, exhibiting different degrees of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The nature of any long palindrome that might exist in the human genome is obscured by the instability of such sequences once cloned in Escherichia coli. We des"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16374483,10.1038/sj.jid.5700087,Neurofibromatosis type 1 protein and amyloid precursor protein interact in normal human melanocytes and colocalize with melanosomes.,J Invest Dermatol,2006,1272,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The neurofibromatosis type 1 (NF1) gene product, neurofibromin, is known to interact with Ras, thereby negatively regulating its growth-promoting function. Although this is a well-est"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatosis type 1 (NF1) gene product, neurofibromin, is known to interact with Ras, thereby negatively regulating its growth-promoting function. Al"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
1639394,10.1016/0888-7543(92)90140-n,A yeast artificial chromosome contig encompassing the type 1 neurofibromatosis gene.,Genomics,1992,765,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ct cloning of large regions of the genome. A YAC contig map of approximately 700 kb encompassing the region surrounding the type 1 neurofibromatosis (NF1) locus on 17q11.2 has been constructed. A single YAC containing the entire NF1 locus has been constructed by homologous recombination in yeast. In th"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The yeast artificial chromosome (YAC) system (Burke et al., 1987, Science 236: 806-812) allows the direct cloning of large regions of the genome. A YAC contig map"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16397625,10.1038/sj.embor.7400602,A novel bipartite phospholipid-binding module in the neurofibromatosis type 1 protein.,EMBO Rep,2006,912,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumour predisposition syndrome associated with numerous clinical complications. Mutations in the tumour suppressor gene NF1 are responsi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumour predisposition syndrome associated with numerous clinical complications. Mutations in the tumour suppres"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16418572,10.4161/cbt.5.3.2404,Sichuan pepper extracts block the PAK1/cyclin D1 pathway and the growth of NF1-deficient cancer xenograft in mice.,Cancer Biol Ther,2006,1585,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""KT activation at the concentrations that block either cancer growth or PAK1 activation. The Chinese pepper extract selectively inhibits the growth of NF1-deficient malignant peripheral nerve sheath tumor (MPNST) cells, without affecting the growth of normal fibroblasts, and suppresses the growth of NF1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""There is increasing evidence that more than 70% of cancers including pancreatic, breast and prostate cancers as well as neurofibromatosis (NF) are highly "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16513807,10.1093/hmg/ddl023,Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.,Hum Mol Genet,2006,1269,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""adenylyl cyclase (AC) pathway in the Drosophila brain, which is disrupted by mutations in the epidermal growth factor receptor (EGFR), neurofibromin (NF1) and Ras, but not Galpha(s). This is the first demonstration in a metazoan that a receptor tyrosine kinase (RTK) pathway, acting independently of the"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NFI) is a common genetic disorder that causes nervous system tumors, and learning and memory defects in humans, and animal model"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,BMC Neurosci,2006,1869,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: It has been estimated that more than 50% of patients with Neurofibromatosis type 1 (NF1) have neurobehavioral impairments which include attention deficit/hyperactivity disorder, visual/spatial learning disabilities, and a myriad of other"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""involved in the pathogenic process, gene expression analysis was performed comparing the expression profiles in various brain regions for control and Nf1+/- heterozygous mice. Gene expression analysis was performed for hippocampal samples dissected from postnatal day 10, 15, and 20 mice utilizing the Affy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: It has been estimated that more than 50% of patients with Neurofibromatosis type 1 (NF1) have neurobehavioral impairments which include attentio"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16537381,10.1073/pnas.0510651103,Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein.,Proc Natl Acad Sci U S A,2006,1235,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The Ras --> Raf --> MEK1/2 --> extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway couples mitogenic signals to cel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16571745,10.1523/JNEUROSCI.4865-05.2006,Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells.,J Neurosci,2006,1476,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwann cell-axon interaction is the hallmark feature of peripheral nerves, yet the intracellular signals underlying this interaction are unknown. Schwann cells extend proce"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16581517,10.1016/j.cub.2006.02.063,The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling.,Curr Biol,2006,1515,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The precise coordination of signals that control proliferation is a key feature of growth regulation in developing tissues . While much has been learned abo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16619545,,Expression of emmprin and matrix metalloproteinases (MMPs) in peripheral nerve sheath tumors: emmprin and membrane-type (MT)1-MMP expressions are associated with malignant potential.,Anticancer Res,2006,1612,7394,0,1,3,4,"{""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""limma"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. MPNST Cell Models Human MPNST S462 cells were kindly provided by Dr. Conxi Lazaro (Institut Catal\u00e0 d\u2019Oncologia, Barcelona, Spain"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""2. Materials and Methods 2.1. MPNST Cell Models Human MPNST S462 cells were kindly provided by Dr. Conxi Lazaro (Institut Catal\u00e0 d\u2019Oncologia, Barcelona, Spain). Murine sMPNST and cisMPNST cells were kindly provided"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" stained with GIEMSA solution for 1 h. Images were acquired using a Leica DMIL LED microscope equipped with a Leica ICC50 HD camera and analyzed with ImageJ software 1.47b. 2.8. Spheroid Formation Assays Cells were seeded in low-adhesion 96-well culture plates with round bottoms and centrifuged at 400\u00d7  g"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""MMPs, the following analyses were performed: For microarray datasets (all of the mentioned ones aside  GSE178989 ), expression was analyzed using the limma pipeline (DOI: 10.18129/B9.bioc.limma). Expressed genes were considered as having \u22120.9 z-scores of expression (normalized on gene expression in the f"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:limma"": [""methods""]}",False
16793550,10.1016/j.molcel.2006.05.011,The kelch proteins Gpb1 and Gpb2 inhibit Ras activity via association with the yeast RasGAP neurofibromin homologs Ira1 and Ira2.,Mol Cell,2006,973,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The G protein-coupled receptor Gpr1 and associated Galpha subunit Gpa2 govern dimorphic transitions in response to extracellular nutrients by signaling coordi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,Hum Mol Genet,2006,1345,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromas are common tumors found in neurofibromatosis type 1 (NF1) patients. These complex tumors are composed of Schwann cells, mast cells, fibroblasts and perineurial cells embedded in collagen that provide a latt"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""w that two of the prevalent heterozygous cells found in neurofibromas, mast cells and fibroblasts interact directly to contribute to tumor phenotype. Nf1+/- mast cells secrete elevated concentrations of the profibrotic transforming growth factor-beta (TGF-beta). In response to TGF-beta, both murine Nf1+/-"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromas are common tumors found in neurofibromatosis type 1 (NF1) patients. These complex tumors are composed of Schwann cells, mast cells, fibrobla"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16870183,10.1016/j.febslet.2006.07.018,NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region.,FEBS Lett,2006,559,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have studied the splicing regulation of NF1 exons 36 and 37. We show that they not only require an intact exonic Splicing Enhancer (ESE) within exon 37, but also need the genomic region stretch"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have studied the splicing regulation of NF1 exons 36 and 37. We show that they not only require an intact exonic Splicing Enhancer (ESE) within exon 37, but also need the genomi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
16894610,10.1002/dvdy.20883,Regulation of the neurofibromatosis 2 gene promoter expression during embryonic development.,Dev Dyn,2006,1971,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations in the Neurofibromatosis 2 (NF2) gene are associated with predisposition to vestibular schwannomas, spinal schwannomas, meningiomas, and ependymomas. Presently, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
16906226,10.1172/JCI28341,The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.,J Clin Invest,2006,1400,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1; also known as von Recklinghausen's disease) is a common autosomal-dominant condition primarily affecting neural crest-derived tissues. The disease g"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1; also known as von Recklinghausen's disease) is a common autosomal-dominant condition primarily affecting neural crest-deriv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
1696266,10.1083/jcb.111.2.645,Angiogenic and invasive properties of neurofibroma Schwann cells.,J Cell Biol,1990,1121,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromas are benign tumors from patients with von Recklinghausen Neurofibromatosis (NF1) that are comprised primarily of Schwann cells. These Schwann cells are found both in association with axons and in the extracellular matrix that is "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromas are benign tumors from patients with von Recklinghausen Neurofibromatosis (NF1) that are comprised primarily of Schwann cells. These Schwann"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17053831,10.1172/JCI29092,Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.,J Clin Invest,2006,1444,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) have a high incidence of osteoporosis and osteopenia. However, understanding of the cellular and molecular basis of these sequelae is incomplete. Os"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) have a high incidence of osteoporosis and osteopenia. However, understanding of the cellular and molecular basis of these s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17075701,10.1007/s10162-006-0056-5,Electrophysiological validation of a human prototype auditory midbrain implant in a guinea pig model.,J Assoc Res Otolaryngol,2006,2115,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The auditory midbrain implant (AMI) is a new treatment for hearing restoration in patients with neural deafness or surgically inaccessible cochleae who cannot be"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
17090653,10.1182/blood-2006-05-025395,Beta common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant mice.,Blood,2007,1242,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating protein for Ras. Children wit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""ildren with NF1 are predisposed to juvenile myelomonocytic leukemia (JMML) and lethally irradiated mice given transplants with homozygous Nf1 mutant (Nf1-/-) hematopoietic stem cells develop a fatal myeloproliferative disorder (MPD) that models JMML. We investigated the requirement for signaling through t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) syndrome is caused by germline mutations in the NF1 tumor suppressor, which encodes neurofibromin, a GTPase activating prot"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17210637,10.1128/MCB.00572-06,"Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.",Mol Cell Biol,2007,1441,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations of the neurofibromatosis 2 (NF2) tumor suppressor gene have frequently been detected not only in schwannomas and other central nervous system tumors of NF2 patie"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
17215387,10.1523/JNEUROSCI.3370-06.2007,Phosphatidylinositol 3-kinase and Akt nonautonomously promote perineurial glial growth in Drosophila peripheral nerves.,J Neurosci,2007,1873,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""lian perineurium). Growth and proliferation within mammalian peripheral nerves are increased by Ras pathway activation: loss-of-function mutations in Nf1, which encodes the Ras inhibitor neurofibromin, cause the human genetic disorder neurofibromatosis, which is characterized by formation of neurofibro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Drosophila peripheral nerves, structured similarly to their mammalian counterparts, comprise a layer of motor and sensory axons wrapped by an inner peri"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,Neurogenetics,2007,1569,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/+;Trp53-/+cis"": ""426a3531-5785-4972-83ad-d88e54d2ef7f""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common cancer predisposition syndrome affecting the nervous system, with elevated risk for both astrocytoma and peripheral nerve sheath "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/+;Trp53-/+cis"": {""context"": ""suggest that either variation in Nf1 levels is not responsible for the differences in astrocytoma and peripheral nerve sheath tumor susceptibility in Nf1-/+;Trp53-/+cis mice, or that certain mouse strains have evolved compensatory mechanisms for differences in Nf1 expression."", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common cancer predisposition syndrome affecting the nervous system, with elevated risk for both astrocytoma and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1-/+;Trp53-/+cis"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17295913,10.1186/1471-2350-8-4,Functional analysis of splicing mutations in exon 7 of NF1 gene.,BMC Med Genet,2007,1562,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecting about 1:3,500 individuals. NF1 exon 7 displays weakly defined exon-intron boundaries, and is particularly prone to missplicing. METHODS: In this study we investigated the expressio"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 is one of the most common autosomal dominant disorders, affecting about 1:3,500 individuals. NF1 exon 7 displays weakly"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17548515,10.1083/jcb.200703010,Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.,J Cell Biol,2007,0,8818,0,0,2,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell culture and expression vectors Wild-type and  Nf2 \n \u2212/\u2212  primary MEFs were prepared as described previously ( Lallemand et al., "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""assay LDCs plated on glass coverslips were infected with Ad.Nf2 wt  or Ad.Nf2 L64P  when \u223c50% confluent. After 4\u20135 d, confluent monolayers were serum starved in 1% BSA in DME for 2 h, incubated for 30 min at 37\u00b0C with 2 \u03bcg/ml Tr-EGF (E3480; Molecular Probes) or 10 \u03bcg/ml Alexa Fluor 488-Transferrin ( T13"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
17558420,10.1038/labinvest.3700591,Imatinib mesylate inhibits cell invasion of malignant peripheral nerve sheath tumor induced by platelet-derived growth factor-BB.,Lab Invest,2007,1862,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is rare, highly aggressive, resistant to radiochemotherapy, and associated with poor prognosis. Basic research to d"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
17581973,10.1523/JNEUROSCI.0933-07.2007,Distinct functional domains of neurofibromatosis type 1 regulate immediate versus long-term memory formation.,J Neurosci,2007,1283,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a dominant genetic disorder that causes tumors of the peripheral nervous system. In addition, >40% of afflicted children have learning difficulti"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a dominant genetic disorder that causes tumors of the peripheral nervous system. In addition, >40% of afflicted children"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17649826,,Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.,Anticancer Res,2007,0,513,0,0,1,1,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The cNF working group, a subgroup of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) consortium, was formed to review and inform clinica"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods""]}",False
17786186,10.1593/neo.07304,MMP-13 and p53 in the progression of malignant peripheral nerve sheath tumors.,Neoplasia,2007,1319,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""mited treatment options. Factors contributing to tumor progression are largely unknown. We therefore examined MPNST from 22 neurofibromatosis type 1 (NF1) patients, 14 non-NF1 patients, and 14 neurofibroma patients for matrix metalloproteinase 13 (MMP-13) expression. Because wild-type and mutant p53 we"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are sarcomas with poor prognosis and limited treatment options. Factors contributing to tumor progression are larg"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
1783401,10.1016/0888-7543(91)90017-9,cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product.,Genomics,1991,766,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Von Recklinghausen neurofibromatosis, or type 1 neurofibromatosis (NF1), is a common autosomal dominant disorder characterized by abnormalities in multiple tissues derived from the embryonic neural crest. Portions of the"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Von Recklinghausen neurofibromatosis, or type 1 neurofibromatosis (NF1), is a common autosomal dominant disorder characterized by abnormalities in multiple"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
17868749,10.1016/j.mrfmmm.2007.07.015,Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity.,Mutat Res,2008,1766,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is a genetic disorder characterized by the formation of bilateral schwannomas of the eighth cranial nerve. Although the pro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,Brain Pathol,2008,1318,5084,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""METHODS \n Mice.  To obtain  Nf2 \n flox2/flox2 \n ;p16 \n Ink4a*/*  mice,  Nf2 \n flox2/flox2  mice  (4)  on the FVB/N background were bred to  p16 \n Ink4a*/*  mice  (11)  on a FVB/N/129Ola mixed background, and the resulting  Nf2 \n flox2/+ ;  p16 \n Ink4a*/+  mice were inter"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
17962031,10.1016/j.nbd.2007.09.002,Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth.,Neurobiol Dis,2008,1192,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Meningiomas, common tumors arising from arachnoidal cells of the meninges, may occur sporadically, or in association with the inherited disorder, neurofibromatosis 2 (NF2). Mo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18032726,10.1101/gr.6859308,Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics.,Genome Res,2008,707,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Many human diseases, including Fanconi anemia, hemophilia B, neurofibromatosis, and phenylketonuria, can be caused by 5'-splice-site (5'ss) mutations that are not predicted to disrupt splicing, according to position"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18055911,10.1136/jmg.2007.053785,Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification.,J Med Genet,2007,1181,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofibromatosis type 1 (NF1). Of these, 13"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""To estimate the contribution of single and multi-exon NF1 gene copy-number changes to the NF1 mutation spectrum, we analysed a series of 201 Italian patients with neurofib"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18057212,10.1523/JNEUROSCI.3123-07.2007,Electrical stimulation of the midbrain for hearing restoration: insight into the functional organization of the human central auditory system.,J Neurosci,2007,1579,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The cochlear implant can restore speech perception in patients with sensorineural hearing loss. However, it is ineffective for those without an implantable cochle"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18186933,10.1186/1471-2121-9-1,The role of Drosophila Merlin in spermatogenesis.,BMC Cell Biol,2008,1786,5605,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Fly stocks Flies were maintained at 25\u00b0C in standard cornmeal yeast-agar medium. Various  Merlin  mutant strains were generously provided by Rick G. Fehon at University o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,Epigenetics,2008,1663,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" affect tumorigenesis depending on which parental allele undergoes alteration. We have shown previously in a mouse model of neurofibromatosis type 1 (NF1) that inheriting mutant alleles of Nf1 and Trp53 on chromosome 11 from the mother or father dramatically changes the tumor spectrum of mutant progeny"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Imprinted genes are monoallelically expressed from either the maternal or paternal genome. Because cancer develops through genetic and epigenetic alterati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18218617,10.1074/jbc.M708206200,"Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.",J Biol Chem,2008,0,1837,0,0,1,1,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods A deep sequencing next-generation sequencing assay for the molecular diagnosis of DoSM was run on 936 individuals with DoSM. Materials and Methods Samples from 936 individuals wi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods""]}",False
18242512,10.1016/j.ccr.2008.01.002,Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.,Cancer Cell,2008,935,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" self-renewal program of stem/progenitor cells can cause tumorigenesis. By utilizing genetically engineered mouse models of neurofibromatosis type 1 (NF1), we demonstrated that plexiform neurofibroma, the only benign peripheral nerve sheath tumor with potential for malignant transformation, results fro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Recent evidence suggests that alterations in the self-renewal program of stem/progenitor cells can cause tumorigenesis. By utilizing genetically engine"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,Cancer Cell,2008,876,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis is caused by the loss of neurofibromin (Nf1), leading to peripheral nervous system (PNS) tumors, including neurofibromas and malignant peripheral nerve sheath tumors (MPNSTs). A long-standing q"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis is caused by the loss of neurofibromin (Nf1), leading to peripheral nervous system (PNS) tumors, including neurofibromas and malignant p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18272679,10.1523/JNEUROSCI.5236-07.2008,Neurofibromin is required for barrel formation in the mouse somatosensory cortex.,J Neurosci,2008,1193,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""d protein kinase) and and PI-3 kinase (phosphatidylinositol 3-kinase) pathways, and is mutated in humans with the condition neurofibromatosis type 1 (NF1). Neurofibromin is widely expressed in the developing and adult nervous system, and a common feature of NF1 is deficits in intellectual development. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The rodent barrel cortex is a useful system to study the role of genes and neuronal activity in the patterning of the nervous system. Several genes encodin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18328429,10.1016/j.ccr.2008.01.030,A conditional mouse model for malignant mesothelioma.,Cancer Cell,2008,834,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant mesothelioma is a devastating disease that has been associated with loss of Neurofibromatosis type 2 (NF2) and genetic lesions affecting RB and P53 pathways. We introduced similar lesions in the mesothelial lining of the thoracic "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,J Pharmacol Exp Ther,2008,1438,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""90-8"": ""0f404e70-2acf-4877-bcd5-6da81d9fa41e""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disorder that is driven by the loss of neurofibromin (Nf) protein function. Nf contains a Ras-GTPase-activating protein domain, which d"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:ST88-14"": {""context"": ""nhibitors (FTIs), 1 and 2, alone or in combination with lovastatin, on two NF1 malignant peripheral nerve sheath tumor (MPNST) cell lines, NF90-8 and ST88-14. Single treatments of 1, 2, or lovastatin had no effect on Ras prenylation or MPNST cell proliferation. However, low micromolar combinations of 1 or "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:90-8"": {""context"": ""sferase inhibitors (FTIs), 1 and 2, alone or in combination with lovastatin, on two NF1 malignant peripheral nerve sheath tumor (MPNST) cell lines, NF90-8 and ST88-14. Single treatments of 1, 2, or lovastatin had no effect on Ras prenylation or MPNST cell proliferation. However, low micromolar combinati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disorder that is driven by the loss of neurofibromin (Nf) protein function. Nf contains a Ras-GTPase-activatin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:ST88-14"": [""abstract""], ""cell_lines:90-8"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18371380,10.1016/j.stem.2007.07.008,Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms.,Cell Stem Cell,2007,1103,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) develop abnormalities of both neuronal and glial cell lineages, suggesting that the NF1 protein neurofibromin is an essential regulator of neuroglia"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) develop abnormalities of both neuronal and glial cell lineages, suggesting that the NF1 protein neurofibromin is an essenti"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,Mol Cancer Ther,2008,1539,373,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Experimental design MPNST (MPNST and ST8814) and dedifferentiated liposarcoma (LS141 and DDLS) human tumor cell lines were characterized for Ras activation"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
18442999,10.1093/hmg/ddn134,Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway.,Hum Mol Genet,2008,1756,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions as a negative regulator of"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""en this observation, we tested whether heterozygosity of Nf1 would lead to vaso-occlusive disease in genetically engineered mice in vivo. Strikingly, Nf1+/- mice have increased neointima formation, excessive vessel wall cell proliferation and Erk activation after vascular injury in vivo. Further, this eff"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is a genetic disorder caused by mutations in the NF1 tumor suppressor gene. Neurofibromin is encoded by NF1 and functions a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18445079,10.1111/j.1750-3639.2008.00165.x,Altered adhesive structures and their relation to RhoGTPase activation in merlin-deficient Schwannoma.,Brain Pathol,2009,1339,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomas are Schwann cell tumors of the nervous system that occur spontaneously and in patients with neurofibromatosis 2 (NF2) and lack the tumor suppressor merl"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,Cancer Res,2008,1189,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We previously reported that central nervous system (CNS) inactivation of Nf1 and p53 tumor suppressor genes in mice results in the development of low-grade to high-grade progressive astrocytomas. When the tumors achieve high g"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We previously reported that central nervous system (CNS) inactivation of Nf1 and p53 tumor suppressor genes in mice results in the development of low-grade"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,Mol Cancer Ther,2008,1388,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nt peripheral nerve sheath tumors (MPNST) are chemoresistant sarcomas with poor 5-year survival that arise in patients with neurofibromatosis type 1 (NF1) or sporadically. We tested three drugs for single and combinatorial effects on collected MPNST cell lines and in MPNST xenografts. The mammalian tar"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are chemoresistant sarcomas with poor 5-year survival that arise in patients with neurofibromatosis type 1 (NF1) o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18503770,10.1016/j.febslet.2008.05.018,The pathological splicing mutation c.6792C>G in NF1 exon 37 causes a change of tenancy between antagonistic splicing factors.,FEBS Lett,2008,671,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have previously identified an ESE in NF1 exon 37 whose disruption by the pathological mutation c.6792C>G caused aberrant splicing. We now investigate the RNA-protein complexes affected by th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have previously identified an ESE in NF1 exon 37 whose disruption by the pathological mutation c.6792C>G caused aberrant splicing. We now investigate the RNA"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18614544,10.1093/hmg/ddn194,Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.,Hum Mol Genet,2008,1420,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neuroglial progenitor cells using the brain"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""To study the role of the neurofibromatosis-1 (NF1) gene in mammalian brain development, we recently generated mice in which Nf1 gene inactivation occurs in neurogli"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,JAMA,2008,2258,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""CONTEXT: Neurofibromatosis type 1 (NF1) is among the most common genetic disorders that cause learning disabilities. Recently, it was shown that statin-mediated inhibition of 3-hydroxy-3-m"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""CONTEXT: Neurofibromatosis type 1 (NF1) is among the most common genetic disorders that cause learning disabilities. Recently, it was shown that statin-mediated in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,Cancer Res,2008,1455,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis 2 (NF2) is an inherited cancer syndrome in which affected individuals develop nervous system tumors, including schwannomas, meningiomas,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,Otol Neurotol,2008,1653,570,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods VS xenografts were established in the interscapular fat pad in nude mice for 4 weeks. Initially, a small cohort of animals was treated with the ErbB2 inhibitor"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,Laryngoscope,2008,1716,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""OBJECTIVES/HYPOTHESIS: Determine the role of estrogen receptor (ER) and progesterone receptor (PR) expression in sporadic and neurofibromatosis 2 (NF2)-related vestibular schwann"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18671844,10.1186/1741-7015-6-21,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,BMC Med,2008,2979,6350,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Cortical injury was induced bilaterally in the  tuberositas tibiae  in Nf1Prx1 mutant mice and littermate controls according to a method described previously. Paraffin as well as methacrylate sections were analysed from each"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Cortical injury was induced bilaterally in the  tuberositas tibiae  in Nf1Prx1 mutant mice and littermate controls according to a method described previo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
18768391,10.1182/blood-2008-04-155085,Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.,Blood,2008,1258,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 locus, which encodes neurofibromin, a negative regulator of Ras. Patients with NF1 devel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 locus, which encodes neurofibromin, a negative regulator of Ras"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,Sarcoma,2008,1014,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""cal data. EGFR RNA was also quantified by RT-PCR in 20 other MPNSTs and 14 dermal neurofibromas. Half of the patients had a neurofibromatosis type 1 (NF1). EGFR expression, detected in 86% of MPNSTs, was more frequent in NF1 specimens and closely associated with high-grade and p53-positive areas. MPNST"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumours (MPNSTs) are highly malignant and resistant. Transformation might implicate up regulation of epidermal growth factor rece"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18800150,10.1038/jid.2008.274,Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.,J Invest Dermatol,2009,1365,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibromas constitute a serious burden for patients with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder characterized by pigmentary changes and tumorous skin lesions (neurofibromas). Despite the prominence of these"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibromas constitute a serious burden for patients with neurofibromatosis type 1 (NF1), a common autosomal dominant disorder characterized by pi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18923024,10.1523/JNEUROSCI.2537-08.2008,Tumor suppressor schwannomin/merlin is critical for the organization of Schwann cell contacts in peripheral nerves.,J Neurosci,2008,1744,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomin/merlin is the product of a tumor suppressor gene mutated in neurofibromatosis type 2 (NF2). Although the consequences of NF2 mutations on Schwann cell pr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,Cancer Biol Ther,2008,1163,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is characterized by the abnormal proliferation of neuroectodermal tissues and the development of certain tumors, particularly neurofibromas, which m"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis Type 1 (NF1) is characterized by the abnormal proliferation of neuroectodermal tissues and the development of certain tumors, particular"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,Otol Neurotol,2009,2179,476,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Patient excised vestibular schwannomas were cultured and transduced with firefly luciferase expressing lentivirus. One million cells were stereotactically injected into the rig"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
18953429,10.1593/neo.08642,"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP.",Neoplasia,2008,1431,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the occurrence of schwannomas and meningiomas. Several studies have exam"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18953430,10.1593/neo.08652,Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.,Neoplasia,2008,1436,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Signaling events leading to Schwann cell tumor initiation have been extensively characterized in the context of neurofibromatosis (NF). Similar tumors are also observed in patients with the endocr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,J Neurooncol,2009,1484,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis 2 locus (NF2) is inactivated through mutation and loss of heterozygosity (LOH) in 40-65% of all sporadic meningiomas, while the role of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
18984156,10.1016/j.cell.2008.08.041,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,Cell,2008,1113,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rigenic cells and their surrounding microenvironment are critical for tumor progression yet remain incompletely understood. Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a common genetic disorder characterized by complex tumors called neurofibromas. Genetic s"", ""confidence"": 0.7, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": "" to allow neurofibroma progression in the context of Schwann cell Nf1 deficiency. Further, genetic or pharmacologic attenuation of c-kit signaling in Nf1+/- hematopoietic cells diminishes neurofibroma initiation and progression. Finally, these studies implicate mast cells as critical mediators of tumor in"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Interactions between tumorigenic cells and their surrounding microenvironment are critical for tumor progression yet remain incompletely understood. Germli"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,Cell,2008,1085,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""and show that disruption of this mechanism accounts for the learning deficits in a mouse model for learning disabilities in neurofibromatosis type I (NF1). Our results demonstrate that neurofibromin modulates ERK/synapsin I-dependent GABA release, which in turn modulates hippocampal LTP and learning. A"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We uncovered a role for ERK signaling in GABA release, long-term potentiation (LTP), and learning, and show that disruption of this mechanism accounts for the l"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
18988803,10.2353/ajpath.2008.080376,Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.,Am J Pathol,2008,1416,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Lack of expression of neurofibromin in neurofibromatosis 1 and its lethal derivative, malignant peripheral nerve sheath tumors (MPNSTs), is thought to result in t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19016857,10.1111/j.1742-4658.2008.06734.x,Polypyrimidine tract binding protein regulates alternative splicing of an aberrant pseudoexon in NF1.,FEBS J,2008,1062,2803,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""enes, understanding the functional significance of deep intronic nucleotide variants represents a difficult challenge. We previously reported that an NF1 intron 30 exonization event is triggered from a single correct nomenclature is 'c.293-279 A>G' mutation [Raponi M, Upadhyaya M & Baralle D (2006) Hum"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods Minigene construction Patient or control DNA was used for PCR amplification with oligonucleotides carrying a non-complementary tail f"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""lculated as a percentage of the total expression of all isoforms following normalization. Statistical analysis (student\u2019s t test) was performed using GraphPad Prism software. cDNA Sequencing Individual PCR fragments were purified using the GeneJET Gel Extraction Kit (Thermo Scientific). Confirmatory sequencing of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""rd primer used was: 5\u2032TAATACGACTCACTATAGGG 3\u2032. PCR products were analyzed by electrophoresis on 1.5% agarose gels and band intensity quantified using IMAGEJ. To account for differences in product length, band intensities of each splicing isoform were normalized to the length of the wild-type splice for ea"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
1903357,10.1016/0888-7543(91)90410-g,"cDNA sequence and genomic structure of EV12B, a gene lying within an intron of the neurofibromatosis type 1 gene.",Genomics,1991,1726,6665,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The gene responsible for neurofibromatosis type 1 (NF1), one of the more common inherited human disorders, was identified recently, and segments of it were cloned. Two translocation breakpoints that inter"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods We utilized the Open Targets Genetics (OTG) database to pinpoint potential causal variants and target genes for EC. To explore the pleiotropic effects of gene expression on E"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ative causal genes from association signals, OTG offers several approaches: (I) closest genes, which identifies the gene closest to the transcription start site; (II) locus-to-gene (L2G) score, which ranks genes based on a machine learning algorithm trained on over 400 gold-standard positive GWAS loci o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
19041782,10.1016/j.stem.2008.10.003,Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential.,Cell Stem Cell,2008,1214,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ast (SM/Fb)-like cells, and neurons. Genetic and pharmacologic tools revealed that sphere formation requires signaling from the EGFR tyrosine kinase. Nf1 loss of function amplifies this progenitor pool, which becomes hypersensitive to growth factors and confers tumorigenesis. DhhCre;Nf1(fl/fl) mouse ne"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Defining growth factor requirements for progenitors facilitates their characterization and amplification. We characterize a peripheral nervous system embryonic d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,Glia,2009,1741,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ether brain tumor suppressor genes were differentially expressed in these distinct populations of astroglia. Interestingly, neurofibromatosis type 1 (NF1) gene expression was decreased at both the RNA and protein levels in neocortical astroglia relative to astroglia from the other brain regions. To det"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Numerous studies have suggested that astrocytes in the central nervous system (CNS) exhibit molecular and functional heterogeneity. In this regard, astrogl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
19333415,10.3390/ijms10020407,Drosophila melanogaster as a model organism of brain diseases.,Int J Mol Sci,2009,902,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Drosophila melanogaster has been utilized to model human brain diseases. In most of these invertebrate transgenic models, some aspects of human disease "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19427284,10.1016/j.stem.2009.04.010,The neurofibroma cell of origin: SKPs expand the playing field.,Cell Stem Cell,2009,327,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mounting evidence suggests that stem/progenitor cells may be the cells of origin for many tumor types. In this issue of Cell Stem Cell, Le et al. (2009) demonstrate that skin-derived precur"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19427294,10.1016/j.stem.2009.03.017,Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.,Cell Stem Cell,2009,987,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The tumor predisposition disorder neurofibromatosis type I (NF1) is one of the most common genetic disorders of the nervous system. It is caused by mutations in the Nf1 tumor-suppressor gene, which encodes a GTPas"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The tumor predisposition disorder neurofibromatosis type I (NF1) is one of the most common genetic disorders of the nervous system. It is caused by mutations i"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
19430883,10.1007/s11060-009-9867-7,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,J Neurooncol,2009,1688,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is a tumor suppressor gene syndrome characterized by multiple schwannomas, especially vestibular schwannomas (VS), and meni"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19434310,,Preliminary study regarding the utility of certain immunohistochemical markers in diagnosing neurofibromas and schwannomas.,Rom J Morphol Embryol,2009,771,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The present study shows the histopathological and immunohistochemical aspects encountered in 49 benign tumors with neural origin diagnosed in the Pathology "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19621444,10.1002/ajmg.c.30217,Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.,Am J Med Genet C Semin Med Genet,2009,1461,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The field of medical genetics is rapidly advancing, and therapeutic options to treat genetic syndromes are becoming increasingly available. An understanding of the pathophysiology of v"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19710506,10.1182/blood-2009-02-205146,Nf1 deficiency cooperates with oncogenic K-RAS to induce acute myeloid leukemia in mice.,Blood,2009,963,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Hyperactive RAS signaling is caused by mutations in RAS genes or a deficiency of the neurofibromatosis gene (NF1) and is common in myeloid malignancies. In mice, expression of oncogenic K-RAS or inactivation of Nf1 in hematopoietic cells results in myeloprolifer"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Hyperactive RAS signaling is caused by mutations in RAS genes or a deficiency of the neurofibromatosis gene (NF1) and is common in myeloid malignancies. In"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
19877719,10.1021/pr900834h,Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.,J Proteome Res,2010,1747,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Meningiomas are among the most frequent tumors of the brain and spinal cord accounting for 15-20% of all central nervous system tumors and frequently associated wit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
19966217,10.1073/pnas.0901932106,Cardiac and vascular functions of the zebrafish orthologues of the type I neurofibromatosis gene NFI.,Proc Natl Acad Sci U S A,2009,895,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""urred in recent years, largely aided by the development of relevant animal models. Von Recklinghausen neurofibromatosis is caused by mutations in the NF1 gene, which encodes neurofibromin, a large protein that modulates the activity of Ras. Here, we describe the identification and characterization of z"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Von Recklinghausen neurofibromatosis is a common autosomal dominant genetic disorder characterized by benign and malignant tumors of neural crest origin. S"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,EMBO Mol Med,2009,1234,14583,0,5,1,6,"{""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""90-8"": ""0f404e70-2acf-4877-bcd5-6da81d9fa41e"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S520"": ""c0a60dec-8ead-43c5-abc2-b06b89dd20cd""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""MATERIALS AND METHODS NF acquisition Diagnosis of NF1 used published criteria (Gutmann et al,  1997 ). We snap froze tumour tissues at the time of surgery from patients undergoing treatment at Massachuse"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS NF acquisition Diagnosis of NF1 used published criteria (Gutmann et al,  1997 ). We snap froze tumour tissues at the time of surgery "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""ormation (Ars et al,  2000 ; Serra et al,  2001 ; Upadhyaya et al,  2006 ). MPNST cell cultures We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously (Miller et al,  2006 ). We isolated RNA from cells under standard growth conditions for each cell line. "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:90-8"": {""context"": ""s et al,  2000 ; Serra et al,  2001 ; Upadhyaya et al,  2006 ). MPNST cell cultures We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously (Miller et al,  2006 ). We isolated RNA from cells under standard growth conditions for each cell line. RNA isolatio"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": "" S10  of Supporting Information (Ars et al,  2000 ; Serra et al,  2001 ; Upadhyaya et al,  2006 ). MPNST cell cultures We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously (Miller et al,  2006 ). We isolated RNA from cells under standard growth conditions "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S520"": {""context"": ""ng Information (Ars et al,  2000 ; Serra et al,  2001 ; Upadhyaya et al,  2006 ). MPNST cell cultures We maintained MPNST cell lines ST88-14, STS26T, S520, S462, 88-3, 90-8 and YST1 as described previously (Miller et al,  2006 ). We isolated RNA from cells under standard growth conditions for each cell "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:90-8"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:S520"": [""methods""]}",False
20176786,10.1177/0192623309357075,Bioluminescent approaches for measuring tumor growth in a mouse model of neurofibromatosis.,Toxicol Pathol,2010,1257,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibomatosis (NF1) patients are susceptible to multiple tumors of the nervous system including neurofibromas, optic glioma, malignant peripheral nerve sheath tumors (M"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": "" multiple tumors of the nervous system including neurofibromas, optic glioma, malignant peripheral nerve sheath tumors (MPNSTs), and astrocytoma. The Nf1+/-;Trp53+/- (NPcis) mouse model of NF1 spontaneously develops astrocytoma and MPNSTs that are very similar to human NF1 tumors. To use this model for te"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibomatosis (NF1) patients are susceptible to multiple tumors of the nervous system including neurofibromas, optic glioma, malignant peripheral nerve"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20187887,10.1111/j.1469-8749.2010.03624.x,"Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.",Dev Med Child Neurol,2010,1064,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""k for describing and classifying health and health-related states. The aim of the present study was to review literature on neurofibromatosis type 1 (NF1) using ICF-CY guidelines and to highlight findings about the quality of life of children with NF1. METHOD: Electronic databases were searched to iden"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""AIM: The World Health Organization's International Classification of Functioning, Disability and Health adapted for children and young people (ICF-CY) is a framew"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,Otol Neurotol,2010,1943,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""HYPOTHESIS: To investigate the early events in molecular progression toward schwannoma tumorigenesis, we developed an in vitro model of human Schwann cell tumorigenesis by merlin knock"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20233966,10.1182/blood-2009-07-232504,Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.,Blood,2010,1334,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""logic parameters and do not spontaneously develop myeloid malignancies. The 5A3(fl) deletion does not cooperate with oncogenic Kras(G12D) expression, Nf1 inactivation, or retroviral mutagenesis to accelerate leukemia development and did not modulate responsiveness to antileukemia drugs. These studies d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Monosomy 7 and del(7q) are associated with adverse features in myeloid malignancies. A 2.5-Mb commonly deleted segment (CDS) of chromosome band 7q22 is implicated as harboring"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20428190,10.1038/jid.2010.100,NF-1Score: a prediction score for internal neurofibromas in neurofibromatosis-1.,J Invest Dermatol,2010,1416,2566,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Study Cohort We retrospectively evaluated pediatric patients presenting with CALMs at birth to assess the risk of developing NF1"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""terials and Methods 2.1. Study Cohort We retrospectively evaluated pediatric patients presenting with CALMs at birth to assess the risk of developing NF1 in these children. Data were collected from the medical records of subjects followed at the Specialized Center for NF1 Care in IRCCS G. Gaslini, Geno"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
20511180,10.1093/neuonc/noq012,ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma.,Neuro Oncol,2010,1843,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Vestibular schwannomas (VS) arising sporadically or in patients with neurofibromatosis type 2 (NF2) consistently lack expression of Merlin, a tumor suppressor. "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,Cancer Res,2010,1490,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1 GEM"": ""b07051a7-b584-45ae-82ad-f7bb85c1dea5""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ount for microenvironmental influences on central nervous system tumorigenesis. Previous studies from our laboratories have used neurofibromatosis-1 (NF1) genetically engineered mouse (GEM) models to understand the spatial restriction of glioma formation to the optic pathway of young children. Based on"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1 GEM"": {""context"": ""e gliomas rarely form in children with NF1. Focal cAMP reduction was achieved by forced expression of phosphodiesterase 4A1 (PDE4A1) in the cortex of Nf1 GEM strains. Ectopic PDE4A1 expression produced hypercellular lesions with features of human NF1-associated glioma. Conversely, pharmacologic elevation o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Current models of oncogenesis incorporate the contributions of chronic inflammation and aging to the patterns of tumor formation. These oncogenic pathway"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1 GEM"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20600672,10.1016/j.neuroscience.2010.06.017,Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.,Neuroscience,2010,1803,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The purpose of this study was to investigate the progression of changes in retinal ganglion cells and optic nerve glia in neurofibromatosis-1 (NF1) genetically-engineered mice with optic glioma. Optic glioma tumors were generated in Nf1+/- mice lacking Nf1 expression in GFAP+ cells (astrocytes)."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""ganglion cells and optic nerve glia in neurofibromatosis-1 (NF1) genetically-engineered mice with optic glioma. Optic glioma tumors were generated in Nf1+/- mice lacking Nf1 expression in GFAP+ cells (astrocytes). Standard immunohistochemistry methods were employed to identify astrocytes (GFAP, S100beta),"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The purpose of this study was to investigate the progression of changes in retinal ganglion cells and optic nerve glia in neurofibromatosis-1 (NF1) genetical"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20606732,,CD44 and p53 immunoexpression patterns in NF1 neoplasms - indicators of malignancy and infiltration.,Int J Clin Exp Pathol,2010,2252,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) provides a unique system to evaluate the complete range of neoplastic expressions, from encapsulated benignity to invasiveness and malignancy. This "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) provides a unique system to evaluate the complete range of neoplastic expressions, from encapsulated benignity to invasiven"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20643348,10.1016/j.devcel.2010.06.015,The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.,Dev Cell,2010,1031,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The conserved Hippo signaling pathway regulates organ size in Drosophila and mammals. While a core kinase cascade leading from the protein kinase Hippo (Hpo) (M"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20643380,10.1016/j.nurt.2010.05.001,Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex.,Neurotherapeutics,2010,1553,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Until recently, the neuropsychiatric phenotype of tuberous sclerosis complex (TSC) was presumed to be caused by the structural brain abnormalities and/or sei"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20668197,10.1523/JNEUROSCI.0283-10.2010,A distinct set of Drosophila brain neurons required for neurofibromatosis type 1-dependent learning and memory.,J Neurosci,2010,1556,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Nonspecific cognitive impairments are one of the many manifestations of neurofibromatosis type 1 (NF1). A learning phenotype is also present in Drosophila melanogaster that lack a functional neurofibromin gene (nf1). Multiple studies have indicated th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Nonspecific cognitive impairments are one of the many manifestations of neurofibromatosis type 1 (NF1). A learning phenotype is also present in Drosophila melanogaster that lack "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20668201,10.1523/JNEUROSCI.0840-10.2010,Merlin inhibits neurite outgrowth in the CNS.,J Neurosci,2010,1394,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 gene product merlin is known to provoke gliogenic tumors as a result of its mutagenic loss. Merlin's physiological anti-mitogenic"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20675406,10.1101/gad.1938710,Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.,Genes Dev,2010,1465,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The molecular signals that control the maintenance and activation of liver stem/progenitor cells are poorly understood, and the role of liver progenitor cells in h"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
20680410,10.1007/s11010-010-0551-1,The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.,Mol Cell Biochem,2010,1666,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibromas commonly found in patients with Neurofibromatosis type I (NF1) have a 5% risk of being transformed into malignant peripheral nerve sheath tumors (MPNST). Germline mutations in the NF1 gene coding for neurofibrom"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:STS-26T"": {""context"": "" effectors of Ras in cell lines from MPNST patients by demonstrating that knockdown of NF1 expression using siRNA in a NF1 wild type MPNST cell line, STS-26T, activates the Ras/ERK1,2 pathway and increases AP-1 binding and activity. We believe this is the first time the transactivation of AP-1 has been lin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:ST88-14"": {""context"": ""ated ERK1,2 and phosphorylated JNK expression concomitant with increased AP-1 activity. MAP kinase pathways (ERK1,2 and JNK) were further examined in ST88-14, a neurofibromin-deficient MPNST cell line. The basal activity of ERK1,2 but not JNK was found to increase AP-1 activity. These experiments further c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibromas commonly found in patients with Neurofibromatosis type I (NF1) have a 5% risk of being transformed into malignant peripheral nerve she"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:STS-26T"": [""abstract""], ""cell_lines:ST88-14"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20686603,10.1371/journal.pone.0011858,The 4q12 amplicon in malignant peripheral nerve sheath tumors: consequences on gene expression and implications for sunitinib treatment.,PLoS One,2010,1773,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ral nerve sheath tumors (MPNST) are highly aggressive tumors which originate from Schwann cells and develop in about 10% of neurofibromatosis type 1 (NF1) patients. The five year survival rate is poor and more effective therapies are needed. Sunitinib is a drug targeting receptor tyrosine kinases (RTK)"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": ""d copy number suggesting a central role of PDGFRA within the amplicon. Studying the effect of sunitinib on 5 MPNST cell lines revealed that cell line S462 harboring the 4q12 amplicon was extremely sensitive to the drug with an IC50 below 1.0 microM. Moreover, sunitinib induced apoptosis and prevented PD"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are highly aggressive tumors which originate from Schwann cells and develop in about 10% of neu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,Clin Cancer Res,2010,1409,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PURPOSE: Plexiform neurofibromas (pNF) are Schwann cell tumors found in a third of individuals with neurofibromatosis type 1 (NF1). pNF can undergo transformation to malignant peripheral nerve sheath tumors (MPNST). There are no identified serum biomarkers of pNF tumor burden or"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: Plexiform neurofibromas (pNF) are Schwann cell tumors found in a third of individuals with neurofibromatosis type 1 (NF1). pNF can undergo trans"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20856158,10.1097/MAO.0b013e3181f20655,MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival.,Otol Neurotol,2010,1719,218,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We examined miR-21 expression in VSs. To determine the functional significance of miR-21 expression in VS cells, we transfected primary human VS cultures with anti-m"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
20876733,10.1101/gad.1957110,Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner.,Genes Dev,2010,1193,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ells (NSCs) from different brain regions exhibit varying capacities for self-renewal and differentiation. In this study, we used neurofibromatosis-1 (NF1) as a model system to elucidate a novel molecular mechanism underlying brain region-specific NSC functional heterogeneity. We demonstrate that Nf1 lo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Recent studies have shown that neuroglial progenitor/stem cells (NSCs) from different brain regions exhibit varying capacities for self-renewal and dif"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
20890305,10.1038/onc.2010.453,Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer.,Oncogene,2011,1169,5296,0,1,1,2,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell lines Human embryonic kidney (HEK293), colon cancer (HT29), ovarian cancer (SKOV3 and TOV21G), lung cancer (NCIH460), breast can"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""Materials and methods Cell lines Human embryonic kidney (HEK293), colon cancer (HT29), ovarian cancer (SKOV3 and TOV21G), lung cancer (NCIH460), breast cancer (MCF7), and mouse normal schwann (SW10) cells were obt"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""]}",False
21031597,10.1002/humu.21387,Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.,Hum Mutat,2011,1295,16151,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Material and Methods Patients and Neurofibromas A total of 518 dermal neurofibromas (dNFs) from 113 Neurofibromatosis type 1 (NF1) patients were included in this study. The patients were diagnosed according to standard diagnostic criteria [DeBella et al.,  2000 ]. All patients g"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Material and Methods Patients and Neurofibromas A total of 518 dermal neurofibromas (dNFs) from 113 Neurofibromatosis type 1 (NF1) patients were included i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": "" the Gentra Puregene Kit (Qiagen, Chatsworth, CA) following manufacturer's instructions. In all cases, purity and quality of DNA was assessed using a nanodrop spectrophotometer and gel electrophoresis analysis. All DNA samples were stored and preserved at 4\u00b0C and at \u2212 80\u00b0C. LOH Analysis and Mutational Mecha"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "". [ 1999 ], and recommended by the instrument's manufacturer [Applied Biosystems, Gene Mapper Software, Loss of Heterozygosity (LOH) Analysis Getting Started Guide]. To assess the presence of LOH we performed an allelic imbalance analysis, described by the expression Q LOH  [Hahn et al.,  1995 ] conside"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
2105641,,Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.,Am J Hum Genet,1990,1170,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis 2 or bilateral acoustic neurofibromatosis (NF2) is a severe autosomal dominant disorder characterized by the development of multiple tum"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,PLoS One,2010,1280,5652,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methodology/Principal Findings Using a specific peptide inhibitor of group I Paks, we show that loss of Pak activity restores normal cell movement in cells lacking "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""assay reagent according to manufacture's instructions (Pierce). Pak activation was stimulated by adding PDGF-BB (Sigma) at 5 ng/ml for 5 min to serum-starved cells. The antibodies used in this study include Pak1; Pak2; Mek1/2; phospho-MEK1 (Ser298); Erk1/2; phospho-Erk1/2 (Thr202/Tyr204); Akt; phospho-A"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
21074722,10.1016/j.devcel.2010.10.008,"The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex.",Dev Cell,2010,1017,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 (NF2) tumor suppressor, Merlin, is a FERM (Four point one, Ezrin, Radixin, Moesin) domain-containing protein whose loss results i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21084862,10.4161/cc.9.22.13838,Merlin's tumor suppression linked to inhibition of the E3 ubiquitin ligase CRL4 (DCAF1).,Cell Cycle,2010,910,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The mechanism by which the FERM domain protein Merlin, encoded by the tumor suppressor NF2, restrains cell proliferation is poorly understood. Prior studies have suggested that Mer"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,J Neurosci Methods,2011,789,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Benign schwannomas are common tumors of the cranial and peripheral nerves, causing pain and loss of function. The development of effective therapy for these tumors has bee"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,J Neuropathol Exp Neurol,2011,1426,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""umor growth and progression are heavily influenced by the local microenvironment. Previous studies from our laboratory have used Neurofibromatosis-1 (NF1) genetically engineered mice to characterize the role of stromal cells and signals to optic glioma formation and growth. Previously, we have shown th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""enetically engineered mice to characterize the role of stromal cells and signals to optic glioma formation and growth. Previously, we have shown that Nf1+/- microglia in the tumor microenvironment are critical cellular determinants of optic glioma proliferation. To define the role of microglia in tumor fo"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Whereas carcinogenesis requires the acquisition of driver mutations in progenitor cells, tumor growth and progression are heavily influenced by the local "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21182951,10.1016/j.mcn.2010.12.006,Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length.,Mol Cell Neurosci,2011,1557,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The Neurofibromatosis type 2 tumor suppressor, schwannomin (Sch) is a plasma membrane-cytoskeleton linking protein that regulates receptor signaling and actin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
2119504,10.1073/pnas.87.18.7255,Genetic and physical map of the von Recklinghausen neurofibromatosis (NF1) region on chromosome 17.,Proc Natl Acad Sci U S A,1990,998,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The von Recklinghausen neurofibromatosis 1 (NF1) locus has been previously assigned to the proximal long arm of chromosome 17, and two NF1 patients have been identified who have constitutional bala"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The von Recklinghausen neurofibromatosis 1 (NF1) locus has been previously assigned to the proximal long arm of chromosome 17, and two NF1 patients have been i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,Cancer Res,2011,1293,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""l procedure for administering fractionated cranial irradiation (CI) and investigated the incidence and spectrum of cancer in control and heterozygous Nf1 mutant mice irradiated to a moderate (15 Gy) or high dose (30 Gy). Heterozygous Nf1 inactivation cooperated with CI to induce solid tumors and myeloi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Secondary malignant neoplasms (SMN) are increasingly common complications of cancer therapy that have proven difficult to model in mice. Clinical observations"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2121371,10.1016/0092-8674(90)90151-4,The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins.,Cell,1990,721,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The von Recklinghausen neurofibromatosis locus, NF1, encodes a protein with homology restricted to the catalytic region of the RAS GTPase-activating protein, GAP, and with extensive homology to the IRA"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The von Recklinghausen neurofibromatosis locus, NF1, encodes a protein with homology restricted to the catalytic region of the RAS GTPase-activating protein, G"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,Mol Cancer Ther,2011,1565,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The identification of mammalian target of rapamycin (mTOR) as a major mediator of neurofibromatosis-1 (NF1) tumor growth has led to the initiation of clinical trials using rapamycin analogs. Previous studies from our laboratory have shown that durable resp"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The identification of mammalian target of rapamycin (mTOR) as a major mediator of neurofibromatosis-1 (NF1) tumor growth has led to the initiation of clinical trials using rapamycin ana"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21255467,10.1186/1471-2377-11-9,SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis.,BMC Neurol,2011,1102,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Schwannomatosis is a disease characterized by multiple non-vestibular schwannomas. Although biallelic NF2 mutations are found in schwannomas, no"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21324880,10.1101/gr.109678.110,Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors.,Genome Res,2011,1897,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Aberrant DNA methylation (DNAm) was first linked to cancer over 25 yr ago. Since then, many studies have associated hypermethylation of tumor suppressor g"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21352477,10.1111/j.1601-183X.2011.00685.x,Motor deficits in neurofibromatosis type 1 mice: the role of the cerebellum.,Genes Brain Behav,2011,1735,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disease, characterized by various neurocutaneous symptoms, cognitive impairments and problems in fine and gross"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominantly inherited disease, characterized by various neurocutaneous symptoms, cognitive impairments and p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21402777,10.1128/MCB.00609-10,FERM domain phosphoinositide binding targets merlin to the membrane and is essential for its growth-suppressive function.,Mol Cell Biol,2011,1371,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatosis type 2 tumor suppressor protein, merlin, is related to the ERM (ezrin, radixin, and moesin) family of plasma membrane-actin cytoskeleton"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
2142531,10.1073/pnas.87.14.5435,Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.,Proc Natl Acad Sci U S A,1990,1797,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""von Recklinghausen neurofibromatosis (NF1) is a common hereditary disorder characterized by neural crest-derived tumors, particularly benign neurofibromas whose malignant transformation to ne"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""von Recklinghausen neurofibromatosis (NF1) is a common hereditary disorder characterized by neural crest-derived tumors, particularly benign neurofibromas "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,Bone,2011,1550,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder caused by mutation of the NF1 tumor suppressor gene. Spinal deformities are common skeletal manifest"", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder caused by mutation of the NF1 tumor suppressor gene. Spinal deformities are"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21454924,10.18632/oncotarget.251,"miRNA signature of schwannomas: possible role(s) of ""tumor suppressor"" miRNAs in benign tumors.",Oncotarget,2011,1048,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""miRNAs have been recently implicated as drivers in several carcinogenic processes, where they can act either as oncogenes or as tumor suppressors. Schwan"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21460792,10.3791/2558,Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents.,J Vis Exp,2011,2754,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Although in vitro screens are essential for the initial identification of candidate therapeutic agents, a rigorous assessment of the drug's ability to inhibit tumor g"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21465658,10.1002/ajmg.a.33965,Multiple increased osteoclast functions in individuals with neurofibromatosis type 1.,Am J Med Genet A,2011,1565,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ncluding scoliosis, tibial dysplasia, sphenoid wing dysplasia, and decreased bone mineral density (BMD) are associated with neurofibromatosis type 1 (NF1). We report the cellular phenotype of NF1 human-derived osteoclasts and compare the in vitro findings with the clinical phenotype. Functional charact"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Skeletal abnormalities including scoliosis, tibial dysplasia, sphenoid wing dysplasia, and decreased bone mineral density (BMD) are associated with neurofibromatosi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21478499,10.1093/hmg/ddr149,Neurofibromin (Nf1) is required for skeletal muscle development.,Hum Mol Genet,2011,1441,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encoding a Ras-GAP protein, neurofibromin, which negatively regulates Ras signaling. B"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a multi-system disease caused by mutations in the NF1 gene encoding a Ras-GAP protein, neurofibromin, which negatively r"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21479127,10.7150/jca.2.90,Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists.,J Cancer,2011,1716,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""the most common mesenchymal tumor of the digestive tract. GISTs develop with relatively high incidence in patients with Neurofibromatosis-1 syndrome (NF1). Mutational activation of KIT or PDGFRA is believed to be a driving force in the pathogenesis of familial and sporadic GISTs. Unlike those tumors, N"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Gastrointestinal Stromal Tumor (GIST) is the most common mesenchymal tumor of the digestive tract. GISTs develop with relatively high incidence in patients"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,Cancer Res,2011,1399,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tem cells or their progenitors, followed by alterations of the surrounding microenvironment (loss of extrinsic control). In neurofibromatosis type 1 (NF1), deregulation of Ras signaling results in development of multiple neurofibromas, complex tumors of the peripheral nerves. Neurofibromas arise from t"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Stem cells are under strict regulation by both intrinsic factors and the microenvironment. There is increasing evidence that many cancers initiate through acquisit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21563229,10.1002/gcc.20876,Effects of splicing mutations on NF2-transcripts: transcript analysis and information theoretic predictions.,Genes Chromosomes Cancer,2011,1145,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""This study examined the effects of 22 putative splicing mutations in the NF2 gene by means of transcript analysis and information theory based prediction. Fourteen mutations were within the dinucleotide acceptor and donor regions, often referred "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21596366,10.1016/j.ajhg.2011.04.017,Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.,Am J Hum Genet,2011,1648,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Moyamoya is a cerebrovascular angiopathy characterized by a progressive stenosis of the terminal part of the intracranial carotid arteries and the compensatory develop"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21636709,10.1093/neuonc/nor035,Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies.,Neuro Oncol,2011,1306,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/+;Trp53-/+cis"": ""426a3531-5785-4972-83ad-d88e54d2ef7f""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""or successful treatment. Recent efforts to comprehensively identify mutations and gene expression changes in glioblastoma have shown that mutation of NF1 is a common alteration in human glioblastoma. We have developed and characterized a panel of 14 tumor lines from grades II through IV astrocytomas de"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/+;Trp53-/+cis"": {""context"": ""ration in human glioblastoma. We have developed and characterized a panel of 14 tumor lines from grades II through IV astrocytomas developed from our Nf1-/+;Trp53-/+cis mouse model and have used this panel to characterize signal transduction pathways and inhibitors that are candidate therapeutic targets for astrocyto"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A growing body of work suggests that astrocytomas and glioblastoma multiforme will require carefully tailored, molecularly targeted therapy for successful"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1-/+;Trp53-/+cis"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21659924,10.1097/MAO.0b013e31821f7d88,"ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas.",Otol Neurotol,2011,1485,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Pharmacologic agents targeted against the ErbB family, or the intracellular pathways that mediate their effects, could slow clinical progression"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21666496,10.1097/NEN.0b013e31822200aa,Comparative characterization of the human and mouse third ventricle germinal zones.,J Neuropathol Exp Neurol,2011,1549,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Recent evidence indicates differences in neural stem cell biology in different brain regions. For example, we demonstrated that neurofibromatosis 1 (NF1) tumor suppressor gene inactivation leads to increased neural stem cell proliferation and gliogenesis in the optic chiasm and brainstem but not in th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Recent evidence indicates differences in neural stem cell biology in different brain regions. For example, we demonstrated that neurofibromatosis 1 (NF"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2167436,10.1128/mcb.10.9.4658-4666.1990,"Evi-2, a common integration site involved in murine myeloid leukemogenesis.",Mol Cell Biol,1990,1212,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BXH-2 mice have the highest incidence of spontaneous retrovirally induced myeloid leukemia of any known inbred strain and, as such, represent a valuable model system for identifying cellular proto-oncogen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,Am J Hematol,2011,1261,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rative/myelodysplastic (MPD/MDS) hematopoietic disorder more common in patients with any one of at least three distinct genetic lesions, specifically NF1 gene loss and PTPN11 and NRAS mutations. NF1 and PTPN11 are molecular lesions associated with Neurofibromatosis Syndrome Type I (NF1 Syndrome) and No"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Juvenile Myelomonocytic Leukemia (JMML) is a relentlessly progressive myeloproliferative/myelodysplastic (MPD/MDS) hematopoietic disorder more common in patients with any one of at least three dis"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21697395,10.1158/1535-7163.MCT-11-0309,Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells.,Mol Cancer Ther,2011,1231,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a life-threatening complication of neurofibromatosis type 1 (NF1). NF1 is caused by mutation in the gene encoding neurofibromin, a negative regulator of Ras signaling. There are no effective pharmacologic therapies"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a life-threatening complication of neurofibromatosis type 1 (NF1). NF1 is caused by mutation in the gene encodin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,BMC Med,2011,0,5265,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""titative real-time polymerase reaction were applied to investigate expression of cartilage-specific genes in mice bearing conditional inactivation of NF1 in the developing limbs. These mice do not develop tumours but recapitulate aspects of NF1 bone dysplasia, including deregulation of cartilage differ"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods In situ  hybridization and quantitative real-time polymerase reaction were applied to investigate expression of cartilage-specific genes in mice bearing conditiona"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
21727212,10.1093/neuonc/nor056,Nilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2.,Neuro Oncol,2011,1914,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Loss of the tumor suppressor merlin is a cause of frequent tumors of the nervous system, such as schwannomas, meningiomas, and ependymomas, which occur spontaneously o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21748792,10.1002/jor.21497,Hyperactivation of mTOR critically regulates abnormal osteoclastogenesis in neurofibromatosis Type 1.,J Orthop Res,2012,1414,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with nerofibromatosis Type 1 (NF1) frequently suffer a spectrum of bone pathologies, such as abnormal skeletal development (scoliosis, congenital bowing, and congenital pseudoarthrose"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""art, from abnormal osteoclastogenesis. Enhanced RAS/PI3K activity has been reported to contribute to abnormal osteoclastogenesis in Nf1 heterozygous (Nf1+/-) mice. However, the specific downstream pathways linked to NF1 abnormal osteoclastogenesis have not been defined. Our aim was to determine whether ma"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with nerofibromatosis Type 1 (NF1) frequently suffer a spectrum of bone pathologies, such as abnormal skeletal development (scoliosis, congenital bowing, and "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21750658,10.1593/neo.11356,Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.,Neoplasia,2011,1150,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations in the Neurofibromatosis 2 gene (NF2) predispose to tumors of the nervous system, mainly schwannomas and meningiomas. The NF2 gene encodes for the tumor suppress"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21778190,10.1093/neuonc/nor072,"AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.",Neuro Oncol,2011,2032,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is an autosomal-dominant disease that results in the formation of bilateral vestibular schwannomas (VSs) and multiple menin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21855613,10.1016/j.brainresbull.2011.08.005,Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system.,Brain Res Bull,2012,1679,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1), the most common genetic disorder affecting the human nervous system, is characterized by the development of multiple benign Schwann cell tumors in "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1), the most common genetic disorder affecting the human nervous system, is characterized by the development of multiple benig"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21878642,10.1074/jbc.M111.246850,KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1.,J Biol Chem,2011,1269,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Recent genetic studies in Drosophila identified Kibra as a novel regulator of the Hippo pathway, which controls tissue growth and tumorigenesis by inhi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
21896734,10.1073/pnas.1019012108,Neurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent manner.,Proc Natl Acad Sci U S A,2011,1457,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""t of rapamycin (mTOR) pathway is a central regulator of glial and glioma cell growth. In this regard, mutational inactivation of neurofibromatosis-1 (NF1), tuberous sclerosis complex (TSC), and PTEN genes is associated with glioma formation, such that pharmacologic inhibition of mTOR signaling results "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Converging evidence from the analysis of human brain tumors and genetically engineered mice has revealed that the mammalian target of rapamycin (mTOR) pathw"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21903164,10.1016/j.mcn.2011.08.008,Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner.,Mol Cell Neurosci,2012,1877,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c"", ""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Children with the neurofibromatosis-1 (NF1) cancer predisposition syndrome exhibit numerous clinical problems that reflect defective central nervous system (CNS) neuronal function, including l"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""earning disabilities, attention deficit disorder, and seizures. These clinical features result from reduced NF1 protein (neurofibromin) expression in NF1+/- (NF1 heterozygosity) brain neurons. Previous studies have shown that mouse CNS neurons are sensitive to the effects of reduced Nf1 expression and exh"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": "" neurons. Second, CNS neurons exhibit Nf1 gene-dependent increases in RAS pathway signaling, but no further decreases in cAMP levels were observed in Nf1-/- CNS neurons relative to their Nf1+/- counterparts. Third, neurofibromin regulates CNS neurite length and growth cone areas in a cAMP/PKA/Rho/ROCK-dep"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Children with the neurofibromatosis-1 (NF1) cancer predisposition syndrome exhibit numerous clinical problems that reflect defective central nervous system "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21931722,10.1371/journal.pone.0024454,The probable cell of origin of NF1- and PDGF-driven glioblastomas.,PLoS One,2011,0,2446,0,0,1,1,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Mice \n Gtv-a ink4a/arf  mice were used at an age ranging from 5 to 13 weeks for all experiments. Animal experiments were conducted using protocols approved by the Institut"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods""]}",False
21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,Transl Neurosci,2010,1251,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations of the neurofibromin gene (NF1) cause neurofibromatosis type 1 (NF1), a disease in which learning disabilities are common. Learning deficits also are observed in mice with a hetero"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Mutations of the neurofibromin gene (NF1) cause neurofibromatosis type 1 (NF1), a disease in which learning disabilities are common. Learning deficits also are observed in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21949657,10.1371/journal.pgen.1002281,The receptor tyrosine kinase Alk controls neurofibromin functions in Drosophila growth and learning.,PLoS Genet,2011,1158,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nhibitory in both processes. Consistently, dAlk activation reduced body size and caused learning deficits resembling phenotypes of null mutations in dNf1, the Ras GTPase Activating Protein-encoding conserved ortholog of the Neurofibromatosis type 1 (NF1) disease gene. We show that dAlk and dNf1 co-loca"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Anaplastic Lymphoma Kinase (Alk) is a Receptor Tyrosine Kinase (RTK) activated in several cancers, but with largely unknown physiological functions. We report two unexpected roles for the D"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
21980365,10.1371/journal.pone.0024917,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,PLoS One,2011,1333,9570,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""sity Animal Care and Use Committee (IACUC). This study was approved by IACUC via Protocol Number 0000003401 originally approved on 6/19/09. Animals \n Nf1+/\u2212  mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA)  [50] .  Nf1  mice were provided by Dr. Luis"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1+/-"": {""context"": "" two animal models of NF1, PeriCre(+);Nf1(flox/-) and Col2.3Cre(+);Nf1(flox/-) mice. Adoptive transfer experiments demonstrate a critical role of the Nf1+/- marrow microenvironment in the impaired fracture healing in both models and adoptive transfer of WT bone marrow cells improves fracture healing in th"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Ethics statement Animal care and experiments were conducted according to the guidelines established by the Indiana University Animal Care and Use Committee (IACUC). This study w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ed (\u03c3\u200a=\u200a0.8 and support\u200a=\u200a1.0), and thresholded (22% of maximum possible gray scale value) as previously described  [53] . Scanning for the femur was started at 15% of the total femur length measured from the tip of the femoral condyle and extended proximally for 200 slices. The area for trabecular anal"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
22105171,10.1172/JCI45677,Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.,J Clin Invest,2011,1421,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tions in the gene encoding valosin-containing protein (VCP), the underlying disease mechanism remains elusive. Like IBMPFD, neurofibromatosis type 1 (NF1) is an autosomal dominant disorder. Neurofibromin, the protein encoded by the NF1 gene, has been shown to regulate synaptogenesis. Here, we show that"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD) is an autosomal dominant disorder characterized by progressive myopathy that is often accompanied by bone weakening and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,G3 (Bethesda),2011,1137,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ipomas, macrocephaly, and learning disabilities including ADHD and developmental delays. Since the earliest signs of LS and neurofibromatosis type 1 (NF1) syndrome are pigmentary findings, the two are indistinguishable and individuals with LS may meet the National Institutes of Health diagnostic criter"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Legius syndrome (LS) is an autosomal dominant disorder caused by germline loss-of-function mutations in the sprouty-related, EVH1 domain containing 1 (SPRED1) gen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22433254,10.1016/j.neulet.2012.03.009,Lovastatin regulates brain spontaneous low-frequency brain activity in neurofibromatosis type 1.,Neurosci Lett,2012,1623,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In the neurofibromatosis type 1 (NF1) mouse model, lovastatin, used clinically for hypercholesterolemia, improves cognitive dysfunction. While such impairment has been studied in NF1, th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In the neurofibromatosis type 1 (NF1) mouse model, lovastatin, used clinically for hypercholesterolemia, improves cognitive dysfunction. While such impairment ha"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22449146,10.1186/1423-0127-19-33,From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation.,J Biomed Sci,2012,1532,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Both Neurofibromatosis type I (NF1) and inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) are autosomal dominant genetic disorders. These two di"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Both Neurofibromatosis type I (NF1) and inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) are autosomal dominant geneti"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22550514,10.1155/2012/646725,Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.,Stem Cells Int,2012,976,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The most characteristic feature of neurofibromatosis type 1 (NF1) is the development of neurofibromas. It has been suggested that these tumors are caused by somatic inactivation of the wild-type NF1 allele, but the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The most characteristic feature of neurofibromatosis type 1 (NF1) is the development of neurofibromas. It has been suggested that these tumors are caused by somati"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22821737,10.1002/ajmg.a.35535,The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.,Am J Med Genet A,2012,1838,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""archers and clinicians, the Learning Disabilities Network (LeaDNet), was established in 2006. Initially, LeaDNet focused on neurofibromatosis type 1 (NF1), a common single gene disorder with a frequency of 1:3,000. Although NF1 is best recognized as an inherited tumor predisposition syndrome, learning,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Learning disabilities and other cognitive disorders represent one of the most important unmet medical needs and a significant source of lifelong disabilit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,PLoS One,2012,1197,4168,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Material and Methods Ethics Statement All the human samples used in this study were provided by patients who had given their written informed consent. The "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""sing the Gentra Puregene Kit (Qiagen) following manufacturer's instructions. Concentration, purity and quality of the DNA were first assessed using a nanodrop spectrophotometer and gel electrophoresis analysis. For an accurate quantification of DNA concentration, samples were further quantified using Quant-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:NanoDrop"": [""methods""]}",False
22961690,10.1002/pbc.24281,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,Pediatr Blood Cancer,2013,1691,0,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""GROUND: Sorafenib targets multiple pathways thought to be crucial in growth of plexiform neurofibroma (PN) in children with neurofibromatosis type 1 (NF1). Sorafenib has been tolerated with manageable toxicities in adults and children with refractory cancer. We conducted a separate study in this popula"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Sorafenib targets multiple pathways thought to be crucial in growth of plexiform neurofibroma (PN) in children with neurofibromatosis type 1 (NF"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": "" dose (MTD) was determined from toxicities observed during the first three cycles. RESULTS: Nine children enrolled, median age 8 (6-12) years. At the starting 115\u2009mg/m(2) /dose (n\u2009=\u20095), two experienced dose-limiting grade 3 pain in their PN. At the de-escalated 80\u2009mg/m(2) /dose (n\u2009=\u20094), approximately 40"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
23055477,10.1523/JNEUROSCI.3242-12.2012,Neurofibromatosis type 1: modeling CNS dysfunction.,J Neurosci,2012,1109,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial neoplasms (optic gliomas, "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,Cancer Res,2012,1684,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""g of their pathogenesis. It is currently not possible to predict or prevent this devastating late complication. Individuals with neurofibromatosis I (NF1) are at increased risk of developing therapy-induced cancers for unclear reasons. To model SMNs, we replicated clinical radiotherapy and delivered fr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Second malignant neoplasms (SMN) are therapy-induced malignancies and a growing problem in cancer survivors, particularly survivors of childhood cancers. The lack of experimental models"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23087000,10.1126/science.1226929,Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.,Science,2012,1018,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Glioblastoma multiforme (GBM) is the most common and aggressive malignant primary brain tumor in humans. Here we show that gliomas can originate from differentiated cells "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23213372,10.1242/bio.20122121,Stability of the tumor suppressor merlin depends on its ability to bind paxillin LD3 and associate with 1 integrin and actin at the plasma membrane.,Biol Open,2012,1603,9360,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Antibodies and western blotting The following antibodies were used: mouse monoclonal against GAPDH (1:1000, Millipore); rabbit monocl"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""on 5.0). Western blotting was conducted using standard protocols. Three independent experiments were performed and the half-life was calculated using GraphPad Prism version 5.00 with an exponential decay model (one phase decay, fitting method least square), where half-life is computed as ln (2)/K and K is the rat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
23221337,10.1172/JCI63193,Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.,J Clin Invest,2013,1310,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Children with neurofibromatosis type 1 (NF1) are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) that is refractory to conventional chemo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Children with neurofibromatosis type 1 (NF1) are predisposed to juvenile myelomonocytic leukemia (JMML), an aggressive myeloproliferative neoplasm (MPN) tha"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23221339,10.1172/JCI66167,Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk.,J Clin Invest,2013,1496,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) predisposes individuals to the development of juvenile myelomonocytic leukemia (JMML), a fatal myeloproliferative disease (MPD). In genetically engi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) predisposes individuals to the development of juvenile myelomonocytic leukemia (JMML), a fatal myeloproliferative disease ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23221341,10.1172/JCI60578,MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.,J Clin Invest,2013,1340,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNST). These incurable peripheral nerve tumors result from loss"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) patients develop benign neurofibromas and malignant peripheral nerve sheath tumors (MPNST). These incurable peripheral nerv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23222849,10.1101/gr.142604.112,Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.,Genome Res,2013,1510,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Low-grade brain tumors (pilocytic astrocytomas) arising in the neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome are hypothesized to result from a combination of germline and acquired somatic NF1 tumor suppressor gene mu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Low-grade brain tumors (pilocytic astrocytomas) arising in the neurofibromatosis type 1 (NF1) inherited cancer predisposition syndrome are hypothesized to r"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,Ann Neurol,2013,784,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Children with neurofibromatosis type 1 (NF1) are prone to learning and behavioral abnormalities, including problems with spatial learning and attention. The molecular etiology for these deficit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Children with neurofibromatosis type 1 (NF1) are prone to learning and behavioral abnormalities, including problems with spatial learning and attention. The"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23239959,10.1159/000342698,Partial Blindness to Submicron Topography in NF1 Haploinsufficient Cultured Fibroblasts Indicates a New Function of Neurofibromin in Regulation of Mechanosensoric.,Mol Syndromol,2012,1152,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nd translate them into biochemical signals. In this study, cell responses to surfaces with submicron topographies were investigated in cultured human NF1 haploinsufficient fibroblasts. Age-matched fibroblasts from 8 patients with neurofibromatosis type 1 (NF1(+/-)) and 9 controls (NF1(+/+)) were cultur"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Cells sense physical properties of their extracellular environment and translate them into biochemical signals. In this study, cell responses to surfaces with submicron topo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23244685,10.1186/1479-7364-6-18,Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1.,Hum Genomics,2012,1420,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type-1 (NF1), resulting from NF1 gene loss of function, is characterized by an increased risk of developing benign and malignant peripheral nerve sheath tumors ("", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type-1 (NF1), resulting from NF1 gene loss of function, is characterized by an increased risk of developing benign and malignant periphe"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23267122,,"Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.",Anticancer Res,2013,994,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 protein (NF2) is an underappreciated tumor suppressor involved in a broad range of nervous system tumors. Inactivation of the NF2"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23268719,10.1021/np300696g,Isobutylhydroxyamides from the pericarp of Nepalese Zanthoxylum armatum inhibit NF1-defective tumor cell line growth.,J Nat Prod,2013,499,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""A neurofibromatosis type 1 (NF1)-based bioassay-guided phytochemical investigation on Zanthoxylum armatum collected in Nepal led to the isolation of new timuramides A-D (1-4) and si"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A neurofibromatosis type 1 (NF1)-based bioassay-guided phytochemical investigation on Zanthoxylum armatum collected in Nepal led to the isolation of new tim"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23308224,10.1371/journal.pone.0053447,"Neurofibromatosis type 2 tumor suppressor protein, NF2, induces proteasome-mediated degradation of JC virus T-antigen in human glioblastoma.",PLoS One,2013,1780,8134,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Ethics Statement - clinical Samples Human brain tumor tissue was obtained from surgical resections or brain biopsy under the approval"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""e (GE Healthcare) or secondary antibodies conjugated to alkaline phosphatase for detection with CDP-Star (Perkin Elmer). Bands were quantified, using ImageJ software, and normalized to loading control. Co-immunoprecipitation U-87 MG cells were transfected with expression plasmids as described in their res"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""peroxidase for detection with ECL chemiluminescence (GE Healthcare) or secondary antibodies conjugated to alkaline phosphatase for detection with CDP-Star (Perkin Elmer). Bands were quantified, using ImageJ software, and normalized to loading control. Co-immunoprecipitation U-87 MG cells were transfecte"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
23312374,10.1016/j.tins.2012.12.002,Modeling cognitive dysfunction in neurofibromatosis-1.,Trends Neurosci,2013,836,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s found in over 10% of children in the general population. However, in the common inherited cancer predisposition syndrome, neurofibromatosis type 1 (NF1), the prevalence of these cognitive deficits approaches 70%. As a monogenic disorder, NF1 provides a unique genetic tool to identify and dissect mech"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Cognitive dysfunction, including significant impairments in learning, behavior, and attention, is found in over 10% of children in the general population. However, in the common inherited cancer predis"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23318430,10.1038/onc.2012.579,EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors.,Oncogene,2014,1024,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR) overe"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,Oncotarget,2013,0,6632,0,1,3,4,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""NanoDrop""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:S462"": {""context"": ""luwe (University Hospital Eppendorf, Germany) or the ATCC and were cultured as recommended. Unless noted otherwise, cells were seeded at 1.0 \u00d7 10 4  (S462 cell-line) or 3.0 \u00d7 10 4  (2884 and 2885 cell-lines) cells/well in 24-well culture plates and allowed to adhere for 24 hours prior to the denoted tre"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ired two-tailed Student's t-tests with p>0.05. Two way ANOVA was used to determine significance between treatments for  in vivo  tumour volumes using GraphPad Prism."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS In vivo  animal models Four-month-old male  NOD/SCID  mice were anesthetized with isofluorane and orthotopically implanted with 1 mm "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""d reverse-transcriptase PCR and real-time PCR Genomic DNA was extracted with the DNeasy extraction kit (Qiagen) and preparations were measured with a NanoDrop (Thermo-Fisher). For real-time, genomic PCR, reactions were run in triplicate with an Applied Biosystems 7000 series machine (Invitrogen). RNA was ex"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:S462"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:NanoDrop"": [""methods""]}",False
23348505,10.1126/science.1233009,"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.",Science,2013,978,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We report genomic analysis of 300 meningiomas, the most common primary brain tumors, leading to the discovery of mutations in TRAF7, a proapoptotic E3 ubi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23356716,10.1111/bpa.12039,Miniaturized handheld confocal microscopy identifies focal brain invasion in a mouse model of aggressive meningioma.,Brain Pathol,2013,1343,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Invasion of the brain parenchyma by a meningioma classified by histological criteria as World Health Organization (WHO) grade I meningioma, implies that the tumor has g"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23406822,10.1186/1866-1955-5-3,"Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities.",J Neurodev Disord,2013,2088,8954,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We studied 14 children with NF1 and 14 typically developing children matched for age, gender, IQ and right/left-handedness. Regional subcortical volumes and cortical gyral measureme"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We studied 14 children with NF1 and 14 typically developing children matched for age, gender, IQ and right/left-handedness. Regional subcortical volumes and cortical gyra"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""WM parcellation is performed as described in Salat  et al . [ 49 ]. Statistical analyses Statistical analyses were performed with PAWS Statistics 18 (SPSS Inc., Chicago, IL, USA). First, we verified the normality assumption for the different parameters using the Shapiro-Wilk test. All data were normally"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
23413263,10.1093/brain/aws353,Loss of SOX10 function contributes to the phenotype of human Merlin-null schwannoma cells.,Brain,2013,1610,8365,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Reagents Adenoviruses expressing green fluorescent protein (GFP), KROX20/GFP, Cre recombinase, JNK-binding domain of JNK-interacting "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""n was knocked down in Schwann cells using 3 nM of validated small interfering RNA oligos Rn_Nf2_2 and Rn_Nf2_3 in combination. Alternatively, 3 nM Allstars negative control was used as a scrambled control. Small interfering RNA/lipid complexes were prepared using 6 \u00b5l of HiPerfect\u00ae reagent and incubated"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
23423222,10.1158/1541-7786.MCR-12-0593,RAS/MEK-independent gene expression reveals BMP2-related malignant phenotypes in the Nf1-deficient MPNST.,Mol Cancer Res,2013,1315,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of germline mutations in Nf1 gene as well as sporadically. Neurofibromin, encoded by the Nf1 gene, functions as a GTPase-activating protein (GAP) whose mutation leads to activati"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a type of soft tissue sarcoma that occurs in carriers of germline mutations in Nf1 gene as well as sporadically."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23424002,10.1002/ana.23813,Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.,Ann Neurol,2013,795,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""on-neoplastic stromal cells in influencing tumor growth and progression. Leveraging a genetically engineered mouse model of neurofibromatosis type 1 (NF1)-associated optic glioma, we now demonstrate that stromal microglia express the CX3CR1 chemokine receptor, such that reduced CX3CR1 expression decrea"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Although traditional models of carcinogenesis have largely focused on neoplastic cells, converging data have revealed the importance of non-neoplastic stromal ce"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity.",Health Qual Life Outcomes,2013,1834,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder with significant impact on health-related quality of life (HRQOL). Research in understanding the pat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder with significant impact on health-related quality of life (HRQOL)"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23434321,10.1016/j.cell.2013.01.053,CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.,Cell,2013,1092,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""arcomas that arise in connective tissue surrounding peripheral nerves. They occur sporadically in a subset of patients with neurofibromatosis type 1 (NF1). MPNSTs are highly aggressive, therapeutically resistant, and typically fatal. Using comparative transcriptome analysis, we identified CXCR4, a G-pr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that arise in connective tissue surrounding peripheral nerves. They occur sporadically i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23446537,,"[Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].",Turk Psikiyatri Derg,2013,1790,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""OBJECTIVE: The aim of this study was to investigate health-related quality of life (HRQoL) in children with neurofibromatosis type 1 (NF1) and to determine the factors affecting HRQoL in these children, with particular emphasis on NF1-specific findings and complications. MATERIALS AND M"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""OBJECTIVE: The aim of this study was to investigate health-related quality of life (HRQoL) in children with neurofibromatosis type 1 (NF1) and to determine the factors affecting HRQoL in these children, with pa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23457304,10.1074/jbc.M112.442244,Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.,J Biol Chem,2013,1610,0,0,1,1,2,"{""cell_lines"": {""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:ST88-14"": {""context"": "") overexpress PDGF receptor-\u03b2 and generate an aberrant intracellular calcium increase in response to PDGF-BB. Using the human MPNST Schwann cell line ST88-14, we demonstrate that, in addition to a transient phosphorylation of Akt, PDGF-BB stimulation produces an atypical sustained phosphorylation of Akt th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1-derived Schwann cells isolated from malignant peripheral nerve sheath tumors (MPNSTs) overexpress PDGF receptor-\u03b2 and generate an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:ST88-14"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23475878,10.1158/2159-8290.CD-13-0017,An unholy alliance: cooperation between BRAF and NF1 in melanoma development and BRAF inhibitor resistance.,Cancer Discov,2013,800,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In this issue of Cancer Discovery, 2 studies provide new evidence implicating loss of the tumor suppressor neurofibromin (NF1) in the biologic behavior of cutaneous melanoma. The first study from Maertens and colleagues describes a new transgenic mouse model in which mutant "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In this issue of Cancer Discovery, 2 studies provide new evidence implicating loss of the tumor suppressor neurofibromin (NF1) in the biologic behavior of cutaneous melanoma"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23487764,10.1073/pnas.1218173110,NMR-based functional profiling of RASopathies and oncogenic RAS mutations.,Proc Natl Acad Sci U S A,2013,1709,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""coded by RASopathy genes in mammalian cell extracts. By measuring GAP activity from tumor cells, we demonstrate how loss of neurofibromatosis type 1 (NF1) increases RAS-GTP levels in NF1-derived cells. We further applied this methodology to profile Noonan Syndrome (NS)-derived SOS1 mutants. Combining N"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Defects in the RAS small G protein or its associated network of regulatory proteins that disrupt GTPase cycling are a major cause of cancer and developmental RASopath"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",Cancer Discov,2013,1085,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Genetic changes required for the formation and progression of human Schwann cell tumors remain elusive. Using a Sleeping Beauty forward genetic screen, we identified s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23555837,10.1371/journal.pone.0059931,Genetic interactions between neurofibromin and endothelin receptor B in mice.,PLoS One,2013,1562,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""When mutations in two different genes produce the same mutant phenotype, it suggests that the encoded proteins either interact with each other, or act in parallel to fulfill a si"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23583712,10.1016/j.febslet.2013.03.035,Neurofibromin interacts with the cytoplasmic Dynein Heavy Chain 1 in melanosomes of human melanocytes.,FEBS Lett,2013,842,6576,0,1,7,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""clusterProfiler"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin (NF1) is encoded by the NF1 tumour suppressor gene. Mutations result in a disorder known as Neurofibromatosis Type 1 (NF-1), and patients are often diagno"", ""confidence"": 0.7, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Heterozygous and homozygous dync1h1-deficient zebrafish were confirmed through Sanger sequencing. Morphological changes and retinal phenotypes were assesse"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""q 6000. Clean reads were aligned to the zebrafish reference genome (Ensembl, GRCz11) using Hisat2 (version 2.0.5), and mRNA expression quantified via featureCounts (version 1.5.0-p3). Differential expression analysis used DESeq2 (version 1.20.0) with a threshold of |log2 (FoldChange)|\u22651 and adjusted  P  value \u2264 "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""hway enrichment analyses were conducted using ClusterProfiler ( http://www.genome.jp/kegg/ ). Statistical Analysis Data analyses were performed using GraphPad Prism 9, with results indicated as mean \u00b1 SD. The Shapiro\u2013Wilk test was used to assess whether the data obeyed the normal distribution. If the data obeyed "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""embryos. RNA sequencing was performed using Illumina NovaSeq 6000. Clean reads were aligned to the zebrafish reference genome (Ensembl, GRCz11) using Hisat2 (version 2.0.5), and mRNA expression quantified via featureCounts (version 1.5.0-p3). Differential expression analysis used DESeq2 (version 1.20.0) w"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": "")|\u22651 and adjusted  P  value \u2264 0.05. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using ClusterProfiler ( http://www.genome.jp/kegg/ ). Statistical Analysis Data analyses were performed using GraphPad Prism 9, with results indicated as mean \u00b1 SD. The Sh"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""mbl, GRCz11) using Hisat2 (version 2.0.5), and mRNA expression quantified via featureCounts (version 1.5.0-p3). Differential expression analysis used DESeq2 (version 1.20.0) with a threshold of |log2 (FoldChange)|\u22651 and adjusted  P  value \u2264 0.05. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes ("", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""vernight with primary antibodies at 4\u00b0C. Following incubation with HRP-conjugated secondary antibodies, chemiluminescence was used for detection, and ImageJ was used for protein quantification. Experiments were repeated three times. Quantitative Real-Time Polymerase Chain Reaction Analysis Total RNA from "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,Nat Genet,2013,1133,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are sarcomas of Schwann cell lineage origin that occur sporadically or in association with the inherited syndrome"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23714726,10.1158/1078-0432.CCR-12-3167,Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.,Clin Cancer Res,2013,1517,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""PURPOSE: The growth and survival of neurofibromatosis type 2 (NF2)-deficient cells are enhanced by the activation of multiple signaling pathways includin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23723300,10.1158/1078-0432.CCR-12-3922,Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma.,Clin Cancer Res,2013,1925,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""d D (SDHB, SDHD), succinate dehydrogenase assembly factor 2, von Hippel-Lindau (VHL), rearranged during transfection (RET), neurofibromatosis type 1 (NF1), and myc-associated factor X. RESULTS: In SDHx-related PGLs, a significant decrease in complex II activity (P < 0.0001) and a significant increase i"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: Pheochromocytomas and paragangliomas (PGL) are neuroendocrine tumors of sympathetic and parasympathetic paraganglia. This study investigated the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23749527,10.1158/2159-8290.CD-13-0192,Extending the convergence of canonical WNT signaling and classic cancer pathways for treatment of malignant peripheral nerve sheath tumors.,Cancer Discov,2013,439,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are incurable tumors of the Schwann cell lineage that progress unpredictably from benign plexiform neurofibromas. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23762458,10.1371/journal.pone.0066024,Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice.,PLoS One,2013,2034,15729,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""in St. Louis (protocol nos. 20120110 and 20110111) and are in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals. Mice \n Nf1  OPG mice used in the present studies are  Nf1 +/\u2212 mice that have a loss of neurofibromin expression in glial (GFAP+) cells (previously referred to a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Ethics Statement All experimental protocols were approved by the Animal Studies Committee of Washington University in St. Louis (prot"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
23848554,10.1186/1471-2164-14-473,MicroRNAome profiling in benign and malignant neurofibromatosis type 1-associated nerve sheath tumors: evidences of PTEN pathway alterations in early NF1 tumorigenesis.,BMC Genomics,2013,1493,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a common dominant tumor predisposition syndrome affecting 1 in 3,500 individuals. The hallmarks of NF1 are the development of peripheral nerve sh"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a common dominant tumor predisposition syndrome affecting 1 in 3,500 individuals. The hallmarks of NF1 are the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23858101,10.1158/1535-7163.MCT-13-0189,NF1 deletion generates multiple subtypes of soft-tissue sarcoma that respond to MEK inhibition.,Mol Cancer Ther,2013,1716,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Soft-tissue sarcomas are a heterogeneous group of tumors arising from connective tissue. Recently, mutations in the neurofibromin 1 (NF1) tumor suppressor gene were identified in multiple subtypes of human soft-tissue sarcomas. To study the effect of NF1 inactivation in the initiation "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Soft-tissue sarcomas are a heterogeneous group of tumors arising from connective tissue. Recently, mutations in the neurofibromin 1 (NF1) tumor suppressor gene were "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23863460,10.1093/hmg/ddt333,Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.,Hum Mol Genet,2013,1890,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder affecting 1 in 3500 individuals. Patients with NF1 are predisposed to debilitating skeletal manifestations, including o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder affecting 1 in 3500 individuals. Patients with NF1 are predisposed to debilitating skeletal ma"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
23863479,10.1242/dev.096537,Tumor suppressor Nf2 limits expansion of the neural progenitor pool by inhibiting Yap/Taz transcriptional coactivators.,Development,2013,1373,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Brain development requires a precise balance between expansion of the neural progenitor pool and the production of postmitotic neurons and glia. Disrupt"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
23907387,10.1093/nar/gkt656,An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.,Nucleic Acids Res,2013,2963,19026,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""xpressions. The top-left panel of  Figure 2  demonstrates a simple joint association model. The mRNA expression of BHLHE40 is jointly associated with NF1 mutation (positive) and RBP1 DNA methylation (negative). The union of the association models for all target genes constitute a bipartite network with"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Data sources and processing The following multi-modal GBM data were downloaded from the TCGA data portal website ( https://tcga-data."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" modeling framework to prioritize molecular aberrations and incrementally incorporate candidate effectors to the model according to their priorities. Starting with an empty model without any effector, we incrementally selected the effectors that provided additional explanatory power relative to the prec"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
23928514,10.1097/MAO.0b013e3182956169,Natural compounds as potential treatments of NF2-deficient schwannoma and meningioma: cucurbitacin D and goyazensolide.,Otol Neurotol,2013,1871,447,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The  Nf2 -deficient mouse schwannoma Sch10545 and human benign meningioma Ben-Men-1 cells were treated with various concentrations of cucurbitacin D and goyazensolide. The effect on cell proliferation was determined using resazurin assays. Flo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
23934191,10.1038/onc.2013.320,LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2.,Oncogene,2014,0,10590,0,0,5,5,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""FlowJo"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Inhibitors LIMK1/2 inhibitor, BMS-5 (CAS name N-( 5 \u2013(192,6-dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl)thiazol-2-yl)isobutyra"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""sing the BD FACSDiva\u2122 6.1.3 software. FlowJo software (Tree Star, Inc, Ashland, OR, USA) was used for analysis of acquired data. Statistical analysis GraphPad Prism version 5.0 for Windows (GraphPad, La Jolla, CA, USA) was used for statistical analysis and graph generation of experimental data from three independ"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""g to manufacturer\u2019s instruction. Samples were analyzed with a BD Canto-II flow cytometer using the BD FACSDiva\u2122 6.1.3 software. FlowJo software (Tree Star, Inc, Ashland, OR, USA) was used for analysis of acquired data. Statistical analysis GraphPad Prism version 5.0 for Windows (GraphPad, La Jolla, CA, "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""say performed according to manufacturer\u2019s instruction. Samples were analyzed with a BD Canto-II flow cytometer using the BD FACSDiva\u2122 6.1.3 software. FlowJo software (Tree Star, Inc, Ashland, OR, USA) was used for analysis of acquired data. Statistical analysis GraphPad Prism version 5.0 for Windows (Grap"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""raA (1:500) and \u03b2-Actin (1:15 000) followed by corresponding secondary antibodies (1:20 000). Western blots were quantified by densitometry using NIH ImageJ software. Intensities were normalized to \u03b2-actin loading controls. LIMK1 and LIMK2 knockdown in Nf2 \u0394Ex2 MSCs Nf2  MSCs were plated onto PLL-coated ("", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
23960073,10.1074/jbc.M113.510933,"FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas.",J Biol Chem,2013,1715,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The p21-activated kinases (PAKs) are immediate downstream effectors of the Rac/Cdc42 small G-proteins and implicated in promoting tumorigenesis in various types of cancer including brea"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24012335,10.1016/j.cell.2013.08.025,Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.,Cell,2013,1087,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Although Merlin/NF2 was discovered two decades ago as a tumor suppressor underlying Neurofibromatosis type II, its precise molecular mechanism remains poorly unde"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24035394,10.1016/j.celrep.2013.08.011,Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.,Cell Rep,2013,1201,7607,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""EXPERIMENTAL PROCEDURES Mice PlpCreERT; Nf1fl / +; eGFP  and  PlpCreERT; Nf1fl / fl; eGFP  mouse husbandry, tamoxifen injections, tissue processing, histology, and electron microscopy were perf"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""EXPERIMENTAL PROCEDURES Mice PlpCreERT; Nf1fl / +; eGFP  and  PlpCreERT; Nf1fl / fl; eGFP  mouse husbandry, tamoxifen injections, tissue processing, histol"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""e diameter of each axon by the diameter of the same axon together with its myelin sheath in 1,000\u20132,000 axons per animal (n = 3\u20135 per genotype) using ImageJ software. Western Blots Optic nerves (n = 3\u20135 animals/genotype) were individually lysed and sonicated in 200 \u03bcl lysis buffer on ice and then clarifie"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ll stain (1:1,000; Invitrogen) was also used. Behavior Behavioral assessments were completed on 3- to 4-month-old male  CNP-HRas  animals. Locomotor, startle, Morris water maze, and parallel bar tasks were assessed as previously described ( Skelton et al., 2011 ;  Vorhees and Williams, 2006 ;  Kamens an"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,J Transl Med,2013,2679,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumors (MPNST) are rare highly aggressive sarcomas that affect 8-13% of people with neurofibromatosis type 1. "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24065580,10.1177/0883073813500849,Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.,J Child Neurol,2013,1109,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Children with neurodevelopmental disorders are at increased risk for sleep issues, which affect quality of life, cognitive function, and behavior. To determ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24101736,10.1093/neuonc/not120,Detection of tumor progression in optic pathway glioma with and without neurofibromatosis type 1.,Neuro Oncol,2013,1725,583,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods From a retrospective review of a cohort of 69 patients, 54 patients met inclusion criteria (31 with primary chemotherapy, 4 with primary radiotherapy, a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
24132643,10.1002/path.4294,EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis.,J Pathol,2014,1330,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumours (MPNSTs), which develop sporadically or from neurofibromatosis, recur frequently with high metastatic potential and poor "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24211110,10.1016/j.ajpath.2013.09.022,Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.,Am J Pathol,2014,1713,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) results from mutations in the NF1 tumor-suppressor gene, which encodes neurofibromin, a negative regulator of diverse Ras signaling cascades. Arteri"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) results from mutations in the NF1 tumor-suppressor gene, which encodes neurofibromin, a negative regulator of diverse Ras s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24213576,10.1038/onc.2013.477,PPAR/ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.,Oncogene,2014,1234,4375,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Plasmids pBABE-puro- Pten  was obtained by cloning mouse  Pten  into pBABE-puro and pBABE-puro- Mek -DD   and pWZL-hygro-H-RASV12 wer"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""rotein on the  71 Ubiquitin C  gene (for mouse genes) or  \u03b2-Actin  gene (for human genes). Statistical analysis All data analysis was performed using GraphPad Prism v 5.0 (GraphPad Software, La Jolla, CA). Values represent means \u00b1 S.E.M., as indicated. Statistical significance was assessed using one-tailed Studen"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
24232507,10.1007/s00401-013-1209-3,Neuregulin-1 overexpression and Trp53 haploinsufficiency cooperatively promote de novo malignant peripheral nerve sheath tumor pathogenesis.,Acta Neuropathol,2014,1782,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""heath tumors (MPNSTs) are Schwann cell-derived malignancies that arise from plexiform neurofibromas in patients with mutation of the neurofibromin 1 (NF1) gene. We have shown that the growth factor neuregulin-1 (NRG1) also contributes to human neurofibroma and MPNST pathogenesis and that outbred C57BL/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are Schwann cell-derived malignancies that arise from plexiform neurofibromas in patients with mutation of the ne"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24249801,10.1212/01.wnl.0000435743.49414.b6,Achieving consensus for clinical trials: the REiNS International Collaboration.,Neurology,2013,1774,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The neurofibromatoses (NF)--including neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and schwannomatosis--are related tumor-suppressor syndromes characterized by a predisposition to multiple tumor types an"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The neurofibromatoses (NF)--including neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and schwannomatosis--are related tumor-suppressor syndromes charac"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24249802,10.1212/01.wnl.0000435745.95155.b8,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,Neurology,2013,1377,306,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eurofibromatosis and Schwannomatosis Visual Outcomes Committee is to define the best functional outcome measures for future neurofibromatosis type 1 (NF1)-associated optic pathway glioma (OPG) clinical trials. METHODS: The committee considered the components of vision, other ophthalmologic parameters a"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods: The committee considered the components of vision, other ophthalmologic parameters affected by OPG, potential biomarkers of visual function, and quality of life measures to"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
24249804,10.1212/01.wnl.0000435744.57038.af,Recommendations for imaging tumor response in neurofibromatosis clinical trials.,Neurology,2013,1724,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""OBJECTIVE: Neurofibromatosis (NF)-related benign tumors such as plexiform neurofibromas (PN) and vestibular schwannomas (VS) can cause substantial morbidity. Clinica"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24249806,10.1212/01.wnl.0000435747.02780.bf,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,Neurology,2013,1730,470,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: The REiNS PRO group selected core endpoint domains important to assess in NF. The members developed criteria to rate PRO measures, including patient charac"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
24259290,10.18632/oncotarget.1422,Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis.,Oncotarget,2013,1437,9458,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Inhibitors The SIRT2 inhibitors AGK-2; CAS name 2-Cyano-3-[5-(2,5-dichlorophenyl)-2-furanyl]-N-5-quinolinyl-2-propenamide and AK1; CA"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""al volume of concentrated proteins from medium and 10 \u03bcg of protein of cell lysates were analyzed by western blotting for HMGB1. Statistical Analysis GraphPad Prism version 5.0 for Windows (GraphPad, La Jolla, CA, USA) was used for statistical analysis and graph generation. AGK-2 and AK1 dose-response experiments"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""mary antibodies, followed by their corresponding secondary antibodies at 1:20,000. Quantification of western blots was done by densitometry using NIH ImageJ software. Immunofluorescence Control and merlin-mutant MSC were plated on coated German glass coverslips (200 \u03bcg/ml PLL and 10 \u03bcg/ml Laminin) and imm"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
24261697,10.1111/bpa.12110,High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.,Brain Pathol,2014,1442,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Meningiomas are common central nervous system tumors. The World Health Organization (WHO) defines three grades, predictive of the risk of recurrence. These tumors c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24285727,10.1158/0008-5472.CAN-13-1934,Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors.,Cancer Res,2014,1352,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal disorder that affects neural crest-derived tissues, leading to a wide spectrum of clinical presentations. Patients commonly present "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal disorder that affects neural crest-derived tissues, leading to a wide spectrum of clinical presentations. P"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24295733,10.1016/j.brainresbull.2013.11.005,Rapamycin improves sociability in the BTBR T(+)Itpr3(tf)/J mouse model of autism spectrum disorders.,Brain Res Bull,2014,1588,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Overactivation of the mammalian target of rapamycin (mTOR) has been implicated in the pathogenesis of syndromic forms of autism spectrum disorders (ASDs),"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24297905,10.1073/pnas.1222078110,Regulation of Son of sevenless by the membrane-actin linker protein ezrin.,Proc Natl Acad Sci U S A,2013,1313,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Receptor tyrosine kinases participate in several signaling pathways through small G proteins such as Ras (rat sarcoma). An important component in the a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24309211,10.1093/brain/awt327,Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling.,Brain,2014,1380,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Axonal surface proteins encompass a group of heterogeneous molecules, which exert a variety of different functions in the highly interdependent relationship bet"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24336571,10.1126/science.1247005,Genome-scale CRISPR-Cas9 knockout screening in human cells.,Science,2014,1022,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s whose loss is involved in resistance to vemurafenib, a therapeutic RAF inhibitor. Our highest-ranking candidates include previously validated genes NF1 and MED12, as well as novel hits NF2, CUL3, TADA2B, and TADA1. We observe a high level of consistency between independent guide RNAs targeting the sa"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The simplicity of programming the CRISPR (clustered regularly interspaced short palindromic repeats)-associated nuclease Cas9 to modify specific genomic loci suggests a n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,Ann Neurol,2014,1725,442,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1 GEM"": ""b07051a7-b584-45ae-82ad-f7bb85c1dea5""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods De-identified clinical data were analyzed to determine the impact of sex on optic glioma-associated visual decline in children with NF1. In addition,  Nf1  GEM were employed as experimental platforms to investigate sexually dimorphic differences in learning/memory, visual acuity, reti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1 GEM"": {""context"": "" Deidentified clinical data were analyzed to determine the impact of sex on optic glioma-associated visual decline in children with NF1. In addition, Nf1 GEM were employed as experimental platforms to investigate sexually dimorphic differences in learning/memory, visual acuity, retinal ganglion cell (RGC) "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods De-identified clinical data were analyzed to determine the impact of sex on optic glioma-associated visual decline in children with NF1. In addition,  Nf1  GEM were employed as expe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1 GEM"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
24431436,10.1523/JNEUROSCI.3096-13.2014,Neurofibromin is the major ras inactivator in dendritic spines.,J Neurosci,2014,836,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ique in combination with 2-photon glutamate uncaging, we show that neurofibromin, in which loss-of-function mutations cause Neurofibromatosis Type 1 (NF1), contributes to the majority (\u223c90%) of Ras inactivation in dendritic spines of pyramidal neurons in the CA1 region of the rat hippocampus. Loss of n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In dendritic spines, Ras plays a critical role in synaptic plasticity but its regulation mechanism is not fully understood. Here, using a fluorescence resonan"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",PLoS One,2014,1950,10896,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Mouse breeding and genotyping Nf1Prx1 and Nf1Col1 mice were bred and genotyped as described previously  [11] ,  [13] . All experimental procedures were approved by the \u2018Landesamt f\u00fcr "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Mouse breeding and genotyping Nf1Prx1 and Nf1Col1 mice were bred and genotyped as described previously  [11] ,  [13] . All experiment"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""to map mineralization degree and element gradients in whole humeri tissues from respective Nf1Prx1 samples. Analysis of EDX images was performed with ImageJ (Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, imagej.nih.gov/ij/, 1997\u20132012)."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
24470552,10.1093/neuonc/not317,Treatment of orthotopic malignant peripheral nerve sheath tumors with oncolytic herpes simplex virus.,Neuro Oncol,2014,1804,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eripheral nerve sheath tumors (MPNSTs) are an aggressive and often lethal sarcoma that frequently develops in patients with neurofibromatosis type 1 (NF1). We developed new preclinical MPNST models and tested the efficacy of oncolytic herpes simplex viruses (oHSVs), a promising cancer therapeutic that "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": ""Mouse MPNST cell lines formed tumors with varying growth kinetics. A single intratumoral injection of G47\u0394 in sciatic nerve tumors derived from human S462 MSLCs in athymic mice or mouse M2 (37-3-18-4) cells in immunocompetent mice significantly inhibited tumor growth and prolonged survival. Local IL-12 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUNDS: Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive and often lethal sarcoma that frequently develops in patients with neurofib"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24500418,10.1093/neuonc/nou004,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",Neuro Oncol,2014,1704,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: RAS is dysregulated in neurofibromatosis type 1 (NF1) related plexiform neurofibromas (PNs). The activity of tipifarnib, which blocks RAS signaling by inhibiting its farnesylation, was tested in childre"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: RAS is dysregulated in neurofibromatosis type 1 (NF1) related plexiform neurofibromas (PNs). The activity of tipifarnib, which blocks RAS signal"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24506781,10.1089/nat.2013.0461,Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases.,Nucleic Acid Ther,2014,561,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24558021,10.1093/neuonc/nou020,Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas.,Neuro Oncol,2014,1727,467,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Large sets of human schwannomas, totaling 68 tumors, were analyzed using complementary proteomic approaches. RTK arrays identified the most frequently ac"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,PLoS One,2014,1080,2415,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods \n NF2  transgenes and genetic rescue experiments Transgenes expressing the indicated  NF2  proteins were cloned with N-terminal Flag "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""),  ApGal4/P[hNF2  - using Trizol (Invitrogen). cDNA was produced using the Taqman kit (ABI) and quantitative PCR performed using the LightCycler FastStart SYBR green system (Roche). Iso1 ]; P[hNF2 Iso1 ]/+, ApGal4/+; (2X)P[hNF2 Iso2 ]/+"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
24619350,10.1007/s00415-014-7303-1,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,J Neurol,2014,1648,2819,0,1,2,3,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Ethical approval The study was approved as a clinical evaluation, with study number 3711, by the Clinical Audit Group committee at Guy\u2019s and St Thomas\u2019 National H"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": "" exclusion criteria NIFTI-QOL data were collected for all patient visits to the national NF2 services at Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust, Oxford University Hospitals NHS Trust, Addenbrooke\u2019s Hospital, Cambridge University NHS Foundation Trust, Central Manchester University Hospitals Foundat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""naire due to visual or motor difficulties were assisted by a specialist nurse. Statistics The NFTI-QOL, clinical, and genetic data were analysed with SPSS using correlation, linear regression, and analysis of variance (ANOVA) tools as required."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
24676424,10.2340/00015555-1843,Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.,Acta Derm Venereol,2014,935,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 syndrome (NF1) is caused by mutations in the NF1 gene. Availability of new sequencing technology prompted us to search for an alternative method for NF1 mutation a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 syndrome (NF1) is caused by mutations in the NF1 gene. Availability of new sequencing technology prompted us to search for an alt"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,Oncotarget,2014,1710,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ft tissue sarcomas that occur spontaneously, or from benign plexiform neurofibromas, in the context of the genetic disorder Neurofibromatosis Type 1 (NF1). The current standard treatment includes surgical resection, high-dose chemotherapy, and/or radiation. To date, most targeted therapies have failed "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that occur spontaneously, or from benign plexiform neurofibromas, in the context of the "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24686726,10.1038/oncsis.2014.10,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,Oncogenesis,2014,1662,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Dysregulation of Sonic hedgehog (Shh) signaling has been implicated in glioma pathogenesis. Yet, the role of this pathway in gliomagenesis remains controv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24753394,10.1002/pbc.25041,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,Pediatr Blood Cancer,2014,1704,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""al anti-inflammatory, antifibrotic agent with activity in idiopathic pulmonary fibrosis, may mediate anti-tumor activity in neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN) by inhibition of fibroblast proliferation and collagen synthesis. The primary objective of this open label, single "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Pirfenidone, an oral anti-inflammatory, antifibrotic agent with activity in idiopathic pulmonary fibrosis, may mediate anti-tumor activity in ne"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24815379,10.1016/j.jmoldx.2014.02.007,Application of COLD-PCR for improved detection of NF2 mosaic mutations.,J Mol Diagn,2014,1439,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Somatic mosaicism represents the coexistence of two or more cell populations with different genotypes in one person, and it is involved in >30 monogenic disorders. Somat"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,PLoS One,2014,1199,8643,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods To identify potential therapeutic targets for these tumors, we leveraged primary mouse  Nf2 -deficient spinal cord neural progenitor cells. Materials and Methods Ethics Stateme"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ined with DAPI. Statistical Analysis Statistical significance (p<0.05) was determined using the appropriate test as described in figure legends using GraphPad Prism 5.0 software (GraphPad Inc., La Jolla CA)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
24832557,10.1016/j.ajpath.2014.04.006,Trp53 haploinsufficiency modifies EGFR-driven peripheral nerve sheath tumorigenesis.,Am J Pathol,2014,1614,0,0,1,1,2,"{""cell_lines"": {""HSC1\u03bb"": ""a0193c87-8813-4841-92e7-ee5095bd94fe""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:HSC1\u03bb"": {""context"": ""cate that TP53 haploinsufficiency and increased EGFR expression co-occur in human MPNST samples. Concurrent modulation of EGFR and TP53 expression in HSC1\u03bb cells significantly increased proliferation and anchorage-independent growth in vitro. Transgenic mice heterozygous for a Trp53-null allele and overe"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are genetically diverse, aggressive sarcomas that occur sporadically or in association with neurofibromatosis typ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:HSC1\u03bb"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491775,,Genetic analysis of eight loci tightly linked to neurofibromatosis 1.,Am J Hum Genet,1989,924,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The genetic locus for neurofibromatosis 1 (NF1) has recently been mapped to the pericentromeric region of chromosome 17. We have genotyped eight previously identified RFLP probes on 50 NF1 familie"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The genetic locus for neurofibromatosis 1 (NF1) has recently been mapped to the pericentromeric region of chromosome 17. We have genotyped eight previously identified RFLP"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491777,,Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.,Am J Hum Genet,1989,1275,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) gene has been localized to the pericentromeric region of chromosome 17. We have screened six multigenerational families with multiple, tightly linke"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) gene has been localized to the pericentromeric region of chromosome 17. We have screened six multigenerational f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491778,,Flanking markers for the gene causing von Recklinghausen neurofibromatosis (NF1).,Am J Hum Genet,1989,749,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosome 17. We have used additional DNA ma"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The defective gene causing von Recklinghausen neurofibromatosis (NF1), one of the most common inherited disorders affecting the human nervous system, was recently mapped to chromosom"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491779,,A refined genetic map of the region of chromosome 17 surrounding the von Recklinghausen neurofibromatosis (NF1) gene.,Am J Hum Genet,1989,1129,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) gene has been mapped to the pericentromeric region of chromosome 17. We conducted linkage analyses of NF1 by using 10 polymorphic DNA markers from t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) gene has been mapped to the pericentromeric region of chromosome 17. We conducted linkage analyses of NF1 by usi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491781,,Close flanking markers for neurofibromatosis type I (NF1).,Am J Hum Genet,1989,612,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""A genetic linkage study with 16 polymorphic DNA markers spanning the region 17p11-17q24 in 22 NF1 families is presented. Close linkage between NF1 and eight pericentromeric markers (HHH202, EW206, CRI-L946, EW203, EW301, FG2, p17H8, and CRI-L581) "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A genetic linkage study with 16 polymorphic DNA markers spanning the region 17p11-17q24 in 22 NF1 families is presented. Close linkage between NF1 and eight pericentromeric markers (HHH202,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491782,,"Linkage analysis of neurofibromatosis type I, using chromosome 17 DNA markers.",Am J Hum Genet,1989,845,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The gene for von Recklinghausen neurofibromatosis type 1 (NF1) has recently been mapped to the pericentromeric region of human chromosome 17. To further localize the NF1 gene, linkage analysis using chromosome 1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The gene for von Recklinghausen neurofibromatosis type 1 (NF1) has recently been mapped to the pericentromeric region of human chromosome 17. To further localize "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491783,,Physical mapping of the von Recklinghausen neurofibromatosis region on chromosome 17.,Am J Hum Genet,1989,1495,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) locus has been linked to chromosome 17, and recent linkage analyses place the gene on the proximal long arm. NF1 probably resides in 17q11.2, since "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The von Recklinghausen neurofibromatosis (NF1) locus has been linked to chromosome 17, and recent linkage analyses place the gene on the proximal long arm. NF1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491784,,Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.,Am J Hum Genet,1989,1703,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In addition to reporting, in accompanying papers, their individual analyses of mapping the neurofibromatosis type 1 (NF1) gene on chromosome 17, members of the International Consortium for NF1 Linkage contributed their data for our joint analysis to determine the exact "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In addition to reporting, in accompanying papers, their individual analyses of mapping the neurofibromatosis type 1 (NF1) gene on chromosome 17, members of the Intern"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2491785,,"The order of loci in the pericentric region of chromosome 17, based on evidence from physical and genetic breakpoints.",Am J Hum Genet,1989,1125,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Previous genetic analyses of chromosome 17 markers and NF1 (Fain et al. 1987) were extended in an attempt to order marker loci that map physically to 17cen----17q12. Three additional markers (HHH202, CRI-L581"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Previous genetic analyses of chromosome 17 markers and NF1 (Fain et al. 1987) were extended in an attempt to order marker loci that map physically to 17"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,Genome Biol,2014,1848,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ecurrent breakpoints. The mechanisms underlying these non-recurrent copy number changes have not yet been fully elucidated. RESULTS: We analyze large NF1 deletions with non-recurrent breakpoints as a model to investigate the full spectrum of causative mechanisms, and observe that they are mediated by v"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Genomic disorders are caused by copy number changes that may exhibit recurrent breakpoints processed by nonallelic homologous recombination. How"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
24997609,10.1038/nm.3583,"Asfotase- improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",Nat Med,2014,1302,11836,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" and drugs All procedures were approved by the Vanderbilt University Medical Center\nInstitutional Animal Care and Use Committee (IACUC). WT and  Col2-Nf1  KO\nmice were generated by crossing  Nf1 flox/flox  mice and\n Nf1 flox/+ ;  \u03b11(II)\ncollagen-Cre  breeders .  54 , 55 Nf1 flox/flox \nmice and  Nf1 flo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Animals and drugs All procedures were approved by the Vanderbilt University Medical Center\nInstitutional Animal Care and Use Committee (IACUC). WT and  Col2-Nf1  KO"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""in which the p-value was adjusted ( p adj  <\n0.05) by Holm-Sidak\u2019s method or Dunn\u2019s method (non-parametric).\nStatistical analysis was performed using GraphPad PRISM (v6.0a, La Jolla, CA). Data are\nprovided as mean +/\u2212 SD."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""r data acquisition\nensured wavenumber calibration consistency. Spectral intensities for known Raman peaks and\npeak ratios were extracted using custom Matlab software (Mathworks, Natick, MA) to\ngenerate markers of bone composition for mineralization (v1 Phosphate/Proline) and\ncrystallinity (crystal grain s"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,J Bone Miner Res,2015,2089,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disease with an incidence of 1/3000, caused by mutations in the NF1 gene, which encodes the RAS/GTPase-activating protein n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is an autosomal dominant disease with an incidence of 1/3000, caused by mutations in the NF1 gene, which encodes the RAS/GT"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25079666,10.3791/51093,Primary culture of human vestibular schwannomas.,J Vis Exp,2014,1227,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Vestibular schwannomas (VSs) represent Schwann cell (SC) tumors of the vestibular nerve, compromising 10% of all intracranial neoplasms. VSs occur in either spo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25113746,10.1093/hmg/ddu414,A murine model of neurofibromatosis type 2 that accurately phenocopies human schwannoma formation.,Hum Mol Genet,2015,1446,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is an autosomal dominant genetic disorder resulting from germline mutations in the NF2 gene. Bilateral vestibular schwannom"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25184332,10.1371/journal.pone.0106767,Heat hyperalgesia and mechanical hypersensitivity induced by calcitonin gene-related peptide in a mouse model of neurofibromatosis.,PLoS One,2014,1886,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ating protein, exhibit a nociceptive phenotype and probed a possible contribution by calcitonin gene-related peptide. In the absence of inflammation, Nf1+/- mice (B6.129S6 Nf1<tm1Fcr>/J) and wild type littermates responded comparably to heat or mechanical stimuli, except for a subtle enhanced mechanica"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""ating protein, exhibit a nociceptive phenotype and probed a possible contribution by calcitonin gene-related peptide. In the absence of inflammation, Nf1+/- mice (B6.129S6 Nf1<tm1Fcr>/J) and wild type littermates responded comparably to heat or mechanical stimuli, except for a subtle enhanced mechanical s"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""This study examined whether mice with a deficiency of neurofibromin, a Ras GTPase activating protein, exhibit a nociceptive phenotype and probed a possible contribution by calci"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25246427,10.1093/neuonc/nou287,The impact of coexisting genetic mutations on murine optic glioma biology.,Neuro Oncol,2015,1758,522,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Nf1 +/\u2212 mice were intercrossed with  Nf1 flox/flox  mice, which were then crossed with  Nf1 flox/flox ; GFAP-Cre mice, to generate  Nf1 flox/mut ; GFAP-C"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1+/-"": {""context"": ""udy was to leverage Nf1 genetically engineered mouse strains to define the functional significance of these changes to optic glioma biology. METHODS: Nf1+/- mice were intercrossed with Nf1(flox/flox) mice, which were then crossed with Nf1(flox/flox); GFAP-Cre mice, to generate Nf1(flox/mut); GFAP-Cre (FMC"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Nf1 +/\u2212 mice were intercrossed with  Nf1 flox/flox  mice, which were then crossed with  Nf1 flox/flox ; GFAP-Cre mice, to generate  Nf1 flox/mut ; GFAP-Cre (FMC) mice"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
25274808,10.1523/JNEUROSCI.2894-13.2014,Hippocampal dysregulation of neurofibromin-dependent pathways is associated with impaired spatial learning in engrailed 2 knock-out mice.,J Neurosci,2014,1631,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Genome-wide association studies indicated the homeobox-containing transcription factor Engrailed-2 (En2) as a candidate gene for autism spectrum disorders (ASD). Accordingly, En2 knock-out (En2(-/-)) mice show anatomic"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25289889,10.1097/NEN.0000000000000126,Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades.,J Neuropathol Exp Neurol,2014,1591,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Chemotherapeutic agents effective against malignant peripheral nerve sheath tumors (MPNSTs) are urgently needed. We recently found that tamoxifen potently impe"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25325900,10.1089/gtmb.2014.0109,The use of next-generation sequencing in molecular diagnosis of neurofibromatosis type 1: a validation study.,Genet Test Mol Biomarkers,2014,1459,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""AIMS: We assessed the validity of a next-generation sequencing protocol using in-solution hybridization-based enrichment to identify NF1 mutations for the diagnosis of 86 patients with a prototypic genetic syndrome, neurofibromatosis type 1. In addition, other causative genes for class"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""AIMS: We assessed the validity of a next-generation sequencing protocol using in-solution hybridization-based enrichment to identify NF1 mutations for the diagnosis of 86 patients with a prototypi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated caf-au-lait macule count identified using multi-platform analysis.,PLoS Genet,2014,1818,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant, monogenic disorder of dysregulated neurocutaneous tissue growth. Pleiotropy, variable expressivity and few NF1 genotype-ph"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant, monogenic disorder of dysregulated neurocutaneous tissue growth. Pleiotropy, variable expressivit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25335493,10.1038/ejhg.2014.220,Expanding the mutational spectrum of LZTR1 in schwannomatosis.,Eur J Hum Genet,2015,1390,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomatosis is characterized by the development of multiple non-vestibular, non-intradermal schwannomas. Constitutional inactivating variants in two genes, SMARCB1 and, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25336744,10.1242/dev.111260,The tumor suppressor Nf2 regulates corpus callosum development by inhibiting the transcriptional coactivator Yap.,Development,2014,1585,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The corpus callosum connects cerebral hemispheres and is the largest axon tract in the mammalian brain. Callosal malformations are among the most common cong"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,PLoS One,2014,1396,5533,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Ethical approvals For the donation of human biological samples approval OB-061/05 by the Institutional Review Board of the University"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""amburg 112/11 by the Animal Care and Use Committee of Hamburg. Specimen and  in vitro  study The donor of the study specimen was a 12-year-old female NF1 patient, diagnosed according to the modified National Institutes of Health criteria  [18] . A parent of the patient gave informed written consent in "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""thylene glycol 300. Imatinib (as the mesylate salt) was dissolved in sterile water. Oral administration at a daily dose of 100 mg/kg of the drugs was started on day 7 after implantation and was continued to day 35. Body weights of the mice were recorded daily and the drug dosage was adjusted accordingly"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
25360213,,A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2.,Am J Transl Res,2014,1640,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Mutations in the merlin tumor suppressor gene cause Neurofibromatosis type 2 (NF2), which is a disease characterized by development of multiple benign tumors in the nervo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25367036,10.1101/gad.246603.114,NF1 regulation of RAS/ERK signaling is required for appropriate granule neuron progenitor expansion and migration in cerebellar development.,Genes Dev,2014,1259,3924,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Animals NF1 flox/flox , hGFAP-cre , and  Nestin-CreER  lines were generated as described ( T2 Zhu et al. 2001 ;  Zhuo et al. 2001 ;  Chen et al. 2009 ).  NF1 ,  "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Animals NF1 flox/flox , hGFAP-cre , and  Nestin-CreER  lines were generated as described ( T2 Zhu et al. 2001 ;  Zhuo et al. 2001 ;  "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" were followed by Tukey\u2019s-Kramer post hoc test for significance. A value of  P  < 0.05 was deemed statistically significant. Data were analyzed using GraphPad Prism, version 6.02 (GraphPad Software)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
25377441,10.1111/pme.12620,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,Pain Med,2015,1735,615,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eeks (0\u20136 scale); higher scores indicate more pain interference. Eligible participants included individuals 6\u201325 years with neurofibromatosis type 1 (NF1) and cancer. Internal consistency was assessed; validity was examined by correlating PII scores with existing measures of pain interference (Modified"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods. We adapted the PII for English-speaking participants and created a parallel parent proxy measure. Respondents indicate how much pain has interfered with the child\u2019s life in"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,Dev Biol,2015,917,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Molecular mechanisms governing the maintenance and proliferation of dorsal root ganglia (DRG) progenitors are largely unknown. Here we reveal that the Hippo pa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25437375,10.1016/j.cortex.2014.10.019,"Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.",Cortex,2015,2019,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder characterized by a broad spectrum of cognitive deficits. In particular, executive dysfunction is recognized as a co"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder characterized by a broad spectrum of cognitive deficits. In particular, executive dysfunct"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25452392,10.1093/neuonc/nou317,Evidence of polyclonality in neurofibromatosis type 2-associated multilobulated vestibular schwannomas.,Neuro Oncol,2015,1807,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 2 (NF2) is a tumor syndrome that results from mutation of the NF2 tumor suppressor gene. The hallmark of NF2 is the prese"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25475340,10.1186/s13023-014-0202-9,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,Orphanet J Rare Dis,2014,1885,7476,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods The sample comprised 92 individuals with NF1. Paper frames, with a central square measuring 100\u00a0cm 2 , were placed on the back, abdomen and thigh. Images were taken, transferred to a computer an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The sample comprised 92 individuals with NF1. Paper frames, with a central square measuring 100\u00a0cm 2 , were placed on the back, abdomen and thigh. Images were taken, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""trained examiner (RMA; examiner A). Neurofibromas on genitals and scalp were not included. Statistical analysis For statistical analysis, we used the SPSS software (IBM\u00ae SPSS\u00ae, v. 20.0, Armonk, NY, USA) and Excel 2011 (Microsoft Corporation, Redmond, WA, USA).  P  values less than 0.05 were considered s"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
25480913,10.1212/WNL.0000000000001129,Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis.,Neurology,2015,1262,391,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: We used exome sequencing, Sanger sequencing, and copy number analysis to screen 65 unrelated individuals with schwannomatosis who were negative for a germline  NF2  or  SMARCB1  muta"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
25483400,10.1016/j.biopsych.2014.07.031,Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.,Biol Psychiatry,2015,1725,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: The neurofibromatosis type 1 (Nf1) gene encodes a GTPase activating protein that negatively regulates small GTPases of the Ras family. METHODS: We assessed alcohol-related behaviors i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: The neurofibromatosis type 1 (Nf1) gene encodes a GTPase activating protein that negatively regulates small GTPases of the Ras family. METHODS: "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
2551169,,Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.,Am J Pathol,1989,904,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Multiple peripheral nervous tumors were induced in 45 of 60 (75.0%) Syrian golden hamsters by transplacental administration of N-ethyl-N-nitro-sourea. Moreover, m"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25517743,10.1016/j.ccell.2014.10.007,NF GEMMs already! The power and promise of mouse tumor models.,Cancer Cell,2014,351,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibromas are one of the most common tumors encountered in individuals with the neurofibromatosis type I (NF1) cancer predisposition syndrome. In this issue of Cancer Cell, Chen and colleagues define the cell of origin for murine Nf1 plexiform neurofibroma an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibromas are one of the most common tumors encountered in individuals with the neurofibromatosis type I (NF1) cancer predisposition syndrome. I"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25534823,10.1093/neuonc/nou329,Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.,Neuro Oncol,2015,1957,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Children with neurofibromatosis type 1 (NF1) develop optic pathway gliomas, which result from impaired NF1 protein regulation of Ras activity. One obstacle to the implementation of biologically"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Children with neurofibromatosis type 1 (NF1) develop optic pathway gliomas, which result from impaired NF1 protein regulation of Ras activity. O"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,Elife,2014,1204,12287,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""thods Control and mutant mice Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an  Nf1  mutation into different cell lineages during cerebellar development. The control mice for  Nf1 hGFAP CKO mice are a pool of phenotypically indisting"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Control and mutant mice Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ed under an Olympus BX51 microscope. Images were captured and subjected to analysis. Lengths, areas and the number of cells were quantified using the ImageJ software package. Statistical analysis was carried out using unpaired two-tailed Student's t-test. Comparisons across more than two groups were based"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,Discov Med,2014,1666,456,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We performed exome sequencing on five malignant meningiomas on the Illumina HiSeq2000 platform using Agilent SureSelect Human All Exon kits. We used wANNOVA"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
25551830,10.1371/journal.pone.0115916,Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden.,PLoS One,2014,1523,8133,0,3,2,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tner (Cincinnati Children's Hospital, Cincinnati OH) and were grown as described  [17] ,  [19] . All MPNST cell lines, except STS26T was derived from NF1 patients. STS26T is a sporadic MPNST with no known NF1 mutations  [20] . Primary neurofibroma cells were isolated immediately from resected tumor tis"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Material and Methods Ethics statement All MPNST cell lines used in this article have previously been published. For detailed information about ST8814, T265"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": "" in this article have previously been published. For detailed information about ST8814, T265 and STS26T please refer to  [17] , for information about S462-TY and the establishment of the S462-TY xenograft model refer to  [18] . The xenograft mouse models were in compliance with federal guidelines and un"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""aterial and Methods Ethics statement All MPNST cell lines used in this article have previously been published. For detailed information about ST8814, T265 and STS26T please refer to  [17] , for information about S462-TY and the establishment of the S462-TY xenograft model refer to  [18] . The xenograft "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""tween 8 to 32 folds. After incubation overnight, we could detect the sAXL level at a concentration as low as 1 pg/ml with the dose dependent readings starting from 8 pg/ml (data not shown). To detect the sAXL in conditioned media, MPNST cell lines were grown in culture until 70% confluence. Plates were "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
25557241,10.1016/j.fertnstert.2014.11.021,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,Fertil Steril,2015,1783,10066,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PARTICIPANTS/MATERIALS, SETTING, METHODS A PGT assay was developed for 281 couples with 218 different variants in  NF1 . Newly described variants (n\u2009=\u200976) were scored using the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""PARTICIPANTS/MATERIALS, SETTING, METHODS A PGT assay was developed for 281 couples with 218 different variants in  NF1 . Newly described variants (n\u2009=\u200976"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
25596744,10.18632/oncotarget.2810,Group I Paks as therapeutic targets in NF2-deficient meningioma.,Oncotarget,2015,1404,11078,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""METHODS Meningioma cell lysates Lysates from 11 primary meningioma cells of different WHO grades and 3 arachnoidal cell lines were kindly provided by Dr. Vijaya Ramesh, Harvard Medical School "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
2562822,,Fine structure DNA mapping studies of the chromosomal region harboring the genetic defect in neurofibromatosis type I.,Am J Hum Genet,1989,1310,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""To better map the location of the von Recklinghausen neurofibromatosis (NF1) gene, we have characterized a somatic cell hybrid designated 7AE-11. This microcell-mediated, chromosome-transfer construct harbors a centromeric se"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""To better map the location of the von Recklinghausen neurofibromatosis (NF1) gene, we have characterized a somatic cell hybrid designated 7AE-11. This microcel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25692621,10.4161/15384047.2014.972765,Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.,Cancer Biol Ther,2015,1278,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Vestibular schwannoma (VS), the fourth most common intracranial tumor, arises from the Schwann cells of the vestibular nerve. Although several pathways have bee"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
2573276,,Refined physical and genetic mapping of the NF1 region on chromosome 17.,Am J Hum Genet,1989,1022,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""A total of 15 polymorphic markers were used to construct a genetic map that encompasses the NF1 locus on chromosome 17. The markers were a subset of a large collection of chromosome 17-specific probes and were selected for marker typing in NF1 f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A total of 15 polymorphic markers were used to construct a genetic map that encompasses the NF1 locus on chromosome 17. The markers were a subset of a large collection of "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,Cell Rep,2015,1177,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""esistance. Unfortunately, there is a lack of comparable reagents for the study of pediatric low-grade glioma (LGG). Leveraging a neurofibromatosis 1 (Nf1) genetically engineered mouse LGG model, we report the isolation of CD133(+) multi-potent low-grade glioma stem cells (LG-GSCs), which generate gliom"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The availability of adult malignant glioma stem cells (GSCs) has provided unprecedented opportunities to identify the mechanisms underlying treatment resistance. Unfortunately, there is a lack of comparable reagents f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25788518,10.1093/hmg/ddv103,Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.,Hum Mol Genet,2015,1360,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant neurologic condition characterized by significant clinical heterogeneity, ranging from malignant cancers to cognitive"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant neurologic condition characterized by significant clinical heterogeneity, ranging from malig"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,J Clin Neurol,2015,1673,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND AND PURPOSE: Individualized drug testing for tumors using a strategy analogous to antibiotic tests for infectious diseases would be highly desira"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25877069,10.1007/s11626-015-9885-z,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,In Vitro Cell Dev Biol Anim,2015,1354,8077,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Isolation of mouse primary mesothelial cells and mesothelioma cells from a NF2+/\u2212 mouse. Mesothelial cells were isolated from 4 to 6\u00a0"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""NF2_RV mutant (5\u2032-CTATCAGGACATAGCGTTGG-3\u2032) primers. The cell line RN5 was isolated from an Nf2+/\u2212 mouse that was repeatedly injected with crocidolite starting at 8\u00a0wk of age (7\u2009\u00d7\u2009400\u00a0\u03bcg). Briefly, a clearly discernible tumor localized on the liver was dissected from the mouse 21\u00a0wk after the first injec"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
25884485,10.1186/s40246-015-0025-3,Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.,Hum Genomics,2015,1521,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type-1 (NF1) is a complex neurogenetic disorder characterised by the development of benign and malignant tumours of the peripheral nerve sheath (MPNSTs). Whilst "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type-1 (NF1) is a complex neurogenetic disorder characterised by the development of benign and malignant tumours of the periph"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25887585,10.1186/s12859-015-0485-4,NMF-mGPU: non-negative matrix factorization on multi-GPU systems.,BMC Bioinformatics,2015,2417,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: In the last few years, the Non-negative Matrix Factorization ( NMF ) technique has gained a great interest among the Bioinformatics community, s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25893273,10.1007/s13361-015-1143-9,High spatial resolution imaging mass spectrometry of human optic nerve lipids and proteins.,J Am Soc Mass Spectrom,2015,1366,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The human optic nerve carries signals from the retina to the visual cortex of the brain. Each optic nerve is comprised of approximately one million nerve fibers that are"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
25917016,10.1002/jbmr.2538,"Nf1 Haploinsufficiency Alters Myeloid Lineage Commitment and Function, Leading to Deranged Skeletal Homeostasis.",J Bone Miner Res,2015,1440,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approx"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Although nullizygous loss of NF1 leads to myeloid malignancies, haploinsufficient loss of NF1 (Nf1) has been shown to contribute to osteopenia and osteoporosis which occurs in approximately 50% of neurofibromatosis type 1 (NF1) patients. Bone marrow mononuclear cells of ha"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,Mol Psychiatry,2015,1053,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Cognitive impairments are a major clinical feature of the common neurogenetic disease neurofibromatosis type 1 (NF1). Previous studies have demonstrated that increased neuronal inhibition underlies the learning deficits in NF1, however, the molecular mechanism unde"", ""confidence"": 0.7, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Cognitive impairments are a major clinical feature of the common neurogenetic disease neurofibromatosis type 1 (NF1). Previous studies have demonstrated that increase"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25946318,10.1097/NEN.0000000000000201,Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.,J Neuropathol Exp Neurol,2015,1428,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin, the tumor suppressor encoded by the neurofibromatosis type 1 (NF1) gene, potentially suppresses the activation of H-Ras, N-Ras, and K-Ras. However, it is not known whether these classic Ras proteins are hyperactivat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin, the tumor suppressor encoded by the neurofibromatosis type 1 (NF1) gene, potentially suppresses the activation of H-Ras, N-Ras, and K-Ras. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25962619,10.1038/mp.2015.55,"ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.",Mol Psychiatry,2016,997,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" genes Dopamine transporter (DAT1) and Latrophilin (LPHN3), and of a gene causing a monogenic disorder with frequent ADHD comorbidity: Neurofibromin (NF1). The locomotor signature was not found in control models and could be ameliorated by methylphenidate, validating its relevance to symptoms of the di"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Attention-deficit/hyperactivity disorder (ADHD) is a common, highly heritable neuropsychiatric disorder with hyperactivity as one of the hallmarks. Aberrant dopamine signali"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
25963359,10.4103/0366-6999.156783,Auditory Rehabilitation in Rhesus Macaque Monkeys (Macaca mulatta) with Auditory Brainstem Implants.,Chin Med J (Engl),2015,1850,657,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: Six adult rhesus macaque monkeys ( M. mulatta ) were included. Under general anesthesia, a multichannel ABI was implanted into the lateral recess of the fourth v"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
26000738,10.1371/journal.pgen.1005235,Monoallelic loss of the imprinted gene Grb10 promotes tumor formation in irradiated Nf1+/- mice.,PLoS Genet,2015,1752,7146,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ture conditions Mouse tumor cell lines were grown as previously described [ 40 ]. Cell lines used were established from tumors arising in irradiated  Nf1 \n  F1 mice [ +/- 14 , 15 , 59 ]. Human cell lines were obtained from ATCC. Retroviral vectors including HA-tagged retroviral WT-Grb10 and Grb10-AA (S"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Ethics statement Tumor samples obtained from previously described mouse models were analyzed. All animal procedures were approved by "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""ay Cloning. To generate lentivirus, Grb10, MEKDD or GFP (9\u03bcg) plasmids were co-transfected with packaging plasmids \u03948.9 (9 \u03bcg) and VSVG (4.5 \u03bcg) into HEK293T cells using lipofectamine 2000 (Invitrogen). Two days after transfection, retroviral or lentiviral supernatants were harvested and filtered. Recipie"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""ed for the represented experiment. PCR array RNA was extracted with the RNAeasy kit (Qiagen). RNA purity was assessed by UV spectrophotometry using a Nanodrop p1000 (Thermo Scientific). cDNA was generated from 1 \u03bcg RNA with the Qiagen RT2 First Strand Kit. Genomic DNA was removed with the Qiagen Genomic DNA"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:NanoDrop"": [""methods""]}",False
26039236,10.3390/ijms160612345,Hyperactive RAS/PI3-K/MAPK Signaling Cascade in Migration and Adhesion of Nf1 Haploinsufficient Mesenchymal Stem/Progenitor Cells.,Int J Mol Sci,2015,1504,488,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""4.1. Animals and Materials Nf1  mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA, USA) in a C57BL/6J.129 background and backcross"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4.1. Animals and Materials Nf1  mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA, USA) in a C57BL/6J.129 background and b"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,PLoS One,2015,0,9435,0,0,4,4,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""STAR"", ""GATK"", ""BWA"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:STAR"": {""context"": ""0 ul, with 2uL 10X PCR buffer containing 1.5mM MgCl 2  (Qiagen, Hilden Germany), 0.25 mM of each dNTP, 0.5 uM of forward and reverse primers, 0.5U HotStarTaq Plus (Qiagen, Hilden, Germany) and 100 ng of genomic DNA. SYTOs 9 (Invitrogen, Eugene, Oregon, USA) was used as the intercalating dye in HRMA. PCR"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""enome hg19 with BWA MEM [ 22 ]. Alignments were soft-clipped based on forward and reverse primers length and position in each read by custom scripts. GATK version 2.5.2 [ 23 ] was used to recalibrate base qualities and realign aligned reads around indels. Regions with coverage less than or equal 100x in"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": "") according to the manufacturer\u2019s instructions. Data analysis and processing Amplicon reads were aligned against the human reference genome hg19 with BWA MEM [ 22 ]. Alignments were soft-clipped based on forward and reverse primers length and position in each read by custom scripts. GATK version 2.5.2 "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Patients and Calibration samples Constitutional DNA samples were obtained from peripheral blood leukocytes. DNA was extracted from bl"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:STAR"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:R"": [""methods""]}",False
26073082,10.1038/onc.2015.207,Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.,Oncogene,2016,1283,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to neurofibromas but the driver(s) that contribute to neurofibroma formation are not fully understood. By cross comparison "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to neurofibromas but the driver(s) that contribute to neurofibroma formation are not fully underst"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26073604,10.1016/j.str.2015.04.021,The SWI/SNF Subunit INI1 Contains an N-Terminal Winged Helix DNA Binding Domain that Is a Target for Mutations in Schwannomatosis.,Structure,2015,824,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""SWI/SNF complexes use the energy of ATP hydrolysis to remodel chromatin. In mammals they play a central role in regulating gene expression during differentiation and proliferation."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
26150484,10.1073/pnas.1501032112,In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.,Proc Natl Acad Sci U S A,2015,1457,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""\""Caf\u00e9-au-lait\"" macules (CALMs) and overall skin hyperpigmentation are early hallmarks of neurofibromatosis type 1 (NF1). One of the most frequent monogenic diseases, NF1 has subsequently been characterized with numerous benign Schwann cell-derived tumors. It is well e"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""\""Caf\u00e9-au-lait\"" macules (CALMs) and overall skin hyperpigmentation are early hallmarks of neurofibromatosis type 1 (NF1). One of the most frequent monogenic diseases, NF1 has subsequently be"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",Front Cell Neurosci,2015,1571,11152,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Animals and Experiments Generation of the  Fmr1  KO ( Mientjes et al., 2006 ),  Nf1  ( +/- Jacks et al., 1994 ), and  H-ras  mice ( G12V Schuhmacher et al., 2008 ) has been described previously.  Tsc1  animals were obtained by crossi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Animals and Experiments Generation of the  Fmr1  KO ( Mientjes et al., 2006 ),  Nf1  ( +/- Jacks et al., 1994 ), and  H-ras  mice ( G"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ured using the region-of-interest function in Volocity; images of calyx terminals were binary thresholded using the built-in thresholding function of ImageJ 1.46 (isodata algorithm). As a measure for the size of principal neurons, we identified the slice with the largest cross-section in image stacks and "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ve pressure of 300 mbar. When inside the brainstem the pressure was lowered to \u223c30 mbar after passing the brain surface, and to 0 mbar when recording started. Recordings were performed at the depth of 250\u2013500 \u03bcm from brain surface. A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Ana"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""A speaker probe was inserted into the left ear canal and was stabilized with silicone elastomer. A 2-noise-burst stimulation protocol was designed in MATLAB (Version R2008a), which consists of two 400 ms bursts of wide band noise (bandwidth 2\u201340 kHz; 80 dB SPL) with intervals of 40, 80, 160, 320, 640, or "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,Oncotarget,2015,1880,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Meningiomas are the most common primary intracranial adult tumor. All Neurofibromatosis 2 (NF2)-associated meningiomas and ~60% of sporadic meningiomas show loss of"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
26258444,10.1371/journal.pone.0129151,Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation.,PLoS One,2015,1506,13576,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Animal housing and genotyping Animals were kept according to local governmental and institutional animal care regulations (Zweckverba"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""d using ECL (Pierce-Thermo Scientific) and film (Hyperfilm ECL; GE Healthcare). Signal intensity quantification was carried out on scanned film using ImageJ software (open source software available at  rsb.info.nih.gov/ij/ ). Fertility and sperm analysis Assessment of fertility was carried out by mating o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
26272820,10.1101/gad.261677.115,Neurofibromatosis-1 regulation of neural stem cell proliferation and multilineage differentiation operates through distinct RAS effector pathways.,Genes Dev,2015,883,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common neurodevelopmental disorder caused by impaired function of the neurofibromin RAS regulator. Using a combination of Nf1 genetically engin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common neurodevelopmental disorder caused by impaired function of the neurofibromin RAS regulator. Using a combination"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26344136,10.1016/j.mod.2015.08.008,NF2/Merlin is required for the axial pattern formation in the Xenopus laevis embryo.,Mech Dev,2015,1268,14946,0,1,3,4,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. Our study examined male and female animals, and similar findings are reported for both sexes. Generation of Nf2-cKO mice. The animals were main"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""mental Table 2 . For lentivirus packaging, the second-generation packaging plasmids (psPAX2 and pMD2.G) and lentivirus vector were cotransfected into HEK293T cells (3101HUMGNHu17, BMCR) using the Lipofectamine 8000 transfection reagent (Beyotime, C0533) following manufacturer\u2019s instructions as described ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s, 1-way or 2-way ANOVA was performed. A  P  value less than 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 9 (GraphPad Software). Study approval. All the animal experiments were approved by the animal committee of Zhejiang Sci-Tech University (201911001). "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" embryo collection. EdU staining was performed based on the BeyoClick EdU-594 (C0078S, Beyotime). The Edu +  osteoprogenitor cells were counted using ImageJ (NIH) for data analysis. EdU +  cells were calculated from 3 samples using ImageJ. Apoptosis assay. The apoptosis was determined by TUNEL labeling as"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
26344771,10.1016/j.celrep.2015.08.015,Mutational Analysis of Ionizing Radiation Induced Neoplasms.,Cell Rep,2015,1115,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s has not been examined. Using our mouse models of SMNs, we performed whole exome sequencing of neoplasms induced by fractionated IR in wild-type and Nf1 mutant mice. Using non-negative matrix factorization, we identified mutational signatures that did not segregate by genetic background or histology. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Ionizing radiation (IR) is a mutagen that promotes tumorigenesis in multiple exposure contexts. One severe consequence of IR is the development of second malign"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26461061,10.1038/bjc.2015.345,"Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.",Br J Cancer,2015,1911,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Both the number and size of tumours in NF1 patients increase in response to the rise in steroid hormones seen at puberty and during pregnancy. The size of tumours decreases after delivery, sug"", ""confidence"": 0.7, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Both the number and size of tumours in NF1 patients increase in response to the rise in steroid hormones seen at puberty and during pregnancy. T"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26478990,10.1111/jnc.13396,A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.,J Neurochem,2015,1770,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition caused by dominant loss-of-function mutations of the tumor suppressor gene NF1 that encodes neurofibromin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic condition caused by dominant loss-of-function mutations of the tumor suppressor gene NF1 t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26490262,10.1111/jnc.13401,Nuclear import mechanism of neurofibromin for localization on the spindle and function in chromosome congression.,J Neurochem,2016,2053,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type-1 (NF-1) is caused by mutations in the tumor suppressor gene NF1; its protein product neurofibromin is a RasGTPase-activating protein, a property that has yet to explain aneuploidy, most often observed in astrocyte"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type-1 (NF-1) is caused by mutations in the tumor suppressor gene NF1; its protein product neurofibromin is a RasGTPase-activating prote"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26509978,10.1371/journal.pone.0141735,Functional Analysis of Mutations in Exon 9 of NF1 Reveals the Presence of Several Elements Regulating Splicing.,PLoS One,2015,1595,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is one of the most common human hereditary disorders, predisposing individuals to the development of benign and malignant tumors in the nervous syst"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is one of the most common human hereditary disorders, predisposing individuals to the development of benign and malignant t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26530423,10.1534/g3.115.021170,Chemically Induced Oncogenesis in the Peripheral Nervous System Is Suppressed in Congenic BDIX.BDIV-Mss1 and -Mss7 Rats.,G3 (Bethesda),2015,1680,4600,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Congenic breeding and genotyping The inbred rat strains, BDIX (tumor-susceptible) and BDIV (tumor-resistant), were bred and maintaine"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""cific curves were compared with log rank tests.  P  < 0.05 was considered significant. Statistical evaluations were carried out with SigmaPlot 11 and SPSS V21. Data availability Rat strains are available upon request.  File S1  contains a list of microsatellites used in speed congenic breeding and final"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""tion of a polymorphism map of chromosome 10 Single-nucleotide polymorphism (SNP) data of the parental rat strains BDIX and BDIV were generated by the STAR Consortium ( STAR Consortium  ). The SNP map of chromosome 10 was constructed by SNPlotyper ( et al.  2008 http://snplotyper.mcw.edu/ ) by the use of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
26536237,10.1371/journal.pgen.1005611,Anaplastic Lymphoma Kinase Acts in the Drosophila Mushroom Body to Negatively Regulate Sleep.,PLoS Genet,2015,983,4762,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""  [ 40 ], MB-Gal80 [ 41 ], D52H-GAL4 [ 42 ], c687-GAL4 [ 61 ], 6B-GAL4 [ 62 ], InSITE106-GAL4 [ 63 ],Cha-GAL4 [ 64 ], Kurs45-GAL4 [ 65 ] were gifts.  Nf1 \n  and  P1 Nf1 \n  alleles were reported [ P2 22 ] and were outcrossed into an  iso31  background for 7 generations.  Alk \n /CyO was a gift from Dr. J"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Fly lines The following lines were used previously in the lab [ 33 ,  37 ,  60 ]: Elav-Gal4, 201Y-GAL4, c739-GAL4, 238Y-GAL4, c309-GA"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
26549023,10.1038/onc.2015.404,"The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.",Oncogene,2016,1861,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin has broad tumor-suppressor functions as its mutations have been identified in multiple benign tumors and malignant cancers. In all schwannomas, th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
26554010,10.1073/pnas.1512570112,Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.,Proc Natl Acad Sci U S A,2015,1194,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Hearing loss is the main limitation of radiation therapy for vestibular schwannoma (VS), and identifying treatment options that minimize hearing loss are "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
26558359,10.5507/bp.2015.057,A novel genetic- and cell-based tool for assessing the efficacy and toxicity of anticancer drugs in vitro.,Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2016,2250,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" wells of the 96-well plates using a simple and inexpensive method, and subjected to digital PCR for measuring relative copy numbers of a target gene NF1 to that of a reference gene RPP30. The NF1 gene is known to be heterozygously deleted in these tumor cells while the RPP30 gene has two copies in bot"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""AIMS: To develop an in vitro tool for assessing the efficacy and toxicity of anticancer drugs using mixed culture containing both tumor and non-tumor cells. Such in vitro tool s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,PLoS One,2015,2093,5041,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Tissue Specimens Schwannomatosis tumors were collected from surgical cases from December 2012 through October 2014, occurring at John"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
26658687,10.1016/j.jhep.2015.11.028,RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.,J Hepatol,2016,1727,276,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Here, we develop a new model of reversible induction of the liver size in mice using siRNA-nanoparticles targeting two kinases of Hippo pathway, namely, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
26740486,10.1016/j.ajpath.2015.10.023,The Challenge of Cancer Genomics in Rare Nervous System Neoplasms: Malignant Peripheral Nerve Sheath Tumors as a Paradigm for Cross-Species Comparative Oncogenomics.,Am J Pathol,2016,1678,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""hat occur sporadically, after radiotherapy, and in neurofibromatosis type 1. Studies of human neurofibromatosis type 1-associated tumors suggest that NF1 tumor suppressor loss in Schwann cells triggers cell-autonomous and intercellular changes, resulting in development of benign neurofibromas; subseque"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Comprehensive genomic analyses of common nervous system cancers provide new insights into their pathogenesis, diagnosis, and treatment. Although analogous "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26740548,10.1093/hmg/ddv635,Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.,Hum Mol Genet,2016,1815,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Persons with neurofibromatosis type 1 (NF1) have a predisposition for premature and severe arterial stenosis. Mutations in the NF1 gene result in decreased expression of neurofibromin, a negat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Persons with neurofibromatosis type 1 (NF1) have a predisposition for premature and severe arterial stenosis. Mutations in the NF1 gene result in decreas"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,Sci Rep,2016,0,8961,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ble initial and boundary conditions to ensure the existence, uniqueness and non-negativity of the solution ( Fig. 1D ). To examine the effect of the  Nf1  mutation on bone fracture healing, the parameter values of the factors describing the aberrant cellular behaviour of  Nf1  haploinsufficient and  Nf"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods The multiscale computational model of bone regeneration was established previously and has been described in detail elsewhere 14 17 ."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
26840085,10.18632/oncotarget.7099,Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.,Oncotarget,2016,0,8280,0,2,2,4,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""90-8"": ""0f404e70-2acf-4877-bcd5-6da81d9fa41e""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PNST and was kindly provided by G. H. De Vries (Hines VA Hospital, Illinois, USA) [ 44 ]. MPNST cell lines 90-8, 88-14 and 96-2 were established from NF1-associated MPNST: 90-8 and 88-14 were kindly provided by Pr. N. Ratner (Cincinnati Children's Hospital Medical Center, Ohio, USA) and 96-2 was purcha"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:90-8"": {""context"": ""MATERIALS AND METHODS MPNST cell lines The MPNST-derived cell lines STS26T, 90-8, 88-14, and 96-2 were maintained in advanced RPMI-1640 with 15% heat-inactivated FBS, 2.75\u2030 Bovine Pituitary Extract, 100U/ml penicillin, and 100\u03bcg/m"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS MPNST cell lines The MPNST-derived cell lines STS26T, 90-8, 88-14, and 96-2 were maintained in advanced RPMI-1640 with 15% heat-inact"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" of continuous exposure of increasing doses of drugs as described by the manufacturer (Cell Biolabs). Cell cycle analysis MPNST cell lines were serum-starved for 24h and then treated with different drug concentrations. Drug effects on cell cycle were determined by FITC-coupled anti-BrdU antibodies (BD B"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""cell_lines:90-8"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
26861207,10.1186/s12964-016-0128-z,Feedback activation of neurofibromin terminates growth factor-induced Ras activation.,Cell Commun Signal,2016,1922,9300,0,2,3,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Cell culture and treatments/stimulations Cervical cancer (HeLa) cells, Mouse embryonic fibroblasts (MEF), H-Ras -/- , N-Ras -/- , K-Ras lox/lox  MEFs (kindly pro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Tpools purchased from Dharmacon (Dharmacon RNAi Technologies, Thermo Fisher Scientific, Lafayette, USA): Human RASA1 (5921) (L-005276-00-0005), Human NF1 (L-003916-00-0005), Human DAB2IP (L-008249-01-0005), Human RPS6KA3 (L-003026-00-0005), Human RPS6KA1 (L-003025-00-0005), Map2k1 (L-003571-00-0005), M"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""c fibroblasts (MEF), H-Ras -/- , N-Ras -/- , K-Ras lox/lox  MEFs (kindly provided by Mariano Barbacid, Madrid, Spain) and Human Embryonic Kidney 293 (HEK293T) cells were cultured at 37\u00a0\u00b0C and 5\u00a0% CO 2  atmosphere in DMEM (Dulbecco\u2019s modified Eagle\u2019s medium) supplemented with 10\u00a0% (v/v) fetal calf serum. I"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ction, the supernatant was harvested, filtrated through a 0.45\u00a0\u03bcM filter and used to infect 293\u00a0T cells. 48\u00a0h post-infection, puromycin selection was started to obtain the stable cell line. Transient transfections were performed using Polyethylenimine as described [ 64 ]. ON-TARGETplus siRNA-SMARTpool\u2122 "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""arameters of each model were adjusted to allow Ras-GTP dynamics to match Fig.\u00a0 1a . All simulations were performed with the SimBiology toolbox within MATLAB R2013b. Details of the model are described in the supplementary information (Additional file  2 : Table S1). Availability of supporting data The data"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,J Proteomics,2016,1784,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""UNLABELLED: Neurofibromatosis type 1 (NF1) is a common neurogenetic disorder, in which affected individuals develop tumors of the nervous system. Children with NF1 are particularly prone to b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""UNLABELLED: Neurofibromatosis type 1 (NF1) is a common neurogenetic disorder, in which affected individuals develop tumors of the nervous system. Children with NF1 ar"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26896440,10.1534/g3.115.026484,Neurofibromin Loss of Function Drives Excessive Grooming in Drosophila.,G3 (Bethesda),2016,0,6456,0,1,4,5,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""STAR"", ""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""dard protocols. They were housed in incubators (Darwin Chambers) maintained at 25\u00b0, 60% relative humidity, and kept on a 12:12 light:dark cycle. The  nf1 P1  mutation was backcrossed for six generations into the  wCS10  genetic background. Dopamine transporter, fumin ( fmn ), mutant flies were compared"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""  ). Total grooming time was calculated as the sum of all grooming events. et al.  2014 Statistical analysis Statistical analyses were carried out in Graphpad Prism. Data were considered normally distributed if no significant deviation from normality was detected by the D\u2019Agostino-Pearson omnibus test. Normally d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""nated to distribute any circadian variation equally across all groups. Manual scoring of videos was carried out by an observer blind to the genotype. Start and stop frames were noted for each grooming event, which was further categorized according to which body part the fly was grooming: front legs, hea"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Fly strains Flies were raised on cornmeal/agar food medium according to standard protocols. They were housed in incubators (Darwin Ch"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""time bin was averaged across 5\u00a0d, and then these data points were averaged across flies, to plot day and night activity across zeitgeber time. Custom Matlab (Mathworks) scripts were used to plot sleep and activity profiles. Sleep was calculated using a standard 5 min inactivity window ( Shaw  ). et al.  2"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/-catenin Pathway Driving Neurofibroma Initiation.,Cell Rep,2016,1121,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse models, and molecular analyses. We mapped an Nf1-Stat3-Arid1b/\u03b2-catenin pat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse models, and molecular analyses. We mapped an Nf1-S"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
26908603,10.1093/hmg/ddw039,NF1 germline mutation differentially dictates optic glioma formation and growth in neurofibromatosis-1.,Hum Mol Genet,2016,1906,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common neurogenetic condition characterized by significant clinical heterogeneity. A major barrier to developing precision medicine approaches "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common neurogenetic condition characterized by significant clinical heterogeneity. A major barrier to developing preci"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27021207,10.1002/ajmg.a.37623,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,Am J Med Genet A,2016,1794,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder affecting about 1 in 3,500 individuals. Chronic pain is commonly reported among individuals with NF1 and p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder affecting about 1 in 3,500 individuals. Chronic pain is commonly reported among i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27078850,10.18632/oncotarget.8640,Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.,Oncotarget,2016,1153,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" pairs of formalin fixed archival specimens. We identified recurrent evidence of MAP-kinase pathway activation as three patients had neurofibromin 1 (NF1) mutations, with one of these patients also harboring an oncogenic KRAS G13D mutation. We also observed recurrent evidence of Wnt/\u03b2-catenin pathway a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Urachal adenocarcinoma is a rare bladder malignancy arising from the urachal remnant. Given its rarity and the lack of knowledge about its genetic chara"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27081657,10.1002/acn3.288,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,Ann Clin Transl Neurol,2016,0,16089,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Patients and Methods Design A prospective double\u2010blind, placebo\u2010controlled, randomized 14\u2010week clinical trial was conducted in individuals with NF1 between January 2010 and March 2013. The study is registered at clinicaltrials.gov, trial #  NCT00352599 . Participants Participants were recruited f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Patients and Methods Design A prospective double\u2010blind, placebo\u2010controlled, randomized 14\u2010week clinical trial was conducted in individuals with NF1 between January 2010 and March 201"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
27103823,10.2147/OTT.S95597,Triterpenoid saponin flaccidoside II from Anemone flaccida triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors via the MAPK-HO-1 pathway.,Onco Targets Ther,2016,926,5909,0,3,1,4,"{""cell_lines"": {""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:ST88-14"": {""context"": ""Materials and methods Cells and reagents The NF1-deficient human MPNST cell lines ST88-14 and S462 were cultured in Dulbecco\u2019s Modified Eagle\u2019s Medium (10% fetal bovine serum, 1% penicillin\u2013streptomycin, 1%  l -glutamine, and 1% sodium pyr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""Materials and methods Cells and reagents The NF1-deficient human MPNST cell lines ST88-14 and S462 were cultured in Dulbecco\u2019s Modified Eagle\u2019s Medium (10% fetal bovine serum, 1% penicillin\u2013streptomycin, 1%  l -glutamine, and 1% sodium pyruvate) an"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cells and reagents The NF1-deficient human MPNST cell lines ST88-14 and S462 were cultured in Dulbecco\u2019s Modified Eagle\u2019s Medium (10%"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Materials and methods Cells and reagents The NF1-deficient human MPNST cell lines ST88-14 and S462 were cultured in Dulbecco\u2019s Modified Eagle\u2019s Medium (10% fetal bovine serum, 1% penicillin\u2013streptom"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:ST88-14"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
27159396,10.1172/JCI85183,Cotargeting MNK and MEK kinases induces the regression of NF1-mutant cancers.,J Clin Invest,2016,1634,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin 1-mutant (NF1-mutant) cancers are driven by excessive Ras signaling; however, there are currently no effective therapies for these or other Ras-dependent tumors. W"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin 1-mutant (NF1-mutant) cancers are driven by excessive Ras signaling; however, there are currently no effective therapies for these or other "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27216189,10.1158/0008-5472.CAN-15-1144,YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.,Cancer Res,2016,1039,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The Hippo-YAP pathway has emerged as a major driver of tumorigenesis in many human cancers. YAP is a transcriptional coactivator and while details of YAP regulation are quickly eme"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27285107,10.1038/cdd.2016.54,Merlin inhibits Wnt/-catenin signaling by blocking LRP6 phosphorylation.,Cell Death Differ,2016,1013,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin, encoded by the NF2 gene, is a tumor suppressor that acts by inhibiting mitogenic signaling and is mutated in Neurofibromatosis type II (NF2) dise"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27313208,10.1073/pnas.1607298113,The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.,Proc Natl Acad Sci U S A,2016,1385,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) and Legius syndrome are related diseases with partially overlapping symptoms caused by alterations of the tumor suppressor genes NF1 (encoding the p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) and Legius syndrome are related diseases with partially overlapping symptoms caused by alterations of the tumor suppressor "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27345717,10.5483/bmbrep.2016.49.7.104,"Merlin, a regulator of Hippo signaling, regulates Wnt/-catenin signaling.",BMB Rep,2016,1027,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin, encoded by the NF2 gene, is a tumor suppressor that exerts its function via inhibiting mitogenic receptors at the plasma membrane. Although multi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27363027,10.18632/oncotarget.10248,Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.,Oncotarget,2016,1094,8909,0,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""TopHat"", ""R"", ""HTSeq""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Cell culture conditions The SC4 and HEI193 cell lines were obtained from The House Ear Institute and ATCC, respectively. The hSC2\u03bb ce"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ctivity was evaluated 24 hours after treatment using CellTiter-Glo (Promega, USA) as a read-out of viability. The EC 50  values were calculated using Graphpad Prism. In vivo  tumor models and imaging All animal experiments were approved by the Scripps Institutional Animal Care and Use Committee and performed in a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""tion of 0.4 pM in emulsion PCR to link to the sequencing beads. For analysis, the sequencing reads in color-space were mapped to the mm9 genome using Tophat [ 29 ]. The number of reads falling into each gene defined in the RefSeq gene annotations was quantified using HTSeq-count [ 30 ]. Samples from three"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HTSeq"": {""context"": "" mapped to the mm9 genome using Tophat [ 29 ]. The number of reads falling into each gene defined in the RefSeq gene annotations was quantified using HTSeq-count [ 30 ]. Samples from three independent experiments were sequenced, combined, and analyzed to produce the final DESeq data. The RNA-Seq data is "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:HTSeq"": [""methods""]}",False
27385209,10.18632/oncotarget.10359,"Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.",Oncotarget,2016,1369,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""loped a molecular signature for clustering adult diffuse gliomas based on the extent of RTK pathway activities. Glioma gene modules co-expressed with NF1 (NF1-M), Sprouty (SPRY-M) and PTEN (PTEN-M) were identified, their signatures enabled robust clustering of adult diffuse gliomas of WHO grades II-IV "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Inter-individual variability causing elevated signaling of receptor tyrosine kinases (RTK) may have hampered the efficacy of targeted therapies. We develop"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27418650,10.3324/haematol.2015.136002,Stat5 is critical for the development and maintenance of myeloproliferative neoplasm initiated by Nf1 deficiency.,Haematologica,2016,1820,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Juvenile myelomonocytic leukemia is a rare myeloproliferative neoplasm characterized by hyperactive RAS signaling. Neurofibromin1 (encoded by the NF1 gene) is a negative regulator of RAS activation. Patients with neurofibromatosis type 1 harbor loss-of-function mutations in NF1 and have a 200- to 5"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Juvenile myelomonocytic leukemia is a rare myeloproliferative neoplasm characterized by hyperactive RAS signaling. Neurofibromin1 (encoded by the NF1 gene) is a negative regulator of RAS ac"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,Front Hum Neurosci,2016,713,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type I (NF1) is a neurogenetic disease marked by multiple cognitive and learning problems. Genetic variants may account for phenotypic variance in NF1. Here, we "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type I (NF1) is a neurogenetic disease marked by multiple cognitive and learning problems. Genetic variants may account for phenotypic v"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27467574,10.1371/journal.pone.0159718,Neuron-Specific Deletion of the Nf2 Tumor Suppressor Impairs Functional Nerve Regeneration.,PLoS One,2016,0,8726,0,0,3,3,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:ImageJ"": {""context"": ""ed settings for camera sensitivity, resolution (2,576\u00d71,932 pixels) and illumination were used for all micrographs. Image analysis was conducted with ImageJ version 1.43u. Employing freehand selection tool, axon and myelin were grossly circumscribed and the area adapted using the ABSnake plugin (the gradi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""tatistical analysis Comparisons between groups were conducted using an unpaired t test, with one-way or two-way analysis of variance, if appropriate (SPSS software, Statistical Package for the Social Sciences, USA). In case of repeated measurements, two-way analysis of variance with repeated measures wa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Experimental animals All mice were handled in accordance with local governmental and institutional animal care regulations. The proto"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:R"": [""methods""]}",False
27527646,10.1212/WNL.0000000000002928,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,Neurology,2016,1505,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is associated with neurocognitive deficits that can impact everyday functioning of children, adolescents, and adults with this disease. However, the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is associated with neurocognitive deficits that can impact everyday functioning of children, adolescents, and adults with t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27527648,10.1212/WNL.0000000000002927,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,Neurology,2016,1825,333,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: The REiNS PRO group reviewed and rated existing PRO measures assessing pain intensity, pain interference, and physical functioning using their systematic m"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
27551454,10.1038/cddiscovery.2015.21,Tumor suppressor Nf2/merlin drives Schwann cell changes following electromagnetic field exposure through Hippo-dependent mechanisms.,Cell Death Discov,2015,879,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Previous evidence showed mutations of the neurofibromin type 2 gene (Nf2), encoding the tumor suppressor protein merlin, in sporadic and vestibular schw"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27588404,10.18632/oncotarget.11734,Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.,Oncotarget,2016,1662,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) is an aggressive sarcoma with few treatment options. Tumor immune state has not been characteriz"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27655679,10.18632/oncotarget.12096,Comprehensive adipocytic and neurogenic tissue microarray analysis of NY-ESO-1 expression - a promising immunotherapy target in malignant peripheral nerve sheath tumor and liposarcoma.,Oncotarget,2016,1868,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "", we examined NY-ESO-1 expression in peripheral nerve sheath tumor (PNST) and adipocytic tumors. The PNST TMA included 42 MPNSTs (spontaneous n = 26, NF1-associated n = 16), 35 neurofibromas (spontaneous n = 22, NF-1 associated n = 13), 11 schwannomas, and 18 normal nerves. The LPS TMA included 48 well"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Immunotherapy targeting cancer-testis antigen NY-ESO-1 shows promise for tumors with poor response to chemoradiation. Malignant peripheral nerve"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27706810,10.1002/ijc.30460,"Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor.",Int J Cancer,2017,1611,0,0,2,1,3,"{""cell_lines"": {""sNF02.2"": ""b72d99fd-ee1e-42ec-92b6-9f89e375cce1"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:sNF02.2"": {""context"": ""yzed in the presence or absence of MU in an in vitro as well as in vivo xenograft model using human MPNST cell lines, sNF96.2 (primary recurrent) and sNF02.2 (metastatic). MU significantly inhibited cell proliferation, migration and invasion in both MPNST cell lines. HA binding protein (HABP) staining, par"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:sNF96.2"": {""context"": ""enicity in MPNST cells were analyzed in the presence or absence of MU in an in vitro as well as in vivo xenograft model using human MPNST cell lines, sNF96.2 (primary recurrent) and sNF02.2 (metastatic). MU significantly inhibited cell proliferation, migration and invasion in both MPNST cell lines. HA bind"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Hyaluronan (HA) has been shown to play important roles in the growth, invasion and metastasis of malignant tumors. Our previous study showing that high HA e"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:sNF02.2"": [""abstract""], ""cell_lines:sNF96.2"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27741517,10.18632/oncotarget.12607,"Ral A, via activating the mitotic checkpoint, sensitizes cells lacking a functional Nf1 to apoptosis in the absence of protein kinase C.",Oncotarget,2016,1182,5036,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""sNF02.2"": ""b72d99fd-ee1e-42ec-92b6-9f89e375cce1"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""MATERIALS AND METHODS Reagents and cell lines Human  Nf1 -deficient sNF96.2, proficient sNF02.2 cells or human fibroblasts were obtained from ATCC (Manassas, VA) and the details of the phonotypes of the cel"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Reagents and cell lines Human  Nf1 -deficient sNF96.2, proficient sNF02.2 cells or human fibroblasts were obtained from ATCC (Manassa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF02.2"": {""context"": ""MATERIALS AND METHODS Reagents and cell lines Human  Nf1 -deficient sNF96.2, proficient sNF02.2 cells or human fibroblasts were obtained from ATCC (Manassas, VA) and the details of the phonotypes of the cells were provided by the company. The ce"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""MATERIALS AND METHODS Reagents and cell lines Human  Nf1 -deficient sNF96.2, proficient sNF02.2 cells or human fibroblasts were obtained from ATCC (Manassas, VA) and the details of the phonotypes of the cells were provided by"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF02.2"": [""methods""], ""cell_lines:sNF96.2"": [""methods""]}",False
27748759,10.1038/onc.2016.386,EGFR-Stat3 signalling in nerve glial cells modifies neurofibroma initiation.,Oncogene,2017,733,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an inherited disease in which affected patients are predisposed to develop benign Schwann cell (SC) tumours called neurofibromas. In the mouse, l"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an inherited disease in which affected patients are predisposed to develop benign Schwann cell (SC) tumours called neuro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27755359,10.1097/MAO.0000000000001247,Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.,Otol Neurotol,2017,2092,685,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The novel small molecule PAK inhibitors PI-8 and PI-15 \u2013 tested in schwannoma and meningioma cells \u2013 perturb molecular signaling and induce cell death. MTT (3-(4,5-dimethylthiazol-2-yl)-2,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
27760236,10.1001/jamapsychiatry.2016.2600,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,JAMA Psychiatry,2016,2893,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""d a higher incidence of autism spectrum disorder (ASD) and substantially elevated autistic trait burden in individuals with neurofibromatosis type 1 (NF1). However, important discrepancies regarding the distribution of autistic traits, sex predominance, and association between ASD symptoms and attentio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""IMPORTANCE: Recent reports have demonstrated a higher incidence of autism spectrum disorder (ASD) and substantially elevated autistic trait burden in indiv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27773571,10.1016/j.cub.2016.09.010,NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.,Curr Biol,2016,963,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""CRs transduce these signals and their relevance to brain disorders are not well understood. Here, we identify a major Ras regulator, neurofibromin 1 (NF1), as a direct effector of GPCR signaling via G\u03b2\u03b3 subunits in the striatum. We find that binding of G\u03b2\u03b3 to NF1 inhibits its ability to inactivate Ras."", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""It is well recognized that G-protein-coupled receptors (GPCRs) can activate Ras-regulated kinase pathways to produce lasting changes in neuronal function. Mechani"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27791021,10.1073/pnas.1600914113,Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity.,Proc Natl Acad Sci U S A,2016,339,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Active G protein-coupled receptor (GPCR) conformations not only are promoted by agonists but also occur in their absence, leading to constitutive activity. Assoc"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27833160,10.1038/srep37035,Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.,Sci Rep,2016,1433,7090,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" Rabkin (Massachusetts General Hospital, Harvard Medical School; Boston, Massachusetts) 32 , originally isolated from spontaneously arising tumors in Nf1/Trp53 heterozygous mice obtained from the LF Parada laboratory. The M2 cells were cultured in DMEM with 10% FBS and 1% Penicillin/Streptavidin (Life "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Chemicals and PBNP synthesis PD0325901 (#PZ0162; PD901) was purchased from Sigma-Aldrich (St. Louis, MO). PBNPs were synthesized from their constituent salts purchased from Sigma-Aldrich as previously described 28"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""with propidium iodide (ThermoFisher Scientific, Carlsbad, CA) after treatment. Flow cytometry was performed on a BD FACSCalibur and analyzed with the FlowJo 7.6 software. Dynamic light scattering Hydrodynamic diameter of PBNPs (10\u2009\u03bcg/mL) was measured by dynamic light scattering on a Zetasizer (Malvern Ins"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:FlowJo"": [""methods""]}",False
27913619,10.1534/genetics.116.191957,The Caenorhabditis elegans NF2/Merlin Molecule NFM-1 Nonautonomously Regulates Neuroblast Migration and Interacts Genetically with the Guidance Cue SLT-1/Slit.,Genetics,2017,1582,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""During nervous system development, neurons and their progenitors migrate to their final destinations. In Caenorhabditis elegans, the bilateral Q neurobla"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27920939,10.4103/2152-7806.194058,Epigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumors.,Surg Neurol Int,2016,778,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""THINKING OUTSIDE THE BOX: The polycomb repressive complex 2 (PRC2) is a histone methyltransferase complex known to repress gene expression. There is a large body of experimental evidence tha"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
27923908,10.1084/jem.20160447,Estrogen activation of microglia underlies the sexually dimorphic differences in Nf1 optic glioma-induced retinal pathology.,J Exp Med,2017,1464,4687,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Mice Nf1 ;GFAP-Cre mice ( flox/mut Nf1 +/\u2212  mice with somatic  Nf1  loss in neuroglial progenitor cells) were generated and maintained on a C57BL/6 background"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Mice Nf1 ;GFAP-Cre mice ( flox/mut Nf1 +/\u2212  mice with somatic  Nf1  loss in neuroglial progenitor cells) were generated and maintaine"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" the chiasm) to generate optic nerve volumes as previously reported ( Hegedus et al., 2008 ). Retinal analyses RNFL measurements were performed using ImageJ (National Institutes of Health) software on sections through the plain including pupil and optic nerves. Images were taken at 20\u00d7 fields from 0 to 30"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
27927008,10.14348/molcells.2017.2270,MicroRNA-296-5p Promotes Invasiveness through Downregulation of Nerve Growth Factor Receptor and Caspase-8.,Mol Cells,2017,1636,4400,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Cell culture and transfection Human GBM cell lines (LN229, T98G, and U87MG) were maintained in Dulbecco\u2019s modified Eagle medium (DMEM"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,Gastroenterology,2017,1809,1721,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" that overexpressed MYC. We infected p53 RESULTS: We identified 4 candidate liver tumor suppressor genes not previously associated with liver cancer (Nf1, Plxnb1, Flrt2, and B9d1). CRISPR-mediated knockout of Nf1, a negative regulator of RAS, accelerated liver tumor formation in mice. Loss of Nf1 or ac"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""METHODS: We performed a genome-wide CRISPR/Cas9-based knockout screen of P53-null mouse embryonic liver progenitor cells that overexpressed MYC. We infected  p53 \u2212/\u2212"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
27956565,10.1212/WNL.0000000000003435,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,Neurology,2016,1971,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ficacy of lovastatin on visuospatial learning and attention for treating cognitive and behavioral deficits in children with neurofibromatosis type 1 (NF1). METHODS: A multicenter, international, randomized, double-blind, placebo-controlled trial was conducted between July 2009 and May 2014 as part of t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""OBJECTIVE: To assess the efficacy of lovastatin on visuospatial learning and attention for treating cognitive and behavioral deficits in children with neurofibromatosis type 1 (NF1). METHODS: A multicenter, internation"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,Genes (Basel),2016,103,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis 1 (NF1) is one of the most common genetic disorders and is caused by mutations in the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis 1 (NF1) is one of the most common genetic disorders and is caused by mutations in the"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,N Engl J Med,2016,2440,793,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""METHODS We conducted a phase 1 trial of selumetinib (AZD6244 or ARRY-142886), an oral selective inhibitor of MAPK kinase (MEK) 1 and 2, in children who had neurofibromatosis type 1 an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
28039362,10.1093/neuonc/now267,Defining the temporal course of murine neurofibromatosis-1 optic gliomagenesis reveals a therapeutic window to attenuate retinal dysfunction.,Neuro Oncol,2017,1818,393,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1flox/flox"": ""d2dec4d7-24be-4218-b7b5-63349158aa15"", ""Nf1flox/mut"": ""0ff3a2b6-110b-4352-8abf-74b46c7e55ce""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods. \n Nf1 \n flox/mut  GFAP-Cre (FMC) mice and age-matched  Nf1 flox/flox  (FF) controls were euthanized at defined intervals from 2 weeks to 24 weeks of age. O"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1flox/flox"": {""context"": "" loss has not been fully defined relevant to potential neuroprotective treatment strategies. METHODS: Nf1flox/mut GFAP-Cre (FMC) mice and age-matched Nf1flox/flox (FF) controls were euthanized at defined intervals from 2 weeks to 24 weeks of age. Optic nerve volumes were measured, and optic nerves/retinae analy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1flox/mut"": {""context"": ""that culminate in retinal dysfunction and vision loss has not been fully defined relevant to potential neuroprotective treatment strategies. METHODS: Nf1flox/mut GFAP-Cre (FMC) mice and age-matched Nf1flox/flox (FF) controls were euthanized at defined intervals from 2 weeks to 24 weeks of age. Optic nerve volu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods. \n Nf1 \n flox/mut  GFAP-Cre (FMC) mice and age-matched  Nf1 flox/flox  (FF) controls were euthanized at defined intervals from 2 weeks to 24 weeks of age. Optic nerve volumes w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1flox/flox"": [""abstract""], ""animal_models:Nf1flox/mut"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,Biochimie,2017,890,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The variable manifestation of phenotypes that occur in patients with neurofibromatosis type 1 (NF1) includes benign and malignant neurocutaneous tumors for which no adequate treatment exists. Cell-based screening of known bioactive compounds librar"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The variable manifestation of phenotypes that occur in patients with neurofibromatosis type 1 (NF1) includes benign and malignant neurocutaneous tumors for w"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28067315,10.1038/srep40325,KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors.,Sci Rep,2017,1232,11237,0,2,6,8,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""TopHat"", ""HTSeq"", ""FlowJo"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols using cell lines, pla"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "", and a non-silencing control (NS) pLKO.1-vector were purchased from Sigma-Aldrich. Stable cell line generation Lentiviral particles were prepared in HEK293T cells by co-transfecting the  KANK1  cDNA or shRNA plasmid with pCMV-VSV-G and pCMV-dR8.2. Culture medium containing lentiviral particles was harves"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""d Use Committee (PACUC) (Protocol # 1301000800). Cell lines and cell culture The human malignant peripheral nerve sheath tumor cell lines, STS26T and S462, were kindly provided by Dr. George De Vries, and Dr. Karen Cichowski, respectively. The immortalized neurofibroma cell line HEI-193 30  was purchase"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" Results were analyzed using \u0394Ct method to calculate relative gene mRNA level 46 . Statistical analysis All statistical analyses were performed using GraphPad Prism 6.0\u2009h. Data in paired groups were analyzed using the paired student  t- test. Sample differences among groups were analyzed using two-way ANOVA or un"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""10, or the average score of three continuous bases was under 20. We then mapped the processed reads against the reference human genome (GRCh38) using Tophat2 43 . To quantify number of read counts per transcript, we employed HTSeq 44  with genome annotation downloaded from Ensembl (release 81), and prefor"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HTSeq"": {""context"": ""pped the processed reads against the reference human genome (GRCh38) using Tophat2 43 . To quantify number of read counts per transcript, we employed HTSeq 44  with genome annotation downloaded from Ensembl (release 81), and preformed differential expression analyses using DESeq2 package 45 . Genes with "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": "" with anti-BrdU, and secondary antibody conjugated with Alexa Fluor \u00ae  647. The cells were run through a flow cytometer, and data were analyzed using FlowJo. Immunohistochemistry (IHC) staining and antibodies IHCs were performed using Vectastain Elite ABC kit (Vector Laboratories) according to the manufac"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""r transcript, we employed HTSeq 44  with genome annotation downloaded from Ensembl (release 81), and preformed differential expression analyses using DESeq2 package 45 . Genes with FDR (false discovery rate) less than 10% (adjusted p-value\u2009<\u20090.1), and more than a two-fold change was considered as signific"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""cell_lines:S462"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:HTSeq"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:DESeq2"": [""methods""]}",False
28068329,10.1038/onc.2016.464,The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.,Oncogene,2017,2007,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumor-predisposition disorder due to germline mutations in the tumor suppressor gene NF1. A virtually pathognomonic finding of NF1 is th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumor-predisposition disorder due to germline mutations in the tumor suppressor gene NF1. A virtually pathognom"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28099845,10.1016/j.celrep.2016.12.056,Absence of Neurofibromin Induces an Oncogenic Metabolic Switch via Mitochondrial ERK-Mediated Phosphorylation of the Chaperone TRAP1.,Cell Rep,2017,1079,13988,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""NanoDrop"", ""ImageJ"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We evaluated TRAP1\u2019s clinical relevance for prognostic predictions and its association with tumor immunity and metabolism. TRAP1\u2019s function in hepatocellular carcino"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""pe (LEICA, Germany) to quantitatively analyze cell invasive capability. Statistical analysis Every cellular experiment was performed in three copies. GraphPad Prism 10.0 and R version 2024.04.2 ( https://www.r-project.org/ ) were used to analyze the data. Data is presented using the means\u2009\u00b1\u2009standard error of the "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""CAGC-3\u2032. RNA extraction and RT-qPCR As directed by the manufacturer, total RNA was isolated using an RNA purification kit (Thermo Scientific, USA). A NanoDrop One/One C spectrophotometer (Thermo Scientific) was used to measure the RNA's concentration and purity. A kit called Takara's Reverse Transcription w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ee PBS washes to remove detached cells, a\u00a0serum-free medium was added. Microscope images (LEICA, Germany) were taken at 0 and 24\u00a0h and processed with ImageJ to assess TRAP1 knockdown effects on cell migration and invasion. Transwell cell invasion assay To evaluate the effect of TRAP1 knockdown on the inva"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""he official gene symbols for identification and identifying humans as the species. Finally, we visualized the enrichment results using the R package (ggplot2). Signal pathway analysis We obtained data from the UALCAN database to look into the participation of TRAP1 in the mammalian target of rapamycin (mTO"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,EBioMedicine,2017,1892,13818,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2 Materials and Methods 2.1 Clinical Samples Meningioma and schwannoma specimens were collected after patients consented to the study and given a unique MOT "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" enrichment of 88% using this kit ( Meimoun et al., 2007 ). The protocol was carried out according to the manufacturer's instructions using 2.5\u00a0mg of starting material. Protein concentrations were determined by the BCA protein assay according to the manufacturer's instructions. 2.4 In-gel Digestion Cell"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,BMC Genomics,2017,2123,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: We have identified molecules that exhibit synthetic lethality in cells with loss of the neurofibromin 1 (NF1) tumor suppressor gene. However, recognizing tumors that have inactivation of the NF1 tumor suppressor function is challenging because the loss may o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: We have identified molecules that exhibit synthetic lethality in cells with loss of the neurofibromin 1 (NF1) tumor suppressor gene. However, re"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28191549,,Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma.,J Rare Dis Res Treat,2016,977,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 is characterized by bilateral vestibular schwannomas, which are benign tumors that originate from the nerve sheath and damage the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28193237,10.1186/s12955-017-0607-y,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,Health Qual Life Outcomes,2017,2315,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis 1 (NF1) is an inherited, multi-system, tumour suppressor disorder with variable complications that cause psychological distress and social isolation. The st"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis 1 (NF1) is an inherited, multi-system, tumour suppressor disorder with variable complications that cause psychological distres"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28195122,10.1038/ncomms14433,Integrated genomic analyses of de novo pathways underlying atypical meningiomas.,Nat Commun,2017,1100,17794,0,0,6,6,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""bowtie"", ""R"", ""BWA"", ""GATK"", ""limma""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Clinical materials Institutional Review Board approvals for genetic studies, along with written consent from all study subjects, were obtained at the participating "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""n reference genome (version GRCh37) using Stampy (version 1.0.21) in a hybrid mode with BWA (version 0.5.9-r16) 42 43 . MarkDuplicates algorithm from Picard was used for flagging PCR duplicates. Alignment quality metrics were calculated using CollectAlignmentSummaryMetrics and CalculateHsMetrics utilities"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""7ac and H3K27me3 ChIP and input samples were sequenced for each tumour (1 \u00d7 75\u2009bp, HiSeq 2000). H3K27ac and H3K27me3 reads were aligned uniquely with bowtie (0.12.7) 67  to the human genome (hg19). In H3K27ac, regions of enrichment were identified with MACS (v1.4) 68  whereas in H3K27me3, regions of enric"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""filtering quality measures. The reads were aligned to the human reference genome (version GRCh37) using Stampy (version 1.0.21) in a hybrid mode with BWA (version 0.5.9-r16) 42 43 . MarkDuplicates algorithm from Picard was used for flagging PCR duplicates. Alignment quality metrics were calculated usin"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""ment around putative and known insertion/deletion sites. This was followed by the base quality score recalibration using the Genome Analysis Toolkit (GATK, version 2.5\u20132) 44 . We detected variant sites (point mutations and small indels) for tumour and matched blood pairs using the HaplotypeCaller algori"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""gene expression data. Data was normalized using normal-exponential convolution model-based background correction and quantile normalization using the limma R package 55 . All batches were normalized at once after excluding probes with low quality. Samples estimated to have zero proportion of expressed pr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Picard"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:limma"": [""methods""]}",False
28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,Sci Rep,2017,1551,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targeted interventions may have therapeutic potential in these"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targ"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28392281,10.1016/j.expneurol.2017.04.001,Human stem cell modeling in neurofibromatosis type 1 (NF1).,Exp Neurol,2018,873,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""e key determinants that account for differences between individuals with the same disorder. This need is exemplified by the neurofibromatosis type 1 (NF1) neurogenetic condition. As such, individuals with NF1 are born with a germline mutation in the NF1 gene, but may develop numerous distinct neurologi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The future of precision medicine is heavily reliant on the use of human tissues to identify the key determinants that account for differences between individua"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,Sci Data,2017,0,6656,0,1,7,8,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""TopHat"", ""Cufflinks"", ""GATK"", ""SAMtools"", ""FastQC""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""elease of their tissue samples and any resultant data through a protocol approved by Western IRB (Puyallup, WA). Patient-reported medical, family and NF1 history was also collected. Sample information is available in the table in the data repository (syn5556216; Data Citation 1). Each tumour was sub-di"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""imated using SAMtools  (syn6022474; Data Citation 1). 11 Reads were quantified by both Cufflinks v0.9.3 (ref.  10 ) (syn5492805; Data Citation 1) and FeatureCounts  (syn5493036; Data Citation 1). 12 Code availability All data is currently stored in the synapse web portal, and is accessible using code in the Cuta"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Sample collection Eligible patients between the ages of 18 and 65 who were scheduled to receive elective surgery to remove cutaneous neurofibromas were invited to donate surgical discards as well as blood and urine samples."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": "" for each sample were performed using FastQC (Babraham Bioinformatics, Cambridge, UK). Raw reads were mapped to the reference human genome hg19 using TopHat v2.0 (ref.  10 ) with the -p 4 and -r210 arguments. The alignment metrics of the mapped reads were estimated using SAMtools  (syn6022474; Data Citati"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Cufflinks"": {""context"": ""0 arguments. The alignment metrics of the mapped reads were estimated using SAMtools  (syn6022474; Data Citation 1). 11 Reads were quantified by both Cufflinks v0.9.3 (ref.  10 ) (syn5492805; Data Citation 1) and FeatureCounts  (syn5493036; Data Citation 1). 12 Code availability All data is currently stored "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""ram with default settings. The resulting VCF files (syn5522788; Data Citation 1) were then sorted and updated to remove errors and analysed using the GATK pipeline 7  (syn5522790; Data Citation 1). 8 Somatic mutations were called from BAM files exported by the Dragen alignment using the Java version of "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""nce human genome hg19 using TopHat v2.0 (ref.  10 ) with the -p 4 and -r210 arguments. The alignment metrics of the mapped reads were estimated using SAMtools  (syn6022474; Data Citation 1). 11 Reads were quantified by both Cufflinks v0.9.3 (ref.  10 ) (syn5492805; Data Citation 1) and FeatureCounts  (syn54"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""A-seq data analysis pipeline (syn6035832; Data Citation 1). Briefly, quality control checks on raw sequence data for each sample were performed using FastQC (Babraham Bioinformatics, Cambridge, UK). Raw reads were mapped to the reference human genome hg19 using TopHat v2.0 (ref.  10 ) with the -p 4 and -r"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:Cufflinks"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:FastQC"": [""methods""]}",False
28423318,10.1016/j.celrep.2017.03.073,Oligodendrocyte Nf1 Controls Aberrant Notch Activation and Regulates Myelin Structure and Behavior.,Cell Rep,2017,858,3834,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""i Children\u2019s Hospital Research Foundation Institutional Animal Care and Use Review Committee (IACUC). The generation and genotyping of mice carrying  Nf1 fl/fl  [Nf1tm1Par/J] ( Zhu et al., 2002 ),  PlpCre  [B6.Cg-Tg(Plp1-Cre/ERT)3Pop/J] ( Doerflinger et al., 2003 ),  Hes5 -GFP [Tg1(Hes5GFP)Gsat/Mmmh] ("", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""EXPERIMENTAL PROCEDURES Mouse Strains All mouse studies were approved by the Cincinnati Children\u2019s Hospital Research Foundation Institutional Animal Care a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""sacrificed 6 hr after the last dose. Behavior Behavioral assessments were completed on  pNf1fl /+ mice (F12, backcrossed onto C57BL/6) mice. Acoustic startle response, with prepulse inhibition, was assessed as described ( Vorhees et al., 2011 ). White noise background of 70 dB, prepulses of 73, 77, and "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
28425622,10.1002/jbmr.3155,Targeted Disruption of NF1 in Osteocytes Increases FGF23 and Osteoid With Osteomalacia-like Bone Phenotype.,J Bone Miner Res,2017,821,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1, OMIM 162200), caused by NF1 gene mutations, exhibits multi-system abnormalities, including skeletal deformities in humans. Osteocytes play critical "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1, OMIM 162200), caused by NF1 gene mutations, exhibits multi-system abnormalities, including skeletal deformities in humans. "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28427224,10.18632/oncotarget.15912,Ponatinib promotes a G1 cell-cycle arrest of merlin/NF2-deficient human schwann cells.,Oncotarget,2017,1456,9400,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""FlowJo"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Cell cultures and human vestibular schwannomas The merlin-deficient HSC line was generated from primary fetal HSC purchased from Scie"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" software was used for data acquisition and FlowJo software was used for data analysis. Statistical analysis Statistical analysis was performed using GraphPad Prism v5.0 for Windows. Ponatinib dose-response experiments were analyzed by non-linear regression (four parameters). Other experiments were analyzed by ap"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""asks pre-treated with 0.1% poly-L-lysine (Sigma) and 25 mg/ml laminin (ThermoScientific). Cells from Passage 2 were then seeded in a 96 well plate (Costar, Corning) at 5,000 cells/well in six replicates. After 24 hours of incubation at 37\u00b0C, 5% CO2, cells were treated with ponatinib at different concent"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ribonucleaseA (Invitrogen). A BD FACS Canto-II flow cytometer (BD Biosciences) with the BD FACSDiva\u2122 6.1.3 software was used for data acquisition and FlowJo software was used for data analysis. Statistical analysis Statistical analysis was performed using GraphPad Prism v5.0 for Windows. Ponatinib dose-re"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""C lysates were prepared and analyzed according to manufacturer's instructions. Arrays were visualized with chemiluminescence and were quantified with ImageJ MicroArray_Profile.jar plugin or Carestream software; mean intensity of duplicate spots was calculated. Antibodies and inhibitors Rabbit antibodies a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
28454108,10.18632/oncotarget.16981,Telomere erosion in NF1 tumorigenesis.,Oncotarget,2017,1460,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1; MIM# 162200) is a familial cancer syndrome that affects 1 in 3,500 individuals worldwide and is inherited in an autosomal dominant fashion. Malignan"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1; MIM# 162200) is a familial cancer syndrome that affects 1 in 3,500 individuals worldwide and is inherited in an autosomal d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28489286,10.1002/jnr.24067,Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.,J Neurosci Res,2017,1770,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Recent studies have shown that constitutive activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) in Schwann cells (SCs) increases myel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28502478,10.1016/j.ajpath.2017.02.021,The Cellular Retinoic Acid Binding Protein 2 Promotes Survival of Malignant Peripheral Nerve Sheath Tumor Cells.,Am J Pathol,2017,1096,12981,0,4,4,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive neoplasms that commonly occur in patients with neurofibromatosis type 1 (NF1). Effective chemotherapy is not available. To characterize a therapeutic target for treatment, we investigated the role of cellular retinoic acid bin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": ""embedded specimens of human peripheral nerve sheath tumors. A transient knockdown of CRABP2 was established in human NF1-associated MPNST cell lines (S462, T265, NSF1), and functional effects on viability, proliferation, apoptosis, and cytotoxicity were monitored. Finally, a 45-pathway reporter assay wa"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:T265"": {""context"": ""ed specimens of human peripheral nerve sheath tumors. A transient knockdown of CRABP2 was established in human NF1-associated MPNST cell lines (S462, T265, NSF1), and functional effects on viability, proliferation, apoptosis, and cytotoxicity were monitored. Finally, a 45-pathway reporter assay was perf"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods A strategy of transfecting KYSE-150 cells with vectors or CRABP2 overexpression was applied in this study. Changes in cell proliferation, migration, invasi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""In addition, recombinant lentiviral or control vectors, together with two auxiliary packaging plasmids (pSPAX2 and pMD2G), were co-transfected within HEK293T cultures for lentiviral generation. The cells were cultured for 48\u00a0h, and the supernatant was then collected. The KYSE-150 cell populations were inc"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""Student\u2019s t-test and two-sample t-tests were appropriately applied to assess the statistical significance of the study using SPSS Statistics 26.0 and GraphPad Prism 8.0 software. The grey values of the Western blot bands were obtained using WCIF ImageJ software. Error bars represent the standard deviation from th"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""nificance of the study using SPSS Statistics 26.0 and GraphPad Prism 8.0 software. The grey values of the Western blot bands were obtained using WCIF ImageJ software. Error bars represent the standard deviation from three independent experiments, and p (two-tailed)\u2009<\u20090.01 and p (two-tailed)\u2009<\u20090.05 were de"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""Statistical analysis The Student\u2019s t-test and two-sample t-tests were appropriately applied to assess the statistical significance of the study using SPSS Statistics 26.0 and GraphPad Prism 8.0 software. The grey values of the Western blot bands were obtained using WCIF ImageJ software. Error bars repre"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""abstract""], ""cell_lines:T265"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,Oncotarget,2017,1606,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1flox/mut"": ""0ff3a2b6-110b-4352-8abf-74b46c7e55ce"", ""Nf1flox/mut; GFAP-Cre"": ""0ff3a2b6-110b-4352-8abf-74b46c7e55ce""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""re they frequently form within the optic pathway (optic pathway gliomas; OPGs). Since many OPGs occur in the context of the Neurofibromatosis Type 1 (NF1) cancer predisposition syndrome, we have previously employed Nf1 genetically-engineered mouse (GEM) strains to study the pathogenesis of these low-gr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1flox/mut"": {""context"": ""the murine optic nerve in vivo. However, in contrast to the GFAP-Cre strain where somatic Nf1 inactivation in embryonic neural progenitor/stem cells (Nf1flox/mut; GFAP-Cre mice) results in optic gliomas by 3 months of age in vivo, mice with Nf1 gene inactivation in Olig2+ OPCs (Nf1flox/mut; Olig2-Cre mice) do "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1flox/mut; GFAP-Cre"": {""context"": ""the murine optic nerve in vivo. However, in contrast to the GFAP-Cre strain where somatic Nf1 inactivation in embryonic neural progenitor/stem cells (Nf1flox/mut; GFAP-Cre mice) results in optic gliomas by 3 months of age in vivo, mice with Nf1 gene inactivation in Olig2+ OPCs (Nf1flox/mut; Olig2-Cre mice) do not form o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Low-grade gliomas are one of the most common brain tumors in children, where they frequently form within the optic pathway (optic pathway gliomas; OPGs). Si"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1flox/mut"": [""abstract""], ""animal_models:Nf1flox/mut; GFAP-Cre"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28529006,10.1016/j.jmoldx.2017.05.001,Validation of a Next-Generation Sequencing Pipeline for the Molecular Diagnosis of Multiple Inherited Cancer Predisposing Syndromes.,J Mol Diagn,2017,1636,5751,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""stitution by standard Sanger sequencing. We tested the pipeline using 51 samples from patients with a clinical diagnosis of neurofibromatosis type 1 (NF1), 10 of which without previous molecular characterization of the causative NF1 mutations. We propose a thoroughly validated analysis pipeline that co"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2 Materials and methods 2.1 Patients and samples A total of 467 index patients referred to the Genetics Department of the Portuguese Oncology Institute of Po"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,PLoS One,2017,1868,8471,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods The detailed workflow of selection and pre-processing of microarrays used to obtain the MPNST vs. NF gene signature, translation to E"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": "" ( S2 Appendix ). Study selection Microarray and DNA methylation studies were selected from GEO and ArrayExpress public databases using the key words NF1, MPNST, neurofibromatosis, and neurofibroma; we included high-throughput sequencing, microarray and methylation data. Additional selection criteria w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
28548933,10.18632/oncotarget.17736,KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.,Oncotarget,2017,1771,11058,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ssue collection and processing De-identified 10\u03bcm-thick sections of formalin-fixed paraffin-embedded DNF tissue from 7 male patients with a confirmed NF1 diagnosis and from 10 male patients with sp-DNFs were collected from Washington University Surgical Pathology Department. Total genomic DNA was extra"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Tissue collection and processing De-identified 10\u03bcm-thick sections of formalin-fixed paraffin-embedded DNF tissue from 7 male patient"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""DIC L objective and a Leica EC3 camera. Normal human sural nerve, sp-DNF sections, as well as primary cell cultures of normal human Schwann cells and HEK293T cells were analyzed by immunofluorescence using S100\u03b2 (Millipore CB1040), c-Kit (Millipore; MAB1164), tryptase (Abcam; ab2378), vimentin (DSHB; AMF-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" PFA, incubated in TUNEL substrate for 1 h and imaged using a fluorescent microscope. Statistical analyses All statistical tests were performed using GraphPad Prism 5 software. Student's  t -test, one-way or two-way analysis of variance (ANOVA) with Bonferroni pos t -test correction was employed for all experimen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""s well as HRP-conjugated secondary antibodies (Cell Signaling) and ECL (Fisher) chemiluminescence. Western signal band intensity was quantified using ImageJ Software (National Institutes of Health, USA,  http://imagej.nih.gov/ij  Java 1.7.0_67).  KIR2DL5A/BKD  cell KIR2DL5 expression levels (Figures  2A ,"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""growth factors, Pen/Strep and fetal bovine serum (FBS), unless otherwise stated and were maintained as per the manufacturer's instructions. For serum-starvation experiments ( Supplementary Figure 5 ), Schwann cells were plated on poly-L-lysine-coated plates in the presence of serum (FBS) for 16h, follow"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
28558025,10.1371/journal.pone.0178493,Doxycycline potentiates antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy in malignant peripheral nerve sheath tumor cells.,PLoS One,2017,0,9777,0,2,2,4,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""OSW"": ""7a62af66-384d-419b-b8ac-f4d381b85942""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:S462"": {""context"": ""Material and methods Cell culture Several cell lines from different tissues were collected. The S462 cell line, from a malignant peripheral nerve sheath tumor of a patient with neurofibromatosis type 1, was gifted from Nancy Ratner, University of Cin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:OSW"": {""context"": "" Research Laboratories (ScienCell Research Laboratories, Inc. Carlsbad, CA). All cells were cultured in Dulbecco\u2019s modified Eagle\u2019s medium (DMEM) or Roswell Park Memorial Institute medium (RPMI) with 10% fetal bovine serum (FBS) at 37\u00b0C with 5% CO 2 . ALA-PDT For ALA treatment, the cells were incubated"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Material and methods Cell culture Several cell lines from different tissues were collected. The S462 cell line, from a malignant peripheral nerve sheath tu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""of Vps34 in class III PI3K complexes, and prevent the downstream cascade to form an autophagosome. Cells were pre-treated with 3-MA 30 min before the start of ALA-PDT treatment. Immunocytochemistry using Hoechst 33342, propidium iodide (PI) and monodansylcadaverine (MDC) stains Cells were plated onto co"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:S462"": [""methods""], ""cell_lines:OSW"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
28566755,10.1038/s41598-017-02768-z,Merlin is required for coordinating proliferation of two stem cell lineages in the Drosophila testis.,Sci Rep,2017,1128,4254,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Fly Husbandry and Strains All fly stocks were raised in standard Bloomington medium. The following fly stocks were used:  Mer \n \u2009\n ts"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET.,Eur J Nucl Med Mol Imaging,2017,642,5314,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods \n 18 F-FDG PET data from a cohort of 54 patients (24 female, 30 male, mean age 35.1\u00a0years) with neurofibromatosis-1 (NF1), and clinically suspected malignant transformation"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Methods \n 18 F-FDG PET data from a cohort of 54 patients (24 female, 30 male, mean age 35.1\u00a0years) with neurofibromatosis-1 (NF1), and clinically suspected malignant transformation of neurofibromas into MPNSTs, were included. Scans were performed to a standard clinical protocol"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" previously shown utility and/or robustness when used in clinical  18 F-FDG PET data of cancers [ 17 \u2013 22 ]. Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software. The data distributions were tested for normality using the Shapiro\u2013Wilk test"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""nistration of oral or intravenous contrast agent. The reconstructed PET datasets were imported into in-house texture analysis software implemented in MATLAB (Release 2016a, The MathWorks, Inc., Natick, MA, USA). Voxel intensities within the symptomatic tumour VOI were resampled to yield 64 discrete bins. "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
28595424,10.21037/cco.2017.05.03,Animal models of meningiomas.,Chin Clin Oncol,2017,1440,4761,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2 Materials and Methods 2.1 Preparation of Meningeal Cells From Cas9 Transgenic Mice Twenty mice of Rosa26\u2010LSL\u2010Cas9 knockin were purchased from Jackson Labor"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
28608929,10.1002/path.4927,High-grade serous carcinomas arise in the mouse oviduct via defects linked to the human disease.,J Pathol,2017,267,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Recent studies have suggested that the most common and lethal type of 'ovarian' cancer, i.e. high-grade serous carcinoma (HGSC), usually arises from ep"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28610844,10.1016/j.expneurol.2017.06.015,Overexpression of eIF4F components in meningiomas and suppression of meningioma cell growth by inhibiting translation initiation.,Exp Neurol,2018,958,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Meningiomas frequently display activation of the PI3K/AKT/mTOR pathway, leading to elevated levels of phospho-eukaryotic translation initiation factor 4E binding pr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28637487,10.1186/s40246-017-0109-3,The NF1 somatic mutational landscape in sporadic human cancers.,Hum Genomics,2017,2146,50,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1: Online Mendelian Inheritance in Man (OMIM) #162200) is an autosomal dominantly inherited tumour predisposition syndrome. Heritable constitutional mu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Availability of data and materials Not applicable."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
28644838,10.1371/journal.pone.0178639,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",PLoS One,2017,1773,9482,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Organization and recruitment to the registry The registry questionnaires [ S1 Text ] and consent language [ S2 Text ] were developed in collaboration wi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""strants completed a demographics and family history section. Depending on the type of NF reported, they were directed to a specific questionnaire for NF1, NF2 or SCHW. Disease-specific questionnaires captured features of current published diagnostic criteria [ 12 , 13 , 14 ] and a variety of disease ma"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,Neuroimage Clin,2017,1481,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis Type 1 (NF1) is a genetic disorder that disrupts central nervous system development and neuronal function. Cognitively, NF1 is characterized by difficulties with"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis Type 1 (NF1) is a genetic disorder that disrupts central nervous system development and neuronal function. Cognitively, NF1 is"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28729415,10.1158/0008-5472.CAN-16-2834,An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis.,Cancer Res,2017,221,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the development of multiple tumors in the central nervous system, most n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28764788,10.1186/s13046-017-0567-4,Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion.,J Exp Clin Cancer Res,2017,1814,10560,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The levels of DNMT1 and NF2 expression were studied by qRT-PCR, Western blot, immunofluorescence, and immumohistochemical staining. Methylation in the promoter region of NF2 was dete"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""cells or tissue samples using the TRIzol reagent (Takara) according to the manufacturer\u2019s protocol. Total RNA (1\u00a0\u03bcg) was reverse transcribed with a Bestar\u2122qPCR RT kit (Applied Biosystems) in a 20\u00a0\u03bcl PCR reaction. The levels of the mRNAs and miRNA were quantified by real-time PCR (Stratagene Mx3000P) usi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
28776579,10.1038/modpathol.2017.97,Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.,Mod Pathol,2017,2177,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The diagnosis of malignant peripheral nerve sheath tumors can be challenging and other spindle cell sarcomas commonly enter in the differential diagnosis. Loss of trimethylation at"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28783719,10.1038/nature23291,Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.,Nature,2017,1402,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""activation despite ERK-dependent feedback. Consistent with this hypothesis, melanomas with these class 3 BRAF mutations also harbour RAS mutations or NF1 deletions. By contrast, in lung and colorectal cancers with class 3 BRAF mutants, RAS is typically activated by receptor tyrosine kinase signalling. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Approximately 200 BRAF mutant alleles have been identified in human tumours. Activating BRAF mutants cause feedback inhibition of GTP-bound RAS, are RAS-i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28783725,10.1038/nature23297,A Braf kinase-inactive mutant induces lung adenocarcinoma.,Nature,2017,1824,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, a fact that complicates the development of selective targeted therapies. Yet these tumours harbour a number of alterations w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28813519,10.1371/journal.pone.0183155,"Expression and inhibition of BRD4, EZH2 and TOP2A in neurofibromas and malignant peripheral nerve sheath tumors.",PLoS One,2017,2242,9384,0,6,3,9,"{""cell_lines"": {""90-8"": ""0f404e70-2acf-4877-bcd5-6da81d9fa41e"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {""Anti-NF1"": ""535891d9-4608-48eb-9e61-01201533a5bc""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""edical Research Involving Human Subjects Act do not apply to this research (MEC-2016-213). Cell culture Human MPNST cell lines ST88-14, 90-8TL, T265 (NF1-associated MPNST) and STS26T (sporadic MPNST) were kindly provided by Dr. Eduard Serra (Institute of Predictive and Personalized Medicine of Cancer/I"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Patients and samples From the Erasmus MC patient files, nine neurofibroma type 1 patients were selected of which resected plexiform n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:90-8"": {""context"": "" down in the Medical Research Involving Human Subjects Act do not apply to this research (MEC-2016-213). Cell culture Human MPNST cell lines ST88-14, 90-8TL, T265 (NF1-associated MPNST) and STS26T (sporadic MPNST) were kindly provided by Dr. Eduard Serra (Institute of Predictive and Personalized Medicin"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""S26T (sporadic MPNST) were kindly provided by Dr. Eduard Serra (Institute of Predictive and Personalized Medicine of Cancer/IMPPC, Barcelona, Spain). sNF96.2 and HS53.T were obtained from the ATCC and derived from an NF1-associated MPNST and a cutaneous, NF1-derived, neurofibroma, respectively. Human embry"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""ules laid down in the Medical Research Involving Human Subjects Act do not apply to this research (MEC-2016-213). Cell culture Human MPNST cell lines ST88-14, 90-8TL, T265 (NF1-associated MPNST) and STS26T (sporadic MPNST) were kindly provided by Dr. Eduard Serra (Institute of Predictive and Personalized M"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": "" the Medical Research Involving Human Subjects Act do not apply to this research (MEC-2016-213). Cell culture Human MPNST cell lines ST88-14, 90-8TL, T265 (NF1-associated MPNST) and STS26T (sporadic MPNST) were kindly provided by Dr. Eduard Serra (Institute of Predictive and Personalized Medicine of Can"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1"": {""context"": ""ti-BRD4 (1:10000, A301-985A100, Bethyl Laboratories, Inc), rabbit monoclonal anti-TOP2A (1:1000, D10G9, Cell Signaling Technology), rabbit monoclonal anti-NF1 (1:1000, D7R7D, Cell Signaling Technology), rat monoclonal anti-tubulin (1: 4000, YL1/2, Abcam) and mouse monoclonal anti-\u03b2-actin (1:10000, A5441, Si"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""ons) was isolated using the RecoverAll TM  total nucleic acid isolation kit (Ambion/Life Technologies). RNA quality and quantity were checked using a Nanodrop-1000 (Nanodrop Technologies). Quantitative RT-PCR cDNA was synthesized from 250 ng of total RNA using TaqMan \u00ae  Reverse Transcription Reagents (Therm"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""d, IL, USA) was used to visualise the signal in a ChemiDoc MP Imager (Bio-Rad, Veenendaal, The Netherlands). Protein expression was quantitated using ImageJ, a public domain Java-based image processing program [ 26 ]. Each Western blot was replicated at least three times, depicted are representative blots"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:90-8"": [""methods""], ""cell_lines:sNF96.2"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:T265"": [""methods""], ""antibodies:Anti-NF1"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,Biomol NMR Assign,2017,892,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromin and Sprouty-related EVH1 domain-containing protein 1 (Spred1) both act as negative regulators of the mitogen-activated protein kinase pathwa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
2884037,10.1016/0092-8674(87)90534-4,Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.,Cell,1987,975,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""von Recklinghausen neurofibromatosis (VRNF) is one of the most common inherited disorders affecting the human nervous system. VRNF is transmitted as an aut"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28846462,10.1369/0022155417729357,Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.,J Histochem Cytochem,2017,1474,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased risk for benign and malignan"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common, cancer-predisposing disease caused by mutations in the NF1 tumor gene. Patients with NF1 have an increased ris"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,J Med Genet,2017,1269,9133,0,1,3,4,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We have assessed NF2 clinical phenotype in 142 patients in relation to the UK NF2 Genetic Severity Score to validate its use as a clinical and research tool. Methods NF2 care in England is nationally commission"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""cranial meningioma, spinal meningioma and spinal schwannoma, NF2 eye features, hearing grade, age at first radiotherapy, age at first surgery and age starting bevacizumab. In addition there was moderate but significant correlation with age at loss of useful hearing, and weak but significant correlations"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""cell_lines:XF"": {""context"": ""erity Score was determined based on the phenotype of patients assessed through the Manchester NF2 service. For validation, all patients known to the Oxford NF2 centre who met the\u00a0Manchester NF2 diagnostic criteria and consented to genetic testing were analysed. Seven patients previously used for delin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" different dimensions (eg, mobility, hearing, sight and so on). Last recorded measurements were collected. Statistical analyses were undertaken using SPSS V.23. Genetic severity and hearing grades were treated as ordinal variables. We report standard summary statistics throughout with statistical signif"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
2889831,10.1136/jmg.24.9.536,A genomic search for linkage of neurofibromatosis to RFLPs.,J Med Genet,1987,681,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Our initial attempt to map NF was directed towards chromosomes 4 and 19, both of which had provided positive evidence for linkage in previous reports. Th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
28923059,10.1186/s12964-017-0189-7,Osteoglycin promotes meningioma development through downregulation of NF2 and activation of mTOR signaling.,Cell Commun Signal,2017,2048,9679,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods \n OGN  mRNA expression in human meningiomas was assessed by RNA microarray and RNAscope. The impact of OGN on cell proliferation, colony formation, and mitogen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""wing manufacturer protocols. All slides were digitally scanned using Carl Zeiss Microimaging (Jena, Germany). RNAscope staining was quantified by NIH ImageJ software (Bethesda, USA). Single DAB stained images were obtained using color deconvolution as previously described [ 17 ]. After adjustment of the c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
2896631,10.1016/0888-7543(87)90039-5,Linkage analysis of von Recklinghausen neurofibromatosis to DNA markers on chromosome 17.,Genomics,1987,1076,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Several recent studies indicate that the von Recklinghausen neurofibromatosis (NF1) gene is located near the centromere of chromosome 17 in some families. However, variable expressivity and a very high mutation rate suggest that def"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Several recent studies indicate that the von Recklinghausen neurofibromatosis (NF1) gene is located near the centromere of chromosome 17 in some families. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
28972170,10.1074/jbc.M117.808063,1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin.,J Biol Chem,2017,745,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Cell adhesion to the extracellular matrix or to surrounding cells plays a key role in cell proliferation and differentiation and is critical for proper tissue homeostasis. An "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29032173,10.1016/j.bone.2017.10.012,The reduced osteogenic potential of Nf1-deficient osteoprogenitors is EGFR-independent.,Bone,2018,1956,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene. Recalcitrant bone healing following fracture (i.e. pseudarthrosis) is one of the m"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene. Recalcitrant bone healing following fracture (i.e. pseuda"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29131833,10.1371/journal.pone.0187700,MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro.,PLoS One,2017,1616,0,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""OBJECTIVE: Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by an increased risk of malignant peripheral nerve sheath tumors (MPNST). Chemotherapy of MPNST is stil"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": "" MPNST respond to all-trans retinoic acid (ATRA). We analyzed effects of ATRA and MEK inhibitor (MEKi) combination therapy. METHODS: MPNST cell lines S462, T265, NSF1 were treated with ATRA and MEKi U0126 and PD0325901. We assessed cell viability, proliferation, migration, apoptosis and differentiation "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:T265"": {""context"": "" respond to all-trans retinoic acid (ATRA). We analyzed effects of ATRA and MEK inhibitor (MEKi) combination therapy. METHODS: MPNST cell lines S462, T265, NSF1 were treated with ATRA and MEKi U0126 and PD0325901. We assessed cell viability, proliferation, migration, apoptosis and differentiation as wel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""OBJECTIVE: Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by an increased risk of malignant peripheral nerve sheath tumors (MPNST). Chem"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""abstract""], ""cell_lines:T265"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,Oncotarget,2017,887,7532,0,3,5,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""limma"", ""FlowJo""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Multi-array Average (RMA) normalization. Differential gene expression was predicted using Bioconductor/ limma package [ 25 ]. Cell culture The human  NF1 \u2212/\u2212  MPNST cell line S462TY and  NF1 \n + /  human sporadic MPNST STS-26T cell line have been previously described [ + 26 \u2013 28 ]. Cells were grown in "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Microarray mining We used a pre-clinical and clinical mRNA microarray Affymetrix database consisting of thirteen dermal neurofibromas"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": "" normalization. Differential gene expression was predicted using Bioconductor/ limma package [ 25 ]. Cell culture The human  NF1 \u2212/\u2212  MPNST cell line S462TY and  NF1 \n + /  human sporadic MPNST STS-26T cell line have been previously described [ + 26 \u2013 28 ]. Cells were grown in Dulbecco\u2019s modified Eagle\u2019"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:STS-26T"": {""context"": "" was predicted using Bioconductor/ limma package [ 25 ]. Cell culture The human  NF1 \u2212/\u2212  MPNST cell line S462TY and  NF1 \n + /  human sporadic MPNST STS-26T cell line have been previously described [ + 26 \u2013 28 ]. Cells were grown in Dulbecco\u2019s modified Eagle\u2019s medium (DMEM) supplemented with 20% fetal bov"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" with post-hoc pairwise comparison using the two-step method of Benjamini, Krieger, and Yekutieli to control for a false discovery rate of 0.05 using GraphPad Prism 7 software. Results were considered to be significant when adjusted p \u2264 0.05. Correlation of immunologic marker IHC staining and calculated CTL Targe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""a BD FACS LSR II using BD FACSDiVa software version 4.0 (BD Biosciences). Flow cytometry data analysis was performed using FlowJo version 7.6.5 (Tree Star). Tissue microarray construction The Institutional Review Board at Nationwide Children\u2019s Hospital approved this study. Thirty-six NF1-associated tumo"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""logies) with background correction and Robust Multi-array Average (RMA) normalization. Differential gene expression was predicted using Bioconductor/ limma package [ 25 ]. Cell culture The human  NF1 \u2212/\u2212  MPNST cell line S462TY and  NF1 \n + /  human sporadic MPNST STS-26T cell line have been previously d"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": "" fixative, and analyzed on a BD FACS LSR II using BD FACSDiVa software version 4.0 (BD Biosciences). Flow cytometry data analysis was performed using FlowJo version 7.6.5 (Tree Star). Tissue microarray construction The Institutional Review Board at Nationwide Children\u2019s Hospital approved this study. Thirt"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:STS-26T"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
29179212,10.1159/000485415,LukS-PV-Regulated MicroRNA-125a-3p Promotes THP-1 Macrophages Differentiation and Apoptosis by Down-Regulating NF1 and Bcl-2.,Cell Physiol Biochem,2017,1696,11040,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" apoptosis and differentiation in THP-1 cells treated with LukS-PV. Concordantly, luciferase reporter assays confirmed that neurofibromatosis type 1 (NF1) and B-cell lymphoma 2 (Bcl-2) were direct target genes of miR-125a-3p. Moreover, NF1 knockdown in THP-1 cells significantly promoted differentiation"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Bacterial Strains and rPVL Production and Purification S. aureus  ATCC49775-producing PVL was purchased from the American Type C"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ans \u00b1standard deviations (SDs). Statistical differences between groups were determined via Student\u2019s t-test. The data were analyzed and graphed using GraphPad Prism 8 (GraphPad Software, San Diego, CA, USA). A value of  p  < 0.05 was considered statistically significant. The raw DIA data were processed and analyz"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""me, China) for 5 min. The samples were analyzed via fluorescence microscopy (OMPUS IX73, Tokyo, Japan). The fluorescence intensity was quantified via ImageJ v1.8.0 software, and normalization processing was performed. 2.7. Mouse Experimental Groups and Drug Treatments ICR mice (6\u20138 weeks old, 20\u201325 g in w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""me, Shanghai, China), and the results were detected using a BD AccuriTM C6 Plus (BD Biosciences, Mountain View, CA, USA). The data were analyzed with FlowJo software10.8.1. 2.5. Western Blot Analysis To determine protein levels, total protein was extracted from BMECs using a whole-cell lysis assay (Key GE"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
29179472,10.18632/oncotarget.21075,"BCRP expression in schwannoma, plexiform neurofibroma and MPNST.",Oncotarget,2017,1500,3448,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Material and methods immunohistochemical staining for BCRP was performed on a tissue microarray composed out of 22 vestibular schwannomas, 10 plexiform neu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
29185159,10.1007/s11010-017-3227-2,"The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 (+/-) or NF1 (-/-) genotype derived from human cutaneous neurofibromas.",Mol Cell Biochem,2018,216,7509,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We retrieved the pregnancies of women in the Finnish NF1 cohort and in a 10\u2010fold control cohort from the Finnish Medical Birth Register. Cancers occurring during or after pregnancy were obtained from the Fi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We retrieved the pregnancies of women in the Finnish NF1 cohort and in a 10\u2010fold control cohort from the Finnish Medical Birth Register. Cancers occurring"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ntered the study on the cohort entry date of the respective individual with NF1. In the analysis of women aged 20\u201349\u2009years, the follow\u2010up for cancers started at the cohort entry or the 20th birthday, whichever was later, and ended on the date of death, emigration, 50th birthday, start of a pregnancy, ca"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
29206885,10.1371/journal.pone.0189093,Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?,PLoS One,2017,1936,6576,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-app"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""s measured on PET/MRI and PET/CT, respectively. The level of significance was set to p \u2264.05 for all tests. Statistical tests were performed using IBM SPSS Statistics 21.0 software (IBM Corp., Armonk, NY, USA)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
29249622,10.1016/j.devcel.2017.11.011,Differential Expression of NF2 in Neuroepithelial Compartments Is Necessary for Mammalian Eye Development.,Dev Cell,2018,1010,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The optic neuroepithelial continuum of vertebrate eye develops into three differentially growing compartments: the retina, the ciliary margin (CM), and the retinal "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29290338,10.1016/j.ajhg.2017.12.001,Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.,Am J Hum Genet,2018,1727,20024,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""terial and Methods Individuals and Phenotypic Data A total of 162 individuals heterozygous for a missense mutation affecting one of five neighboring  NF1  codons (Leu844, Cys845, Ala846, Leu847, and Gly848) were included in the study. Blood samples from 78 individuals (67 probands and 11 relatives) wer"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Material and Methods Individuals and Phenotypic Data A total of 162 individuals heterozygous for a missense mutation affecting one of five neighboring  NF1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
29351992,10.1073/pnas.1715999115,Involvement of Aryl hydrocarbon receptor in myelination and in human nerve sheath tumorigenesis.,Proc Natl Acad Sci U S A,2018,347,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor involved in xenobiotic metabolism. Plexiform neurofibromas (PNFs) can transfo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29354122,10.3389/fimmu.2017.01901,Neurofibromin 1 Impairs Natural Killer T-Cell-Dependent Antitumor Immunity against a T-Cell Lymphoma.,Front Immunol,2017,764,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin 1 (NF1) is a tumor suppressor gene encoding a Ras GTPase that negatively regulates Ras signaling pathways. Mutations in NF1 are linked to neurofibromatosis "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin 1 (NF1) is a tumor suppressor gene encoding a Ras GTPase that negatively regulates Ras signaling pathways. Mutations in NF1 are linked to ne"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,Sci Rep,2018,1413,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""RASopathies are a group of heterogeneous conditions caused by germline mutations in RAS/MAPK signalling pathway genes. With next-generation sequencing "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,Neuroscience,2018,1587,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin is the protein product of the NF2 tumor suppressor gene. Germline NF2 mutation leads to neurofibromatosis type 2 (NF2), characterized by multiple "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29409008,10.1093/neuonc/noy009,"Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.",Neuro Oncol,2018,1861,548,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We present the targeted next-generation sequencing (NGS) of  NF2 ,  SMARCB1 ,  LZTR1 ,  SMARCE1 , and  SUFU  tumor suppressor genes, using an amplicon-base"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
29409029,10.1093/neuonc/noy013,The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors.,Neuro Oncol,2018,1337,113,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We analyzed clinical, imaging, and pathology findings of all patients with NF1 and ANF at 3 institutions."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis 1 (NF1) leads to the development of benign and malignant peripheral nerve sheath tumors (MPNST). MPNST have been described to "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""abstract""]}",False
29415745,10.1186/s13023-018-0772-z,Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.,Orphanet J Rare Dis,2018,1150,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by a predisposition to develop multiple benign tumors. A major feature of NF1 is the development of localized cu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder characterized by a predisposition to develop multiple benign tumors. A major feature of NF1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29423604,10.1007/s10803-018-3478-0,Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).,J Autism Dev Disord,2018,769,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)-and questionnaire-based screening instrument w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In a non-selected sample of children with Neurofibromatosis type 1 (NF1) the prevalence rate of autism spectrum disorder (ASD) and predictive value of an observational (ADOS)-and quest"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29426343,10.1186/s12989-018-0244-6,Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition.,Part Fibre Toxicol,2018,2256,18249,0,1,10,11,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R"", ""GraphPad Prism"", ""TopHat"", ""STAR"", ""Fiji"", ""edgeR"", ""limma"", ""HTSeq"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""G CAC ATG ACG GAG GTT GT TP53 reverse TCA TCC AAA TAC TCC ACA CGC AKT1 forward GTC ATC GAA CGC ACC TTC CAT AKT1 reverse AGC TTC AGG TAC TCA AAC TCG T NF1 forward AGA TGA AAC GAT GCT GGT CAA A NF1 reverse CCT GTA ACC TGG TAG AAA TGC GA ATM forward GGC TAT TCA GTG TGC GAG ACA ATM reverse TGG CTC CTT TCG "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Cell cultures and particle preparation Dulbecco\u2019s Modified Eagle Medium (DMEM), Dulbecco\u2019s Modified Eagle Medium: Nutrient Mixture F12 (DMEM/F12), Hank\u2019s Balance"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""cribed [ 57 ]. Briefly, the trimmed reads were mapped to the human transcriptome and reference genome (GRCh37.65/hg19) by using TopHat 2.0 [ 58 ] and Bowtie 2.0 [ 59 ]. Reads were assigned to ensemble gene IDs by using the HTSeq software package. On average, 32,031,451 (+\u2009\u2212\u20093,819,051) reads were assigned "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s concerning nuclear deposition measurements is conducted using one way ANOVA with Tukey\u2019s multiple comparison. These statistics were performed using graphpad Prism 5 for Windows (GraphPad Software, La Jolla, CA,  https://www.graphpad.com/ ). The statistics for RT-PCR is conducted using two-tailed t-test (interva"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""ssed as previously described [ 57 ]. Briefly, the trimmed reads were mapped to the human transcriptome and reference genome (GRCh37.65/hg19) by using TopHat 2.0 [ 58 ] and Bowtie 2.0 [ 59 ]. Reads were assigned to ensemble gene IDs by using the HTSeq software package. On average, 32,031,451 (+\u2009\u2212\u20093,819,051"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""on was defined as the mean methylation level of all CpGs located in a CpG island or shore, between 2000\u00a0bp upstream and 500\u00a0bp downstream of the gene start site as defined by Ensemble gene annotation v75. Individual CpG sites were linked to genes on the basis of the annotation provided by Illumina. Data"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""25\u2009\u00d7\u2009225\u2009\u00d7\u200930\u00a0\u03bcm image volume). Images were captured using the AIM 4.2 software (Carl Zeiss). Images were processed with the image-processing program Fiji (ImageJ v1.47, open source software,  http://fiji.sc/Fiji ). Prior to the analysis, the cell of interest was cropped in a way that non-engulfed CNTs "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""rage, 32,031,451 (+\u2009\u2212\u20093,819,051) reads were assigned to genes. Differential expression between the different exposure methods was calculated by using EdgeR [ 60 ]. Heatmap and correlation analyses For DNA methylation and for gene expression dataset the genes were ranked by their FDR corrected  p  values."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""age was used for data annotation and further filtering [ 53 ]. After data preprocessing, differentially methylated CpG sites were found by using the \u2018limma\u2019 package with a linear modeling approach and empirical Bayes statistics while correcting for batch effect [ 53 ,  54 ]. Gene promoter methylation was"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HTSeq"": {""context"": ""riptome and reference genome (GRCh37.65/hg19) by using TopHat 2.0 [ 58 ] and Bowtie 2.0 [ 59 ]. Reads were assigned to ensemble gene IDs by using the HTSeq software package. On average, 32,031,451 (+\u2009\u2212\u20093,819,051) reads were assigned to genes. Differential expression between the different exposure methods"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""25\u2009\u00d7\u200930\u00a0\u03bcm image volume). Images were captured using the AIM 4.2 software (Carl Zeiss). Images were processed with the image-processing program Fiji (ImageJ v1.47, open source software,  http://fiji.sc/Fiji ). Prior to the analysis, the cell of interest was cropped in a way that non-engulfed CNTs were exc"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:HTSeq"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
29440379,10.1073/pnas.1719966115,Targeting the cMET pathway augments radiation response without adverse effect on hearing in NF2 schwannoma models.,Proc Natl Acad Sci U S A,2018,1790,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type II (NF2) is a disease that needs new solutions. Vestibular schwannoma (VS) growth causes progressive hearing loss, and the standard"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29493886,10.1002/cam4.1326,Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1.,Cancer Med,2018,1494,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""cell lung cancer (NSCLC) patients with EFGR mutations. However, most patients with NSCLC show acquired resistance to EGFR-TKIs, and low expression of NF1 is a mechanism of EGFR-TKI resistance in lung cancer. However, the mechanism by which NF1 is downregulated in EGFR-TKI-resistant NSCLC is unclear. He"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Epidermal growth receptor (EGFR)-targeted tyrosine kinase inhibitors (TKIs) have emerged as first-line drugs for advanced non-small-cell lung cancer (NSCLC)"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29515781,10.18632/oncotarget.24119,CXCR4: A new player in vestibular schwannoma pathogenesis.,Oncotarget,2018,1314,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: CXCR4 is a chemokine receptor that recruits blood stem cells and increases tumor cell growth and invasiveness. We examined CXCR4 expression in v"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29566645,10.1186/s11689-018-9230-4,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",J Neurodev Disord,2018,1552,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type1 (NF1) is associated with a broad range of behavioural deficits, and an imbalance between excitatory and inhibitory neurotransmission has been postulated i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type1 (NF1) is associated with a broad range of behavioural deficits, and an imbalance between excitatory and inhibitory neuro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29570943,10.1111/papr.12695,"The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1.",Pain Pract,2018,1700,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) can experience chronic pain. Previous research has examined the relationship between heart rate variability (HRV) "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) can experience chronic pain. Previous research has examined the relationship between hear"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,Cell Rep,2018,1072,8931,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""NTAL PROCEDURES Fly Lines The GAL4 lines were used previously in the lab ( Bai and Sehgal, 2015 ;  Cavanaugh et al., 2014 ;  Crocker et al., 2010 ).  Nf1 ,  P1 Nf1 , and UAS- P2 Nf1  lines were reported ( Williams et al., 2001 ) and were outcrossed into an  iso31  background for 7 generations. Blooming"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""EXPERIMENTAL PROCEDURES Fly Lines The GAL4 lines were used previously in the lab ( Bai and Sehgal, 2015 ;  Cavanaugh et al., 2014 ;  Crocker et al., 2010 )"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""nd Lomb-Scargle (LS) analysis using the Meta-cycle R program as described ( \u2212/\u2212 Wu et al., 2016 ). Statistics Data were analyzed and plotted with the GraphPad Prism software. Details of statistical analysis are provided in the figure legends, along with the p values corresponding to the asterisks in the figures."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""anti-rabbit secondary antibody. Immunolabeled brains were visualized with a TCS SP5 confocal microscope. Image Analysis All images were analyzed with ImageJ software. For PDF intensity at sLNv dorsal termini, the terminus region was manually selected as a box, including the axon terminus upward from the b"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
29596064,10.1172/JCI99424,Contributions of inflammation and tumor microenvironment to neurofibroma tumorigenesis.,J Clin Invest,2018,1428,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 associates with multiple neoplasms, and the Schwann cell tumor neurofibroma is the most prevalent. A hallmark feature of neurofib"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29626191,10.1038/s41467-018-03648-4,Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2.,Nat Commun,2018,1040,13927,0,1,1,2,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods DNA constructs and protein preparation The neurofibromin 2 constructs, residues 1\u2013312 and 1\u2013339, were cloned into pGEX-2T expression vector (GE Life Sciences) u"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""ta with same IR-Laser power were averaged and were plotted using \u201clogistic\u201d function in the Origin software. Cell culture and transfection conditions HEK293 cells were purchased from ATCC, hSC2\u03bb cells were a gift from Dr. Margaret Wallace ( https://www.nature.com/articles/labinvest201688 ), and SC4 cells "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""]}",False
29629523,10.3988/jcn.2018.14.2.153,Attention Deficit Hyperactivity Disorder in Neurofibromatosis Type 1: Evaluation with a Continuous Performance Test.,J Clin Neurol,2018,1213,4300,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Thirty-five patients (16 males; mean age 9.91 years) attending a multidisciplinary NF1 clinic completed the MOXO test. The findings were compared to 532 healthy age-matched standardized control subjects (285 males) without ADHD. METHODS"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Thirty-five patients (16 males; mean age 9.91 years) attending a multidisciplinary NF1 clinic completed the MOXO test. The findings were compared to 532 h"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
29632086,10.1101/gad.310797.117,Athymic mice reveal a requirement for T-cell-microglia interactions in establishing a microenvironment supportive of Nf1 low-grade glioma growth.,Genes Dev,2018,177,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Pediatric low-grade gliomas (LGGs) frequently do not engraft in immunocompromised mice, limiting their use as an experimental platform. In contrast, murine N"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29649040,10.1097/MAO.0000000000001781,Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.,Otol Neurotol,2018,1837,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""OBJECTIVE: Assess patient-reported outcomes (PRO) for hearing and tinnitus relative to clinical hearing assessment in people with neurofibromatosis 2 (NF2) associated hearing lo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,Oncotarget,2018,77,15550,0,1,6,7,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""Fiji"", ""FlowJo"", ""ImageJ"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Reagents Y100 and Y100B were synthesized by Chembridge Corp (San Diego, CA). The synthesis of Y100 and Y100B was first described by G"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""ts (Pierce) and developed using a standard film processor. Bioenergetic characterization of Y100 Bioenergetics analysis was performed with a Seahorse XF96 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Briefly, 2.0 \u00d7 10 5  U87-MG cells were plated in DMEM with 10% fetal bovine serum, in a Seahor"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""To perform drug sensitivity assays in yeast models (Table  3 ), log-phase cells were diluted to 0.05 OD 600 . Drugs were diluted in SC-Complete media starting at 200 \u03bcM, followed by 9 2-fold serial dilutions to generate a 10-point range of concentrations. 75 \u03bcL of cells were mixed with 75 \u03bcL of drug dil"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""A1RSi confocal microscope equipped with a 60X 1.4 NA objective, a DU4 detector unit, and Nikon Elements software. Image processing was performed with Fiji, built on ImageJ2 [ 62 ,  63 ]. Microarray 5 \u00d7 10 5  immortalized mammary epithelial cells (IMECs) were cultured overnight and treated with DMSO or 1"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""was gated out of the dataset. This experiment was repeated three times, and a representative experiment is shown. Histograms were generated using the FlowJo or FlowLogic flow cytometry analysis software packages. MV-151 active site probe assay U87-MG cells were plated (500,000 cells per well in a 6-well t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""microscope equipped with a 60X 1.4 NA objective, a DU4 detector unit, and Nikon Elements software. Image processing was performed with Fiji, built on ImageJ2 [ 62 ,  63 ]. Microarray 5 \u00d7 10 5  immortalized mammary epithelial cells (IMECs) were cultured overnight and treated with DMSO or 1 \u03bcM Y100 for 8 ho"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""7323) or empty vector (YEp13) using a transformation master mix containing 37% w/v polyethylene glycol MW 3350, 110 \u03bcM lithium acetate, and 307 \u03bcg/mL salmon sperm carrier DNA in sterile water. Cells were incubated in the transformation mixture, including DNA, for 30 minutes at 30\u00b0C before heat shock for 1"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
29666462,10.1038/s41598-018-24484-y,Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.,Sci Rep,2018,1449,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is caused by germline mutations in the NF1 gene and is characterized by caf\u00e9 au lait spots and benign tumours known as neurofibromas. NF1 encodes th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:sNF96.2"": {""context"": ""ranilic acid) as an inhibitor of EMT and found that it attenuated the expression of mesenchymal markers and angiogenesis-related genes in NF1-mutated sNF96.2 cells and in neurofibroma cells from NF1 patients. Tranilast also suppressed the proliferation of neurofibromin-deficient cells in vitro more effecti"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is caused by germline mutations in the NF1 gene and is characterized by caf\u00e9 au lait spots and benign tumours known as neur"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:sNF96.2"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,Sci Rep,2018,1278,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In Neurofibromatosis 1 (NF1) germ line loss of function mutations result in reduction of cellular neurofibromin content (NF1+/-, NF1 haploinsufficiency). The Ras-GAP neurofibrom"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""In Neurofibromatosis 1 (NF1) germ line loss of function mutations result in reduction of cellular neurofibromin content (NF1+/-, NF1 haploinsufficiency). The Ras-GAP neurofibromin is a very large cytoplasmic protein (2818 AA, 319\u2009kDa) involved in the RAS-MAPK pathway. Aside fr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In Neurofibromatosis 1 (NF1) germ line loss of function mutations result in reduction of cellular neurofibromin content (NF1+/-, NF1 haploinsufficiency). The"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29692918,10.1093/nop/npv065,Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation.,Neurooncol Pract,2016,1597,269,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Patients treated with bevacizumab underwent serial prospective MRI, audiology, clinical, CTCAE-4.0 adverse events, and NFTI-QOL quality-of-life assessments. Tumo"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
29704429,10.1002/jnr.24250,Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.,J Neurosci Res,2019,1446,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1 GEM"": ""b07051a7-b584-45ae-82ad-f7bb85c1dea5""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the NF1 gene. The NF1-encoded protein (neurofibromin) is an inhibitor of the oncop"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1 GEM"": {""context"": ""our current understanding of NF1-OPG pathobiology and describe the mechanisms responsible for tumor initiation, growth, and associated vision loss in Nf1 GEM models. We also discuss how Nf1 GEM and other preclinical models can be deployed to identify and evaluate molecularly targeted therapies for OPG, par"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the NF1 gene. The NF1-encoded protein (neurofibromin) is "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1 GEM"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,PLoS One,2018,1813,16477,0,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Animals All animals used in this work were housed under constant temperature and humidity conditions on a 12 h light/dark cycle, with"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" and  Nf2- transfected cells for further experiments. Having measured the impedance curves of these cell lines, we calculated the slope of the curves starting from the minimum CI value after an initial cell adhesion phase, to the maximum of the CI curve. The slopes obtained from growth curves of  contro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""wed comparable cell densities (subconfluent at the beginning of culturing and confluent after 96 hours in culture). Then background was subtracted in ImageJ using a rolling ball radius of 50 pixels. Frequencies of pixels with intensities larger than 20 (out of 255) were recorded for all images and summed "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""ere obtained in a Zeiss Axioskop 2 and Leica DMIRE2, equipped with a DFC350Fx camera. Adobe Photoshop (CS and Elements 15, Adobe Systems) and ImageJ (Fiji 1.51, NIH) were used for digital processing of images (linear adjustments of brightness and contrast). Statistical analysis was performed with R [ 42"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,PLoS One,2018,1512,9899,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""DESeq2"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Mice Nf1  (N),  flox/flox Nf1 flox/null ; GFAP-Cre (OPG-1),  Nf1 flox/R681 *; GFAP-Cre (OPG-2),  Nf1 flox/null ;  Pten flox/wt ; GFAP-Cre (OPG-3), and  Nf1 fl"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Mice Nf1  (N),  flox/flox Nf1 flox/null ; GFAP-Cre (OPG-1),  Nf1 flox/R681 *; GFAP-Cre (OPG-2),  Nf1 flox/null ;  Pten flox/wt ; GFAP"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": "" differential expression and fold change calculations on the RNA-Seq datasets (including all of the OPG datasets) were performed using the R package  DESeq2  version 1.18.1 [ 25 ], including use of Benjamini-Hochberg adjusted p-values [ 26 ] with an adjusted significance level of 0.01. Published microarra"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:DESeq2"": [""methods""]}",False
29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,Invest Ophthalmol Vis Sci,2018,1954,8841,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Nf1  expression in human endothelial cells (EC) was reduced using small hairpin (sh) RNA and EC proliferation, migration, and capacity to form vessel-lik"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1+/-"": {""context"": "" proliferation, migration, and capacity to form vessel-like networks were assessed in response to VEGF and hypoxia. Wild-type (WT), Nf1 heterozygous (Nf1+/-), and Nf1flox/+;Tie2cre pups were subjected to hyperoxia/hypoxia using the oxygen-induced retinopathy model. Retinas were analyzed quantitatively for"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Nf1  expression in human endothelial cells (EC) was reduced using small hairpin (sh) RNA and EC proliferation, migration, and capacity to form vessel-like netw"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""out, neovascular area, and branching were compared by two-way ANOVA with Tukey's post hoc test for multiple comparisons. Analysis was performed using GraphPad Prism version 6.0h (La Jolla, CA, USA).  P  < 0.05 was considered significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""Photoshop (Adobe Systems, Inc., San Jose, CA, USA) for further analysis. Central vessel dropout area was quantified from the digital images using the ImageJ software ( http://imagej.nih.gov/ij/ ; provided in the public domain by the National Institutes of Health, Bethesda, MD, USA) and neovascular area wa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""oration into ECFC was performed according to the manufacturer's instructions (Millipore, Burlington, MA, USA). Briefly, ECFC were progressively serum starved (5% FBS for 24 hours, 1% FBS for 7 hours, 0.125% for experiments) prior to the addition of VEGF (25 ng/mL). Two hours after the addition of VEGF, "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,PLoS One,2018,1725,79,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Detailed materials and methods can be found in  S5 Text ."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
29914349,10.1186/s11689-018-9239-8,Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.,J Neurodev Disord,2018,1684,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Gene mutations within the RAS-MAPK signaling cascade result in Noonan syndrome (NS), neurofibromatosis type 1 (NF1), and related disorders. Recent research has documented an increased risk for social difficulties and features of autism spectrum disorder (ASD) amon"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Gene mutations within the RAS-MAPK signaling cascade result in Noonan syndrome (NS), neurofibromatosis type 1 (NF1), and related disorders. Rece"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29925695,10.1172/jci.insight.120402,A porcine model of neurofibromatosis type 1 that mimics the human disease.,JCI Insight,2018,1445,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Loss of the NF1 tumor suppressor gene causes the autosomal dominant condition, neurofibromatosis type 1 (NF1). Children and adults with NF1 suffer from pathologies i"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Loss of the NF1 tumor suppressor gene causes the autosomal dominant condition, neurofibromatosis type 1 (NF1). Children and adults with NF1 suffer from pathologies includi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,Orphanet J Rare Dis,2018,1846,9637,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""FlowJo"", ""ImageJ"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tained from human third molars, which were extracted following clinical recommendation. Two primary cell cultures were obtained from individuals with NF1 (NF1 group; NF37 and NF87) and three from individuals without NF1 (control group; CT10, CT11 and CT12). Participants were both men and women with age"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Subject selection This study was conducted at Ant\u00f4nio Pedro University Hospital of Universidade Federal Fluminense, Niter\u00f3i, Brazil, between 2013 and 2016, and was approved by the institution\u2019s Ethics Committ"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""SCanto II (BD Bioscienses) flow cytometer and at least 20.000 events were analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software. Adipogenic differentiation For adipogenic differentiation, a triplicate of 5\u2009\u00d7\u200910 3  cells (passage 3) were plated in a 6-well cu"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""rols. Data was acquired using FACSCanto II (BD Bioscienses) flow cytometer and at least 20.000 events were analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software. Adipogenic differentiation For adipogenic differentiation, a triplicate of 5\u2009\u00d7\u200910 3  cells (passag"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""rogenic differentiation, one picture (20\u00d7 magnification) was obtained per quadruplicate at the center of the culture dish. Images were analyzed using ImageJ software v.1.49 (NIH, USA), and the percentage of stained area in each picture was obtained. Pellet analysis after chondrogenic differentiation For t"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""and intra and extracellular vesicles. Statistical analysis Statistical analysis was performed using Statistical Package for Social Sciences software (SPSS v. 20.0; Chicago, IL, USA) at 5% significance level. Proliferation and senescence assays were analyzed using repeated measure ANOVA with Bonferroni C"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,J Neuroradiol,2019,1781,912,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods. \u2013 A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imaging of the PN including MR and PET-CT. The corrected MR datasets were regis"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods. \u2013 A registration and segmentation pipeline was established using a cohort of NF1 patients with histopathological diagnosis of PN or MPNST, and medical imag"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
29982664,10.1093/neuonc/noy046,EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.,Neuro Oncol,2018,1711,448,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods High-throughput kinome analyses were performed in  NF2 -null human arachnoidal and meningioma cell lines to identify functional kinome changes upon  NF2  loss"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,BMC Res Notes,2018,1178,4335,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" aggressive sarcomas characterized by high recurrence rates and early metastases. These tumors arise more frequently within neurofibromatosis type 1 (NF1) and present with resistance during standard chemotherapy leading to increased mortality and morbidity in those patients. In vitro all-trans retinoic"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": ""Materials and methods Cell culture and colony formation assay Human MPNST cell lines S462 and T265 were described previously [ 23 \u2013 26 ]. Cells were cultured in DMEM (4.5\u00a0g/L glucose, 2\u00a0mM  l -glutamine, 10% (v/v) FBS, 100 U/mL penicillin/"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""Materials and methods Cell culture and colony formation assay Human MPNST cell lines S462 and T265 were described previously [ 23 \u2013 26 ]. Cells were cultured in DMEM (4.5\u00a0g/L glucose, 2\u00a0mM  l -glutamine, 10% (v/v) FBS, 100 U/mL penicillin/streptomy"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell culture and colony formation assay Human MPNST cell lines S462 and T265 were described previously [ 23 \u2013 26 ]. Cells were cultur"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""s SZX12 microscope) using Adobe Photoshop CS5 (Adobe Systems Software Ireland Limited 2010), and colonies were counted using the cell counter tool of ImageJ (NIH United States 2014). Xenotransplantation and ATRA quantification Experiments were approved by the federal state authority of nature, environment"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""nces between groups. Kruskal\u2013Wallis test was applied to compare groups of 4 mice for weight gain. A p value\u2009<\u20090.05 was defined to be significant. The SPSS program (IBM SPSS Statistics Standard) was applied."", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""lasma levels were analyzed as described elsewhere [ 28 ]. Pharmacological treatment, tumor volume quantification and preparation Daily oral treatment started 42\u00a0days after subcutaneous implantation over a period of 28\u00a0days. Ten mice were treated with ATRA (15\u00a0mg/kg) or PD0325901 (10\u00a0mg/kg). Intake was s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""methods"", ""abstract""], ""cell_lines:T265"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
30112810,10.1002/cam4.1732,Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.,Cancer Med,2018,1237,5317,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nosis and no effective medical options currently available. MPNSTs can occur either sporadically or in association with the neurofibromatosis type 1 (NF1) syndrome. Importantly, activation of RAS/RAF/MEK/ERK, PI3K/AKT/mTOR, and WNT/CTNNB1 signaling pathways has been reported in both NF1-related and lat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2 MATERIALS AND METHODS 2.1 Purification of DAW22 from the  Ferula ferulaeoides (Steud.) Korov \n DAW22 was isolated from the root of the  Ferula ferulaeoides"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""D5363 AKT inhibitor AZD5363 was prepared as a 100\u00a0mmol/L stock solution in DMSO. 2.3 Cell culture MPNST cell lines including STS\u201026T, 21  ST8814, 22  S462, 23  T265, 24  and S462\u2010TY 25  were cultured in Minimum Essential Media (MEM, Thermo Fisher Scientific, Massachusetts, USA) supplemented with 10% fet"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""inhibitor AZD5363 was prepared as a 100\u00a0mmol/L stock solution in DMSO. 2.3 Cell culture MPNST cell lines including STS\u201026T, 21  ST8814, 22  S462, 23  T265, 24  and S462\u2010TY 25  were cultured in Minimum Essential Media (MEM, Thermo Fisher Scientific, Massachusetts, USA) supplemented with 10% fetal bovine "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""]}",False
30143526,10.1101/gad.317354.118,Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.,Genes Dev,2018,1583,10397,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell culture LDCs are HB-like cells derived from hyperplastic liver lesions in a 12-wk-old  Alb-Cre;Nf2  mouse as described ( lox/lox"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""M with 10% fetal bovine serum (FBS). Adenovirus infection was used for  Nf2  re-expression (Ad5-CMV- Nf2 ). Primary murine SCs ( WT Nf2 lox /lox  or  Nf1 lox /lox ) were cultured on poly-L-lysine/laminin-coated plates in N2 medium (DMEM/F12-HAM, 1\u00d7 N2 supplement [Thermo Fisher], 50 \u00b5g/mL gentamicin [Th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""  or  Nf2 -expressing LDCs at \u223c10 WT 6  per 0.7 cm 2  and incubated for 1 h at 37\u00b0C. Cells were then fixed and stained. Image analysis and statistics ImageJ software (version 2.0, National Institutes of Health) was used for all image processing and analysis. The displayed images were produced from single "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""noviruses were generated using the AdEasy system (Agilent) as described in  WT Chiasson-MacKenzie et al. (2015) . Cells were infected 24 h before the start of the experiment to induce  Nf2  gene expression. An empty adenoviral vector was used as a control (EV). shRNA-expressing lentiviruses were generat"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
30166301,10.1136/bmjopen-2018-021800,Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.,BMJ Open,2018,2217,23065,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""and analysis A randomised, double-blind, placebo-controlled trial of methylphenidate with a two period crossover design. Thirty-six participants with NF1 aged 7\u201316 years will be randomised to one of two treatment sequences: 6 weeks of methylphenidate followed by 6 weeks of placebo or; 6 weeks of placeb"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods and analysis A randomised, double-blind, placebo-controlled trial of methylphenidate with a two period crossover design. Thirty-six participants with NF1 aged 7\u201316 ye"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
30179114,10.1148/radiol.2018172863,Abnormal Morphology of Select Cortical and Subcortical Regions in Neurofibromatosis Type 1.,Radiology,2018,2075,709,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""sis methods, 10 intracranial volume\u2013corrected subcortical and 34 cortical regions of interest (ROIs) were quantitatively assessed in 32 patients with NF1 and 245 age- and sex-matched healthy control subjects. By using linear models, ROI cortical thicknesses and volumes were compared between patients wi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods In this retrospective study, by using clinically obtained three-dimensional T1-weighted MR images and established image analysis meth"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
30181519,10.3390/molecules23092256,Targeting Difficult Protein-Protein Interactions with Plain and General Computational Approaches.,Molecules,2018,1099,21314,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. MD-Based Methods for Studying PPIs: Studying Peptides to Develop Novel Small-Molecule Anticancer Drug Candidates The availability of a general framework to design molecul"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""iogenesis, the process of vascular growth widely exploited by tumors to support their own development and diffusion. To proceed along these lines, we started from the experimentally characterized interactions between the protein Fibroblast Growth Factor-2 (FGF2) and peptides derived from two large extra"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,PLoS One,2018,1258,12483,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Subjects and methods Participants NF1 group In this study, a group of 16 individuals diagnosed with NF1 was investigated by a multidisciplinary assessment team at the Neurofibromatosis Ou"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Subjects and methods Participants NF1 group In this study, a group of 16 individuals diagnosed with NF1 was investigated by a multidisciplinary assessment team at the Neurofi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ubset of the data and then tested on the remaining \u201cunseen\u201d data (cross-validation). This strategy also avoids overfitting, which occurs when a model starts \u201cmemorizing\u201d training data rather than \u201clearning\u201d to generalize from a trend. Different machine learning algorithms would be suited to solve our re"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""ges were spatially processed using the Statistical Parametric Mapping toolbox (SPM8, Wellcome Trust Centre for Neuroimaging, 2008) implemented within Matlab 7.12.0 (MathWorks, Natick, MA, USA). Initially, a gross manual image reorientation and approximate definition of the image center point was applied. "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
30271432,10.1155/2018/6938130,Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study.,Dermatol Res Pract,2018,940,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""From 2005 to 2010, 20 consecutive patients with fully manifested neurofibromatosis type 1 (NF1) underwent elective neurofibroma resection at our institution (Departments of Plastic Surgery and of Odontostomatology). Specimens were photographed "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""From 2005 to 2010, 20 consecutive patients with fully manifested neurofibromatosis type 1 (NF1) underwent elective neurofibroma resection at our institu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,EBioMedicine,2018,1777,9836,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods DNA sequencing and dosage analysis were used to identify the  NF2  mutation status in sporadic schwannomas. The expression and sub-cellular localization of merlin and p53-MDM2 were assesse"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" cytometry analyses using Annexin V-FITC/PI double staining kit (Becton Dickinson, USA). 2.12 Statistics Statistical analysis was performed using the SPSS 17.0 statistics software. All values in the present study were expressed as mean\u202f\u00b1\u202fstandard deviation (SD) from at least three independent experiment"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""32 (# S1748, Beyotime) and Pifithrin (PFT)-\u03b1 (#S1816, Beyotime) were dissolved in DMSO at a concentration of 20\u202fmg/mL until use. Subsequent to a 12\u202fh starving period, the culture medium was replaced with fresh medium containing DMSO vehicle (untreated control) or different concentrations of drugs. A suf"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,EBioMedicine,2018,1881,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type I (NF1) is caused by heterozygous loss-of-function variants in the NF1 gene encoding neurofibromin which serves as a tumor suppressor that inhibits RAS sign"", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type I (NF1) is caused by heterozygous loss-of-function variants in the NF1 gene encoding neurofibromin which serves as a tumo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30284154,10.1007/s40268-018-0248-6,"Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.",Drugs R D,2018,1689,7386,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The primary objective of this phase II, open-label, single-arm trial was to assess whether orally administered everolimus reduced the surface volume of cuta"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""e willing and able to comply with the requirements of the trial. Female patients of childbearing potential were confirmed to not be pregnant prior to starting the trial by assessment of blood beta-human chorionic gonadotropin levels and were required to use highly effective methods of contraception thro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,J Biomed Sci,2018,1449,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a dominantly inherited tumor predisposition syndrome that targets the peripheral nervous system. It is caused by mutations of the NF1 gene which "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a dominantly inherited tumor predisposition syndrome that targets the peripheral nervous system. It is caused "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30335132,10.1093/hmg/ddy361,A proteasome-resistant fragment of NIK mediates oncogenic NF-B signaling in schwannomas.,Hum Mol Genet,2019,1505,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomas are common, highly morbid and medically untreatable tumors that can arise in patients with germ line as well as somatic mutations in neurofibromatosis t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
30381327,10.1074/mcp.RA118.001014,Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA).,Mol Cell Proteomics,2019,2196,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disease that predisposes individuals to developing benign neurofibromas and malignant peripheral nerve sheath tumors (MPNST"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disease that predisposes individuals to developing benign neurofibromas and malignant peripheral n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30470263,10.1186/s40478-018-0635-9,Tonic ATP-mediated growth suppression in peripheral nerve glia requires arrestin-PP2 and is evaded in NF1.,Acta Neuropathol Commun,2018,1055,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eam of P2Y2, \u03b2-arrestin-mediated signaling results in PP2-mediated de-phosphorylation of AKT, and PP2 activity is required for SC growth suppression. NF1 deficient SC show reduced growth suppression by ATP, and are resistant to the effects of \u03b2-arrestin-mediated signaling, including PP2-mediated de-pho"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Normal Schwann cells (SCs) are quiescent in adult nerves, when ATP is released from the nerve in an activity dependent manner. We find that suppressing n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30478285,10.1038/s41598-018-35806-5,Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.,Sci Rep,2018,1450,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are the leading cause of death in neurofibromatosis type 1 (NF1) patients. Current treatment modalities have been largely unsuccessful in improving MPNST patient survival, making the identification of new therapeu"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are the leading cause of death in neurofibromatosis type 1 (NF1) patients. Current treatment modalities have been"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30542122,10.1038/s41388-018-0600-x,STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma.,Oncogene,2019,1215,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibroma, a benign peripheral nerve tumor, is associated with the biallelic loss of function of the NF1 tumor suppressor in Schwann cells. Here, we show that FLLL32, a small molecule inhibitor of JAK2/STAT3 signaling, reduces neurofibroma growth in mice"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibroma, a benign peripheral nerve tumor, is associated with the biallelic loss of function of the NF1 tumor suppressor in Schwann cells. Here,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,PLoS One,2018,1260,7029,0,3,1,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials & methods Experimental animals The NF1 mouse model used in this study has been described elsewhere [ 29 ].  Dsk9  is a missense mutation in the GTPase-activating protein related domain of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": "" per litter than Nf1+/+ control males. Reduced fertility in Nf1+/- male mice is associated with disorganization of the seminiferous epithelium, with exfoliation of germ cells and immature spermatids into the tubule lumen. Morphometric analysis shows that these alterations are associated with decreased"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": ""amined in patients with NF1. In order to assess the role of reduced neurofibromin in the testes, we examined testicular morphology and function in an Nf1+/- mouse model. We found that although Nf1+/- male mice are able to reproduce, they have significantly fewer pups per litter than Nf1+/+ control males. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials & methods Experimental animals The NF1 mouse model used in this study has been described elsewhere [ 29 ].  Dsk9  is a missense mutation in the G"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""cell_lines:XF"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
30615146,10.1093/neuonc/noz002,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,Neuro Oncol,2019,2002,370,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Mouse and human merlin-deficient Schwann cell lines (MD-MSC/HSC) were screened against 6 MEK1/2 inhibitors. Efficacious drugs were tested in orthotopic allograft and  NF"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",Nat Protoc,2019,1500,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type II (NF2) is a disease that lacks effective therapies. NF2 is characterized by bilateral vestibular schwannomas (VSs) that cause pro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
30710873,10.1016/j.nicl.2019.101692,Reduced higher dimensional temporal dynamism in neurofibromatosis type 1.,Neuroimage Clin,2019,1980,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common single gene disorder resulting in multi-organ involvement. In addition to physical manifestations such as characteristic pigmentary chan"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common single gene disorder resulting in multi-organ involvement. In addition to physical manifestations such as chara"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30713041,10.1016/j.stemcr.2019.01.001,Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.,Stem Cell Reports,2019,991,4638,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Experimental Procedures Patients, Plexiform Neurofibromas, and Tumor Processing Tumor samples were kindly provided by NF1 patients after giving written informed consent for iPSC generation and genomic analysis studies. The study was approved by our Institutional Review B"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental Procedures Patients, Plexiform Neurofibromas, and Tumor Processing Tumor samples were kindly provided by NF1 patients after giving written inf"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
30728335,10.1172/jci.insight.98601,Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.,JCI Insight,2019,1243,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibroma is a major contributor to morbidity in patients with neurofibromatosis type I (NF1). Macrophages and mast cells infiltrate neurofibroma, and data from mouse models implicate these leukocytes in neurofibroma development. Antiinflamma"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibroma is a major contributor to morbidity in patients with neurofibromatosis type I (NF1). Macrophages and mast cells infiltrate neurofibroma"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30737893,10.1002/ajmg.a.61069,"Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.",Am J Med Genet A,2019,1400,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Tumor growths, migraine headaches, and other health-related complications reported in patients with neurofibromatosis type 1 (NF1) are often associated with pain. Thus, this study sought to describe and quantify the pain experience in children and young adults with NF1. Surveys "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Tumor growths, migraine headaches, and other health-related complications reported in patients with neurofibromatosis type 1 (NF1) are often associated wit"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
30744170,10.3390/cancers11020202,SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in Vitro.,Cancers (Basel),2019,512,14418,0,3,5,8,"{""cell_lines"": {""SK-N-SH"": ""eb1b960d-bfd7-48d2-b467-c7faf52b4b3a"", ""SK-N-AS"": ""cebfdef3-2323-48d9-bfbb-aa704338eabe"", ""SK-N-FI"": ""1c53f612-f254-487d-a545-186fd4e2b856""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""Fiji"", ""NanoDrop""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Microarray Gene Expression Gene expression analysis was performed using the MegaSampler feature of the publicly available R2: Ge"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:SK-N-SH"": {""context"": ""collected at the Karolinska University Hospital, snap-frozen in liquid nitrogen and stored at \u221280 \u00b0C until further use. The human cell lines SK-N-AS, SK-N-SH, SK-N-DZ, SK-N-FI, SH-EP1, Kelly, SH-SY5Y, and IMR-32 as well as THP-1, Jurkat E6.1, and U937 cells were obtained from the ATCC (American Type Cultur"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:SK-N-AS"": {""context"": ""ssue was collected at the Karolinska University Hospital, snap-frozen in liquid nitrogen and stored at \u221280 \u00b0C until further use. The human cell lines SK-N-AS, SK-N-SH, SK-N-DZ, SK-N-FI, SH-EP1, Kelly, SH-SY5Y, and IMR-32 as well as THP-1, Jurkat E6.1, and U937 cells were obtained from the ATCC (American Ty"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:SK-N-FI"": {""context"": ""arolinska University Hospital, snap-frozen in liquid nitrogen and stored at \u221280 \u00b0C until further use. The human cell lines SK-N-AS, SK-N-SH, SK-N-DZ, SK-N-FI, SH-EP1, Kelly, SH-SY5Y, and IMR-32 as well as THP-1, Jurkat E6.1, and U937 cells were obtained from the ATCC (American Type Culture Collection, LGC "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""oduced by drug A and B. A combination index <0.9 was defined as synergistic, 0.9\u20131.1 as additive and >1.1 as antagonistic. 4.13. Statistical Analysis GraphPad Prism software (versions 7 and 8, GraphPad Inc., San Diego, CA, USA) was used for statistical analysis and graph design. Fisher\u2019s exact test was used to te"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ith the iScript\u2122 cDNA Synthesis Kit (Bio-Rad Laboratories AB, Oslo, Norway). PCR was set up as a 25 \u03bcl reaction mix containing 2 \u03bcL cDNA, 12.5 \u03bcL AccuStart\u2122 II GelTrack PCR SuperMix (Quanta Biosciences, Gaithersburg, MD, USA), 400 nM of each primer (Sigma-Aldrich Norway AS, Oslo, Norway) and 10.1 \u03bcL of "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""on of fresh Opti-MEM. After 72 h the cell viability was assessed and cells were harvested for western blot analysis. Densitometry was performed using Fiji software [ 82 ]. 4.9. Cell Viability Assay To assess the effect of the commercially available SYK inhibitors BAY 61-3606, R406, GS-9973 (Entospletini"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": "" RNA was isolated using the NucleoSpin\u00ae TriPrep Kit (MACHEREY-NAGEL GmbH & Co. KG, D\u00fcren, Germany) and RNA quantity and quality was determined with a NanoDrop\u2122 2000 spectrometer (Thermo Fisher Scientific Inc.). One \u03bcg RNA was used as input for cDNA synthesis with the iScript\u2122 cDNA Synthesis Kit (Bio-Rad Lab"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:SK-N-SH"": [""methods""], ""cell_lines:SK-N-AS"": [""methods""], ""cell_lines:SK-N-FI"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:NanoDrop"": [""methods""]}",False
30796033,10.1158/1078-0432.CCR-18-2437,Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors.,Clin Cancer Res,2019,1194,399,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" BET bromodomain inhibitors have emerged as a promising therapy for numerous cancer types in preclinical studies, including neurofibromatosis type 1 (NF1)-associated malignant peripheral nerve sheath tumor (MPNST). However, potential mechanisms underlying resistance to these inhibitors in different can"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Experimental Design: Through modeling tumor evolution by studying genetic changes underlying the development of MPNST, a lethal sarcoma with no effective m"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
30800298,10.1177/2050312119829680,A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.,SAGE Open Med,2019,1670,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""OBJECTIVE: To explore the impact of plexiform neurofibromas on the lives of adults with neurofibromatosis type 1. BACKGROUND: Neurofibromatosis type 1 is a complex neurog"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
30850948,10.1007/s13238-019-0614-3,Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1.,Protein Cell,2019,631,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The primary cilium is a microtubule-based sensory organelle. The molecular mechanism that regulates ciliary dynamics remains elusive. Here, we report an une"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": "" by inhibiting synthesis/assembly and promoting disassembly. This is mainly mediated by MLN4924-induced phosphorylation of AKT1 at Ser473 under serum-starved, ciliary-promoting conditions. Indeed, pharmaceutical inhibition (by MK2206) or genetic depletion (via siRNA) of AKT1 rescues MLN4924 effect, indi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
30984524,10.2478/bjmg-2018-0019,Next Generation Sequencing Identified a Novel Multi Exon Deletion of the NF1 Gene in a Chinese Pedigree with Neurofibromatosis Type 1.,Balkan J Med Genet,2018,225,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disease involving neurocutaneous abnormalities. Neurofibromatosis type 1 is an autosomal dominant disorder characterized by the neurofi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disease involving neurocutaneous abnormalities. Neurofibromatosis type 1 is an autosomal dominant disorder cha"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31009417,10.1097/j.pain.0000000000001486,Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.,Pain,2019,1704,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common of a group of rare diseases known by the term, \""Neurofibromatosis,\"" affecting 1 in 3000 to 4000 people. NF1 patients present with"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is the most common of a group of rare diseases known by the term, \""Neurofibromatosis,\"" affecting 1 in 3000 to 4000 people. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,Sci Signal,2019,182,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 is an inherited, neoplastic disease associated with schwannomas, meningiomas, and ependymomas and that is caused by inactivation "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3102622,10.1111/1523-1747.ep12466155,A computed image analyzing system for quantitation of melanocyte morphology in caf-au-lait macules of neurofibromatosis.,J Invest Dermatol,1987,1359,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Split-dopa preparation is a commonly used technique to visualize the epidermal melanocytes. It can characterize the number of melanocytes and their tyrosinase (dop"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,Otol Neurotol,2019,1774,9920,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: Six NF2 patients with 11 VS (4 rapidly growing, 7 indolent), were scanned with FLT and FDG using a high-resolution research tomograph (HRRT, Siemens) and a Siemens Biograph TrueV PET"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""V peak  within each tumor. The latter is considered to be less sensitive to the VOI boundary and the uptake distribution ( 37 ). Statistical Analysis SPSS version 23 was used for all statistical analyses. The normality and homogeneity of variance for derived values was assessed using the Shapiro\u2013Wilk an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,Orphanet J Rare Dis,2019,1577,6468,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods This study sought to develop a self-administered questionnaire in French to assess the burden of NF1 (BoN), then translate and linguistically and cross-culturally validate it into American English, standardized methodology applied, as outlined in the"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods This study sought to develop a self-administered questionnaire in French to assess the burden of NF1 (BoN), then translate and linguistically and cross-culturally validate it into American English"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
31053152,10.1186/s13046-019-1183-2,Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth.,J Exp Clin Cancer Res,2019,1887,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""(MPNSTs) are sarcomas of Schwann cell lineage origin that occur sporadically or in association with the inherited syndrome, neurofibromatosis type 1 (NF1). This study aimed to examine the function of High mobility group protein A2 (HMGA2) in NF1 MPNST progression and the underlying molecular mechanism."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumours (MPNSTs) are sarcomas of Schwann cell lineage origin that occur sporadically or in association with th"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31063758,10.1016/j.devcel.2019.04.014,YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.,Dev Cell,2019,1237,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Merlin/NF2 is a bona fide tumor suppressor whose mutations underlie inherited tumor syndrome neurofibromatosis type 2 (NF2), as well as various sporadic "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31081992,10.1002/ajmg.a.61197,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.",Am J Med Genet A,2019,1778,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""symptoms (pain and skin symptoms) and total generic health-related quality of life (HRQOL) in children, adolescents, and young adults with NF Type 1 (NF1) from the patient perspective. The Speech, Communication, Worry, Pain, Skin Itch Bother, and Skin Sensations Scales from the Pediatric Quality of Lif"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The objective was to investigate the serial mediating effects of speech difficulties, patient health communication, and disease-specific worry in the relationship between neurofibromatosis ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31091306,10.1093/hmg/ddz095,Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.,Hum Mol Genet,2019,1299,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibroma (PN) tumors are a hallmark manifestation of neurofibromatosis type 1 (NF1) that arise in the Schwann cell (SC) lineage. NF1 is a common heritable cancer predisposition syndrome caused by germline mutations in the NF1 tumor "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""erves as a gatekeeper tumor suppressor in mice that prevents PN progression by inducing senescence-mediated growth arrest in aberrantly proliferating Nf1-/- SC. Conditional ablation of Nf1 and Arf in the neural crest-derived SC lineage allows escape from senescence, resulting in tumors that accurately phe"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibroma (PN) tumors are a hallmark manifestation of neurofibromatosis type 1 (NF1) that arise in the Schwann cell (SC) lineage. NF1 is a common"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31111915,10.1093/neuonc/noz080,Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.,Neuro Oncol,2019,1677,263,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Optic glioma stem cells (o-GSCs) were generated from this collection of  Nf1  genetically engineered mice, and analyzed for their intrinsic growth properties, as well as the production of chemokines that could differentially a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Optic glioma stem cells (o-GSCs) were generated from this collection of  Nf1  genetically engineered mice, and analyzed for their intrinsic growth properties, as well as the production o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
31131338,10.1002/jbm4.10085,Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits.,JBMR Plus,2019,714,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BMP2 and BMP7, which use bovine Achilles tendon-derived absorbable collagen sponge and bovine bone collagen as scaffold, respectively, have been approved as bone graft substitutes for orthopedic and de"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118026,10.1136/jmg.24.9.515,An exclusion map for Von Recklinghausen neurofibromatosis.,J Med Genet,1987,782,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""By using all the genetic linkage data available between Von Recklinghausen neurofibromatosis (VRNF) and various loci on the autosomes, a graphical display of all the non-excluded areas is presented. The probabil"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118028,10.1136/jmg.24.9.522,Von Recklinghausen neurofibromatosis: a linkage study of candidate and random marker genes.,J Med Genet,1987,436,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" on chromosomes 3 and 5, and chromosome arms 1q, 2p, 4p, 4q, 6q, 7p, 9q, 11p, 11q, and 14q. There was no evidence for genetic heterogeneity at D1S1 (DNF15S2) on chromosome arm 3p, using the Morton test for heterogeneity."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Genotyping, using plasma proteins or DNA polymorphisms or both, was carried out on 30 families selected through probands with Von Recklinghausen disease. The data provide additi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
3118030,10.1136/jmg.24.9.526,Linkage analysis of neurofibromatosis.,J Med Genet,1987,381,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Linkage analysis of neurofibromatosis was performed using genes on chromosomes 1, 8, 11, and 12. No linkage was found between NF and C-myc, AT 3, IGF-1, PTH, and gamma globin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118031,10.1136/jmg.24.9.527,Genetic linkage studies with neurofibromatosis: the question of heterogeneity.,J Med Genet,1987,346,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Three new families are reported for standard gene linkage markers and classical peripheral neurofibromatosis (Von Reckling-hausen disease). Additional da"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118032,10.1136/jmg.24.9.529,DNA linkage analysis in Von Recklinghausen neurofibromatosis.,J Med Genet,1987,688,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We have used DNA linkage analysis in 11 families with Von Recklinghausen neurofibromatosis (VRNF) in order to search for the chromosomal localisation of the defective gene causing this serious neurological dis"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118033,10.1136/jmg.24.9.530,Linkage studies in peripheral neurofibromatosis.,J Med Genet,1987,1002,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Peripheral neurofibromatosis (NF) is one of the most common major genetic disorders in man. Its chromosomal location is unknown and questions regarding s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118034,10.1136/jmg.24.9.532,Linkage analysis of peripheral neurofibromatosis to DNA markers on chromosome 8.,J Med Genet,1987,564,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Linkage relationships of the gene for peripheral neurofibromatosis (NF) were assessed in a large American Caucasian pedigree using two DNA markers located on c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
3118035,10.1136/jmg.24.9.534,Further exclusion data for the Von Recklinghausen neurofibromatosis gene: a genetic linkage study of 19 polymorphic markers.,J Med Genet,1987,244,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Linkage analysis on a panel of 15 Von Recklinghausen neurofibromatosis (VRNF) families with 19 polymorphic markers was carried out using the computer programme M-Link. Our findings have exc"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31189476,10.1186/s12883-019-1338-y,Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.,BMC Neurol,2019,1869,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""r this research and were included in the final analysis. The number of participants in the study was 7314 individuals containing 910 NF patients (642 NF1 and 268 NF2) and 6404 healthy subjects. The mean scores of sub-scales of QoL were significantly lower in NF patients compared with control except for"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: The neurofibromatoses (NF) are a group of genetic disorders that interfere negatively with the quality of life (QoL) and influence physical, emo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31201114,10.1016/j.redox.2019.101224,Loss of GTPase activating protein neurofibromin stimulates paracrine cell communication via macropinocytosis.,Redox Biol,2019,291,8055,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""OSW"": ""7a62af66-384d-419b-b8ac-f4d381b85942""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nta Cruz Biotechnology (Dallas, TX, USA). phox 2.2 Animals Animal experiments were approved by the Laboratory Animal Services at Augusta University.  Nf1  mice were kindly provided by Tyler Jacks (MIT, Boston, MA) and LysM Cre mice were purchased from the Jackson Laboratory.  +/\u2212 Nf1  mice were obtaine"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2 Materials and methods 2.1 Reagents EUK-134, DPI, LY294002, calphostin C, 5-(N-Ethyl-N-isopropyl)amiloride (EIPA), cytochalasin D, FITC-dextran, DCFH-DA, PK"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:OSW"": {""context"": "" and TTC AAT ACC TGC CCA AGG. +/\u2212 2.3 Cell culture Bone marrow-derived monocytes and thioglycollate-elicited peritoneal macrophages were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium (without 2-mercaptoethanol) containing 10% fetal bovine serum (FBS) and supplemented with a 1% antibiot"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""using 500\u202f\u03bcl supernatant. Average pixel intensity was quantified using ImageJ. f/f 2.14 Statistical analysis Statistical analysis was performed using GraphPad Prism (La Jolla, CA, USA). The data are expressed as mean\u202f\u00b1\u202fSD/SEM. Student's t-test and one or two-way ANOVA were used as appropriate for the particular e"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""plates in sterile phosphate-buffered saline (PBS) containing L-012 (400\u202f\u03bcM; Wako Chemicals, USA). Chemiluminescence was measured at 37\u202f\u00b0C using a Lumistar Galaxy (BMG) luminometer. 2.9 DCFH fluorescence Intracellular ROS were measured using 2\u2032, 7\u2032-dichloro-dihydro-fluorescein diacetate (DCFH-DA). Briefl"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""se. Arrays were performed according to the instructions provided by RayBiotech using 500\u202f\u03bcl supernatant. Average pixel intensity was quantified using ImageJ. f/f 2.14 Statistical analysis Statistical analysis was performed using GraphPad Prism (La Jolla, CA, USA). The data are expressed as mean\u202f\u00b1\u202fSD/SEM. "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:OSW"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
31201186,10.1136/bmjopen-2018-026185,An auditory brainstem implant for treatment of unilateral tinnitus: protocol for an interventional pilot study.,BMJ Open,2019,2127,16098,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods and analysis In this pilot study, 10 adults having incapacitating unilateral intractable tinnitus and ipsilateral severe hearing loss will have an ABI implanted. The ABI is switched on 6 weeks after implantation, followed by"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""a paired t-test (if data are normally distributed), although the outcome will be interpreted with caution, since no power calculation was instituted. SPSS (IBM, version\u00a023) will be used. A p value <0.05 is regarded as statistically significant. If needed, analysis will be adjusted for multiple compariso"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
31234911,10.1186/s13041-019-0481-0,Enriched expression of NF1 in inhibitory neurons in both mouse and human brain.,Mol Brain,2019,1102,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disease caused by loss-of-function mutations in NF1 gene, which encodes a GTPase activating protein for RAS. NF1 affects mu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant disease caused by loss-of-function mutations in NF1 gene, which encodes a GTPase activating protei"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31291965,10.1186/s12964-019-0388-5,ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.,Cell Commun Signal,2019,1084,9868,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: We have found that erbB receptor tyrosine kinases drive Ras hyperactivation and growth in NF1-null malignant peripheral nerve sheath tumors (MPNSTs). However, MPNSTs variably express multiple erbB receptors with distinct functional characteris"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods ErbB4 expression was assessed using immunohistochemistry, immunocytochemistry, immunoblotting and real-time PCR. To define erbB4 functions, we generated"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" and two related proteins was assessed using Proteome Profiler Phospho-Kinase Arrays (#ARY003B; R&D Systems, Minneapolis, MN). MPNST cells were serum starved overnight and then stimulated with 10\u2009nM NRG1\u03b2 for 5\u2009min. Cells were lysed and arrays processed and developed per the manufacturer\u2019s recommendatio"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ensities, 3\u20134 independent images of CD31-immunostained sections from each graft (Cre-ablated and control) of UBI-1 and UBI-2 cells were analyzed with ImageJ using the \u201cautomated counting of single-color image\u201d function. RNA interference A pool of four siRNAs targeting erbB4 (L-003128-00-005) and a non-tar"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""lysed and arrays processed and developed per the manufacturer\u2019s recommendations. Signals were quantified using the Protein Array Analyzer Plug In for FIJI. Differentially expressed genes and RNA sequencing Total RNA was isolated using standard Trizol based methods from FACS-sorted UBI1, 2, and 3 cells a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
31296571,10.1074/jbc.RA118.006937,Phosphorylation of Merlin by Aurora A kinase appears necessary for mitotic progression.,J Biol Chem,2019,1360,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Although Merlin's function as a tumor suppressor and regulator of mitogenic signaling networks such as the Ras/rac, Akt, and Hippo pathways is well-documented, in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31312020,10.1038/s41388-019-0883-6,"The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.",Oncogene,2019,1147,2248,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell culture Sc4 is an immortalized Schwann cell line [ 5 ] established from  Nf2 \u0394ex2/\u0394ex3  mice by Marco Giovannini laboratory. RT4"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""-200 system, according to the manufacturer\u2019s instructions (Xenogen, San Francisco, CA). Statistical analysis Statistical analyses were performed with GraphPad Prism 7."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" a humidified atmosphere with 5% CO 2  at 37\u2009\u00b0C. Orthotopic transplantation and bioluminescence imaging All animal experiments were approved by the Wistar Institutional Animal Care and Use Committee and performed in accordance with relevant institutional and national guidelines.  Nf2 +/+  mSCs were firs"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
31427883,10.1155/2019/7656747,Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016).,Sarcoma,2019,1420,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PURPOSE: There are no known effective medical treatments for refractory MPNST. Inactivation of the NF1 tumor suppressor in MPNST results in upregulation of mTOR (mammalian target of rapamycin) signaling and angiogenesis, which contributes to disease pr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: There are no known effective medical treatments for refractory MPNST. Inactivation of the NF1 tumor suppressor in MPNST results in upregulation "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
31511601,10.1038/s41598-019-49705-w,The Secretomes of Painful Versus Nonpainful Human Schwannomatosis Tumor Cells Differentially Influence Sensory Neuron Gene Expression and Sensitivity.,Sci Rep,2019,1483,8250,0,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Cells and media Schwannomatosis cell lines and conditioned media. Schwannomatosis-related tumors were collected from surgical cases from January 2014 through March 2017, occurring at Johns Hopkins School of Medicine. The diagnosis of"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""inful CMs were not significant (Supplemental Fig.\u00a0 2 ). ANOVA analysis with Dunnet multiple comparisons was used to compare the effects of CM groups (Graphpad Prism8). In addition, the percentage of cells responding to KCl, capsaicin, or cinnamaldehyde stimulation was analyzed. An individual cell\u2019s response to st"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""a 2\u2009minute exposure to X-ray film. Data analysis and statistics For cytokine arrays, X-ray films were scanned using a gel imager and quantified using ImageJ. Pixel densities were compared and averaged for the duplicate spots on the blots, normalized to the standard provided, and plotted using Prism 8. For"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""f the supplied 96 well plate. Amplifications were carried out in 96 well plates in a Roche Lightcycler 480 with cycling as follows: 95\u2009\u00b0C 10\u2009min (hot start), and 45 cycles of 95\u2009\u00b0C 15\u2009sec and 60\u2009\u00b0C for 1\u2009min. All reactions were performed in triplicate. Dissociation curve analysis was performed to rule o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type1.,Elife,2019,1194,25776,0,2,5,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""MATLAB"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""0.48_1 m_FC-ZF1.25, Doric Lenses Inc OD: 300 \u03bcm, Length: 1 m Experimental animals Experimental subjects were 8\u201312 week old 129T2/SvEmsJ::C57Bl/6NTac  Nf1 +/+  and  Nf1 +/-  male and female mice that were generated via the F1 cross of 129T2/SvEmsJ male mice (the Jackson Laboratory Stock No: 002065) and "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Key resources table Reagent type  (species) or resource Designation Source or reference Identifiers Additional  information Antibody "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""scribed ( Chan et al., 2017 ;  Saunders et al., 2012 ). Virus production was performed using a published protocol ( Challis et al., 2019 ). In brief, HEK293T cells were triple transfected using polyethylenimine (PEI) to deliver viral pUCmini-iCAP-PHP.eB (Addgene #103005) or pAAV-DJ-Rep-Cap (VPK-420-DK, Ce"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""mbinant DNA reagent pAAV-DJ-Rep-Cap Cell Biolabs, Inc Cat#: VPK-420-DK Software, Algorithm Matlab Mathworks, Inc RRID: SCR_001622 Software, Algorithm GraphPad Prism 7 GraphPad Software, Inc RRID: SCR_002798 Software, Algorithm ABET II Software for Operant Control Lafayette Instrument Company Model 89501 Software,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""e hydroxylase (Rabbit polyclonal) EMD Millipore Cat#: AB152  RRID: AB_390204 IHC (1:1000) Antibody Anti-tyrosine hydroxylase (mouse monoclonal) ImmunoStar Cat#: 22941  RRID: AB_572268 IHC (1:1000) Antibody Anti-GFP (mouse polyclonal) Aves Cat#: GFP-1020  RRID: AB_10000240 IHC (1:1000) Antibody Alexa Flu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""-PHP.eB Addgene Plasmid#: 103005  RRID: Addgene_103005 Recombinant DNA reagent pAAV-DJ-Rep-Cap Cell Biolabs, Inc Cat#: VPK-420-DK Software, Algorithm Matlab Mathworks, Inc RRID: SCR_001622 Software, Algorithm GraphPad Prism 7 GraphPad Software, Inc RRID: SCR_002798 Software, Algorithm ABET II Software for"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""her a Keyence BZ-X fluorescence microscope or Zeiss 880 confocal microscope. Images were analyzed using BZ-X Analyzer software (Keyence Corporation), ImageJ, and/or Imaris (Bitplane). VTA and SNc cell counting was performed on 100 mm, coronal histological sections from Bregma \u22123.2 to \u22123.6 \u03bcm (AP) and aver"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
31558455,10.1136/bmjopen-2019-030601,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,BMJ Open,2019,2002,29069,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods and analysis This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3\u201315 years of age), 70 TD participants (3\u201315 year"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods and analysis This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participan"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
31585900,10.2741/4817,NF2/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells.,Front Biosci (Landmark Ed),2020,155,19658,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""FlowJo"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Ethics statement All procedures executed in chickens were approved by the Institutional Animal Care and Use Committee (IACUC) of Jili"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""as mean \u00b1 SEM and bars with superscript symbols that indicate the significant difference compared with control groups at **  P  < 0.01, *  P  < 0.05. GraphPad Prism version 8 (GraphPad Prism, CA, USA) was applied to form statistical graphs based on the results. Appendix Supplementary materials \n \n Supplementary I"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""GCCATAGTCA 281 MYC KU981087.1 F: ATCAGCAACAACCGAAAATG R: GTCACGCAGGGCAAAGAAAC 132 GDF9 AY566700.2 F: CTATTGCTGCATTCACTGGC R: CCTTGGTGGCGTACATCTTA 269 STAR NM_204686.2 F: GTCCCTCGCAGACCAAGT R: TCCCTACTGTTAGCCCTGA 196 CYP11A1 NM_001001756.1 F: GTGGACACGACTTCCATGACT R: GAGAGTCTCCTTGATGGCGG 174 BCL-2 NM_205"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ic cells comprises the number of cells in the right upper quadrant (Q1-UR) and number of cells in the right lower quadrant (Q1-LR) and analyzed using FlowJo v7.6 software (Stanford University, Stanford, CA, USA). Each experiment was carried out at least three times. ROS detection Reactive Oxygen Species A"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""CTAGTCAGCTGAAGACTTTAAT-3\u2032, which was synthesized by Genepharma (Shanghai, China). Statistical analysis Statistical analysis was carried out using the SPSS12.0 software package. The data were collected and analyzed with a one-way ANOVA followed by Tukey\u2019s multiple-comparison test when more than two group"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
31594823,10.1158/1535-7163.MCT-19-0319,The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor.,Mol Cancer Ther,2020,742,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The carbon and nitrogen components of glutamine are used for multiple biosynthetic processes by tumors. Glutamine metabolism and the therapeutic potential of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31626572,10.1200/JCO.19.01367,"Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.",J Clin Oncol,2019,1422,335,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""PATIENTS AND METHODS Bevacizumab was given for 6 months at 10 mg/kg every 2 weeks, followed by 18 months at 5 mg/kg every 3 weeks. The primary end point was hearing response defined by word recogn"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
31650029,10.1016/j.omto.2019.09.001,STING Restricts oHSV Replication and Spread in Resistant MPNSTs but Is Dispensable for Basal IFN-Stimulated Gene Upregulation.,Mol Ther Oncolytics,2019,1452,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNSTs) are an aggressive soft-tissue sarcoma amenable only to surgical resection. Oncolytic herpes simplex viruses (oHSV"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31652930,10.3390/genes10110839,The Role of Co-Deleted Genes in Neurofibromatosis Type 1 Microdeletions: An Evolutive Approach.,Genes (Basel),2019,134,6598,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2. Methodology 2.1. Background In a previous study conducted by our group ninety-three unrelated NF1 probands who met the NIH diagnostic criteria were recruited at the Oncogenetics clinics of the Hospital de Cl\u00ednicas de Porto Alegre, located in the s"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Methodology 2.1. Background In a previous study conducted by our group ninety-three unrelated NF1 probands who met the NIH diagnostic criteria were recruited at the Oncogene"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ve selection is expected) and background (those not expected to exhibit positive selection). We set CodeML to estimate branch lengths by using random starting points (fix_blenght = \u22121). All models were run using the F3x4 option for expected codon frequencies based on third codon positions. Finally, the "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
31730023,10.1186/s40360-019-0369-8,Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).,BMC Pharmacol Toxicol,2019,2304,1810,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""pectively), are both cancer predisposition syndromes that disproportionately affect cells of neural crest origin. New therapeutic approaches for both NF1 and NF2 are badly needed. In promising previous work we demonstrated that two non-steroidal analogues of 2-methoxy-oestradiol (2ME2), STX3451(2-(3-br"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods STX3451 and STX2895 were tested in dose-dependent studies for their effects on growth parameters of malignant and benign NF2 human tumour cell lines in vitro. The mechanisms"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
31752929,10.1186/s13041-019-0517-5,The impact of RASopathy-associated mutations on CNS development in mice and humans.,Mol Brain,2019,1234,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The RAS signaling pathway is involved in the regulation of developmental processes, including cell growth, proliferation, and differentiation, in the centr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31756343,10.1016/j.lfs.2019.117079,Activation of PLC/AKT/IB/p65 signaling increases inflammation in mast cells to promote growth of cutaneous neurofibroma.,Life Sci,2019,1550,11495,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""AIM: Cutaneous neurofibroma (cNF), a hallmark feature of neurofibromatosis type 1 (NF1), results in psychological and physical damage to patients. Considering the important role of mast cells in neurofibroma development, the aim of this"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2 Method and materials 2.1 Reagents Rabbit polyclonal antibodies to IL-1\u03b2, catalase, and p-Akt (Ser473) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, US"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,J Biol Chem,2020,50,16682,0,2,3,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Experimental procedures Cloning of neurofibromin constructs DNA constructs were generated for the various fragments and full-length neurofibromin using Gat"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""gments and full-length neurofibromin using Gateway recombinational cloning ( 28 ). Entry clones were produced by PCR amplification of portions of the NF1 gene from Addgene construct 70423, which contains a codon-optimized version of human NF1 isoform 2 ( NM_000267.3 ) to ensure stability of the plasmid"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "" the final negatively-stained EM model of neurofibromin holoprotein using the ATSAS tool EM2DAM. Immunoprecipitation and Western blotting An NF1-null HEK293T cell line was generated using CRISPR to knock out both alleles of  NF1 . HEK293T and NF1-null 293T cells were maintained in DMEM with 10% fetal bovi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""perose-6 Increase (GE Healthcare) in a 16/60 column. For all final proteins, concentrations were determined by measuring sample absorbance at 280 nm (Nanodrop 2000C Spectrophotometer, Thermo Fisher Scientific) and using the extinction coefficient calculated from the amino acid sequence. Size-exclusion chrom"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""gCl 2  with a final concentration of 2.5 \u03bc m  phosphate sensor protein (Thermo Fisher Scientific) and 20 \u03bc m  GTP and kept on ice until the assay was started. NF1 proteins were diluted in the same buffer and added to the assay along with controls containing no NF1 proteins or added phosphate. A 96-well "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
31836719,10.1038/s41597-019-0317-x,Engaging a community to enable disease-centric data sharing with the NF Data Portal.,Sci Data,2019,446,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""A significant challenge facing rare disease communities is finding a sufficient quantity and variety of data to develop and test disease-specific hypotheses. Here we describe an appr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
31848332,10.1038/s41467-019-13640-1,A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,Nat Commun,2019,1089,6196,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Trial oversight This was an exploratory clinical study of VEGFRs peptide vaccination for progressive NF2. All protocols were approved by the Keio Univer"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" comparing clinical course after vaccination with that before vaccination (as control) in each case. All statistical analyses were performed with IBM SPSS software (IBM Corp., Armonk, NY, USA). A  P -value of <0.05 was considered statistically significant. Because we conducted only one statistical test "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
31852972,10.1038/s41598-019-56022-9,AR facilitates YAP-TEAD interaction with the AM promoter to enhance mast cell infiltration into cutaneous neurofibroma.,Sci Rep,2019,1208,10416,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Statement of methods The relevant guidelines and regulations were followed for all methods used in this study. Approval was obtained from the institutional review board of the "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""ined (0.1% crystal violet) and counted to evaluate mast cell recruitment. The results are showed as mean\u2009\u00b1\u2009SD. In vivo  mast cell recruitment assay shNf1-SW10 cells (3\u2009\u00d7\u200910 6 ) were suspended in medium containing Matrigel (1:4; BD Biosciences, San Jose, CA, USA) and subcutaneously injected into the rig"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""col. The experiments were repeated three times. Statistical analysis For statistical analysis between two groups, Student\u2019s t-test was employed using GraphPad Prism version 5.0 software (San Diego, CA, USA). For comparison of three groups, one-way ANOVA and LSD t-test (Fisher\u2019s least significant difference t-test"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""(San Diego, CA, USA). For comparison of three groups, one-way ANOVA and LSD t-test (Fisher\u2019s least significant difference t-test) were employed using SPSS (for Windows 10.0). For the correlation analysis, Spearman\u2019s correlation test was used with SPSS. A  P \u2009<\u20090.05 was defined as statistically significa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
31860870,10.18632/aging.102529,Circular RNA NF1-419 enhances autophagy to ameliorate senile dementia by binding Dynamin-1 and Adaptor protein 2 B1 in AD-like mice.,Aging (Albany NY),2019,682,11539,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R"", ""STAR"", ""edgeR"", ""ImageJ"", ""bowtie2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Senescent astrocyte preparation Murine cerebral cortical cells from a 1-day-old rat were dissociated after a 30 min trypsinization (0"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""r at least 1 week prior to the initiation of the experiments. Mice were randomly allocated into 3 groups of 8 animals each: SAMP8 model group, ss circNF1-419 -OV-AAV infected group, and sh circNF1-419 -OV-AAV infected group. Newborn KM mice and Balb/c mice were obtained from the Center of Laboratory An"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""nced with an Illumina HiSeq TM  2500 flowcell. Computational analysis of circRNAs The reads were first mapped to the latest UCSC transcript set using Bowtie2 version 2.1.0 [ 52 ] and the gene expression level was estimated using RSEM v1.2.15 [ 53 ]. For lincRNA expression analysis, we used the transcripts"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""DR option was used to calculate the significance of the canonical pathway. For circRNA expression analysis, the reads were mapped to the genome using STAR [ 55 ]. DCC [ 56 ] was used to identify circRNA and to estimate the circRNA expression. TMM (trimmed mean of M-values) was used to normalize gene exp"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""//www.lncipedia.org ). TMM (trimmed mean of M-values) was used to normalize gene expression. Differentially expressed genes were identified using the edgeR program [ 54 ]. Genes showing altered expression with  p  < 0.05 and a more than 1.5 folds change was considered differentially expressed. Pathway an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""P), Atg12 (Protein, 1825-1-AP), LC3A (abcam, 128025), LC3B I, and LC3B II proteins were assessed by western blot with band intensity quantified using ImageJ software (NIH) as described previously [ 25 ]. Briefly, global brain tissue was dissected from treated mice (purchased from the Beijing HFK Bioscienc"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": ""nced with an Illumina HiSeq TM  2500 flowcell. Computational analysis of circRNAs The reads were first mapped to the latest UCSC transcript set using Bowtie2 version 2.1.0 [ 52 ] and the gene expression level was estimated using RSEM v1.2.15 [ 53 ]. For lincRNA expression analysis, we used the transcripts "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:bowtie2"": [""methods""]}",False
31881853,10.1186/s12885-019-6442-2,A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.,BMC Cancer,2019,2336,19059,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tumors with MAPK/ERK pathway activation. The TRAM-01 study is a phase II multicentric open-label basket trial including four groups. Group 1 includes NF1 patients with progressing/refractory glioma. Group 2 includes NF1 patients with plexiform neurofibroma. Group 3 includes patients with progressing/re"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The primary objective is to determine the objective response rate of trametinib as a single agent for treatment of progressing/refractory tumors with MAPK/E"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""re adverse events (SAE) will be monitored. Analyse the serum levels of trametinib. Analysis of trough level will be done twice (at day 22, and before starting cycle 16 or at progression whichever comes first). Assess changes in quality of life over treatment phases and compare pre and post changes acros"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
31915440,10.1155/2019/9493837,Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.,Int J Pediatr,2019,0,6303,0,1,2,3,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods  111 children aged between 6 and 12 years (53 NF1 plus ADHD, 28 NF1-only, 30 ADHD-only) performed the German version of the intelligence test WISC-IV and a continuous performance test (T.O.V.A.) to a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""fessional position and family income. 2.3. Data Analyses Data were analyzed using the 25th version of the IBM Statistical Package for Social Science (SPSS). Group (NF1 ADHD ; NF1 control ; ADHD control ) served as between subject factor and full-scale IQ, sex, and age as covariates, where appropriate. D"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods  111 children aged between 6 and 12 years (53 NF1 plus ADHD, 28 NF1-only, 30 ADHD-only) performed the German version of the intelligence test WISC-IV and a conti"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:R"": [""methods""]}",False
31936793,10.3390/cancers12010177,Contribution of mTOR and PTEN to Radioresistance in Sporadic and NF2-Associated Vestibular Schwannomas: A Microarray and Pathway Analysis.,Cancers (Basel),2020,780,7555,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""limma"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Material and Methods 4.1. Patients and Tumors Vestibular schwannoma tumor samples were retrospectively collected from 67 patients (39 males and 28 females)"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""All subsequent DE analysis steps were performed in the language R (version 3.1.1) [ 84 ] mainly with the packages \u201caffy\u201d (version 1.42.3) [ 85 ] and \u201climma\u201d (version 3.20.9) [ 86 , 87 ]. Initially, the expression data from all 74 chips were quantile normalized with RMA (robust multichip average) [ 88 ]. "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:limma"": [""methods""]}",False
32089640,10.1155/2020/5784876,Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).,Sarcoma,2020,1042,8698,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Patient Population Patients aged \u226516 years with histologically confirmed unresectable/refractory sarcoma (phase 1) and MPNST (ph"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""ting serum cholesterol and triglycerides \u2264300\u2009mg/dL; and QTcF \u2264480\u2009ms were eligible. Patients had recovered from all prior therapy. For patients with NF1, diagnostic criteria for NF1 were documented [ 23 ]. The multi-institutional trial was coordinated through Sarcoma Alliance for Research through Coll"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" for detecting a true success probability of at least 25% versus the null hypothesis success rate of 5% or less. PD endpoints were analyzed using the GraphPad prism 6.0 statistical software.  p  values were calculated using a two-way analysis of variance. A  p  value of <0.05 was considered to indicate a statisti"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""p )-Akt, eiF2 \u03b1 ,  p -eIF2 \u03b1 ,  p -S6, and Hsp70. Signal intensity of the autoradiogram was quantified using densitometry scanning and analyzed using ImageJ software (National Institutes of Health, Bethesda, MD). The absorbance of each phosphoprotein lane was recorded, and protein levels were determined a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,Genes (Basel),2020,1359,9443,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""clusterProfiler"", ""pheatmap"", ""R"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" ]. All data analyzed in this article are stored on the NF Data Portal [ 24 ] ( http://nfdataportal.org ) with analyses stored at  http://synapse.org/nf1landscape . To recapitulate the analysis from these data, all relevant code can be found at  https://github.com/Sage-Bionetworks/NF_LandscapePaper_201"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Materials Implementation and Data and Code Availability All analyses were performed using the R programming language. A comprehe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": "" to be stored on the NF Data Portal ( Table 1 ). Specifically, raw fastq files were downloaded from Synapse and transcripts were quantified using the Salmon pseudo-alignment tool [ 36 ] with Gencode V29 transcriptome. Links to specific datasets and the access teams required to download them can be found u"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""ch cluster to generate a consensus protein activity prediction for each latent variable cluster. Then, we used gene set enrichment analysis (via the \u201cclusterProfiler\u201d R package [ 48 ]) to assess whether drug targets were enriched in the five consensus protein lists. Drug-wise target lists were obtained from the Dr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""ering and Drug Enrichment Analysis A heatmap and subclusters of latent variables that had similar VIPER protein predictions were generated using the \u201cpheatmap\u201d R package [ 47 ]. We observed five clear clusters of latent variables; these clusters were defined using the R cutree function to isolate the five c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Salmon"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:pheatmap"": [""methods""]}",False
32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,Mol Genet Genomic Med,2020,1333,8447,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GATK"", ""BWA"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods A derivation cohort of 28 patients with a prior negative NSD panel and either NFNS or a suspicion of NSD and caf\u00e9\u2010au\u2010lait spots underwent  NF1  and  SPRED1  sequencing. To further determine the utility and burden of adding these genes, a validation cohort of 505 patients with a suspected RAS"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods A derivation cohort of 28 patients with a prior negative NSD panel and either NFNS or a suspicion of NSD and caf\u00e9\u2010au\u2010lait spots underwent  NF1  and  SPRED1"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""e paired end mode; Illumina). Sequence reads were aligned to the reference sequence (GRCh37) using bwa\u2010mem v0.7.10, followed by variant calling using GATK, version 1.0.4705 (McKenna et al.,  2010 ). For the validation cohort, Sanger sequencing was used to confirm all clinically significant variants and "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""quencing using the MiSeq\u2010M01450 instrument (150\u2010base paired end mode; Illumina). Sequence reads were aligned to the reference sequence (GRCh37) using bwa\u2010mem v0.7.10, followed by variant calling using GATK, version 1.0.4705 (McKenna et al.,  2010 ). For the validation cohort, Sanger sequencing was used"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""]}",False
32108657,,Diagnostic sequence for early diagnosis of neurofibromatosis type 1 using NIH criteria.,Stomatologija,2019,913,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Early diagnosis of neurofibromatosis is significant to start the multidisciplinary approach of this type of patient. This syndrome may be first identifie"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""Early diagnosis of neurofibromatosis is significant to start the multidisciplinary approach of this type of patient. This syndrome may be first identified in pediatric dental care. This study is about a 9-year"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
32144278,10.1038/s41598-020-60156-6,Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.,Sci Rep,2020,1731,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is an inherited disorder characterized by bilateral vestibular schwannomas (VS) that arise from neoplastic Schwann cells (S"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32152628,10.1093/neuonc/noaa053,Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions.,Neuro Oncol,2020,1690,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Understanding the natural history of non-malignant peripheral nerve sheath tumors (PNSTs) in neurofibromatosis type 1 (NF1) is critical to optimal clinical care and the development of meaningful clinical trials. METHODS: We longitudinally analyzed growth of plexiform neur"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Understanding the natural history of non-malignant peripheral nerve sheath tumors (PNSTs) in neurofibromatosis type 1 (NF1) is critical to optim"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32181506,10.1111/dmcn.14517,Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.,Dev Med Child Neurol,2020,1817,697,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""siveness Scale, Second Edition (SRS-2) and the Social Skills Improvement System - Rating Scales (SSIS-RS), in children with neurofibromatosis type 1 (NF1). The aim of the study was to provide objective evidence as to which behavioural endpoint should be used in clinical trials. METHOD: Cross-sectional "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods A literature search was conducted in PubMed and Google Scholar using the keyword \u201cneurofibromatosis type 1\u201d and Boolean operators \u201cand/or\u201d in conjunction wit"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
32187457,10.1056/NEJMoa1912735,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,N Engl J Med,2020,2311,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: No approved therapies exist for inoperable plexiform neurofibromas in patients with neurofibromatosis type 1. METHODS: We conducted an open-labe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32190165,,Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.,Ont Health Technol Assess Ser,2020,4624,1002,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We performed a systematic literature search of the clinical evidence. We assessed the risk of bias of each included study using the Risk of Bias in Non-rand"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
32193699,10.1007/s00262-020-02548-1,Upregulated immuno-modulator PD-L1 in malignant peripheral nerve sheath tumors provides a potential biomarker and a therapeutic target.,Cancer Immunol Immunother,2020,1457,880,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Sera from a total of 125 NF1 patients with quantified internal tumor load were included, and 25 of them had MPNSTs. A total of six immuno-modulatory factors (IGFBP-1, PD-L1, IFN-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Sera from a total of 125 NF1 patients with quantified internal tumor load were included, and 25 of them had MPNSTs. A total of six immuno-modulatory fact"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
32194680,10.3892/ol.2020.11299,ADAM9: A novel player in vestibular schwannoma pathogenesis.,Oncol Lett,2020,1808,7240,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Tissue samples The study was approved by the local ethics committee of the University Hospital W\u00fcrzburg with the statement number 145"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
32212796,10.31557/APJCP.2020.21.3.699,The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers.,Asian Pac J Cancer Prev,2020,1738,3865,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methodology: A total of 59 benign and malignant spindle cell tumours (18 MPNST and 41 of its histologic mimickers which included 10 schwannoma, 13 neurofibroma, 4 synovial sarcoma, 3 fibrosarcoma, 2 gastrointestinal s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""Microscopy for immunoreactivity was evaluated by a single independent pathologist who is blinded to the case. Data were statistically analyzed by IBM SPSS version 24, using chi-square test or fisher-exact test. "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,Genes (Basel),2020,1966,10694,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1)-related Malignant Peripheral Nerve Sheath Tumors (MPNST) are highly resistant sarcomas that account for significant mortality. The mechanisms of the"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Murine MPNST Tumorgrafts and Treatment Immediately following the euthanasia of tumor-bearing mice, 15\u201325 mg portions of each tum"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""tions were analyzed by two-sided Spearman\u2019s rank correlation rho. For correlation plots, data were fit by stat_smooth using loess with span = 1 using ggplot2 (v3.2.1). Missing data points (due to a failure to meet RPPA quality control standards) were omitted from the analysis. All analyses were done using "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ggplot2"": [""methods""]}",False
32252313,10.3390/pharmaceutics12040317,A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy.,Pharmaceutics,2020,1274,6261,0,3,2,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2. Materials and Methods 2.1. Cell Lines All MPNST cell lines, T265, ST8814, and S462-TY, derived from NF1 patients. These cell lines were a kind gift from Professor Nancy Ratner (Cincinnati Children\u2019s Hospital, Cincinnati, OH, USA) and were grown as descr"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Cell Lines All MPNST cell lines, T265, ST8814, and S462-TY, derived from NF1 patients. These cell lines were a kind gift from Pr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""2. Materials and Methods 2.1. Cell Lines All MPNST cell lines, T265, ST8814, and S462-TY, derived from NF1 patients. These cell lines were a kind gift from Professor Nancy Ratner (Cincinnati Children\u2019s Hospital, Cincinnati, OH, USA) an"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""2. Materials and Methods 2.1. Cell Lines All MPNST cell lines, T265, ST8814, and S462-TY, derived from NF1 patients. These cell lines were a kind gift from Professor Nancy Ratner (Cincinnati Children\u2019s Hospital, Cinci"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""val rate was evaluated by Kaplan\u2013Meier survival curve and the difference were analyzed by log-rank test. Statistical analysis was conducted using IBM SPSS Statistics software, version 17.0. The  p  values < 0.05 was considered statistically significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
32252413,10.3390/genes11040387,Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.,Genes (Basel),2020,1666,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""sing on multi-omic analysis of malignant peripheral nerve sheath tumors (MPNSTs), the most aggressive tumor associated with neurofibromatosis type 1 (NF1). Here we present a summary of current knowledge gaps, a description of our consortium and the cohort we have assembled, and an overview of our plans"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The Genomics of Malignant Peripheral Nerve Sheath Tumor (GeM) Consortium is an international collaboration focusing on multi-omic analysis of malignant peripheral nerve sheath tum"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32272491,10.1634/theoncologist.2020-0069,The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities.,Oncologist,2020,1711,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ials using oral inhibitors of MEK, the mitogen-activated protein kinase kinase, have demonstrated benefit for patients with neurofibromatosis type 1 (NF1)-associated tumors, particularly progressive low-grade gliomas and plexiform neurofibromas. Given this potential of MEK inhibition as an effective me"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Early-phase clinical trials using oral inhibitors of MEK, the mitogen-activated protein kinase kinase, have demonstrated benefit for patients with neurof"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32281771,10.1097/CORR.0000000000001239,Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.,Clin Orthop Relat Res,2020,6080,2202,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods This study was a retrospective chart review and prospective genetic study on patients with schwannomatosis who were treated surgically. The clinical criteria to diagnos"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
32317644,10.1038/s41467-020-16007-z,Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.,Nat Commun,2020,101,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""An amendment to this paper has been published and can be accessed via a link at the top of the paper."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32352002,10.1155/2020/6051210,Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors.,Biomed Res Int,2020,67,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Cancer research has considerably progressed with the improvement of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32353955,10.3390/genes11050477,New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,Genes (Basel),2020,159,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is a common genetic disorder and cancer predisposition syndrome (1:3000 births) caused by mutations in the tumor suppressor gene"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis Type 1 (NF1) is a common genetic disorder and cancer predisposition syndrome (1:3000 births) caused by mutations in the tumor suppressor"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32354889,10.21873/invivo.11872,Propranolol Specifically Suppresses the Viability of Tumorous Schwann Cells Derived from Plexiform Neurofibromas In Vitro.,In Vivo,2020,1371,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND/AIM: Plexiform neurofibromas (PNFs) are benign tumors of the periph eral nerves sheath, which can damage neighboring organs, impair functions, ca"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32408052,10.1016/j.omtn.2020.04.012,Mutation-Directed Therapeutics for Neurofibromatosis Type I.,Mol Ther Nucleic Acids,2020,1427,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" we summarize the state-of-the-art of various therapeutic approaches and assess their applicability to the genetic disorder neurofibromatosis type I (NF1). NF1 is caused by the loss of function of neurofibromin, a tumor suppressor and downregulator of the Ras signaling pathway. The condition is charact"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Significant advances in biotechnology have led to the development of a number of different mutation-directed therapies. Some of these techniques have matured to a level that has allowed testing in clinical trials, but few have "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,Laryngoscope,2021,1929,381,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: Using a variety of transgenic mouse lines we investigated how expression of Neurod1 affects medulloblastoma (MB) growth, schwannoma tumor progression, vestibular"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,Nat Commun,2020,1013,18079,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""BWA"", ""GraphPad Prism"", ""STAR"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" 15 spreads per clone were analyzed. Organoid transfection and genotyping For generating mutant organoid lines for selected genes ( Trp53 ,  Brca1 ,  Nf1 , and  Pten ), the CRISPR-Cas9-mediated genome editing was used. The single-guide RNAs (sgRNAs) were designed by using the CRISPR Design tool (Zhang "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Mice Wild-type  C57BL/6  and  B6J.129(B6N)-Gt(ROSA)26Sor  (JAX stock #026175) tm1(CAG-cas9*,-EGFP)Fezh/J  mice strains were used for derivation of wild-type and  36 Cas9/GFP -expressing organoids, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""na NextSeq500 by using 75-bp paired-end sequencing. Paired-end reads from Illumina sequencing were aligned to the mouse genome (GRCm38 assembly) with BWA . The raw data file consists of a total number of reads for each gene (without UMI correction) that were uniquely mapped to the transcriptome (with a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""mode microplate reader (Tecan). Results were normalized to vehicle (100%) and baseline control (Staurosporine 1\u2009\u03bcmol/L; 0%). Data were analyzed using GraphPad Prism software (version 7.04) and lines were fitted using the option \u201clog(inhibitor) vs normalized response\u2013variable slope\u201d. Drug screening results were co"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""anoids. For induction of ciliogenesis, DAPT (10\u2009\u00b5M, Tocris) was added to the WNT-deprived culture medium and analysis was performed 2 weeks after the start of the treatment. The organoids could be reproducibly derived from over four independent isolations. Derivation of OSE organoids Ovaries were subjec"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""I correction) that were uniquely mapped to the transcriptome (with a mapping quality above 60), and that had the appropriate transcription direction. DESeq2 (v1.18.0) package was used to normalize count data and for differential gene expression analysis in program R (R version 3.5.1, Bioconductor version "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" and overlaid with 250-\u03bcl medium. Images of the organoids were taken every day for a week, organoid sizes were measured (12 organoids per line) using ImageJ software (version 1.51j8). Subsequently, from the resulting data, the growth curves were constructed in Microsoft Excel 2019. Experiment was repeated"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
32461616,10.1038/s41467-019-10717-9,"Characterising the loss-of-function impact of 5' untranslated region variants in 15,708 individuals.",Nat Commun,2020,1112,11900,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Ethics statement We have complied with all relevant ethical regulations. This study was overseen by the Broad Institute\u2019s Office of Research Subject Protection and the Partners Human Research Co"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ere downloaded from  22 https://gnomad.broadinstitute.org/downloads  and queried using Hail version 0.2 ( https://hail.is ). Definition of 5\u2019UTRs The start and end positions and sequence of the 5\u2019UTRs of all protein-coding genes were downloaded from Ensembl biomart (Human genes GRCh37.p13) and filtered "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods"", ""abstract""]}",False
32471868,10.1074/jbc.RA119.010981,Genetic disruption of the small GTPase RAC1 prevents plexiform neurofibroma formation in mice with neurofibromatosis type 1.,J Biol Chem,2020,100,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common cancer predisposition syndrome caused by mutations in the"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32494228,10.1016/j.rpor.2020.04.010,Molecular targets for NF1-associated malignant peripheral nerve sheath tumor.,Rep Pract Oncol Radiother,2020,1232,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eral Nerve Sheath Tumor (MPNST) is a soft-tissue neurosarcoma. It can occur sporadically, after radiotherapy or in patients with Neurofibromatosis 1 (NF1). The hereditary disorder, NF1, is a common cancer predisposition syndrome. The main genetic feature is the mutation of the NF1 tumor suppressor gene"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant Peripheral Nerve Sheath Tumor (MPNST) is a soft-tissue neurosarcoma. It can occur sporadically, after radiotherapy or in patients with Neurofibromatosis "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32599735,10.3390/genes11060691,From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor.,Genes (Basel),2020,1105,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""aggressive soft tissue sarcomas that occur with significantly increased incidence in people with the neuro-genetic syndrome neurofibromatosis type I (NF1). These complex karyotype sarcomas are often difficult to resect completely due to the involvement of neurovascular bundles, and are relatively chemo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are rare, aggressive soft tissue sarcomas that occur with significantly increased incidence in people with the neu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32608378,10.23750/abm.v91i7-S.9961,Advanced pharmacological therapies for neurofibromatosis type 1-related tumors.,Acta Biomed,2020,1206,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is an autosomal dominant tumor-predisposition disorder that is caused by a heterozygous loss of function variant in the NF1 gene, which encodes a pr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis Type 1 (NF1) is an autosomal dominant tumor-predisposition disorder that is caused by a heterozygous loss of function variant in the NF1"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32642733,10.1093/noajnl/vdz061,KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors.,Neurooncol Adv,2020,1598,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumor (MPNST) constitutes the leading cause of neurofibromatosis type 1-related mortality. MPNSTs contain high"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,Neurooncol Adv,2020,1616,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Cutaneous neurofibromas (cNFs) are the most common tumors in people with neurofibromatosis type 1 (NF1) and are associated with reduced quality of life. There is currently no widely accepted standardized language for describing cNFs clinically or histo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Cutaneous neurofibromas (cNFs) are the most common tumors in people with neurofibromatosis type 1 (NF1) and are associated with reduced quality "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32642739,10.1093/noajnl/vdaa017,Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromes.,Neurooncol Adv,2020,1370,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "". The recent success of treatment trials for the benign tumors plexiform neurofibromas in the tumor predisposition syndrome neurofibromatosis type 1 (NF1) can be used as a model for the development of clinical trials in other tumor predisposition syndromes. In this article, we review the unique challen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Up to 10% of all pediatric cancer patients may have an underlying germline mutation which predisposed them to develop a malignancy. With more patients being tested for and di"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,Neurooncol Adv,2020,1115,6900,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods A cross-sectional study of adults with NF1 and NF2 attending a tertiary center. Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain interference) and disease-specific questio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods A cross-sectional study of adults with NF1 and NF2 attending a tertiary center. Patients completed generic measures (SF-36, EQ-5D-5L, and PROMIS pain inte"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,Nat Commun,2020,1203,36983,0,2,8,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {""Anti-NF1"": ""535891d9-4608-48eb-9e61-01201533a5bc""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""R"", ""GATK"", ""SAMtools"", ""MATLAB"", ""FlowJo"", ""ImageJ"", ""RStudio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Animal studies The floxed  p53  alleles ( p53 floxE2\u201310 ) and ( p53 LSLR172H ) have been described previously . Most of the  26 , 39 p53 null CKO ( p53 \u0394E2\u201310 CKO, hGFAP-cre+;  p53 floxE2\u201310/floxE2\u201310 ) and  p53 R172H CKO "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": "" 1:2000, Cell Signaling), rabbit anti-S6 (2217S, 1:2000, Cell Signaling), mouse anti-p120 (Anti-Ras-GAP, 610040, 1:1000, BD Biosciences), rabbit anti-Nf1 (SC-67, 1:1000, Santa Cruz Biotechnology), and mouse anti-\u03b2-Actin (A5316, 1:20000, Sigma-Aldrich). Establishment of primary tumor and SVZ cell lines "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1"": {""context"": ""364S, 1:2000, Cell Signaling), rabbit anti-S6 (2217S, 1:2000, Cell Signaling), mouse anti-p120 (Anti-Ras-GAP, 610040, 1:1000, BD Biosciences), rabbit anti-Nf1 (SC-67, 1:1000, Santa Cruz Biotechnology), and mouse anti-\u03b2-Actin (A5316, 1:20000, Sigma-Aldrich). Establishment of primary tumor and SVZ cell lines "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": "" was utilized to map the paired-end clean reads to the mouse reference genome (mm9). SAMtools 44  (version 1.0) is used for sorting the BAM file, and Picard (version 1.111) is utilized to mark duplicate reads. Single-nucleotide variant is then identified using GATK 45  (version 3.8), and is subsequently a"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": "" is used for sorting the BAM file, and Picard (version 1.111) is utilized to mark duplicate reads. Single-nucleotide variant is then identified using GATK 45  (version 3.8), and is subsequently annotated using ANNOVAR 46  (version 2015Dec). CNV is detected by control-FREEC 47  (version 9.9). 48 CNV anal"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""d and low-quality reads. Burrows\u2013Wheeler Aligner  (version 0.7.8) was utilized to map the paired-end clean reads to the mouse reference genome (mm9). SAMtools 44  (version 1.0) is used for sorting the BAM file, and Picard (version 1.111) is utilized to mark duplicate reads. Single-nucleotide variant is then"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""eighted images for tumor volume measurements using in-house software (The Center for Molecular Imaging, University of Michigan, Ann Arbor) running in MATLAB (MathWorks, Natick, MA, version 2016b). In brief, tumor volumes were determined by multiplying the number of tumor voxels by the voxel volume. In eac"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""propidium iodide and 0.3\u2009mg/ml DNase-free RNase A) for 30\u2009min at 37\u2009\u00b0C. Then the samples were acquired using BD FACS Canto II and further analyzed by FlowJo software. Normal cerebral cortex was used as control for normal diploid DNA content. 41 Metaphase spread, spectral karyotype (SKY) analysis To prepar"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ome number counting, the metaphase images were captured using the fluorescence microscope (Olympus BX-63) and the chromosome number was counted using ImageJ software. SKY analysis was performed by using a mouse SKY probe kit (Applied Spectral Imaging, Vista, CA) according to the manufacturer\u2019s protocol, f"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": ""tained from SKY analysis to build NJ trees for each sample, based on the pairwise distance between each two metaphases. We developed R codes and used RStudio (version 1.2.5033), R package \u201cAnalyses of Phylogenetics and Evolution\u201d (APE, version 5.2), and MEGAX (version 0.1, for MAC) to generate SKY-based ph"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""antibodies:Anti-NF1"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:RStudio"": [""methods""]}",False
32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",J Oncol,2020,1502,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis Type 2- (NF2-) associated vestibular schwannomas (VSs) are histologically benign tumors. This study aimed to determine disease-related g"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,Transl Res,2021,1799,0,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a heritable cancer predisposition syndrome resulting from mutations in the NF1 tumor suppressor gene. Genotype-phenotype correlations for NF1 are"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1+/-"": {""context"": "" and metabolic phenotype featuring short stature, low body mass index, increased insulin sensitivity, and protection from diabetes. Nf1 heterozygous (Nf1+/-) mice accurately reflect the dominant inheritance of NF1 and are regularly employed as a model of NF1. Here, we sought to identify whether Nf1+/- mic"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a heritable cancer predisposition syndrome resulting from mutations in the NF1 tumor suppressor gene. Genotype-phenotype"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
3280697,10.1111/1523-1747.ep12460896,"Monoclonal antibody (AFH1) immunoreactive on morphologically abnormal basal melanocytes within dysplastic nevi, nevocellular nevus nests, and melanoma.",J Invest Dermatol,1988,1397,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The mouse monoclonal antibody AFH1 was produced using formalin-fixed, sham paraffin-embedded human melanoma cell culture line A375 as immunogen. Reactivity of this antibody was assessed by im"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific Nf1 deletion is rescued by inhibition of nitric oxide synthase.,Proc Natl Acad Sci U S A,2020,20,9131,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" and Use Committee and in accordance with the NIH  Guide for the Care and Use of Laboratory Animals  ( 65 ). Animals. Inducible Plp- Cre  ( 66 ) and  Nf1 fl/+  ( 67 ) mice were maintained on a pure C57BL/6 background and genotyped by PCR according to publicly available protocols ( 22 ). Tamoxifen was a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Ethics Statement. All animal procedures were conducted with the approval of the Institutional Animal Care and Use Committee and in ac"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,Cancers (Basel),2020,202,5911,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""edgeR"", ""limma"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""4. Materials and Methods 4.1. Selection of NF1 Ontologies The complete list of NF1 gene ontologies (GO) and phenotype ontologies were obtained in the AmiGO and Human Phenotype Ontology (HPO) datab"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Selection of NF1 Ontologies The complete list of NF1 gene ontologies (GO) and phenotype ontologies were obtained in the AmiGO an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": "" expression analysis for TCGA data was performed by extracting the data with  TCGAbiolinks  package and evaluating differential gene expression with  edgeR  package. All analyses were performed in R v.3.6.2. 4.4. Random Walk Analysis The heterogeneous networks comprising both the genes and phenotypes sel"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""averaging (RMA) normalization was applied using  oligo  or  affy  R packages (R v.3.6.2). The differentially expressed genes were obtained using the  limma  package (R v.3.6.2).  Firstly, for TCGA, we selected seven somatic tumors with nonsense mutations in  NF1  ( NF1 -ns): bladder urothelial carcinoma "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" R v.3.6.2. 4.4. Random Walk Analysis The heterogeneous networks comprising both the genes and phenotypes selected were assembled in the  RandomWalkRestartMH  package, in R v.3.6.2, and the random walk analysis was performed with the same package. 4.5. Database Research  Other databases consulted to obt"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
32869517,10.1002/mgg3.1400,Genome-wide association study of caf-au-lait macule number in neurofibromatosis type 1.,Mol Genet Genomic Med,2020,836,13812,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""enome\u2010wide association analysis of the number of caf\u00e9\u2010au\u2010lait macules (CALM) that are considered a tumor\u2010like trait as a clinical phenotype modifying NF1. 2 METHODS 2.1 NF1 patients and CALM number in CALM1 and CALM2 cohorts CALM1 and CALM2 studies were approved by the Institutional Review Boards (IRB)"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods In this study, we performed a genome\u2010wide association analysis of the number of caf\u00e9\u2010au\u2010lait macules (CALM) that are considered a tumor\u2010like trait as a clinical phenotype "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""h METAL (Willer, Li, & Abecasis,\u00a0 2010 ) with weights proportional to the square\u2010root of the sample size for each study (Stouffer, Suchman, Devinney, Star, & Williams,  1949 ), with genomic control correction of input statistics enabled. Heterogeneity analyses including I 2  statistics, the percentage o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,BMC Cancer,2020,2504,8685,0,3,3,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""h and without starvation. In a PA28 overexpression cancer cell model leading to p53 inactivation, thereby reflecting a key molecular feature in human NF1 associated MPNST, known functions of 3-BrPA to block mitochondrial activity and glycolysis were reproduced, however oncogenic cells displayed a parti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:S462"": {""context"": ""Methods Viability of MPNST cell lines S462, NSF1, and T265 in response to increasing doses (0\u2013120\u2009\u03bcM) of 3-BrPA was analyzed by CellTiter-Blue\u00ae assay. Additionally, we investigated viability, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""Methods Viability of MPNST cell lines S462, NSF1, and T265 in response to increasing doses (0\u2013120\u2009\u03bcM) of 3-BrPA was analyzed by CellTiter-Blue\u00ae assay. Additionally, we investigated viability, reactive oxygen "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Viability of MPNST cell lines S462, NSF1, and T265 in response to increasing doses (0\u2013120\u2009\u03bcM) of 3-BrPA was analyzed by CellTiter-Blue\u00ae assay. Additionally, we investigated viability, reactive oxygen speci"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""l glycolysis as well as a partial resistance to stress provoked by nutrient deprivation. 3-BrPA treatment was not associated with an increase of ROS. Starvation sensitized MPNST to treatment. CONCLUSIONS: Aggressive MPNST cells are sensitive to 3-BrPA therapy in-vitro with and without starvation. In a P"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:MATLAB"": {""context"": ""ent of determination, r 2 . The graphical representation of the results and the statistical hypothesis testing were performed by the software package MATLAB\u00ae, version R2007a (The MathWorks, Inc., Natick, MA, USA)."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:S462"": [""methods"", ""abstract""], ""cell_lines:T265"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""abstract""], ""computational_tools:MATLAB"": [""methods""]}",False
33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,Cancer Res,2020,1284,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Loss of the RAS GTPase-activating protein (RAS-GAP) NF1 drives aberrant activation of RAS/MEK/ERK signaling and other effector pathways in the majority of malignant peripheral nerve sheath tumors (MPNST). "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Loss of the RAS GTPase-activating protein (RAS-GAP) NF1 drives aberrant activation of RAS/MEK/ERK signaling and other effector pathways in the majority of malignan"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33080011,10.1093/neuonc/noaa237,"Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.",Neuro Oncol,2021,1836,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""mporal and spatial localization associated with different genetic mutations (eg, BRAF genomic alterations, mutations in the neurofibromatosis type 1 [NF1] gene) for reasons that remain unclear. NF1 low-grade gliomas typically arise in the optic pathway of young children as optic pathway gliomas (OPGs),"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Brain tumors are the most common solid tumors of childhood, but little is understood about the factors that influence their development. Pediatr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,Sci Rep,2020,1493,8156,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods The Indiana University Institutional Review Board approved this prospective study. All NF1 subjects participated with informed consent in a phase II clinical trial of imatinib mesylate (Imatinib) for the treatment of PNs . Inclusion criteri"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The Indiana University Institutional Review Board approved this prospective study. All NF1 subjects participated with informed consent in a phase II clinical trial of i"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,Mol Genet Genomic Med,2020,1430,11364,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nts at each stage provided written informed consent prior to inclusion in the study. Eligibility requirements included; age of 18 or above, confirmed NF1 diagnosis, \u22651 pNF, ability to understand and complete questionnaires independently and ability to provide written informed consent. Patients were exc"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Qualitative interviews were conducted with patients to generate questionnaire content. Face and content validity of the draft scale was assessed by cognitive debriefin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
33160273,10.1016/j.scr.2020.102068,Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.,Stem Cell Res,2020,1167,10308,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""percent of aligned fibers by dividing the among of fibers that deviated less than 20\u00b0 from the neutral axis [ 26 ]. Schwann cell culture Immortalized NF1 patient derived Schwann cell (NF SC, NF-/-) line, ipNF 95.11b and Wild type Schwann cell (WT SC, NF+/+) line, ipn 02.8 were utilized for all experime"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods HA hydrogels Hyaluronic acid (HA) hydrogels were made using previously described methods using 3% methacrylated HA and 0.05% I2959 photoinitiator [ 25 ]. Bri"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" were made during slow focus to obtain clear images. Images were captured at 10k and 15k magnifications. Fiber diameter and angle were measured using ImageJ (v1.53a) with at least 200 fibers per fiber type. Fiber diameter was measured manually. The angle tool was used to measure the orientation of the fib"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""ugh the stimulation chamber (Voltage Out) were captured from Channel 1 and Channel 2 of an oscilloscope (Rigol) connected to a Raspberry Pi running a Python script to store the data in near real time through the USB port connection. The plates were UV sterilized before the hydration to prevent contaminati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
33197677,10.1016/j.ctim.2020.102581,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,Complement Ther Med,2021,1598,399,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: The study recruited adult patients with moderate to severe tinnitus for six months or more. In total, 81 patients were assessed for eligibility, 78 were enrolled"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,J Biol Chem,2021,0,10375,0,0,7,7,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""R"", ""GraphPad Prism"", ""STAR"", ""SAMtools"", ""edgeR"", ""FastQC""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:Picard"": {""context"": ""ibraries relying on\u00a0the gene annotation provided for Ensembl GRCh37 (v. 75). Quality checking of alignments was assessed by a custom script\u00a0utilizing Picard Tools ( http://broadinstitute.github.io/picard/ ), RNASeQC ( 56 ), RSeQC ( 57 ), and samTools ( 58 ). Differentially expressed genes in pair-wise com"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental procedures Cell lines and reagents Human cell lines included an  NF2 -null immortalized MN line Ben-Men-1,  NF2  AC-CRISPR, and two independen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""  (threshold cycle) method, and expression levels were quantitated relative to control (normalized to 1.0). Column scatter plots were generated using Graphpad Prism 8, and data values are represented as mean\u00a0\u00b1\u00a0SD. Within each group, Student  t  test was performed with a value of  p \u00a0< 0.05 considered significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ols were run on a NextSeq 500 using a v2 high output 75 cycle kit. Sequence reads were aligned to human reference genome\u00a0Ensembl GRCh37 (v.75), using STAR (v. 2.5.2a) ( 55 ) with parameters \u2018\u2013outSAMunmapped Within \u2013outFilterMultimapNmax 1 \u2013outFilterMismatchNoverLmax 0.1 \u2013alignIntronMin 21 \u2013alignIntronMa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""g of alignments was assessed by a custom script\u00a0utilizing Picard Tools ( http://broadinstitute.github.io/picard/ ), RNASeQC ( 56 ), RSeQC ( 57 ), and samTools ( 58 ). Differentially expressed genes in pair-wise comparisons were identified by edgeR's quasi-likelihood F test (v. 3.18.1) ( 59 ), which was run "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""te.github.io/picard/ ), RNASeQC ( 56 ), RSeQC ( 57 ), and samTools ( 58 ). Differentially expressed genes in pair-wise comparisons were identified by edgeR's quasi-likelihood F test (v. 3.18.1) ( 59 ), which was run at the R platform (v. 3.4) on genes with greater than 10 counts across replicates per con"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""es were sequenced on Illumina HiSeq2500 platform, generating paired-end sequencing reads of 75\u00a0bp. Quality checking of\u00a0sequence reads was assessed by fastQC (v.0.10.1) ( http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ ). Libraries concentration was determined by Qubit, and quality assessment and"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:Picard"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:FastQC"": [""methods""]}",False
33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",Brain,2021,1546,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""TK/Ras/PI3K, RB and TP53 pathways are critical for human gliomagenesis. Here, several transgenic zebrafish lines with single or multiple deletions of nf1, tp53 and rb1 in astrocytes, were established to genetically induce gliomagenesis in zebrafish. In the mutant with a single deletion, we found only t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The molecular pathogenesis of glioblastoma indicates that RTK/Ras/PI3K, RB and TP53 pathways are critical for human gliomagenesis. Here, several transgenic zebrafi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,Cell Transplant,2020,1636,9014,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" connections and causing vision to gradually worsen with time. This tumor forms in children with a genetic condition called neurofibromatosis type 1 (NF1), causing tumors to grow on nerves. In normal conditions, glial cells are there to support and protect nerve cells but, in NF1-OPG, glial cells have "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods C6 Cell Culture C6 cells were cultured based on the protocol provided by ATCC (culture method, CCL-107, USA). Briefly, confluent T75,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""-Aldrich, USA) was placed on surgical eye and artificial tears were used every 5 min to prevent dryness of eyes during the surgical procedure. Before starting rats were placed on stereotaxic frame with heating pad to keep them warm throughout the procedure. A 1-inch incision was made in the skin overlyi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""ium. Digital images were obtained with an epifluorescence microscope using \u00d720 objective (Leica, DM2500). Electronic image files were processed using MATLAB software (MathWorks Inc., R2019a, USA). Flow Cytometry Assay of C6 Cells The phenotype of C6 cells was analyzed using flow cytometry with the MACSQua"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,Acta Neuropathol Commun,2021,1094,7705,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Seurat"", ""Cell Ranger"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type I (NF1) is a neurocutaneous genetic syndrome characterized by a wide spectrum of clinical presentations, including benign peripheral nerve sheath tumor call"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods qPCR Gene expression was determined as previously described [ 44 ]. Briefly, RNA extraction was performed using the TRIzol reagent, reverse transcription "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""anscript counts of each cell were quantified using barcoded UMI and 10xBC sequences. The gene x cell expression matrices were loaded to the R package Seurat version 3.0.0 for downstream analyses. Cells with low quality were filtered out based on at least 200 genes being detected per 1000 UMIs and mitochon"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""er. The expression data has been deposited in NCBI's Gene Expression Omnibus (GEO) and is accessible through GEP series accession number  GSE163028 . Cell Ranger version 3.0.0 (10\u00d7 Genomics) was used to process the raw sequencing data. Briefly, raw BCL files were converted to FASTQ files and aligned to the hum"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""]}",False
33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,Nat Med,2021,169,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) plexiform neurofibromas (PNs) are progressive, multicellular neoplasms that cause morbidity and may transform to sarcoma. Treatment of Nf1"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) plexiform neurofibromas (PNs) are progressive, multicellular neoplasms that cause morbidity and may transform to sarcoma. T"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33484105,10.1002/ajmg.a.62081,Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.,Am J Med Genet A,2021,1316,22330,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""R"", ""GraphPad Prism"", ""SAMtools"", ""ComplexHeatmap"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Experimental Design: cfDNA was isolated from plasma samples of a novel cohort of 101 patients with NF1 and 21 healthy controls and underwent whole-genome sequencing. We investigated diagnosis-specific signatures of copy-number alterations with  in sili"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental Design: cfDNA was isolated from plasma samples of a novel cohort of 101 patients with NF1 and 21 healthy controls and underwent whole-genome s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""diversity score; *, < 0.1; **, < 0.001; ***, < 0.0001. NMF deconvolution of fragment-length profiles Fragment lengths, extracted from bam files using Picard (v.4.0.1.2) and filtered to remove lengths outside the 30- to 700-bp range, were structured into a count matrix with samples as rows and fragment len"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s were compared using the Kruskal\u2013Wallis H test with pairwise comparisons using the Dunn test. Statistical analyses were performed using R v.4.2.2 or GraphPad Prism 10. Figure 6. cfDNA fragment-length NMF adjudicates diagnostic challenges and granularly classifies across healthy and disease states.  A,  NMF of cf"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""icated, and filtered as described above. Resulting bam files were then downsampled to a normalized depth of 25\u00d7 using subsample seed values 0 to 4 in samtools v1.17 ( 25 ), resulting in five replicates per sample. Downsampling was repeated using seed values 0 to 4 to target coverages of 15\u00d7, 10\u00d7, 6\u00d7, 3\u00d7, 1\u00d7"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": "" fragment ratios, chromosomal arm-level z-scores, 4-mer end-motif diversity scores, and fragment-length NMF scores were represented by heatmaps using ComplexHeatmap (v.2.14.0) with supervised clustering using the diagnostic cohort (MPNST, AN, PN, and healthy) and with samples in each cohort ranked from the highes"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": "" method described by Zhou and colleagues ( 31 ). Briefly, a matrix of cfDNA samples and end-motif frequencies was subjected to NMF analysis using the Python sklearn (v.1.3.2) decomposition module. The percentage contribution of each F-profile in each sample was determined by non-negative least squares reg"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Picard"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:ComplexHeatmap"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,JAMA Netw Open,2021,3132,2729,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tal number of 119\u2009538 non-Mayo samples. 9 , 10 Statistical Analysis To analyze the coexistence pattern of genes of interest ( KRAS ,  NRAS ,  HRAS ,  NF1 ,  PTPN11 ,  CBL ), distributions of samples based on  BRAF  alteration status ( BRAF altered  and  BRAF unaltered ) and alteration status of genes o"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Targeted next generation sequencing data from 2745 cancer samples (lung cancer, colorectal cancer, and melanoma) that have undergone clinical testing at "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,J Clin Oncol,2021,1391,7810,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s. METHODS Study Design and Population Patients were enrolled at NF Clinical Trials Consortium sites. Inclusion criteria included age \u2265 16 years with NF1 and an unresectable PN either with significant progression in the past year (defined as \u2265 20% increase in the volume, \u2265 13% increase in the product o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""METHODS Inclusion criteria included age \u2265 16 years and a PN that was either progressive or causing significant morbidity. First-dose pharmacokinetics were performed. Pati"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "", or definitely related to mirdametinib held drug until the toxicity was completely resolved. If toxicity resolved within 2 weeks, mirdametinib was restarted at a lower dose (Appendix Table A 2 , online only). Toxicities requiring removal from protocol therapy included: any mirdametinib-related DLT that"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,Sci Rep,2021,1356,11035,0,1,9,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R"", ""TopHat"", ""STAR"", ""NanoDrop"", ""Trimmomatic"", ""ImageJ"", ""SPSS"", ""bowtie2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ith 5% of CO 2  in DMEM medium supplemented with 1X N2 (Calbiochem) and 10\u00a0ng/mL bFGF (Invitrogen). Primary Schwann cells previously isolated from an NF1 patient nerve biopsy, were thawed and cultured on Poly-L-Lysine (0.1\u00a0mg/mL) and laminin (4\u00a0\u00b5g/mL) coated plates in Schwann Cell Media (SCM)\u2009+\u2009forskol"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell culture PC12 cells (ATCC CRL-1721) were grown on Collagen IV-coated dishes (25\u00a0\u03bcg/ml) and maintained in RPMI 1640 medium, supple"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""rm with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the counts matrix was processed "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""he Illumina HiSeq 2000 platform with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" extraction was performed using Maxwell 16 LEV simplyRNA Purification Kit (Promega) according to manufacturer\u2019s instructions. Libraries were prepared starting from 200\u00a0ng of RNA per sample with the TruSeq stranded mRNA Illumina procedure. Libraries were quantified using the KAPA library quantitation kit"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""antification and reverse transcription (RT) Total RNA was extracted using Tripure Isolation Reagent (Roche). Quality and quantity were assessed using NanoDrop spectrophotometer and gel electrophoresis analysis. For an accurate quantification, size and integrity of the RNA was determined with Bioanalyzer (RN"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""it for Illumina GA and sequenced on the Illumina HiSeq 2000 platform with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""entiated cells over total cells in the field. Neurite extension was measured by determining the length of at least 10\u201320 neurites per field using the ImageJ  (versions 1.45\u00a0s and 1.8.0_172;  72 https://imagej.nih.gov/ij/download.html ) plugin NeuronJ . Neurite thickness was analyzed using ImageJ 73  (vers"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" assuming equal variances. An event was considered significant with a  P  value\u2009<\u20090.05. The statistical analysis was performed using PASW Statistics (SPSS Inc. Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.;  http://www.spss.com.hk/statistics/ ), while graphical representat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": ""rm with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the counts matrix was processed i"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:bowtie2"": [""methods""]}",False
33622177,10.1080/21655979.2021.1885864,Chrysophanol inhibits the osteoglycin/mTOR and activats NF2 signaling pathways to reduce viability and proliferation of malignant meningioma cells.,Bioengineered,2021,1765,4335,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Cell culture HBL-52 cells were obtained from Bafeier Biotechnology (Wuhan, China). Cells were cultured in DMEM medium (Sigma-Aldrich,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
33625502,10.1001/jamapsychiatry.2020.4783,"Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.",JAMA Psychiatry,2021,3572,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""IMPORTANCE: Patients coping with rare diseases need psychosocial support. OBJECTIVE: To evaluate the efficacy of a brief, transdiagnostic, peer-delivered i"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
33671872,10.3390/children8020145,Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1).,Children (Basel),2021,1400,5061,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nce with IRB regulations and the ethical standards of the American Psychological Association (APA). Inclusion criteria were the clinical diagnosis of NF1, proficiency in English, age 8:0 to 18:11, and enrollment in the third grade or above. Exclusion criteria included active chemotherapy treatment, def"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Participants Participants were recruited through the comprehensive neurofibromatosis clinic in the oncology department of a majo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""tially aversive and socially inappropriate behaviors known to increase the risk for bullying victimization [ 29 , 32 , 64 ]. 2.3. Analysis Procedures SPSS Version 26.0.0 was used for all analyses. Prior to conducting study analyses, data were screened for multivariate normal distribution, linearity, and"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of NF1 Variants.,Cancers (Basel),2021,90,6241,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""4. Materials and Methods  4.1. Patients We analyzed a series of 29 germinal variants in the  NF1  gene identified in patients referred to our center between 2005 and 2019 for a clinical diagnosis/suspicion of neurofibromatosis type 1 according to"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods  4.1. Patients We analyzed a series of 29 germinal variants in the  NF1  gene identified in patients referred to our center between 2"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""llele and one with the variant to test were retained for expression experiments and the correctness of each vector was verified by direct sequencing. HEK293 cells (6 \u00d7 10 5 ) were transfected with 1 \u00b5g of the wild type or the mutated minigene using Lipofectamine 2000 (ThermoFisher Scientific, Watham, MA, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" 67 ]. A schematic representation of the minigene construct is depicted in  Supplementary Figure S4 . Densitometric analyses were performed using the ImageJ (Image Processing and analysis in Java) software ( https://imagej.nih.gov/ij/  Assessing on 28 December 2020)."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,Front Genet,2021,482,7146,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Study Subjects Five probands suspected of having NF and nine relatives were from the outpatient department of the First Affiliated Ho"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""ood Genomic DNA Miniprep Kit (Axygen, Corning, Jiangsu, China) and DNeasy Blood & Tissue Kit (Qiagen, Germany). The DNA purity was determined using a NanoDrop one spectrophotometer and quantified with a Qubit 2.0 Fluorometer using the Qubit dsDNA HS Assay Kit (Life Technologies, Thermo Fisher Scientific, In"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:NanoDrop"": [""methods""]}",False
33817379,10.1016/j.heliyon.2021.e06518,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,Heliyon,2021,2672,8767,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s study were to evaluate the efficacy and safety of using topical diclofenac 25 mg/ml in the treatment of cutaneous neurofibromas in individuals with NF1. 2.2 Study design and population The study was an open, controlled, prospective, proof-of-concept clinical trial conducted at UNIFESO Medical School "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The study was an open, controlled and prospective proof-of-concept clinical trial. The topical treatment consisted of two steps: cNF microporation using a laser device followed b"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""rence to study protocol was evaluated at Visit 2, 3 and 4. 2.5 Statistical analysis Data was collected on a clinical research form and analyzed using GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego California USA). Frequency tables were generated and central tendencies (mean, median, mode) we"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
33850471,10.7150/ijms.52431,Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma.,Int J Med Sci,2021,1000,5948,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" Tong University School of Medicine (Shanghai, China). Informed consent was provided by all patients. All patients were diagnosed with pNF related to NF1 according to the diagnostic criteria approved by the National Institutes of Health (suffering from two or more of the following: six or more caf\u00e9-au-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Patients and tissue samples In total, 17 pNF tumor tissue specimens were collected from January 2009 to December 2019 at the Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""lowed by Tukey's test. A  P -value less than 0.05 ( P  < 0.05) was considered to indicate a significant difference. All analyses were conducted using SPSS (version 17.0) software (SPSS Inc., USA)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
33903738,10.1038/s41431-021-00892-z,Identifying challenges in neurofibromatosis: a modified Delphi procedure.,Eur J Hum Genet,2021,1689,8326,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""l experience within our work package group of EU-PEARL (work package 7 (WP7)), we produced a list of the most common and important manifestations for NF1, NF2 and SWN to be included in the first questionnaire to NF experts. Selecting and contacting NF experts for the Delphi questionnaires and consensus"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We used a five-staged modified Delphi procedure, consisting of two questionnaires and a consensus meeting for NF experts, a survey and consensus meeting for patient representatives, and a fi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""nto both Delphi questionnaires. A subset of these positive responders ( n \u2009=\u200912) were asked to participate in the NF expert consensus meeting. At the start of each questionnaire participants received an announcement email, followed by a second email with a hyperlink to the questionnaire. The deadline fo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
33911094,10.1038/s41598-021-87686-x,"Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum.",Sci Rep,2021,1717,6454,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""seases, Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital in Denmark and all the participants had a clinical diagnosis of NF1 in accordance with by the National Institutes of Health Consensus Conference . 16 The study population comprised 277 patients with NF1 of which 102 w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Participants Patients were all recruited from the outpatient clinic at the Centre for Rare Diseases, Department of Paediatrics and Adolescent Medicine, A"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
33948356,,Cordycepin inhibits the proliferation of malignant peripheral nerve sheath tumor cells through the p53/Sp1/tubulin pathway.,Am J Cancer Res,2021,721,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is one of the most common hereditary neurocutaneous disorders. In addition to skin pigmentation and cutaneous neurofibroma, some patients developed "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is one of the most common hereditary neurocutaneous disorders. In addition to skin pigmentation and cutaneous neurofibroma,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33963463,10.1007/s10689-021-00259-9,The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.,Fam Cancer,2022,1668,8185,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods This is a pilot, prospective longitudinal cohort study conducted through a tertiary hospital adult NF1 clinic and an established breast cancer risk management clinic in Sydney, Australia. The study involved three sub-studies. This paper will report on "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods This is a pilot, prospective longitudinal cohort study conducted through a tertiary hospital adult NF1 clinic and an established brea"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""h a poorer prognosis compared to the general population. Therefore, international management guidelines recommend regular screening in women with NF1\u00a0starting from 30 to 35 years. As the psychological impacts of breast cancer screening in other high-risk populations cannot be extended to women with NF1,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:SPSS"": {""context"": ""oung cohort (mean age 35.61 at T1) and therefore there were not enough women in a 40\u201349\u00a0year age group for analysis. Analysis was performed using IBM SPSS Statistics for Windows, Version 25.0.  IBM SPSS Statistics Version 25 . Armonk, MY: IBM Corp."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
33963966,10.1007/s10803-021-05043-3,Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.,J Autism Dev Disord,2022,743,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis 1 (NF1) is a single gene disorder\u00a0associated with working Memory (WM) impairments. The aim of this study was to investigate P300 event-related potential (ER"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis 1 (NF1) is a single gene disorder\u00a0associated with working Memory (WM) impairments. The aim of this study was to investigate P300 event-r"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
33972401,10.1523/JNEUROSCI.1605-20.2021,Associative Learning Requires Neurofibromin to Modulate GABAergic Inputs to Drosophila Mushroom Bodies.,J Neurosci,2021,105,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Cognitive dysfunction is among the hallmark symptoms of Neurofibromatosis 1, and accordingly, loss of the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,Cell Death Dis,2021,1297,6743,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tin (#13E5), MEK1/2, Akt, c-Raf, ERK, phospho-MEK1/2 (#41G9), phospho-Akt (#D9E), phospho-c-Raf (#56A6), phospho-ERK (#D13.14.4E), MMP1 (#E9S9N), and NF1 (#D7R7D), as well as anti-rabbit IgG HRP-linked antibody were purchased from Cell Signaling Technology. Antibody for Aryl hydrocarbon receptor (AHR, "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Reagents and antibodies Dermal fibroblast cells were cultured with Minimum Essential Eagle\u2019s Medium (Sigma-Aldrich, St. Louis, MI, US"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34012067,10.1038/s41436-021-01170-5,Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.,Genet Med,2021,1259,830,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""statements for the two rounds of the Delphi process (data S1, S2, S3, S4, S5, and  Supplemental Material and Methods ) regarding potential changes to NF1 diagnostic criteria. The Steering Committee actively sought input from patients, families, and advocates regarding the proposed criteria and the new "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We used a multistep process, beginning with a Delphi method involving global experts and subsequently involving non-NF experts, patients, and foundations/patient advocacy g"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34020694,10.1186/s13023-021-01866-6,"The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.",Orphanet J Rare Dis,2021,1448,7380,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods A total of 212 individuals were stratified into two groups (NF1 and matched controls) using a cross-sectional design that collected a one-time response. Methods Participants Two groups were recruited between March"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods A total of 212 individuals were stratified into two groups (NF1 and matched controls) using a cross-sectional design that collected a one-time response. Methods Participants Two gr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronalactivity-dependent initiation of optic glioma.,Nature,2021,190,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurons have recently emerged as essential cellular constituents of the tumour microenvironment, and their activity has been shown to increase the growth "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34043012,10.1093/neuonc/noab130,RNA sequence analysis reveals ITGAL/CD11A as a stromal regulator of murine low-grade glioma growth.,Neuro Oncol,2022,1860,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" for in vitro functional studies, while LGG growth in mice was assessed using anti-CD11a neutralizing antibody treatment of Neurofibromatosis type 1 (Nf1) optic glioma mice in vivo. RESULTS: We identified Itgal/CD11a enrichment in GAM relative to other DAM populations, which was confirmed in several in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Emerging insights from numerous laboratories have revealed important roles for nonneoplastic cells in the development and progression of brain t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34049498,10.1186/s11689-021-09364-3,Early differences in auditory processing relate to Autism Spectrum Disorder traits in infants with Neurofibromatosis Type I.,J Neurodev Disord,2021,1278,23693,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""inal study, we examined auditory repetition suppression and change detection at 5 and 10 months in infants with and without Neurofibromatosis Type 1 (NF1), a condition associated with higher likelihood of developing ASD. Methods Participants We recruited 25 infants with NF1 and 52 typically developing "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods In this longitudinal study, we examined auditory repetition suppression and change detection at 5 and 10 months in infants with and without Neurofibromatosis Type 1 (NF1), a condition associated wi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34053190,10.1002/acn3.51386,Transcriptomic signature of painful human neurofibromatosis type 2 schwannomas.,Ann Clin Transl Neurol,2021,767,1121,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Subjects and Methods Patient tumor samples Patient\u2010derived tumors were formalin\u2010fixed paraffin\u2010embedded (FFPE) and these tumor blocks along with pain status were obtained from Patholog"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,Int J Mol Sci,2021,1064,6599,0,1,2,3,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Cell Culture Primary human Schwann cells (NHSC) isolated from human spinal nerve were purchased from ScienCell Research Laborato"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "". Lentiviruses encoding  RABL6A  shRNAs (KD1 and KD2), empty vector (CON), and shRNA RB1 (RB1 KD) were produced by lipofection of viral constructs in HEK293T cells and infected into target cells using established methods [ 13 ]. Transduced cells were harvested 3 to 5 days after infection, depending on the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""-conjugated secondary antibodies and enhanced chemiluminescence (ECL, Amersham, Buckinghamshire, UK). Densitometry quantification was performed using ImageJ (NIH). 4.6. Immunofluorescence Cells were plated on poly-D-lysine-coated chamber slides (Corning Ref 354632) and incubated overnight. Slides were was"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
34075397,10.1093/hmg/ddab106,PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).,Hum Mol Genet,2021,1617,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis Type II (NF2) is an autosomal dominant cancer predisposition syndrome in which germline haploinsufficiency at the NF2 gene confers a gre"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34079083,10.1038/s41388-021-01773-x,WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth.,Oncogene,2021,1394,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas that cause significant mortality in adults with neurofibromatosis type 1. We c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34123937,10.12890/2021_002424,Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1.,Eur J Case Rep Intern Med,2021,1198,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""UNLABELLED: Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disease involving the skin and central nervous system (CNS), and also characterized by skeletal and spinal schwannomas "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""UNLABELLED: Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disease involving the skin and central nervous system (CNS), and also characterized by skeleta"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34155781,10.1002/ajmg.a.62392,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,Am J Med Genet A,2021,2159,8597,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "", single\u2010arm, single center, Phase 2a clinical trial was designed to assess the safety and compliance of L\u2010carnitine supplementation in children with NF1. The trial was registered on the Australian New Zealand Clinical Trials Registry with ACTRN number 12618002021257 (Study protocol:  https://anzctr.or"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2 SUBJECTS AND METHODS 2.1 Study design and participants This open\u2010label, single\u2010arm, single center, Phase 2a clinical trial was designed to assess the safety and compliance of L\u2010carnitine suppleme"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""tation is used to treat primary carnitine deficiency. However, as L\u2010carnitine supplementation had never been previously clinically trialed in NF1, we started the first three participants 1 month apart. As there were no adverse events in these children, the remaining three participants were started on L\u2010"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
34215596,10.1136/bmjopen-2020-042856,Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.,BMJ Open,2021,1881,4586,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods In a cross-sectional online survey, we investigated the psychological burden and care needs in different areas of patients\u2019 lives. We included adult patients"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
34229750,10.1186/s13023-021-01934-x,Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.,Orphanet J Rare Dis,2021,2349,9728,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""pheatmap"", ""RStudio"", ""R"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods An in silico interactome of RASopathy proteins was generated using pathway enrichment analysis/STRING tool, including identification of main hub proteins. We also integ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""of RASopathy-related genes including 27 RASopathy genes:  A2ML1 ,  BRAF ,  CBL ,  HRAS ,  KAT6B ,  KRAS ,  LZTR1 ,  MAP3K8 ,  MEK1 ,  MEK2 ,  MRAS ,  NF1 ,  NRAS ,  PPP1CB ,  PTPN11 ,  RAF1 ,  RASA1 ,  RASA2 ,  RIT1 ,  RRAS ,  RRAS2 ,  SHOC2 ,  SOS1 ,  SOS2 ,  SPRED1 ,  SPRY1  and  SYNGAP1 ; and 5 extr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""n original data. R 3.63 [ 142 ] and RStudio 1.2.5042 [ 143 ] were used to generate a heatmap representing fold changes of each phosphosite (R package pheatmap [ 144 ]). Clustering analysis was done in NS and NSML by selecting manually from quantitative data dysregulated phosphoproteins with available inform"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": ""filter out noise in the data. Qualitative data was processed in parallel assigning up- and down-regulation based on original data. R 3.63 [ 142 ] and RStudio 1.2.5042 [ 143 ] were used to generate a heatmap representing fold changes of each phosphosite (R package pheatmap [ 144 ]). Clustering analysis was "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""in with correlation to the cognate RASopathy syndrome, were represented in a bubble plot using R 3.63 [ 142 ] and RStudio 1.2.5042 [ 143 ] (R package ggplot2). Gene ontology analysis and biological processes The 27 RASopathy proteins (Fig.\u00a0 3 B) and the 33 dysregulated phosphoproteins in the RASopathy inte"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:pheatmap"": [""methods""], ""computational_tools:RStudio"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
34230196,10.1212/WNL.0000000000012439,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,Neurology,2021,1630,568,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""on coefficients (ICCs) and coefficients of variation (CVs) were calculated to assess reliability and measurement error. RESULTS: Twenty patients with NF1 and 13 with NF2 were enrolled; median age was 12 years (interquartile range [IQR] 9-17 years) and 29 years (IQR 22-38 years), respectively. By MMT, w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Patients \u22655 years of age with weakness in at least 1 muscle group by manual muscle testing (MMT) were eligible. Maximal isometric muscle strength of a weak muscle gro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34230198,10.1212/WNL.0000000000012421,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,Neurology,2021,1729,428,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""(3) the World Health Organization Quality of Life-BREF for adult psychosocial trials. The highest-rated disease-specific measures were (1) the PedsQL NF1 Module for NF1 trials, (2) the NF2 Impact on Quality of Life Scale for NF2 trials, and (3) the Penn Acoustic Neuroma Quality of Life Scale for NF2 tr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods The PRO working group of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration used systematic methods to rev"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34230200,10.1212/WNL.0000000000012437,Imaging Evaluation of Plexiform Neurofibromas in Neurofibromatosis Type 1: A Survey-Based Assessment.,Neurology,2021,1805,479,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods An institutional review board\u2013exempt survey was administered to medical practitioners caring for individuals with NF1 at the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) meeting in September 2019. The survey included questions on respondent de"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods An institutional review board\u2013exempt survey was administered to medical practitioners caring for individuals with NF1 at the Response Evaluation in Neurofibromatosis an"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34230203,10.1212/WNL.0000000000012424,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,Neurology,2021,1731,622,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The REiNS Patient-Reported Outcomes Working Group systematically evaluated published patient-reported outcome measures of (1) hearing function and (2) hear"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
34230204,10.1212/WNL.0000000000012427,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,Neurology,2021,1587,110,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""OBJECTIVE: In order to explore the use of Skindex scoring in patients with neurofibromatosis type 1 (NF1) across multiple clinical sites and inform design of additional quality of life measures, we analyzed correlations between Skindex, site, and clinica"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods The relationship between clinical factors and Skindex scores were explored by clinic site and overall."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34230205,10.1212/WNL.0000000000012422,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,Neurology,2021,1458,658,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ed studies, domains assessed, availability of standard scores, psychometric properties, and feasibility to determine their appropriateness for use in NF1 clinical trials."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Searches were conducted via PubMed and  ClinicalTrials.gov  to identity social skills outcome measures with English language versions used in clinical tri"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34230208,10.1212/WNL.0000000000012430,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,Neurology,2021,1823,537,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We administered an anonymous online survey to all REiNS members. Facilitators and barriers to patient representative involvement were solicited using a modified fr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,Nat Commun,2021,1078,12570,0,3,5,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {""Anti-NF1 monoclonal antibody"": ""14d77c57-f623-4f0f-84a9-148a46fd5cc8"", ""Anti-NF1"": ""535891d9-4608-48eb-9e61-01201533a5bc""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""MATLAB"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Drosophila  husbandry and stocks Flies were cultured on cornmeal/agar food medium according to standard protocol and housed at 25\u2009\u00b0C, 60% relative humid"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""re cultured on cornmeal/agar food medium according to standard protocol and housed at 25\u2009\u00b0C, 60% relative humidity, on a 12:12 light:dark cycle. The  Nf1 P1  mutation was backcrossed six generations into the  w CS10  genetic background and  w CS10  flies were used as controls. Genetic control for  Nf1 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1 monoclonal antibody"": {""context"": ""aF/Na 3 VO 4 /\u03b2-glycerophosphate). Immunoprecipitations were performed using 400\u2009\u00b5g of total protein in 1\u2009ml IP buffer incubated with 200\u2009\u03bcl of mAb21 anti-Nf1 monoclonal antibody supernatant  for 1\u2009h at 4\u2009\u00b0C. Immunocomplexes were precipitated with a mix of Protein A- and Protein G-Sepharose beads (1:1, Sigma) for 1\u2009h at 4\u2009\u00b0C b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1"": {""context"": ""aF/Na 3 VO 4 /\u03b2-glycerophosphate). Immunoprecipitations were performed using 400\u2009\u00b5g of total protein in 1\u2009ml IP buffer incubated with 200\u2009\u03bcl of mAb21 anti-Nf1 monoclonal antibody supernatant  for 1\u2009h at 4\u2009\u00b0C. Immunocomplexes were precipitated with a mix of Protein A- and Protein G-Sepharose beads (1:1, Sigm"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""), Kruskal\u2013Wallis with post-hoc Dunn (nonparametric), or Kaplan\u2013Meier with Mantel\u2013Cox (Log-rank) tests. All statistical analyses were performed using GraphPad Prism 8.1.2 and Graphpad Prism 9.0.0. Immunohistochemistry experiment was performed in >5 nervous systems in 3 different experiments. Biological materials "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ed-dye solution made with a water-based dye. The latch-lid chamber with flies were left to equilibrate to incubator conditions (25\u2009\u00b0C) for 1\u2009h before starting the experiment (unless otherwise stated). Vacuum grease was applied between the latch-lid and chamber to reduce atmospheric and temperature fluct"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""n field area, habituated for 15\u2009min, and a 5-min video recording was recorded for analysis. Videos were collected using the Image Acquisition Tool in Matlab. Grooming was manually scored by watching videos frame-by-frame in Matlab R2015b and start and stop frames were recorded for each grooming event. Gro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""e atmospheric and temperature fluctuations. Images were captured every 15\u2009min using a time-lapse image software (PhenoCapture 3.3) and analyzed using Fiji 2.0, measuring the liquid meniscus position in each capillary. This measurement was subtracted from a reference image and repeated at each time point"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""antibodies:Anti-NF1 monoclonal antibody"": [""methods""], ""antibodies:Anti-NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
34264955,10.1371/journal.pone.0252048,Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.,PLoS One,2021,1262,14711,0,1,2,3,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Compounds and library The MIPE ( M echanism  I nterrogation  P lat e s) oncology compound library 4.0 consisting of 745 FDA-approved "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""omega, Madison, WI). The potency (IC 50 ) and efficacy (maximum % inhibition) of each compound in each cell line were calculated as described [ 10 ]. HEK293T cells used for NanoBRET assays were cultured in Dulbecco\u2019s Modified Eagle Medium supplemented with 10% fetal bovine serum and penicillin-streptomyci"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ere treated with 0.1% DMSO as the vehicle control. Cell viability was measured after 72 h of treatment using CellTiter-Glo. DRCs were generated using GraphPad Prism 7.0 ( www.graphpad.com ). For the schwannoma-relevant cell panel, HS01, HS11, and MS02 cells were seeded in 384-well plates overnight and incubated w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
34297428,10.1111/bpa.13007,RNA-sequencing highlights differential regulated pathways involved in cell cycle and inflammation in orbitofacial neurofibromas.,Brain Pathol,2022,1367,8426,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Salmon"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2 METHODS 2.1 Tumor samples and controls Snap frozen tissue from orbitofacial NF (n\u00a0=\u00a010) obtained from middle eastern patients and non\u2010orbitofacial NF (n\u00a0=\u00a04 plexiform,"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": "" NF were large tumors with plexiform components. No localized cutaneous/dermal NFs were studied. All patients studied satisfied clinical criteria for NF1. Clinicopathologic features of these patients are illustrated in Figure  1  and summarized in Table  1  (orbitofacial NFs) and Table  S1  (non\u2010orbito"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ysis For the low\u2010input RNA library preparation workflow, the quality of total RNA was measured by the Agilent Bioanlayzer to determine RNA integrity. Starting material was between 500\u00a0pg and 100\u00a0ng of total RNA and construction of the whole transcriptome library was prepared as directed in the Nugen Ova"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""tification Quality checks and preprocessing were performed to ensure the quality of the libraries. Gene expression quantification was performed using salmon (v1.3.0) ( 14 ) and transcript models from the FANTOM Cage\u2010Associated\u2010Transcriptome (FANTOM\u2010CAT) robust set ( 15 ), which we previously used to analy"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
34352618,10.1016/j.scr.2021.102474,Characterization of UMi031-A-2 inducible pluripotent stem cell line with a neurofibromatosis type 2-associated mutation.,Stem Cell Res,2021,697,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The UMi031-A-2 hiPSC line contains a CRISPR-induced homozygous, Neurofibromatosis Type 2 (NF2) mutation (L64P (CTG\u00a0>\u00a0CCG)) in the NF2 gene that encodes a merlin tumor suppressor. This line "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34377779,10.1212/NXG.0000000000000616,Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1.,Neurol Genet,2021,984,7334,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Fifty-nine patients with NF1 aged 5\u201327 years on an MEKi clinical trial treating plexiform neurofibroma underwent pretreatment and follow-up cognitive assessments over 48 weeks of"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Fifty-nine patients with NF1 aged 5\u201327 years on an MEKi clinical trial treating plexiform neurofibroma underwent pretreatment and follow-up cognitive assessments over 48 weeks of treatment. Per"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34409538,10.1007/s11060-021-03826-3,Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.,J Neurooncol,2021,1696,393,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""INTRODUCTION: Neurofibromatoses (NFs; NF1, NF2 and Schwannomatosis) are incurable genetic syndromes characterized by nerve sheath tumors and often accompanied by substantial emotional distres"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods We used baseline data from an RCT of a mind\u2013body intervention aimed at improving quality of life in adults with NF. Participants ( N  = 214) who endorsed pain completed measu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34416167,10.1016/j.ccell.2021.07.023,Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.,Cancer Cell,2021,358,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Rationally sequencing and combining PD-1/L1-and MAPK-targeted therapies may overcome innate and acquired resistance. Since increased clinical benefit o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
34428430,10.1016/j.devcel.2021.08.004,Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.,Dev Cell,2021,958,23871,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""CellProfiler"", ""STAR"", ""Fiji"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""e gliomas (pLGGs)-the most common brain tumor in children-during development remains largely unknown. Using mouse models of neurofibromatosis type 1 (NF1)-associated pLGGs in the optic pathway (NF1-OPG), we demonstrate that NF1-OPG arose from the vulnerability to the dependency of Mek-Erk/MAPK signalin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials Availability The  Mapk1  mouse model is available upon request to the lead contact. A172V METHODS EXPERIMENTAL MODEL DETAILS Mice All experiments"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ash for 10 minutes in TBS. Signals were visualized on the Odyssey CLx (LI-COR) using ImageStudio Ver 5.2 (LI-COR). Data was analyzed through Fiji and GraphPad Prism 10.1.2. If applicable, the PVDF membrane was stripped in Restore Western Blot Stripping Buffer (Thermo Fisher Scientific), followed by 30 minutes at "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""100%) for 5 minutes each. Slides are then put into two washes of xylene for 5 minutes each and cover slipped with DPX mountant media (Sigma-Aldrich). CellProfiler (ver 4.2.8) was used to quantify the images. Heart Immunohistochemistry: Histological analysis was conducted on formalin-fixed tissues, paraffin-embe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""d using Anymaze software (Stoelting Company, Wood Dale, IL). There were 3 phases of the experiment: training, acquisition, and reversal learning. The starting quadrant was rotated in acquisition and reversal phases so no mouse started in the same quadrant on consecutive trials. Distance, speed, latency,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": "" by one wash for 10 minutes in TBS. Signals were visualized on the Odyssey CLx (LI-COR) using ImageStudio Ver 5.2 (LI-COR). Data was analyzed through Fiji and GraphPad Prism 10.1.2. If applicable, the PVDF membrane was stripped in Restore Western Blot Stripping Buffer (Thermo Fisher Scientific), followe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""5) and a fold change cutoff of |1.5|. The following packages were used for subsequent downstream analysis:  ReactomePA  (Reactome Pathway analysis),  ggplot2  (bargraphs and volcano plot),  ggpubr  (stats on bargraphs), and  ssGSEA2  (post-translational modification-signature enrichment analysis or PTM-SEA"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,PLoS Med,2021,3160,15890,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""BWA"", ""SAMtools""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ze analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) to distinguish between MPNST and PN in patients with NF1. Following in silico enrichment for short cfDNA fragments and copy number analysis to estimate the fraction of plasma cfDNA originating from tumor (t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods and findings This multi-institutional study from the National Cancer Institute and Washington University in St. Louis used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WG"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""emultiplexed, and raw reads were quality filtered using fastp v.0.2. Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17. Aligned reads were deduplicated with Samtools v.1.7, then downsampled to 10 million read pairs (WGS coverage approximately 0.6\u00d7), or separa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""sing fastp v.0.2. Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17. Aligned reads were deduplicated with Samtools v.1.7, then downsampled to 10 million read pairs (WGS coverage approximately 0.6\u00d7), or separately for comparison purposes to 5 million read pairs (WG"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:BWA"": [""methods""], ""computational_tools:SAMtools"": [""methods""]}",False
34487172,10.1093/neuonc/noab211,Machine learning approach to differentiation of peripheral schwannomas and neurofibromas: A multi-center study.,Neuro Oncol,2022,1767,508,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We assembled a cohort of schwannomas and neurofibromas from 3 independent institutions and extracted high-dimensional radiomic features from gadolinium-enhanced, T1-weigh"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
34534577,10.1016/j.jid.2021.07.164,Combined Cyclin-Dependent Kinase InhibitionOvercomes MAPK/Extracellular Signal-Regulated Kinase Kinase Inhibitor Resistance in Plexiform Neurofibroma of Neurofibromatosis Type I.,J Invest Dermatol,2022,1653,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rug resistance mechanisms, and identified potential combination therapies to overcome resistance. By screening drug efficacy among six MEKis in human NF1-deficient PNF cell lines, TAK-733 was found to reduce PNF cell viability the most. We then cultured the TAK-733\u2012resistant cells and explored the pote"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""MAPK/extracellular signal-regulated kinase kinase (MEK) 1/2 inhibitors (MEKis) have recently achieved surprising success in treating unresectable plexiform neu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34570301,10.1007/s11060-021-03852-1,Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.,J Neurooncol,2021,1704,452,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PURPOSE: Neurofibromatoses (NF; NF1, NF2, and schwannomatosis) are incurable tumor suppressor syndromes with heterogeneous symptoms. Emotional distress (e.g., depression, anxiety, stres"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods We performed structural equation modeling mediation analysis on baseline measures of QoL (physical health, psychological, social relationships, environmenta"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants.,Genes (Basel),2021,147,6614,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Study Subjects We retrospectively analyzed the gDNA and cDNA variants identified from 653 patients tested for  NF1  sequencing b"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""4. Materials and Methods 4.1. Study Subjects We retrospectively analyzed the gDNA and cDNA variants identified from 653 patients tested for  NF1  sequencing between January 2006 and December 2020. In accordance with the American College of Medical Genetics and Genomics/Association for Molecula"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""urification Kit (Promega, Madison, WI, USA) according to the manufacturer\u2019s instructions. The concentration and purity of the DNA were measured using NanoDrop (Thermo Fisher Scientific, Waltham, MA, USA). The RNA was extracted with TRIzol methods and 1 \u00b5g of samples were reverse transcribed using Thermo Sci"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""nts were reviewed using Human Genome Variation Database (HGMD \u00ae  Professional release 2021.2,  https://my.qiagendigitalinsights.com/bbp/view/hgmd/pro/start.php , accessed on 1 July 2021), ClinVar ( https://www.ncbi.nlm.nih.gov/clinvar/ , accessed on 1 July 2021), and Leiden Open Variation Database (LOVD"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
34603530,10.3892/etm.2021.10697,Autophagy is involved in neurofibromatosis type I gene-modulated osteogenic differentiation in human bone mesenchymal stem cells.,Exp Ther Med,2021,106,11421,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nits of penicillin/streptomycin and 1% \u03b2-glycerophosphate sodium ( 13 ). Cell transfection and treatment BMSC models with inhibited or overexpressed  NF1  were established using a method similar to that used by a previous study ( 13 ). Briefly, a small interfering RNA (siRNA) targeting  NF1  and a nega"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Culture of human BMSCs BMSCs were purchased from the American Type Culture Collection (cat. no. CRL-3421). They were cultured in Huma"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""tical analysis All experiments were repeated \u2265 three times. The results are expressed as the mean \u00b1 standard deviation. Data were processed using the SPSS 10.0 statistical software (SPSS, Inc.). For between-group comparisons, data were analyzed using an unpaired Student's t-test. One-way analysis of var"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""om temperature with appropriate secondary antibodies conjugated to horseradish peroxidase (HRP). The membranes were incubated with ECL reagent (Immun-Star HRP Substrate kit; cat. no. 1705040; Bio-Rad Laboratories, Inc.). The signals were then visualized and analyzed using Image Lab\u2122 software 5.2 (Bio-Ra"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
34604751,10.1093/noajnl/vdab116,Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.,Neurooncol Adv,2021,1511,6424,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods A retrospective review of whole-body MRI scans from patients with NF1 and PN from CNH and NCI was performed. DNL are defined as lesions >3 cm, distinct from PN and lacking the \u201ccentral dot\u201d feature. Criteria for MR-HIFU"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods A retrospective review of whole-body MRI scans from patients with NF1 and PN from CNH and NCI was performed. DNL are defined as lesions >3 cm, distinct f"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34627329,10.1186/s13023-021-02051-5,Executive functions and quality of life in children with neurofibromatosis type 1.,Orphanet J Rare Dis,2021,1518,7202,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Participants The clinical sample was recruited from a referral center for NF1 located in a university hospital. Participation was voluntary and offered to all parents during medical consultations carried out between May 2013 an"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Participants The clinical sample was recruited from a referral center for NF1 located in a university hospital. Participation was voluntary and offered t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and TP53 Mutant Porcine Models Reveals Overlooked Challenges in Precision Modeling of Human Diseases.,Front Genet,2021,889,11312,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""acility with the capacity to house up to 1,600 pigs, and the capability to raise piglets to maturity. Our process for creating genetically engineered NF1 porcine models is summarized in  Figure 1 . Initial estrus was induced (Day -4) in female pigs by intramuscular (i.m.) administration of 5ml of P.G. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods CRISPR Design, Synthesis, and Validation In the conduct of research utilizing recombinant DNA, the investigator adhered to NIH Guidel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ofector \u2122  (Lonza). Subsequently, cells were recovered in complete growth media for 48h, lysed, and the targeted region was PCR amplified with the hotstart PrimeSTAR GXL DNA polymerase (Takara Bio Inc., Mountain View, CA) and sequenced using the MiSeq platform (Illumina Inc., San Diego, CA; see \u201c Genoty"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
34664663,10.1093/jpepsy/jsab090,Longitudinal Investigation of Early Motor Development in Neurofibromatosis Type 1.,J Pediatr Psychol,2022,1611,607,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Participants with NF1 and a control group of unaffected siblings were enrolled at ages 3\u20138\u2009years and were assessed yearly. Motor functioning was assessed longitudinally us"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Participants with NF1 and a control group of unaffected siblings were enrolled at ages 3\u20138\u2009years and were assessed yearly. Motor functioning was assessed"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34692515,10.3389/fonc.2021.738300,SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas.,Front Oncol,2021,1755,7548,0,2,8,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R"", ""GraphPad Prism"", ""STAR"", ""SAMtools"", ""FastQC"", ""DESeq2"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ined during surgical resection from patients at Beijing Tiantan Hospital between 2019 and 2021. Two of these cases were sporadic MPNSTs, and six were NF1-associated MPNSTs. The histopathological diagnosis was assessed according to the 2016 WHO Classification of Tumors of the Central Nervous System by t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Sequencing Data Gene Expression Omnibus (GEO,  http://www.ncbi.nlm.nih.gov/geo ) is a public functional genomics data repository of h"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""were approved by the Institutional Review Board of the Beijing Tiantan Hospital Ethics Committee. Cell Culture and Reagents The human MPNST cell line sNF96.2 and pNF cell line ipNF05.5 were purchased from the American Type Culture Collection (ATCC, USA). All cell lines were maintained in Dulbecco\u2019s modifie"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""ysis on 2 samples of SUZ12-WT and 2 samples of SUZ12-Mut cells. The hg38.fa file was used as the reference genome sequence to construct an index with Bowtie to complete the ChIP-Seq gene alignment. SAMtools was used to convert the compared SAM files into BAM files and sort them. DeepTools was used to conv"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""tatistical methods used for bioinformatic analysis are detailed in each section of the experimental methods. Statistical analysis was performed using GraphPad Prism version 8. The results were presented as the mean \u00b1 standard deviation (SD) of independent triplicate experiments. Statistical differences between gr"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""mpared SAM files into BAM files and sort them. DeepTools was used to convert the BAM files to BW files to complete the visualization of transcription start sites (TSSs). KEGG Pathway Enrichment Analysis, GO Enrichment Analysis and GSEA of DEGs To understand the functions of the DEGs, we used R software "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""UZ12-Mut cells. The hg38.fa file was used as the reference genome sequence to construct an index with Bowtie to complete the ChIP-Seq gene alignment. SAMtools was used to convert the compared SAM files into BAM files and sort them. DeepTools was used to convert the BAM files to BW files to complete the visu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": "" the patients. Identification of DEGs To identify differentially expressed genes (DEGs) between SUZ12-WT and SUZ12-Mut cells, we used Trim Galore and FastQC to process and optimize the raw data. The hg38.fa file was downloaded from the UCSC Genome Browser as the reference genome sequence. After the index "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""nstructed with Salmon, quantitative gene expression analysis was carried out on 4 samples. With p adj \u2264 0.05 and Log|FC|\u22652 as the screening criteria, DESeq2 was used to perform differential gene expression analysis on 2 samples of SUZ12-WT and 2 samples of SUZ12-Mut cells. The hg38.fa file was used as the"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""ize the raw data. The hg38.fa file was downloaded from the UCSC Genome Browser as the reference genome sequence. After the index was constructed with Salmon, quantitative gene expression analysis was carried out on 4 samples. With p adj \u2264 0.05 and Log|FC|\u22652 as the screening criteria, DESeq2 was used to pe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF96.2"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
34699786,10.1016/j.devcel.2021.10.001,Inhibition of ERK/MAPK signaling as potential therapy to prevent optic pathway glioma in infants with neurofibromatosis type 1.,Dev Cell,2021,361,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ular mechanisms of pLGG gliomagenesis are unclear, as is the progenitor cell of origin. In this issue of Developmental Cell, Jecrois et\u00a0al. show that NF1-associated optic pathway gliomas originate from migrating glial progenitors that have distinct MEK/ERK dependency."", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Pediatric low-grade gliomas (pLGGs) arise primarily at early stages of development. The molecular mechanisms of pLGG gliomagenesis are unclear, as is the pro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34707296,10.1038/s41586-021-04024-x,The structure of neurofibromin isoform 2 reveals different functional states.,Nature,2021,240,18935,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Cloning, expression and purification of human Nf1-23a Full-length human Nf1-23a (Nf1 isoform 2, UniProt accession no.  P21359 ), including an N-terminal strep tag followed by a TEV cleavage site, was"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Cloning, expression and purification of human Nf1-23a Full-length human Nf1-23a (Nf1 isoform 2, UniProt accession no.  P21359 ), including an N-terminal strep tag "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" particles. Further classification using reference-free 2D classification with 100 classes yielded 582,742 particles. Particles were converted into a STAR file and input into RELION v3.1.1 (ref.  33 ) for further processing. 34 To generate a consensus reconstruction, particles were re-extracted in 470 p"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
34728553,10.1158/1541-7786.MCR-21-0373,RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient Conditions.,Mol Cancer Res,2022,1328,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "", which reduced Raf kinase inhibitor protein (RKIP) expression via T\u03b2R1 kinase activity. Here, we show that a selective RKIP inducer (novel chemical, Nf18001) inhibits tumor growth and promotes schwannoma cell differentiation into mature Schwann cells under NF2-deficient conditions. In addition, Nf1800"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""UNLABELLED: Loss of NF2 (merlin) has been suggested as a genetic cause of neurofibromatosis type 2 and malignant peripheral nerve sheath tumor (MPNST). Previously, we demonstrate"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34768015,10.1016/j.ejmg.2021.104386,Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience.,Eur J Med Genet,2022,565,11154,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene Ontology (GO)"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene On"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
34779163,10.7507/1002-1892.202108065,[Expert consensus on diagnosis and management of neurofibromatosis type 1 (2021 edition)].,Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi,2021,1302,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant neoplastic disease caused by mutations in the NF1 gene and one of the most challenging diseases to treat. Patients have a c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant neoplastic disease caused by mutations in the NF1 gene and one of the most challenging diseases to"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,NPJ Genom Med,2021,1416,16026,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tured peripheral blood lymphocytes of nine patients from the pre-implantation genetic testing (PGT) program at our institution, who had a pathogenic  NF1  variant that leads to aberrant splicing (Table  1 ). Pheriphal blood lymphocytes were isolated and stored in DMSO in liquid nitrogen within 24\u2009h aft"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Ethics approval and consent to participate All patients provided written or oral consent for either coded use of their material to study the clinical utility of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""tifier (UMI) in the probe design (NuGen SPET) or by removing identical reads (Agilent Sureselect). Duplicate read pair detection was carried out with Picard tools ( 40 https://github.com/broadinstitute/picard ). Start and end positions from STAR output refer to the first nucleotide in the intron (AG\u2009|\u2009 g "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" performed on a NextSeq500 instrument (Illumina) using NextSeq500/550 high output kit v2 (Illumina). Read alignment RNAseq reads were mapped with the STAR mapper (Version 2.4.1d) and an index created from HS.GRCh37 with 92\u2009bp overhang . We performed unique mapping onto the genome without trimming and wi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Picard"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
35187488,10.1093/noajnl/vdab194,Immune deconvolution and temporal mapping identifies stromal targets and developmental intervals for abrogating murine low-grade optic glioma formation.,Neurooncol Adv,2022,908,8528,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""limma"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""T cell assays, and pharmacologic and antibody-mediated inhibition methods were used in these experiments. Materials and Methods Mice Wild type (WT),  Nf1 flox/flox  (equivalent to WT) ,  9 Nf1 +/\u2212\u200a ,  16 Nf1 +/R681X  (R681X ),  17 Nf1 +/R1278P  (R1278P ),  11 Nf1- OPG ( Nf1 +/\u2212 mice with somatic  Nf1  "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods A combination of bulk and single-cell RNA mouse optic nerve sequencing, immunohistochemistry, T cell assays, and pharmacologic and antibody-mediated inhibition methods were used in these ex"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""h peroxidase-conjugated secondary antibody, and analyzed using a colorimetric assay at 450nm. Statistical Analyses Data analyses were performed using GraphPad Prism using unpaired two-tailed Student\u2019s t-tests (differences between two groups) and one-way or two-way analysis of variance (ANOVA) with Dunnett\u2019s or Tu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" Flow software, version 9.0 . Bulk RNA-seq reads from FAC-sorted CNS cell types 18  were aligned to the Ensembl release 95 v2 top-level assembly with STAR version 2.7.3a 19 . Sequencing performance was assessed for the total number of aligned reads, total number of uniquely aligned reads, and features d"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""ompiled ImmuCC reference file containing gene counts for various immune cell types 20 . Gene-specific analysis was performed using the lognormal with limma-trend shrinkage model 21 , where the results were filtered by  22 P -values and fold-changes, to identify the top 20 most significant marker genes fo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:limma"": [""methods""]}",False
35212372,10.1093/nar/gkac128,Characterizing mobile element insertions in 5675 genomes.,Nucleic Acids Res,2022,1002,16101,0,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bedtools"", ""GATK"", ""R"", ""SAMtools""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Experimental design The data in this study were from two sources: low-coverage (\u223c7.4\u00d7) WGS samples from the 1KGP ( 25 ) and high-cove"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bedtools"": {""context"": ""ion number: nstd144) ( 34 ). Then non-reference MEIs were extracted and compared with the MEIs identified in this study, using \u2018window\u2019 function from BEDtools v2.26.0 ( 35 ). When a site was in \u00b1500\u00a0bp of another site, it was considered as a hit. For comparison with MEIs from gnomAD ( 18 ), we downloaded th"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""ent provinces in China ( 24 ), and this cohort was sequenced using the Illumina platform. The processing from raw FASTQs to BAMs was according to the GATK Best Practices Workflows germline short variant discovery pipeline ( 28 ), as described in ( 24 ). The median depth of the NyuWa samples after genome"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""a_collections/1000_genomes_project/ , which were aligned to the human genome building GRCh38 ( 26 ). The CRAM files were then converted to BAMs using SAMtools v1.9 ( 27 ). The NyuWa dataset contained 2999 individuals including diabetes and control samples collected from different provinces in China ( 24 ), "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bedtools"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:SAMtools"": [""methods""]}",False
35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,Hum Mutat,2022,1474,9724,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2 MATERIALS AND METHODS 2.1 Systematic compilation of missense variants Compilation of known  NF2  missense variants from human disease databases was conduct"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
35426432,10.1093/neuonc/noac100,Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.,Neuro Oncol,2022,1976,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Patients with neurofibromatosis type 1 (NF1) develop benign (BPNST), premalignant atypical (ANF), and malignant (MPNST) peripheral nerve sheath tumors. Radiological differentiation of these ent"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Patients with neurofibromatosis type 1 (NF1) develop benign (BPNST), premalignant atypical (ANF), and malignant (MPNST) peripheral nerve sheath "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
35481324,10.7759/cureus.23466,Evaluating the Evidence: Scientometric Analysis of Highly Cited Neurofibromatosis 1 Publications.,Cureus,2022,1604,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The study of Neurofibromatosis 1 (NF1) is progressing rapidly. This study aimed to identify historical trends in publications focusing on NF1, to find the top 100 most cited publications "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The study of Neurofibromatosis 1 (NF1) is progressing rapidly. This study aimed to identify historical trends in publications focusing on NF1, to find the top 100 most"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,Mol Cancer Ther,2022,1777,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""nt peripheral nerve sheath tumors (MPNST) are soft-tissue sarcomas that are the leading cause of mortality in patients with Neurofibromatosis type 1 (NF1). Single chemotherapeutic agents have shown response rates ranging from 18% to 44% in clinical trials, so there is still a high medical need to ident"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue sarcomas that are the leading cause of mortality in patients with Neurofibromatosis type 1 (NF1). "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
35546306,10.1002/ajmg.a.62773,"A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.",Am J Med Genet A,2022,581,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is a common genetic disorder frequently associated with cognitive deficits. Despite cognitive deficits being a key feature of NF1, the profile of su"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis Type 1 (NF1) is a common genetic disorder frequently associated with cognitive deficits. Despite cognitive deficits being a key feature "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
35584348,10.1200/PO.21.00540,Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.,JCO Precis Oncol,2022,214,4095,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ComplexHeatmap"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""MATERIALS AND METHODS Sequences of 529 cancer driver genes were analyzed in 6,381 tumors, yielding 391  NF1 -mutated tumors in which  NF1  LOH analysis was performed. Driver genes were evaluated by tumor type including malignant peripheral nerve sheath tumo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Sequences of 529 cancer driver genes were analyzed in 6,381 tumors, yielding 391  NF1 -mutated tumors in which  NF1  LOH analysis was"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": ""  NF1  hits in tumor. The VAF in tumor for G629R and S82F was 0.27 and 0.82, respectively. Data and Statistics Genetic data were visualized using the ComplexHeatmap package in R.  Analyses were performed using R version 4.0.3. 27 28 Ethics Declaration This study was reviewed and approved by the University of Cali"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ComplexHeatmap"": [""methods""]}",False
35628517,10.3390/ijms23105707,Molecular Dynamics Simulations Reveal Structural Interconnections within Sec14-PH Bipartite Domain from Human Neurofibromin.,Int J Mol Sci,2022,788,3193,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin, the main RasGAP in the nervous system, is a 2818 aa protein with several poorly characterized functional domains. Mutations in the NF1-encoding gene lead to an autosomal dominant syndrome, neurofibromatosis, with an incidence of 1 out of 3000 newborns. Missense mutations spread in th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Systems Setup The coordinates of the neurofibromin Sec14-PH domain were obtained from the Protein Data Bank [ 20 ] (PDB ID: 2E2X"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""] (PDB ID: 2E2X for the wild type [ 13 ] and PDB ID: 3PG7 for the K1750\u0394 mutant [ 8 ]). Some initial residues were removed so that both WT and mutant started at L1569. Starting point coordinates for the PH domain alone were obtained from the correspondent Sec14-PH structure by removing the Sec14 moiety "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
35677169,10.3389/fonc.2022.898971,Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.,Front Oncol,2022,100,1074,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a dominant hereditary disease characterized by the mutation of the"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods Search Strategy and Information Sources This review was in line with recommendations from the Preferred Reporting Items for Systemati"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
35723774,10.1007/s10072-022-06203-8,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,Neurol Sci,2022,1724,709,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: A high proportion of patients with neurofibromatosis type 1 (NF1) present with functional hearing deficiency as a result of neural abnormality in the late auditory brainstem. METHODS: In this randomized, two-period"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods In this randomized, two-period crossover study, we investigated the hypothesis that remote-microphone listening devices can ameliorate hearing and communicatio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,Database (Oxford),2022,1406,3379,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Initial user story development The concept for this database was inspired by informal conversations with members of the NF1 research "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Materials and Methods Initial user story development The concept for this database was inspired by informal conversations with members of the NF1 research community, and an initial proof of concept database was created using a sampling of research tools. Building on this initial database, anecd"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""on 2.0.0 at the time of writing, available from  https://github.com/nf-osi/nf-research-tools-schema ). This schema was processed with the \u2018schematic\u2019 Python library ( 11 ,  12 ) to generate a MySQL database as well as data intake spreadsheets. Data were manually curated by searching for NF1-relevant tools"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
35741605,10.3390/brainsci12060720,Integrated Drug Mining Reveals Actionable Strategies Inhibiting Plexiform Neurofibromas.,Brain Sci,2022,1580,4344,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is one of the most common genetic tumor predisposition syndromes, affecting up to 1 in 2500 individuals. Up to half of patients with NF1 develop ben"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Data and Code Availability All analyses were performed under the R programming environment. Key packages used include synapser ["", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""analyses were performed under the R programming environment. Key packages used include synapser [ 24 ], tidyverse [ 25 ], dplyr [ 26 ], WGCNA [ 27 ], ggplot2 [ 28 ], enrichplot [ 29 ], and ConsensusClusterPlus [ 30 ]. The experimental data were provided by the NFhackathon 2020 competition, which were downl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ggplot2"": [""methods""]}",False
35759947,10.1016/j.pediatrneurol.2022.06.003,A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.,Pediatr Neurol,2022,1783,8252,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""TRODUCTION: The neurofibromatoses comprise three different genetic conditions causing considerable morbidity and mortality: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis (SWN). This review summarizes recent and ongoing clinical trials involving patients with neurof"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Eligible patients were age\u2005>\u20055 years with a clinical diagnosis of  NF2 -related schwannomatosis ( NF2 -SWN) and at least one volumetrically measurable, progressive VS. Axi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" included major surgery or significant traumatic injury, prior anti-cancer therapies, or any investigational drug and radiation within 4 weeks of the start of the study drug. Other exclusion criteria were prior therapy with agents targeting VEGF or VEGFR, unstable or rapidly progressive disease, known p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
35815410,10.15252/embj.2021108780,Schwann cell precursors represent a neural crest-like state with biased multipotency.,EMBO J,2022,1332,32190,0,0,11,11,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""GraphPad Prism"", ""scVelo"", ""STAR"", ""Fiji"", ""DESeq2"", ""kallisto"", ""scanpy"", ""ImageJ"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Mouse husbandry, strains and genetics All mouse work was performed under a permit approved by the Ethical Committee on Animal Experim"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""unction (NMJ; Mapps  et\u00a0al ,\u2009 2022 ) was downloaded and processed as follows: fastq files were aligned with STAR tool and count matrices generate via featureCounts using mouse genome annotation gencode M27. Count matrix was then analysed via DESeq2 pipeline, where the covariate to compare was FACS sorting of cel"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""within the same litter while adhering to the use of the minimum number of animals. Analysis of statistical significance (Fig\u2009 4 ) was performed using GraphPad Prism 7 and the Holm\u2010Sidak method (\u03b1\u2009=\u20090.05; multiple  t \u2010tests, unpaired) or unpaired  t \u2010test with a two\u2010tailed  P \u2010value. Blinding was not applied, as m"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:scVelo"": {""context"": "" for each plate containing spliced and unspliced transcript counts. The loom file was combined and subset to the previously filtered out cells. Using scvelo tool on python (Van de Sande  et\u00a0al ,\u2009 2020 ), genes with less than 20 spliced counts or unspliced counts were excluded, and the 2,000 top highly var"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ws6/deindexer ) using the nextera index adapters and the 384\u2010well plate layout. Individual fastq files were then mapped to mm10_ERCC genome using the STAR aligner using 2\u2010pass alignment (Dobin  et\u00a0al ,\u2009 2013 ). Reads were filtered for only uniquely mapped and were saved in BAM file format; count matrice"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""h). Imaging and image processing Immunostained sections were imaged using a Zeiss Imager MZ with an ApoTome module. Images were processed using the \u201c Fiji \u201d software, using the \u201cCell Counter\u201d plugin for counting cells. Four to five sections were quantified per embryo from the forelimb axial level, and 2"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""re aligned with STAR tool and count matrices generate via featureCounts using mouse genome annotation gencode M27. Count matrix was then analysed via DESeq2 pipeline, where the covariate to compare was FACS sorting of cells being S100\u03b2\u2010GFP +  or S100\u03b2\u2010GFP + /NG2\u2010dsRed. Differential gene expression was gen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:kallisto"": {""context"": ""ellite glia using published  scRNAseq  data set Published scRNAseq data containing cells from mouse DRG and SCG were downloaded and processed via the kallisto bus pipeline (Bray  et\u00a0al ,\u2009 2016 ; Melsted  et\u00a0al ,\u2009 2021 ) using mouse genome GRCm38 release 97. Cells with less than 200 genes and more than 7.5% "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:scanpy"": {""context"": ""in BAM file format; count matrices were subsequently produced. Estimated count matrices were gathered and converted to anndata python object prior to scanpy processing. Cells with 5\u2009\u00d7\u200910 4 \u2009\u2264 transcripts\u2009\u2265\u20096\u2009\u00d7\u200910 4 , 1,000\u2009\u2264\u2009genes\u2009\u2265\u200910,000 or \u2264\u200915% of ERCC reads were kept. Overview and selection of develo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""opes equipped with 20\u00d7, 40\u00d7 and 63\u00d7 objectives or a Zeiss Imager MZ with an ApoTome module. Images were acquired in the lsm format and processed with ImageJ for export as tiff files. Figures were compiled using Adobe Photoshop and Illustrator. Quantification of  RNAscope \u00ae  in\u2009situ  hybridization Followin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": "" mapped and were saved in BAM file format; count matrices were subsequently produced. Estimated count matrices were gathered and converted to anndata python object prior to scanpy processing. Cells with 5\u2009\u00d7\u200910 4 \u2009\u2264 transcripts\u2009\u2265\u20096\u2009\u00d7\u200910 4 , 1,000\u2009\u2264\u2009genes\u2009\u2265\u200910,000 or \u2264\u200915% of ERCC reads were kept. Overview "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:scVelo"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:kallisto"": [""methods""], ""computational_tools:scanpy"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
35855179,10.25259/SNI_114_2022,Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis.,Surg Neurol Int,2022,1502,2554,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods:  A keyword-based search was performed using the Scopus database. The top 100 articles were grouped based on NF types and the studied entities. The differences "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""tion analysis at 5% level of significance was carried out between the number of citations and the duration of publication in an Excel spreadsheet and SPSS version 26. Selection of the studies included in the discussion section was based on the following criteria to establish narrative review: 1 \u2013 highly"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
35855490,10.1093/noajnl/vdac072,Validation of Bromodomain and Extraterminal proteins as therapeutic targets in neurofibromatosis type 2.,Neurooncol Adv,2022,874,6981,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods A panel of normal and NF2-null Schwann and schwannoma cell lines were used to characterize the impact of the BET inhibitor JQ1 in vitro and in vivo. The mechanism o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""rage quality was too low. High-quality reads were mapped to the human genome (human-USCS: H.sapiens-UCSC-GRCh38hg38: downloaded March 22, 2016) using bowtie version 1.1.2 aligner and peak abundance estimated with macs version 2.1.0. Replicate BRD4 ChIP experiments (\u00b1JQ1 treatment) were processed and signi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bowtie"": [""methods""]}",False
35875109,10.3389/fonc.2022.903177,Preclinical Assessment of MEK Inhibitors for Malignant Peripheral Nerve Sheath Tumors Reveals Differences in Efficacy and Adaptive Response.,Front Oncol,2022,129,5264,0,5,2,7,"{""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials & Methods Cell Lines and Reagents The NF1 +/-  Schwann cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""nd Reagents The NF1 +/-  Schwann cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-associated (ST88-14, T265, S462, and S462TY) and sporadic (STS-26T) MPNST lines were kindly granted by Prof. Vincent Keng and Prof. Jilong Yang ( \n ). All MPNST cell lines were main"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""ds Cell Lines and Reagents The NF1 +/-  Schwann cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-associated (ST88-14, T265, S462, and S462TY) and sporadic (STS-26T) MPNST lines were kindly granted by Prof. Vincent Keng and Prof. Jilong Yang ( \n ). All MPNST cell lin"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Materials & Methods Cell Lines and Reagents The NF1 +/-  Schwann cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-associated (ST88-14, T265, S462, and S462TY) a"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:STS-26T"": {""context"": "" cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-associated (ST88-14, T265, S462, and S462TY) and sporadic (STS-26T) MPNST lines were kindly granted by Prof. Vincent Keng and Prof. Jilong Yang ( \n ). All MPNST cell lines were maintained in high-glucose DMEM supplem"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""ines and Reagents The NF1 +/-  Schwann cell line (sNF02.3 2\u03bb) was obtained from the American Type Culture Collection (ATCC). NF1-associated (ST88-14, T265, S462, and S462TY) and sporadic (STS-26T) MPNST lines were kindly granted by Prof. Vincent Keng and Prof. Jilong Yang ( \n ). All MPNST cell lines wer"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""Band signals were detected using an Amersham Imager 600 (General Electric Company, Boston, MA, United States), and quantification was performed using ImageJ software after normalization to GAPDH. Xenografts Four-week-old male NOD-SCID IL-2 receptor gamma-null mice were purchased from Shanghai Model Organi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:NF1"": [""methods""], ""cell_lines:STS-26T"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
35879407,10.1038/s41431-022-01153-3,Intragenic inversions in NF1 gene as pathogenic mechanism in neurofibromatosis type 1.,Eur J Hum Genet,2022,1485,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1), an autosomal dominant disorder characterized by skin pigmentary lesions and multiple cutaneous neurofibromas, is caused by neurofibromin 1 (NF1) lo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1), an autosomal dominant disorder characterized by skin pigmentary lesions and multiple cutaneous neurofibromas, is caused by"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
35887576,10.3390/jpm12071080,Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.,J Pers Med,2022,149,10336,0,3,2,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""HSC1\u03bb"": ""a0193c87-8813-4841-92e7-ee5095bd94fe""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2.G (Addgene Plasmid #12260) and 5.6 \u03bcg lentiviral expression plasmids of interest\u2014pLKO.1-puro Non-Target shRNA Control Plasmid DNA (Sigma SHC016), shNF1 (TRCN0000039713, TRCN0000039714 (Sigma)\u2014dsRed2-RFP (Addgene 109377), or GFP (Addgene 17448) were combined in deionized water to a total volume of 100"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Cell Culture All cells used in this study were maintained in complete culture medium (DMEM supplemented with 10% fetal bovine se"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""ine (2 mmol/L). Cells were used within 2 months of cryogenic resuscitation. Cells were passaged biweekly into fresh complete culture medium. ST-8814, S462TY [ 30 ], and STS26T were kindly gifted from Nancy Ratner (University of Cincinnati\u2014Cincinnati Children\u2019s Hospital). Immortalized Schwann cells (iHSC"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HSC1\u03bb"": {""context"": ""non-targeting controls were purchased from Sigma Aldrich. Lentiviral supernatants were prepared using the 293T cell line, as detailed above. STS26T, iHSC1\u03bb, and iHSC-2\u03bb cells (1.6\u20132.0 \u00d7 10 5  cells per well) were seeded in 6-well tissue culture plates (VWR) and allowed to attach overnight. The medium was"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" as described above. Membranes were imaged using an Odyssey Clx Imaging System (LI-COR). 2.12. Statistical Analysis IC 50  was calculated by means of Graphpad Prism 9 software using a variable slope with the least squares regression method. Significance between and within groups was determined by one-way ANOVA an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:HSC1\u03bb"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
35970940,10.1038/s41598-022-17873-x,"Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.",Sci Rep,2022,1562,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is associated with GABAergic dysfunction which has been suggested as the underlying cause of cognitive impairments. Previous intervention trials inv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is associated with GABAergic dysfunction which has been suggested as the underlying cause of cognitive impairments. Previou"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36009591,10.3390/biomedicines10082044,Identification of Germinal Neurofibromin Hotspots.,Biomedicines,2022,141,2496,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Neurofibromin Residues, Regions, and Domains Defined in This Study Neurofibromin functional domains were obtained from Uniprot d"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""niprot database [ 47 ], P21359; UniProt, as well as from Interpro [ 48 ], Prosite [ 49 ], and previous published papers [ 50 , 51 ]. 2.2. Analysis of NF1 Variants from Clinvar NF1  variants used in this study were obtained from ClinVar database, release of February of 2020 [ 52 ]. For the study of the "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
36037004,10.1242/dmm.049422,Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.,Dis Model Mech,2022,1347,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurogenetic disorder caused by mutations in the gene neurofibromin 1 (NF1). NF1 predisposes individuals to a variety of sy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal-dominant neurogenetic disorder caused by mutations in the gene neurofibromin 1 (NF1). NF1 predisposes indiv"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36071954,10.1093/burnst/tkac030,Co-culture of Schwann cells and endothelial cells for synergistically regulating dorsal root ganglion behavior on chitosan-based anisotropic topology for peripheral nerve regeneration.,Burns Trauma,2022,2129,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Anisotropic topologies are known to regulate cell-oriented growth and induce cell differentiation, which is conducive to accelerating nerve rege"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36127120,10.1136/bmjopen-2022-065340,Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.,BMJ Open,2022,1927,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""PURPOSE: The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with the monogenetic disorder NF1 using a natio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: The Danish neurofibromatosis 1 (NF1) cohort was initiated to study health-related, socioeconomic and psychological consequences of living with t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36130486,10.1016/j.celrep.2022.111363,Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.,Cell Rep,2022,1135,33030,0,8,15,23,"{""cell_lines"": {""sNF02.2"": ""b72d99fd-ee1e-42ec-92b6-9f89e375cce1"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""infercnv"", ""Picard"", ""bedtools"", ""R"", ""BWA"", ""GraphPad Prism"", ""Seurat"", ""STAR"", ""monocle"", ""Trimmomatic"", ""Cell Ranger"", ""FlowJo"", ""Monocle3"", ""DESeq2"", ""ComplexHeatmap""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ein College of Medicine) and maintained in DMEM10. Cell lines MPNST724 and ST88-14 were kindly provided by Dr. Nancy Ratner and maintained in DMEM10. NF1 patient-derived MPNST cell lines PT2002 and PT2031 were requested through The Johns Hopkins NF1 Biospecimen Repository ( https://www.hopkinsmedicine."", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""STAR\u2605METHODS RESOURCE AVAILABILITY Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF02.2"": {""context"": ""d in DMEM10 (Dulbecco\u2019s Modified Eagle Medium supplemented with 10% fetal bovine serum and 100 U/mL penicillin and 100 \u03bcg/mL streptomycin). Cell line sNF02.2 was purchased from ATCC (Manassas, VA) and maintained in DMEM10. Sporadic MPNST cell line STS-26T was kindly provided by Dr. Steven Porcelli (Albert "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": "" MPNST sample in the laboratory of Dr. Rosandra Kaplan (Pediatric Oncology Branch, NCI) and kindly provided to us to be maintained in DMEM10. Lenti-X HEK293 cells were originally purchased from Takara Bio (Mountain View, CA) and maintained in DMEM10 and kindly provided by Dr. Carol Thiele\u2019s laboratory (Pe"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""per is available from the lead contact upon request. EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell lines and culture conditions MPNST cell lines, T265, S462 and sNF96.2, were kindly provided by Dr. Karlyne Reilly (Pediatric Oncology Branch, NCI) and were maintained in DMEM10 (Dulbecco\u2019s Modified Eagle Med"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""ailable from the lead contact upon request. EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell lines and culture conditions MPNST cell lines, T265, S462 and sNF96.2, were kindly provided by Dr. Karlyne Reilly (Pediatric Oncology Branch, NCI) and were maintained in DMEM10 (Dulbecco\u2019s Modified Eagle Medium suppleme"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": "" cell line STS-26T was kindly provided by Dr. Steven Porcelli (Albert Einstein College of Medicine) and maintained in DMEM10. Cell lines MPNST724 and ST88-14 were kindly provided by Dr. Nancy Ratner and maintained in DMEM10. NF1 patient-derived MPNST cell lines PT2002 and PT2031 were requested through The "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:STS-26T"": {""context"": ""L penicillin and 100 \u03bcg/mL streptomycin). Cell line sNF02.2 was purchased from ATCC (Manassas, VA) and maintained in DMEM10. Sporadic MPNST cell line STS-26T was kindly provided by Dr. Steven Porcelli (Albert Einstein College of Medicine) and maintained in DMEM10. Cell lines MPNST724 and ST88-14 were kindl"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""his paper is available from the lead contact upon request. EXPERIMENTAL MODEL AND SUBJECT DETAILS Cell lines and culture conditions MPNST cell lines, T265, S462 and sNF96.2, were kindly provided by Dr. Karlyne Reilly (Pediatric Oncology Branch, NCI) and were maintained in DMEM10 (Dulbecco\u2019s Modified Eag"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:infercnv"": {""context"": ""n each cluster. Using the immune cells from these MPNST single-cell datasets as a reference, we inferred copy number variation by using the R package inferCNV (inferCNV of the Trinity CTAT Project.  https://github.com/broadinstitute/inferCNV ). Single-cell whole genome sequencing and data processing To prof"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""pping rate of all samples was 97%. Unique alignment was above 86%. There were 1.94\u20134.20% unmapped reads. The mapping statistics were calculated using Picard software. The samples had 0.83% ribosomal bases. Percent coding bases were between 56 and 61%. Percent UTR bases were 28\u201334%, and mRNA bases were bet"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bedtools"": {""context"": ""27me3 and H3K27ac. Overlapped H3K27me3 peaks were identified using the H3K27me3 peak files of all three inducible cell lines in the +Dox condition in BEDTools ( https://bedtools.readthedocs.io/en/latest/index.html ) and BEDOPS ( Neph et al., 2012 ). Bivalent domains marked by both H3K27me3 and H3K4me3 are p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""immed for adapters using Trimmomatic software before the alignment. The trimmed reads were aligned to the reference human genome (version hg19) using BWA ( Li and Durbin, 2009 ). Duplicated reads were discarded. Reads aligned to regions of the hg19 genome known to be prone to artifactual increased alig"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" used in this study were specified in the corresponding  Results  and Methods sections. Statistical analysis was performed in R, Microsoft Excel, and GraphPad Prism software (GraphPad, San Diego, CA). Materials availability DNA constructs and other research reagents generated by the authors wil be distributed upo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": "" were analyzed preliminarily with the Cell Ranger pipeline offered by the 10X Genomics. The generated count matrix was used in downstream analysis in Seurat 4.0. Briefly, gene counts were normalized and scaled before dimensional reduction for the clustering analysis. Cluster biomarkers were identified by "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""STAR\u2605METHODS RESOURCE AVAILABILITY Lead contact Further information and requests for resources and reagents should be directed to and will be fulfilled by"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""eater library size than  GSE142541 , reads were down-sampled from both these datasets to match the library size distribution of cells in  GSE142541 . Monocle3 ( Cao et al., 2019 ;  Trapnell et al., 2014 ) was then used to construct a trajectory from the merged data, where batch correction was internally pe"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""ads per cell. QUANTIFICATION AND STATISTICAL ANALYSIS RNAseq data analysis Reads of the samples were trimmed for adapters and low-quality bases using Trimmomatic ( Bolger et al., 2014 ) before alignment with the reference genome (Human \u2013 hg19) and the annotated transcripts using STAR ( Dobin et al., 2013 ). Th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": "" R package circlize ( Gu et al., 2014 ). Single-cell RNAseq data analysis The single-cell RNA sequencing results were analyzed preliminarily with the Cell Ranger pipeline offered by the 10X Genomics. The generated count matrix was used in downstream analysis in Seurat 4.0. Briefly, gene counts were normalized "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""of MPNST cells stained for human MHC I molecules. Cells were gated to retain live, single cells for downstream analysis of the protein of interest in FlowJo software (BD). The stacked intensity of HLA-A,B,C was visualized in FlowJo. Single-cell RNAseq Patient MPNST samples were directly collected from the"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Monocle3"": {""context"": ""eater library size than  GSE142541 , reads were down-sampled from both these datasets to match the library size distribution of cells in  GSE142541 . Monocle3 ( Cao et al., 2019 ;  Trapnell et al., 2014 ) was then used to construct a trajectory from the merged data, where batch correction was internally per"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""on, the gene expression quantification analysis was performed for all samples using STAR/RSEM ( Li and Dewey, 2011 ) tools. The raw count was used in DESeq2 ( Love et al., 2014 ) for differentially expressed gene analysis. Statistical results of gene expression from DESeq2 were used in gene set enrichment"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": ""ized count, specifically fragments per kilobase of transcript per million mapped reads (FPKM), was used for data visualization in heatmaps. R package ComplexHeatmap ( Gu et al., 2016 ) was used to generate heatmaps in R (version 3.6.1). Raw RNAseq results were aligned to human genome hg19 and converted to bigwig "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF02.2"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:sNF96.2"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:STS-26T"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:infercnv"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:bedtools"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:Monocle3"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ComplexHeatmap"": [""methods""]}",False
36134665,10.1172/jci.insight.154513,Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment.,JCI Insight,2022,1402,11193,0,1,7,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""TopHat"", ""Seurat"", ""edgeR"", ""FastQC"", ""Cell Ranger""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Sample acquisition. Adult male and female  Dhh-Cre;Nf1  mice on a largely C57BL/6 background were used ( fl/fl 11 ). Fresh human PNs from debulking surgeries ( n  = 4 individual tumors) were taken directl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Sample acquisition. Adult male and female  Dhh-Cre;Nf1  mice on a largely C57BL/6 background were used ( fl/fl 11 ). Fresh human PNs from debulking surgeries ( n  = 4 individual tumors) were taken di"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": "".4) and read quality checked with FASTQC. Reads were aligned against the mm10 mouse genome with TopHat. Raw gene counts were calculated using Subread/featureCounts (v1.5.2) and normalized using edgeR\u2019s TMM method. Raw and processed sequencing data files are deposited in NCBI\u2019s GEO ( GSE181986 ). Immunohistochemi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": "". Base calling was preformed using Illumina CASAVA (v1.4) and read quality checked with FASTQC. Reads were aligned against the mm10 mouse genome with TopHat. Raw gene counts were calculated using Subread/featureCounts (v1.5.2) and normalized using edgeR\u2019s TMM method. Raw and processed sequencing data file"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""ing FASTQs and count matrices, are available in the NCBI Gene Expression Omnibus database (GEO  GSE181985 ). Downstream analyses were performed using Seurat (version 3.1.2) ( 80 ), Scrublet (version 0.2.1) ( 32 ), cellHarmony (AltAnalyze version 2.1.4) ( 42 ), and CellPhoneDB (version 2.1.2) ( 45 ). Seura"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""ads were aligned against the mm10 mouse genome with TopHat. Raw gene counts were calculated using Subread/featureCounts (v1.5.2) and normalized using edgeR\u2019s TMM method. Raw and processed sequencing data files are deposited in NCBI\u2019s GEO ( GSE181986 ). Immunohistochemistry (mouse). PNs and normal sciatic"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""ries were amplified with the Ovation RNA-Seq System v2 (Nugen). Base calling was preformed using Illumina CASAVA (v1.4) and read quality checked with FASTQC. Reads were aligned against the mm10 mouse genome with TopHat. Raw gene counts were calculated using Subread/featureCounts (v1.5.2) and normalized us"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""ls were included in this analysis. scRNA-seq analysis. The 10\u00d7 scRNA-Seq libraries from mouse samples were aligned to the mm10 mouse genome using the Cell Ranger pipeline (version 3.0.2, 10\u00d7 Genomics) with default parameters. Detailed Cell Ranger quality metrics for each sample are shown in  Supplemental Table"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""]}",False
36139671,10.3390/cancers14184513,Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development.,Cancers (Basel),2022,1056,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome that affects about 1 in 3000 newborns, is caused by mutations in the  METHODS: We retrieved published liter"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome that affects about 1 in 3000 newborns, is caused by mutations in the  ME"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,Exp Mol Med,2022,1399,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The poor survival and low efficiency of neuronal differentiation limits the therapeutic effects of transplanted neural stem cells in the treatment of spinal c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36300003,10.1016/j.isci.2022.105275,A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.,iScience,2022,137,23529,0,2,4,6,"{""cell_lines"": {""N10"": ""de94c5d9-6feb-402f-a0c6-6ac3389907c6"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""STAR\u2605Methods Key resources table \n \n REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit monoclonal Anti-GAPDH Abcam Cat# ab181602; RRID:  AB_2630358 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:N10"": {""context"": ""CACCCTCAAAG This paper N/A NF2-Exon9 Forward: CCAGGACAAGGCATAACTTCAT This paper N/A NF2-Exon9 Reverse: CGCCAAGTGAGATACCATTCTATA This paper N/A NF2-Exon10 Forward: TCCAGAGCTGACGGCACTA This paper N/A NF2-Exon10 Reverse: GTAGGCATCGGCAAATGAAGAT This paper N/A NF2-Exon11 Forward: TGTTCATTCACCACTAGACTGT This"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""ial and virus strains TOP10 Chemically Competent Cell YEASEN Cat# 11801ES80 Rosetta Competent Cell TIANGEN Cat# CB108 Experimental models: cell lines HEK293T cell lines American Type Culture Collection Cat# CRL-3216;RRID:CVCL_0063 IOMM-Lee cell lines American Type Culture Collection Cat# CRL-3370; RRID:CV"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""p3\u00d7Flag-YAP1 This paper N/A pX459-NF2-mut This paper N/A pMD19-NF2-mut This paper N/A Software and algorithms Snapgene Snepgene N/A ImageJ ImageJ N/A GraphPad Prism 8 GraphPad N/A Adobe Photoshop Adobe Photoshop N/A Resource availability Lead contact Further information and requests for resources and reagents sho"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""S1 This paper N/A p3\u00d7Flag-YAP1 This paper N/A pX459-NF2-mut This paper N/A pMD19-NF2-mut This paper N/A Software and algorithms Snapgene Snepgene N/A ImageJ ImageJ N/A GraphPad Prism 8 GraphPad N/A Adobe Photoshop Adobe Photoshop N/A Resource availability Lead contact Further information and requests for "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""STAR\u2605Methods Key resources table \n \n REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Rabbit monoclonal Anti-GAPDH Abcam Cat# ab181602; RRID:  AB_2630358 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:N10"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
36316421,10.1038/s41598-022-21907-9,Non-invasive brain stimulation modulates GABAergic activity in neurofibromatosis 1.,Sci Rep,2022,1427,19454,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""MATLAB"", ""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rk. Inclusion criteria included (i) Clinical diagnosis made using the National Institute of Health diagnostic criteria  and/or molecular diagnosis of NF1; (ii) No history of intracranial pathology other than asymptomatic optic pathway or other asymptomatic and untreated NF1-associated white matter lesi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Subjects Thirty-one adolescents aged 11\u201317\u00a0years were recruited via the Northern UK NF-clinical research network. Inclusion criteria included (i) Clinical diagnosi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""s were asked to perform a working memory task for 24\u00a0min (4 blocks of 6-min each) during which fMRI data were acquired. AtDCS or sham stimulation was started after the first block of working memory task and continued for 15\u00a0min during which the participant engaged in 2 more blocks of working memory task"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""total responses). RT were calculated only for time to correct response to target stimuli. Statistical analysis Statistical analyses were performed in SPSS version25 and R version 1.2. Pearson\u2019s correlations were used to investigate the relationship between GABA+ in DLPFC and OCC and the behavioural outc"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""d cerebrospinal fluid (CSF) using SPM8 ( http://www.fil.ion.ucl.ac.uk/spm/ ). Voxel registration was performed using custom-made scripts developed in MATLAB by Dr. Nia Goulden, which can be accessed at  http://biu.bangor.ac.uk/projects.php.en . The scripts generated a mask for voxel location by combining "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
36416236,10.1002/glia.24308,LPAR1 and aberrantly expressed LPAR3 differentially promote the migration and proliferation of malignant peripheral nerve sheath tumor cells.,Glia,2023,1753,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwann cell-derived neoplasms known as malignant peripheral nerve sheath tumors (MPNSTs) are the most common malignancy and the leading cause of death in individuals"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype invitro.,Mol Ther Nucleic Acids,2022,123,4131,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Material and methods All procedures performed were in accordance with the ethical standards of the IGTP Institutional Review Board, which approved this stu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" was assessed by western blot (Monoclonal ANTI-FLAG M2 antibody, Sigma-Aldrich, St. Louis, MO). Statistics Statistical analysis was carried out using GraphPad Prism software v7. The Shapiro-Wilk test was used to test normality and for multiple group comparisons, a two-tailed unpaired t test was performed. Statist"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
36444392,10.1002/mgg3.2077,Characterization of health concerns in people with neurofibromatosis type 1.,Mol Genet Genomic Med,2023,1343,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cut"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progre"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36459048,10.1002/jbmr.4755,Molecular Dissection of Somatic Skeletal Disease in Neurofibromatosis Type 1.,J Bone Miner Res,2023,953,11136,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""HISAT2"", ""monocle"", ""NanoDrop""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ldren Biorepository, excess tissue resected during surgery performed as standard\u2010of\u2010care was provided from subjects diagnosed with pseudarthrosis and NF1. Patient\u2010derived samples included in this study include both sexes and multiple races and ethnicities. As previously described, ( \n \n \n 9 \n )  resect"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Human subjects and cell culture All subjects provided written informed consent approved by the UT Southwestern Medical Center Institu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ts were performed for each genotype after normalization. Most data were normalized using a log transformation. Statistical tests were performed using GraphPad Prism (GraphPad, La Jolla, CA, USA)."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""performed independently. scRNA\u2010seq analyses were performed using Partek Flow. Sequence reads were mapped to the human reference genome (GRCh38) using HiSat2. Cells with less than 3000 genes detected were excluded, resulting in removal of 0 and 4 cells in the control and fracture experiments, respectively."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""DRp\u2009<\u20090.01) were detected between the first and last time points utilizing only  EREG \n LOW  cells using GSA. Trajectory analysis was performed using Monocle (v3), ( \n \n \n 20 \n )  and pseudotime was calculated using a root state defined as the trajectory terminus with undifferentiated (day 0) cells. Genes "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": "" (Qiagen) before RNA extraction using the RNeasy Plus Mini Kit (Qiagen) following manufacturer's recommendations. The samples were quantified using a Nanodrop1000 spectrophotometer (Thermo Fisher Scientific). For MEK inhibitor experiments, cells were treated with 2.5\u00a0nM trametinib (Selleck Chemicals, Housto"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:NanoDrop"": [""methods""]}",False
36497280,10.3390/cancers14235798,Knockdown of NCOR2 Inhibits Cell Proliferation via BDNF/TrkB/ERK in NF1-Derived MPNSTs.,Cancers (Basel),2022,1375,11460,0,3,7,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""HISAT2"", ""clusterProfiler"", ""DESeq2"", ""ImageJ"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ll lines (ipNF05.5, ipNF05.5 mixed clones, and ipNF9511.bc) were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Four NF1-derived MPNST cell lines (ST8814, T265, S462, and S462TY) and one sporadic MPNST cell line (STS26T) were kindly donated by Prof. Vincent Keng [ 26 ] "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Cell Culture One normal human Schwann cell (HSC) line and three PNF cell lines (ipNF05.5, ipNF05.5 mixed clones, and ipNF9511.bc"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""nd ipNF9511.bc) were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Four NF1-derived MPNST cell lines (ST8814, T265, S462, and S462TY) and one sporadic MPNST cell line (STS26T) were kindly donated by Prof. Vincent Keng [ 26 ] and Prof. Jilong Yang [ 27 ]. The cells were "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""nes, and ipNF9511.bc) were purchased from the American Type Culture Collection (ATCC, Rockville, MD, USA). Four NF1-derived MPNST cell lines (ST8814, T265, S462, and S462TY) and one sporadic MPNST cell line (STS26T) were kindly donated by Prof. Vincent Keng [ 26 ] and Prof. Jilong Yang [ 27 ]. The cells"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""hai Medical Experimental Animal Care Commission. 2.15. Statistical Analysis Analyses were performed using SPSS Statistics 23.0 (Chicago, IL, USA) and GraphPad Prism version 8.0 (San Diego, CA, USA). Overall survival curves were estimated using the Kaplan\u2013Meier method, and differences in survival were evaluated us"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""erate raw reads. Raw paired-end fastq reads were filtered with TrimGalore (GitHub, San Francisco, CA, USA) and then aligned to the human genome using HISAT2 (Daehwan Kim Lab, Dallas, TX, USA) [ 29 ], followed by reference genome-guided transcriptome assembly and gene expression quantification using String"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": "" (DEGs) were identified by DESeq2 (Bioconductor, Baden-Wuerttemberg, Germany) with cut-off values of a log2|fold-change| > 1 and a  p -adjust < 0.05. ClusterProfiler (Bioconductor, Baden-Wuerttemberg, Germany) was used to perform functional enrichment analysis and the potential genes in the identified modules were"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""antification using String Tie (Center for Computational Biology, Baltimore, MD, USA) [ 30 ]. Differentially expressed genes (DEGs) were identified by DESeq2 (Bioconductor, Baden-Wuerttemberg, Germany) with cut-off values of a log2|fold-change| > 1 and a  p -adjust < 0.05. ClusterProfiler (Bioconductor, Ba"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ith phosphate-buffered saline, and the plates were dried at room temperature. Images of the plates were captured, and the colonies were counted using ImageJ 1.51 (National Institutes of Health, Bethesda, MD, USA). 2.8. Cell Invasion and Migration Assays Transwell assays were performed using hanging cell c"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""with the guidelines established by the Shanghai Medical Experimental Animal Care Commission. 2.15. Statistical Analysis Analyses were performed using SPSS Statistics 23.0 (Chicago, IL, USA) and GraphPad Prism version 8.0 (San Diego, CA, USA). Overall survival curves were estimated using the Kaplan\u2013Meier"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
36604703,10.1186/s13023-022-02607-z,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,Orphanet J Rare Dis,2023,1637,4589,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The original English-language NFTI-QOL was translated into German and then back-translated in order to preserve the questionnaire\u2019s original concepts and in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
36619222,10.7150/ijms.78386,Inhibition of YAP Sensitizes the Selumetinib Treatment for Neurofibromatosis Type 1 Related Plexiform Neurofibroma.,Int J Med Sci,2023,0,7214,0,1,3,4,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Cell culture The human NF1 related neurofibroma Schwann cell lines (ipNF95.11bC and ipNF95.6) were obtained from American Type Culture Collection. The mouse Schwann cell line ("", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""his medium was replaced with 10% CCK-8 and incubated at 37 \u00b0C for 2 hours. The absorbance was measured at 450 nm. The IC50 values were calculated via Graphpad prism 8.0 software (USA). Assessment of Synergistic Effects Combination indices (CI) of drug combinations were evaluated via the Chou-Talalay method using "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""cording to the manufacturer's protocol. Samples were processed immediately using a FACSCalibur flow cytometer (BD, USA). Data was further analyzed by FlowJo 10.4. 20,000 cells were recorded and analyzed in all conditions. Colony formation assay ipNF95.11bC, ipNF95.6 and shNf1-SW10 cells were seeded in 6-w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Cell culture The human NF1 related neurofibroma Schwann cell lines (ipNF95.11bC and ipNF95.6) were obtained from American Type Cultur"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:R"": [""methods""]}",False
36689660,10.1073/pnas.2208960120,Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization.,Proc Natl Acad Sci U S A,2023,70,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The majority of pathogenic mutations in the neurofibromatosis type I ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,PLoS One,2023,1846,12877,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""TM-31"": ""bb9f27dd-53d0-44c2-a1e9-21a7bbd08fb1""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Children\u2019s Hospital Philadelphia Committees for the Protection of Human Subjects (IRB). The need for consent was waived. Cell lines and materials The NF1 patient-derived HGG cell line TM-31 (RRID:CVCL_6735) [ 17 ], purchased from the RIKEN biorepository, is null for NF1, TP53, CDKN2A and ATRX. The Glio"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Material and methods Ethics statement This research was determined to be none-human subject research by the Children\u2019s Hospital Philadelphia Committees for"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:TM-31"": {""context"": ""ommittees for the Protection of Human Subjects (IRB). The need for consent was waived. Cell lines and materials The NF1 patient-derived HGG cell line TM-31 (RRID:CVCL_6735) [ 17 ], purchased from the RIKEN biorepository, is null for NF1, TP53, CDKN2A and ATRX. The Glioblastoma Multiphorme (GBM) LN319 cel"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""rgy study was performed in duplicates. IC50 and Lethal Dose 50 (LD50) values and 95% confidence intervals were calculated to assess drug sensitivity (GraphPad Prism 9 software) and tabulated in  Table 1 . 10.1371/journal.pone.0277305.t001 Table 1 Synergistic evaluations of drug combinations in 5746 and TM31 cell "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:TM-31"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
36759572,10.1038/s41388-023-02620-x,Runx1/3-driven adaptive endoplasmic reticulum stress pathways contribute to neurofibromagenesis.,Oncogene,2023,1342,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to develop plexiform neurofibromas (PNFs). Three endoplasmic reticulum (ER) stress response pathways restore cellular homeo"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) patients are predisposed to develop plexiform neurofibromas (PNFs). Three endoplasmic reticulum (ER) stress response pathwa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36806881,10.1093/neuonc/noad037,Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.,Neuro Oncol,2023,1885,706,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Leveraging data from our previous high-throughput drug screening in NF2 preclinical models, we identified a class of compounds targeting the ubiquitin\u2013prot"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
36809290,10.1371/journal.pone.0281876,Merlin tumor suppressor function is regulated by PIP2-mediated dimerization.,PLoS One,2023,1370,9055,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Plasmids pEGFP-C3-hYAP1 and pEGFP C3-Lats1 (Addgene plasmid # 19053) were gifts from Marius Sudol (Addgene plasmid # 17843). HA-AMOT "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""in each fraction or luciferase activity normalized to the activity in the peak fractions (%) relative to the elution volume in ml were prepared using Graphpad Prism 9 software. PIP 2  and PAK Active PAK2 (Sigma-Aldrich) was incubated with purified Merlin-GFP bound beads and Merlin-NL in 25 mM Tris (pH 7.4), 2 mM "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
36832459,10.3390/children10020330,"Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.",Children (Basel),2023,0,4663,0,1,2,3,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" Neurofibromatosis Referral Center of the University of Campania \u201cLuigi Vanvitelli\u201d. All participants met the following criteria: (i.) a diagnosis of NF1 established according to the revised criteria published by Legius and colleagues [ 1 ]; (ii.) absence of intellectual disability according to the Dia"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""tors, and scores on tests evaluating the level of victimization/cybervictimization behaviors as parallel mediators. This analysis was performed using SPSS Macro PROCESS [ 46 ] and bootstrapping procedure with 5000 samples and replacement from the full sample was applied to construct bias-corrected 95% c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Subjects and Procedure Thirty-eight consecutive participants were recruited at the Pediatric Neurofibromatosis Referral Center o"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:R"": [""methods""]}",False
36844630,10.3892/ol.2023.13707,Genetic variants of cancerassociated genes analyzed using nextgeneration sequencing in small sporadic vestibular schwannomas.,Oncol Lett,2023,688,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Vestibular schwannoma (VS) is the most common tumor of the cerebellopontine angle. Despite the increasing diagnosis of sporadic VS over the past decade, the use"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36849412,10.1124/jpet.122.001431,Combining SOS1 and MEK Inhibitors in a Murine Model of Plexiform Neurofibroma Results in Tumor Shrinkage.,J Pharmacol Exp Ther,2023,698,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ed neurofibromas. Although MEK inhibitors transiently reduce volumes of most plexiform neurofibromas in mouse models and in neurofibromatosis type 1 (NF1) patients, therapies that increase the efficacy of MEK inhibitors are needed. BI-3406 is a small molecule that prevents Son of Sevenless (SOS)1 inter"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1 develop rat sarcoma virus (RAS)-mitogen-activated protein kinase-mitogen-activated and extracellular signal-regulated kinase (RAS"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36854987,10.1186/s13619-022-00150-7,Modeling nervous system tumors with human stem cells and organoids.,Cell Regen,2023,1393,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""astoma (GBM), H3K27M-mutant Diffuse Midline Glioma (DMG) and H3G34R-mutant High-grade Glioma (HGG), Low-grade Glioma (LGG), Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), Medulloblastoma (MB), Atypical Teratoid/rhabdoid Tumor (AT/RT), and meningioma. We further compared these models wi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Nervous system cancers are the 10th leading cause of death worldwide, many of which are difficult to diagnose and exhibit varying degrees of treatment re"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
36866403,10.1093/neuonc/noad053,Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entities.,Neuro Oncol,2023,1866,152,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We investigated 40 tumors histologically diagnosed as ANF and compared their global methylation profile to other peripheral nerve sheath tumors."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
36868466,10.1016/j.ajpath.2023.02.008,A Two-Stage End-to-End Deep Learning Framework for Pathologic Examination in Skin Tumor Diagnosis.,Am J Pathol,2023,1512,11967,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Study subjects The FHCMU-IHC cohort for IHC staining analysis, which included both surgical and ESD specimens, comprised patients who underwent endoscopy and pathological tissue sampli"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""ts used to illustrate individual feature contributions. 34 Computational configuration All analyses were conducted on a Linux CentOS 7.9 server using Python 3.10.15 and the PyTorch 2.2.2 deep learning framework (CUDA 12.4, cuDNN 8.9.2). Hardware specifications included: 4\u00d7NVIDIA GeForce RTX 3090 GPUs (24\u2009"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Python"": [""methods""]}",False
36890585,10.1186/s40478-023-01525-w,Neurofibromatosistype 1-dependent alterations in mouse microglia function are not cell-intrinsic.,Acta Neuropathol Commun,2023,871,13648,0,2,3,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""OSW"": ""7a62af66-384d-419b-b8ac-f4d381b85942""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""limma"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""o minimize suffering. Similarly, all mice used at Washington University were performed under an approved Animal Studies protocol. Mice Wild type and  Nf1 \u2009\u00b1\u2009[ 5 ] mice used in this study were either bred onto a wild type or MacGreen (Csf1r-eGFP; [ 58 ] C57/BL6 background. Conditional microglia-specific"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Ethics statement All procedures involving the handling of living mice were performed in strict accordance with the German Animal Prot"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:OSW"": {""context"": ""\u00a0\u00b5m in diameter in the middle of the observed region. For the recording of microglia surveillance, no laser lesion was performed. IGOR Pro 6.37 (Lake Oswego, USA) was used for data analysis as in Davalos et al. [ 13 ] and Madry et al. [ 42 ]. The sequences of 3D image stacks were converted into sequenc"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""orter ion\u00a0intensities were normalized and\u00a0scaled using median-MAD normalization.. For significance calling two-sample moderated t-tests were applied (limma R package; [ 56 ]. P-values were adjusted using the Benjamini\u2013Hochberg method. Statistics All data are expressed as mean\u2009\u00b1\u2009SEM. A combination of one-"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""rawing a region of interest (ROI) around an area including all their process extensions throughout the 20\u00a0min movie and erasing data around that ROI. Starting with the second frame, we subtracted from each binarized frame the preceding frame and counted the number of pixels\u2009<\u20090 (retracting\u2009=\u2009PR) and\u2009>\u20090"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:OSW"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
36944680,10.1038/s41467-023-37226-0,Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.,Nat Commun,2023,631,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Schwannomas are common sporadic tumors and hallmarks of familial neurofibromatosis type 2 (NF2) that develop predominantly on cranial and spinal nerves. Virtually a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36959711,10.1002/gcc.23140,Modeling human cancer predisposition syndromes using CRISPR/Cas9 in human cell line models.,Genes Chromosomes Cancer,2023,1070,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The advancement of CRISPR mediated gene engineering provides an opportunity to improve upon preclinical human cell line models of cancer predisposing syndromes. This revie"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
36976677,10.1016/j.xpro.2023.102198,Generation of human iPSC-derived neurofibromaspheres for invitro and invivo uses.,STAR Protoc,2023,686,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromas are benign peripheral nervous system tumors associated with neurofibromatosis type 1, which originate from NF1(-/-) Schwann cell precursors. We describe a protocol to generate neurofibromaspheres by differentiating NF1(-/-) Schwann cells from induced pluripote"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromas are benign peripheral nervous system tumors associated with neurofibromatosis type 1, which originate from NF1(-/-) Schwann cell precursors."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,J Clin Invest,2023,1462,8797,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""hTERT ipn02.3 2\u03bb"": ""3a8f5be4-aa22-48f2-9a76-9412010ecd45""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Cell Ranger"", ""ImageJ"", ""Seurat"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Mice. The  H7;Nf1mut  mice have been described previously ( 10 ). Mice were maintained in a clean mouse facility at University of Texas Southwestern Medical Center. Al"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Mice. The  H7;Nf1mut  mice have been described previously ( 10 ). Mice were maintained in a clean mouse facility at University of Texas Southwestern Medical Center. All procedures involving an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:hTERT ipn02.3 2\u03bb"": {""context"": ""EM supplemented with 10% FBS and 1% penicillin-streptomycin. The human pNF cell line hTERT ipNF05.5 (ATCC, CRL-3388) and the normal Schwann cell line hTERT ipn02.3 2\u03bb (ATCC, CRL-3392) were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. All cells were cultured at 37\u00b0C under 5% CO 2 . For "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""ries and sequenced in the Next Generation Sequencing Core at University of Texas Southwestern Medical Center. Analyses of single-cell transcriptomes. Cell Ranger 5.0.1 (10x Genomics,  https://www.10xgenomics.com/ ) was used to process the raw sequencing data. BCL files were converted to FASTQ files and aligned"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""le spinal cord dissection was performed as previously described ( 4 ,  10 ), followed by image capture. The length and width of DRGs were measured by ImageJ (NIH). The volume of each DRG was calculated by the formula length \u00d7 width 2  \u00d7 0.5. Mass spectrometry. Mouse tissues were collected and lysed with t"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""h cell were quantified using unique molecular identifier and valid cell barcode. The gene expression matrix from Cell Ranger was used as input to the Seurat R package (v4.0.2) for downstream analysis ( 53 ). Cells with fewer than 200 genes per cell and high mitochondrial gene content were filtered out. Th"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:hTERT ipn02.3 2\u03bb"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Seurat"": [""methods""]}",False
37149083,10.1016/j.jid.2023.04.014,cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.,J Invest Dermatol,2023,1345,9979,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The questionnaire was translated using forward and backwards translation, and subsequently administered to a sample of 59 patients on two separate occasions. Feasibil"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""2021-0598. All participants provided written consent to participate. Recruitment of participants Patients who met the revised diagnostic criteria for NF1 [ 16 ], aged 18 years or up, who had at least one cNF were recruited when they visited the outpatient Neurology clinic of the Erasmus Medical Centre "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ns (surgical resection, CO2 laser, photocoagulation, electrodessication or diathermy). Statistical analysis Statistical analyses were performed using SPSS version 28.0. Non-parametric tests were used given the non-normal distribution of the data. The total and subdomain scores of the cNF-Skindex, EQ-5D-"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,Nat Commun,2023,1117,18355,0,5,16,21,"{""cell_lines"": {""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""HSC1\u03bb"": ""a0193c87-8813-4841-92e7-ee5095bd94fe"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""bowtie"", ""featureCounts"", ""R"", ""BWA"", ""GATK"", ""STAR"", ""SAMtools"", ""Seurat"", ""NanoDrop"", ""edgeR"", ""monocle"", ""limma"", ""infercnv"", ""ImageJ"", ""bowtie2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Patient samples and clinical annotation Tumor samples and peripheral blood of patients were collected from the University Health Network Brain Tumor Bank (Toronto) and the Mount Sinai Hospital Sa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""ized neurofibroma cell (ipNF06.2A ) were obtained from Dr. Margaret Wallace\u2019s laboratory at the University of Florida. MPNST cell lines (STS-26T 30 , S462 63 , S462TY, T265 64 ) were obtained from Dr. David Largaespada\u2019s laboratory at the University of Minnesota. All cell lines were cultured with Dulbec"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HSC1\u03bb"": {""context"": ""es in each cluster, which were then inspected for canonical immune and stromal cell markers. 62 Cell viability assay Immortalized human Schwann cell (HSC1\u03bb) and immortalized neurofibroma cell (ipNF06.2A ) were obtained from Dr. Margaret Wallace\u2019s laboratory at the University of Florida. MPNST cell lines "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""us flank injection. Cells were in media and Matrigel in a 1:1 ratio. Mice were injected with HSC1\u03bb gGFP ( null n \u2009=\u20094), HSC1\u03bb gPTCH1 ( n \u2009=\u20094), HSC1\u03bb NF1 \u2212/\u2212  gPTCH1 ( n \u2009=\u20094), HSC1\u03bb NF1 \u2212/\u2212  ( n \u2009=\u200912), HSC1\u03bb gGFP ( n \u2009=\u20094), HSC1\u03bb gAPC ( n \u2009=\u20094). Mice were monitored daily. Mice were sacrificed 4 month"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:STS-26T"": {""context"": "" and immortalized neurofibroma cell (ipNF06.2A ) were obtained from Dr. Margaret Wallace\u2019s laboratory at the University of Florida. MPNST cell lines (STS-26T 30 , S462 63 , S462TY, T265 64 ) were obtained from Dr. David Largaespada\u2019s laboratory at the University of Minnesota. All cell lines were cultured w"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""cell (ipNF06.2A ) were obtained from Dr. Margaret Wallace\u2019s laboratory at the University of Florida. MPNST cell lines (STS-26T 30 , S462 63 , S462TY, T265 64 ) were obtained from Dr. David Largaespada\u2019s laboratory at the University of Minnesota. All cell lines were cultured with Dulbecco\u2019s modified Eagl"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""e using BWA-MEM v 0.7.12  with default parameters. PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0 40 . We obtained germline variant calls by joint genotyping and variant quality score recalibration on 20 peripheral blood cont"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": "" cohort of PNSTs were identified using FusionCatcher v1.1.0  with default parameters, which aligns reads to the human reference genome (GRCh38) using Bowtie 53 , 54  (v1.2), Bowtie2 55  (v2.3), Star 56  (v2.7) and BLAT 57  (v0.35). Adjacent and read-through fusions were filtered out from analyses. To redu"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""cate reads were removed. Reads were sorted using SamTools (v.1.3) 50 . Gene expression in raw counts for each sample was calculated by the algorithm \u201cfeatureCounts\u201d in the package Rsubread (v.1.5.0). Data was normalized by counts-per-million (CPM) and then subjected to trimmed means of M (TMM) using edgeR 51  (v"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""on System and paired end sequencing on a HiSeq 2500 platform to a median of 60X. In brief, read pairs were aligned to the hg19 reference genome using BWA-MEM v 0.7.12  with default parameters. PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.7"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": "" 0.7.12  with default parameters. PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0 40 . We obtained germline variant calls by joint genotyping and variant quality score recalibration on 20 peripheral blood controls, in adhere"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" with 75-cycle paired-end protocol to obtain minimum 40 million reads. Sequence data was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0) . Next, duplicate reads were removed. Reads were sorted using SamTools (v.1.3) 50 . Gene expression in raw counts for each sample w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0) . Next, duplicate reads were removed. Reads were sorted using SamTools (v.1.3) 50 . Gene expression in raw counts for each sample was calculated by the algorithm \u201cfeatureCounts\u201d in the package Rsubread (v.1.5.0). Data wa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""dotime analysis Pseudotime analysis was performed as previously described  using Monocle2 60 . Briefly, raw UMI counts from the cleaned and processed Seurat objects was used to generate CellDataSet objects by normalizing the data using a negative binomial distribution with fixed variance. The CellDataSet "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""easy Blood and Tissue Kit (Qiagen, USA). Total RNA was isolated from tumor using the RNeasy Mini Kit (Qiagen, USA). DNA and RNA were quantified using Nanodrop 1000 instrument (Thermo Scientific, USA) and integrity assessed by either agarose gel electrophoresis (DNA) or Agilent 2100 Bioanalyzer (RNA; Agilent"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""eatureCounts\u201d in the package Rsubread (v.1.5.0). Data was normalized by counts-per-million (CPM) and then subjected to trimmed means of M (TMM) using edgeR 51  (v.3.22.3). CPM cutoff values were determined empirically by identifying the minimum value required to achieve the best normalization across samp"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""d using t-SNE of the selected principal components. 59 scRNA-seq pseudotime analysis Pseudotime analysis was performed as previously described  using Monocle2 60 . Briefly, raw UMI counts from the cleaned and processed Seurat objects was used to generate CellDataSet objects by normalizing the data using a "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""re shown in a heatmap from unmethylated state (purple color) to methylated state (red color). Differentially methylated probes were identified using  limma  based modeling approach (Bioconductor) for the methylation subclasses. Absolute mean \u03b2-value difference\u2009>\u20090.1 and adjusted  p -value (FDR-corrected)"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:infercnv"": {""context"": "" neoplastic and non-neoplastic cells were identified. Second, CNAs of neoplastic and non-neoplastic cells were inferred from the snRNA-seq data using inferCNV (v.1.1.1) . After the genes were ordered according to the human GRCh38 assembly, a heatmap illustrating relative expression intensities of neoplastic"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""a) for 1\u2009h at room temperature. Colonies were imaged on Leica S8 AP0 microscope with 12 images per cell line. Automated colony counts were done using ImageJ software  using TKS Batch Count Colonies macro (courtesy of StarrLab). Results shown are a representative example of at least 3 independent experimen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": ""entified using FusionCatcher v1.1.0  with default parameters, which aligns reads to the human reference genome (GRCh38) using Bowtie 53 , 54  (v1.2), Bowtie2 55  (v2.3), Star 56  (v2.7) and BLAT 57  (v0.35). Adjacent and read-through fusions were filtered out from analyses. To reduce false positive detecti"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:HSC1\u03bb"": [""methods""], ""cell_lines:NF1"": [""methods""], ""cell_lines:STS-26T"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:infercnv"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:bowtie2"": [""methods""]}",False
37186028,10.1007/s00439-023-02555-z,Analysis of 200 unrelated individuals with a constitutional NF1 deep intronic pathogenic variant reveals that variants flanking the alternatively spliced NF1 exon 31 [23a] cause a classical neurofibromatosis type 1 phenotype while altering predominantly NF1 isoform type II.,Hum Genet,2023,1613,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 results from loss-of-function NF1 pathogenic variants (PVs). Up to 30% of all NF1 PVs disrupt mRNA splicing, including deep intronic variants. Here, we retrospectively investigated th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 results from loss-of-function NF1 pathogenic variants (PVs). Up to 30% of all NF1 PVs disrupt mRNA splicing, including deep intro"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37217626,10.1038/s41431-023-01377-x,New insights into the molecular basis of spinal neurofibromatosis type 1.,Eur J Hum Genet,2023,1603,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Spinal neurofibromatosis (SNF) is a form of neurofibromatosis type 1 (NF1) characterized by bilateral neurofibromas involving all spinal roots. The pathogenic mechanisms determining the SNF form are currently unknown. To ve"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Spinal neurofibromatosis (SNF) is a form of neurofibromatosis type 1 (NF1) characterized by bilateral neurofibromas involving all spinal roots. The pathogenic me"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37217995,10.1186/s12935-023-02940-8,The genetic landscape and possible therapeutics of neurofibromatosis type 2.,Cancer Cell Int,2023,1683,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2) is a genetic condition marked by the development of multiple benign tumors in the nervous system. The most common tumors as"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
37245145,10.1016/j.jid.2023.01.043,"RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.",J Invest Dermatol,2023,673,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Cutaneous neurofibromas (cNFs) are the most common tumor in people with the rasopathy neurofibromatosis type 1. They number in hundreds or even thousands throughout"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,Neuro Oncol,2023,1681,12742,0,3,10,13,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""JH-2-002"": ""1bc84ef2-208f-4f0e-8045-6be47fd968de"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""R"", ""BWA"", ""GraphPad Prism"", ""GATK"", ""STAR"", ""Trimmomatic"", ""DESeq2"", ""ImageJ"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""D: Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft tissue sarcomas that often develop in patients with neurofibromatosis type 1 (NF1). To address the critical need for novel therapeutics in MPNST, we aimed to establish an ex vivo 3D platform that accurately captured the genomic div"", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""cell_lines:JH-2-002"": {""context"": ""ized as robust (>90% viability at 48 h), good (>50%), or unusable (<50%). We evaluated drug response to \""robust\"" or \""good\"" microtissues, namely MN-2, JH-2-002, JH-2-079-c, and WU-225. Drug response ex vivo predicted drug response in vivo, and enhanced drug effects were observed in select models. CONCLUSIONS"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Genomic analysis was performed on all PDX-tumor pairs. Selected PDX were harvested for assembly into 3D microtissues. Based on prior work in our labs, we evaluated drugs (tra"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""e (ThermoFisher) exclusion on the Countess II machine (Invitrogen). 2D Culture Details In two-dimensional culture, PDX cells and the MPNST cell line, ST88-14 (gift from Dr. Nancy Ratner, PhD, University of Cincinnati), were maintained in DMEM High Glucose (ThermoFisher), 10% FBS (Gibco), and 1% Penicillin-"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": "" FASTQ files were trimmed using Trimmomatic v 0.39 10  and aligned against reference sequence hg38 via BWA-MEM. 30  Duplicate reads were marked using picard \u201cMarkduplicates.\u201d GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files. For PDX sequence data, Xenosplit was used to filte"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": "" reported previously  were used. WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39 10  and aligned against reference sequence hg38 via BWA-MEM. 30  Duplicate reads were marked using picard \u201cMarkduplicates.\u201d GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files. "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""l over total cell count ratio per microtissue was normalized to vehicle-only treated cells to produce percent cell viability. Data were analyzed with GraphPad Prism and dose\u2013response curves generated using nonlinear regression Log(inhibitor) vs. response\u2013variable slope model. Drug Treatment (PDX) Animal experimen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": "" using Trimmomatic v 0.39 10  and aligned against reference sequence hg38 via BWA-MEM. 30  Duplicate reads were marked using picard \u201cMarkduplicates.\u201d GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files. For PDX sequence data, Xenosplit was used to filter mouse-derived reads u"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""laparib) or minced tumor fragments (trabectedin/mirdametinib) were implanted subcutaneously in the flank of 6- to 8-week-old NRG mice. Drug treatment started when tumors reached approximately 50\u2013100 mm 3  in volume and continued for three weeks (trabectedin/olaparib) and 5\u20136 weeks (trabectedin/mirdameti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""of 30M reads per sample. WES Data Analysis WES data from eight patients reported previously  were used. WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39 10  and aligned against reference sequence hg38 via BWA-MEM. 30  Duplicate reads were marked using picard \u201cMarkduplicates.\u201d GATK V4.2 base qua"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""almon-alignment-workflow.cwl , which includes quantitation with the Salmon algorithm.  Gene counts and transcript counts were normalized by using the DESeq2 package. 34 35 PDX Cell Dissociation for 3D Microtissue Assembly All mouse experiments were approved by the Institutional Animal Care and Use Committ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""as used to image z-positions at 50 \u03bcm intervals over a distance of 250 \u03bcm and images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ (NIH). For experimental wells, live cell over total cell count ratio per microtissue was normalized to vehicle-only treated cells to produce percent "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""code v29 with the Common workflow language workflow at  https://github.com/Sage-Bionetworks/rare-disease-workflows/blob/main/rna-seq-workflow/synapse-salmon-alignment-workflow.cwl , which includes quantitation with the Salmon algorithm.  Gene counts and transcript counts were normalized by using the DESeq"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""cell_lines:JH-2-002"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:ST88-14"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
37276689,10.1016/j.ejpn.2023.05.010,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,Eur J Paediatr Neurol,2023,1796,355,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Children with NF1 and cognitive impairments ( n \u2009=\u2009135, 8\u201315 years 11 months) and their parents completed standardized measures assessing children\u2019s HRQoL, behavioral "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Children with NF1 and cognitive impairments ( n \u2009=\u2009135, 8\u201315 years 11 months) and their parents completed standardized measures assessing children\u2019s HRQoL, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
37301319,10.1016/j.jid.2023.03.1688,Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.,J Invest Dermatol,2024,1406,7673,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Reagents and Antibodies Reconstituted basement membrane (rBM; Cultrex TM  with reduced growth factor) and high-concentration col"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""unoResearch (West Grove, PA, USA), respectively. 2.2. Cells and Cell Maintenance The following immortalized human plexiform neurofibroma cell lines ( Nf1 \u2212/\u2212 ; hereafter called pNF1 cells) described in [ 23 ] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC. Primary fibroblasts ( Nf1 +/\u2212 , here"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""s were captured using an inverted Stellaris 5 confocal microscope (Leica Microsystems). Fluorescence intensity of P-glycoprotein was quantified using ImageJ 1.54g software (National Institutes of Health, Bethesda, MD, USA). 2.9. 3D MTT Assay 3D MTT assay was used to assess cell growth and viability as pre"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
37318402,10.1016/j.jid.2022.12.027,Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.,J Invest Dermatol,2023,1065,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""st common genetic disorders of the nervous system and predisposes patients to develop benign and malignant tumors. Cutaneous neurofibromas (cNFs) are NF1-associated benign tumors that affect nearly 100% of patients with NF1. cNFs dramatically reduce patients' QOL owing to their unaesthetic appearance, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 is one of the most common genetic disorders of the nervous system and predisposes patients to develop benign and malignant tumors"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37330719,10.1016/j.jid.2023.01.042,Existing and Developing Preclinical Models for Neurofibromatosis Type 1-Related Cutaneous Neurofibromas.,J Invest Dermatol,2023,1108,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is caused by a nonfunctional copy of the NF1 tumor suppressor gene that predisposes patients to the development of cutaneous neurofibromas (cNFs), t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is caused by a nonfunctional copy of the NF1 tumor suppressor gene that predisposes patients to the development of cutaneou"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37353850,10.1186/s13023-023-02681-x,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,Orphanet J Rare Dis,2023,1029,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: The notion of \""burden\"" has taken a key place in the evaluation of care, particularly in the case of rare diseases. The aim of this study was to "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,JAMA Netw Open,2023,2968,10739,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" 993 patients responded to the flyer, 371 were screened, 286 were eligible, and 228 signed informed consent. Inclusion criteria were (1) diagnoses of NF1, NF2, or schwannomatosis; (2) age 18 years or older; (3) ability to provide informed consent; (4) sixth-grade English reading level or higher; (5) se"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Details of the study design have been previously described.  This study follows the Consolidated Standards of Reporting Trials Extension ( 13 CONSORT Extension ) reporting guideline. The stu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
37406085,10.1158/1078-0432.CCR-22-2854,Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.,Clin Cancer Res,2023,1802,515,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1flox/flox"": ""d2dec4d7-24be-4218-b7b5-63349158aa15""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ted the efficacy of the CDK4/6 inhibitor, abemaciclib, and the ERK1/2 inhibitor, LY3214996, alone and in combination in reducing PNF tumor burden in  Nf1 flox/flox ;PostnCre  mice."", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1flox/flox"": {""context"": ""ated the efficacy of the CDK4/6 inhibitor, abemaciclib, and the ERK1/2 inhibitor, LY3214996, alone and in combination in reducing PNF tumor burden in Nf1flox/flox;PostnCre mice. RESULTS: Converging signatures of CDK4/6 and RAS/MAPK pathway activation were identified within the transcriptome and kinome that were"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Experimental Design: Utilizing RNA sequencing combined with chemical proteomic profiling of the functionally enriched kinome using multiplexed inhibitor be"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1flox/flox"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
37435433,10.1212/NXG.0000000000200003,Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers.,Neurol Genet,2022,0,1655,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods NF1  variants in sporadic cancers were compiled using data curated on the c-Bio database and compared with published germline variants and Genome Aggrega"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods NF1  variants in sporadic cancers were compiled using data curated on the c-Bio database and compared with published germline variants and Genome Aggregation "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
37440099,10.1007/s11060-023-04389-1,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,J Neurooncol,2023,1491,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" is a secondary analysis of a fully powered randomized clinical trial (RCT) of 3RP-NF and health education control (HEP-NF). We recruited adults with NF1, NF2, or schwannomatosis who reported stress or difficulty coping with NF symptoms. Both conditions received 8 weekly 90-minute group sessions; 3RP-N"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: To test the effects of the Relaxation Response Resiliency Program - Neurofibromatosis (3RP-NF), a mind-body resilience program for people with N"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,Molecules,2023,1027,10562,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""DESeq2"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Script RT Reagent Kit with gDNA Eraser (TaKaRa, Japan). Real-time quantitative PCR detection was performed to determine the mRNA expression levels of NF1, ALP, Runx2, Osx and Col1a1 with FastStart Universal SYBR Green Master (Rox) on a LightCycler \u00ae  480 II Real-Time PCR System (Roche, Mannheim, German"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods Reagents. Icariin reagents (purity >99%) were purchased from the National Institute for the Control of Pharmaceutical and Biological "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""oled. After RNA-seq library construction, paired-end sequencing of the library was performed on HiSeq XTen sequencers (Illumina, San Diego, CA, USA). DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples. Genes were considered to be significantly different"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""aKaRa, Japan). Real-time quantitative PCR detection was performed to determine the mRNA expression levels of NF1, ALP, Runx2, Osx and Col1a1 with FastStart Universal SYBR Green Master (Rox) on a LightCycler \u00ae  480 II Real-Time PCR System (Roche, Mannheim, Germany). The conditions were 95 \u00b0C for 5 min, 9"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,Mol Ther Nucleic Acids,2023,0,18038,0,1,7,8,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""StringTie"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""STAR"", ""NanoDrop"", ""FlowJo""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Generation of NF1 NS/+ \u00a0minipigs Generation of a swine nonsense mutation model of NF1 followed a similar strategy as previously described.  Recurrent nonsense mutation"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:StringTie"": {""context"": ""  Schwann cells (n\u00a0= 5). The RNA sequencing data were mapped to the Ensembl Sus Scrofa genome 11.1, release 103  using HISAT2 36  and quantified with StringTie. 37  All graphs were generated using R 38  and tidyverse. 39 40 Protein extraction from cells and tissues For extraction of protein from cells, snap "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Generation of NF1 NS/+ \u00a0minipigs Generation of a swine nonsense mutation model of NF1 followed a similar strategy as previously descr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""on drugs for 24 or 48 h, then harvested for RNA and protein extraction. Statistical analysis All graphs and statistical analyses were performed using GraphPad Prism V9 with the exception of RNA sequencing analysis, which was performed using R. Specific analyses were used as indicated in figure legends to generate"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""  \u2212/\u2212 NF1  and  NS/\u2212 NF1 FS/\u2212 )  Schwann cells (n\u00a0= 5). The RNA sequencing data were mapped to the Ensembl Sus Scrofa genome 11.1, release 103  using HISAT2 36  and quantified with StringTie. 37  All graphs were generated using R 38  and tidyverse. 39 40 Protein extraction from cells and tissues For extra"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""en 20; 2.5% (vol/vol) Triton X-100; 100\u00a0\u03bcg/mL proteinase K) and incubated for 1\u00a0h at 55\u00b0C and 15\u00a0min at 95\u00b0C. PCR used 1\u00a0\u03bcL of prepared lysate in Accustart II PCR Supermix (QuantaBio) according to the manufacturer\u2019s instructions. Gene editing in colonies was detected by direct Sanger sequencing of PCR a"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""d from cells and tissues using the RNeasy mini kit (Qiagen) following manufacturer\u2019s instructions. RNA concentration and quality was measured using a NanoDrop One (Thermo). RT-qPCR was performed using the Bio-Rad CFX96 Real-Time System (Bio-Rad) using technical replicates and Beta-actin as a housekeeping ge"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""d staining. Cells were run through a CytoFLEX flow cytometer (Beckman Coulter) using the Cytexpert software according to the manufacturer\u2019s protocol. FlowJo software was used to determine cell purity. Quantitative reverse transcription PCR Total RNA was extracted from cells and tissues using the RNeasy mi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:StringTie"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
37527526,10.1158/1535-7163.MCT-23-0135,Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.,Mol Cancer Ther,2023,1780,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis Type 2 (NF2) is a tumor predisposition syndrome caused by germline inactivating mutations in the NF2 gene encoding the merlin tumor supp"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,J Neurodev Disord,2023,1339,23837,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""MATLAB"", ""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We compared oscillatory spectral power and theta phase coherence in a paediatric sample with NF1 ( N \u2009=\u200916; mean age: 13.03\u00a0years; female:  n \u2009=\u20097) to an age/sex-matched typically developing control group ( N \u2009=\u200916; mean age: 13.34\u00a0years; female:"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We compared oscillatory spectral power and theta phase coherence in a paediatric sample with NF1 ( N \u2009=\u200916; mean age: 13.03\u00a0years; female:  n \u2009=\u20097) to an age/s"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ing, participants were asked to remain still, in a comfortable/relaxed position, and to minimise eye movements and blinking where possible. Recording started with 2.5\u00a0min of eyes open and 2.5\u00a0min of eyes closed resting state, in which participants were asked to simply relax and not think of anything in "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ietal region pair/load combination (ML, MM, MR\u2009\u00d7\u20091-back, 2-back) for each participant. Statistical analysis Statistical analyses were conducted using SPSS (Version 25). The alpha level was set to 0.05. Visual inspection of Q-Q plots showed that, for each analysis, data were normally distributed. For eac"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""ipants were asked to simply relax and not think of anything in particular. This was followed by recording during the visual n-back task. EEG analysis MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses. Custom functions [ 46 ,  47 ] calling several functions from EEGLAB (version 13."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
37616542,10.1158/1535-7163.MCT-23-0258,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",Mol Cancer Ther,2023,1661,15281,0,2,3,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Cell culture The sNF96.2 cells (RRID:CVCL_K281) were received from ATCC and grown in DMEM (Life Technologies #11965), 10% FBS (Hyclon"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""logies #11965), 10% FBS (Hyclone), 2 mmol/L  l -glutamine and 1% penicillin/streptomycin. JH-2\u2013002 and JH-2\u2013031 MPNST cells were received from the JH NF1 Biospecimen Repository ( http://bit.ly/nf1bank ) and grown in DMEM/F12 (Life Technologies 11320\u2013033), 10% FBS (Gemini), 2 mmol/L  l -glutamine, and 1"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""Materials and Methods Cell culture The sNF96.2 cells (RRID:CVCL_K281) were received from ATCC and grown in DMEM (Life Technologies #11965), 10% FBS (Hyclone), 2 mmol/L  l -glutamine and 1% penicil"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""lds set to detect moderate-to-strong nuclear DAB. Counts were converted to % proliferation [(Ki67 Nuclei Count/Total Nuclei Count) \u00d7 100], plotted in GraphPad Prism (RRID:SCR_002798) and analyzed by ordinary one-way ANOVA with multiple comparisons (*,  P  < 0.05). Data availability statement The data generated in"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""s. For bioanalysis details, please see Supplementary Methods. Pro-905 synthesis and characterization Pro-905 was synthesized in a four-step synthesis starting from 2\u2032,3\u2032-O-isopropylidene-guanosine. 2\u2032,3\u2032-O-isopropylideneguanosine was prepared on the basis of previously described methods ( 26 ) and react"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:sNF96.2"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
37712888,10.1093/hmg/ddad155,A common single nucleotide variant in the cytokine receptor-like factor-3 (CRLF3) gene causes neuronal deficits in human and mouse cells.,Hum Mol Genet,2023,1439,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""own clinical significance. Using human induced pluripotent stem cell (hiPSC) cerebral organoid modeling of the 1.4 megabase Neurofibromatosis type 1 (NF1) deletion syndrome, we previously discovered that the cytokine receptor-like factor-3 (CRLF3) gene, which is co-deleted with the NF1 gene, functions "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Single nucleotide variants in the general population are common genomic alterations, where the majority are presumed to be silent polymorphisms without known clinical sign"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",Acta Neuropathol Commun,2023,2226,6415,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Seurat"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Sample details and preparation Human NF1-associated plexiform neurofibroma samples (Table  1 ) were collected from surgeries at Children\u2019s Hospital Colorado in compliance with all ethical st"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Sample details and preparation Human NF1-associated plexiform neurofibroma samples (Table  1 ) were collected from surgeries at Child"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""iver cell types. Visium spatial transcriptomics Optimal cutting temperature (OCT) compound embedded frozen primary PN samples were sectioned on a Cryostar NX70 cryostat (ThermoFisher) at 10\u00a0\u03bcm sections and mounted on spatial transcriptomic capture slides (Visium, 10\u2009\u00d7\u2009Genomics). The optimal tissue secti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""llumina NovaSeq6000 to obtain 50,000 reads per cell. SnRNA-seq data analysis Raw sequencing reads were processed using CellRanger (10\u2009\u00d7\u2009Genomics) and Seurat 3.1.0.\u00a0C Cells from individual subpopulations were reanalyzed separately using Harmony alignment [ 18 ]. Presto was used for determining differential"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Seurat"": [""methods""]}",False
37772407,10.1177/17407745231201338,Potential endpoints for assessment of bone health in persons with neurofibromatosis type 1.,Clin Trials,2024,1609,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 is a genetic syndrome characterized by a wide variety of tumor and non-tumor manifestations. Bone-related issues, such as scolios"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,Front Oncol,2023,1452,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis Type 1 (NF1) is one of the most common genetically inherited disorders that affects 1 in 3000 children annually. Clinical manifestations vary widely but nearly a"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis Type 1 (NF1) is one of the most common genetically inherited disorders that affects 1 in 3000 children annually. Clinical manifestations"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37848948,10.1186/s13104-023-06515-8,Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas.,BMC Res Notes,2023,1471,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""been demonstrated to accelerate tumor development among populations with genetic and/or molecular susceptibility to cancer. Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder predisposing affected individuals to tumorigenesis, including benign plexiform neurofibromas; however, under"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""OBJECTIVE: In epidemiological and experimental research, high folic acid intake has been demonstrated to accelerate tumor development among populations with genetic and/or molecular suscept"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37886501,10.21203/rs.3.rs-3405297/v1,Simultaneous Inhibition of PI3K and PAK in Preclinical Models of Neurofibromatosis Type 2-related Schwannomatosis.,Res Sq,2023,1320,9837,0,1,4,5,"{""cell_lines"": {""10CM"": ""423cc0f3-8a43-4e10-a9a4-d529aa78f022""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials & Methods Cell Culture Primary human fetal Schwann cells (SC), HS11 and HS13 were acquired from SciencCell Research Laboratories (Carlsbad, CA, U"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:10CM"": {""context"": ""d basic analyzer software. Apoptosis Array Assay Human HS02 MD-SCs and mouse MTC-10 (MS01) MD-SCs cell lines were used. Briefly, cells were seeded on 10cm plates and treated with DMSO (0.001%) or pictilisib (2.5 \u03bcM) for 6h. This time was selected based on previous Incucyte data and coincided with MTC-10"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""wo sections per sample were used for each protein target, with a minimum of 4 ROIs imaged per section to account for tissue heterogeneity. Statistics GraphPad Prism Version 7.04 was used for statistical analysis. One-way analysis of variance (ANOVA) was used to compare IVIS radiance fold change and tumor size bet"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""e, Minneapolis, MA, USA). Arrays were visualized using the Jess System (Biotechne), densitometry was measured and normalized to reference spots using ImageJ Software (NIH, Bethesda, MD, USA). Calculations were carried out using Prism 9 Software (GraphPad, Boston, MA, USA). Pharmacokinetic Studies Male and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" and treated with DMSO (0.001%) or pictilisib (2.5 \u03bcM) for 6h. This time was selected based on previous Incucyte data and coincided with MTC-10 cells started to round up and detach. Cells were lysed and procedure was performed according to the Proteome Profiler Human or Mouse Apoptosis Array Kit (Cat No"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:10CM"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
37949359,10.1016/j.labinv.2023.100285,Characterization of Immune Cell Populations of Cutaneous Neurofibromas in Neurofibromatosis 1.,Lab Invest,2024,1330,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Cutaneous neurofibromas (cNFs) are characteristic of neurofibromatosis 1 (NF1), yet their immune microenvironment is incompletely known. A total of 61 cNFs from 10 patients with NF1 were immunolabeled for different types of T c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Cutaneous neurofibromas (cNFs) are characteristic of neurofibromatosis 1 (NF1), yet their immune microenvironment is incompletely known. A total of 61 cNFs from 10 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
37962219,10.1177/17407745231209224,Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.,Clin Trials,2024,2850,439,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""and Schwannomatosis (REiNS) International Collaboration developed the survey. Eligibility criteria included age \u226518 years, self-reported diagnosis of NF1, NF2, or SWN, and ability to read and understand English. The online survey was distributed internationally by the NF Registry and other NF foundatio"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: NF clinical researchers and patient representatives from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration devel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,Dis Model Mech,2023,1296,15276,0,4,6,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""BJFF.6"": ""8a213a9d-392b-4746-8f59-c12f753d9217"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab"", ""OSW"": ""7a62af66-384d-419b-b8ac-f4d381b85942""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""NanoDrop"", ""DESeq2"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""lity control The original CTL BJFF.6 hiPSCs were generated from commercially available human foreskin fibroblasts (Stemgent, Reprocell, MD, USA). All NF1-mutant hiPSC lines were derived from the CTL BJFF.6 hiPSC line as previously described ( Anastasaki et al., 2020 ). All hiPSC lines used in this proj"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS hiPSC quality control The original CTL BJFF.6 hiPSCs were generated from commercially available human foreskin fibroblasts (Stemgent,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:BJFF.6"": {""context"": ""MATERIALS AND METHODS hiPSC quality control The original CTL BJFF.6 hiPSCs were generated from commercially available human foreskin fibroblasts (Stemgent, Reprocell, MD, USA). All NF1-mutant hiPSC lines were derived "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""hiPSC culture hiPSCs were grown on Geltrex-coated vessels (0.12-0.18\u2005mg/ml, Life Technologies, Grand Island, NY, USA), incubated in StemMACS iPS-Brew XF medium (Miltenyi Biotec, Bergisch Gladbach, Germany), passaged weekly using StemPro Accutase (Life Technologies), and supplemented with 0.5\u2005\u03bcM thiazo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:OSW"": {""context"": ""imental groups. Two-tailed unpaired Student's  t -test was used to compare data between two experimental conditions. IGOR Pro 6.34 (WaveMetrics, Lake Oswego, OR, USA;  https://www.wavemetrics.com/ ) or GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA) was used for statistical analysis. Informati"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""st was used to compare data between two experimental conditions. IGOR Pro 6.34 (WaveMetrics, Lake Oswego, OR, USA;  https://www.wavemetrics.com/ ) or GraphPad Prism 9 (GraphPad Software, San Diego, CA, USA) was used for statistical analysis. Information about the statistical tests and number of experiments is spe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" Partek Flow software, v10.0 ( https://www.partek.com/partek-flow/ ). RNA sequencing reads were aligned to the hg38 Ensembl release 105 assembly with STAR v2.7.8a ( Dobin et al., 2013 ). Gene counts and isoform expression were derived from the Ensembl output. Sequencing performance was assessed for the "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""e ReliaPrep RNA tissue kit (Promega, Fitchburg, USA) according to the manufacturer's instructions. RNA purity and concentration were measured using a NanoDrop 8000 spectrometer (Thermo Fisher Scientific, Schwerte, Germany) and RNA was reverse transcribed into cDNA using the PrimeScript RT reagent kit (Takar"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""ures detected. Normalization size factors were calculated for all gene counts by median ratio. Differential genetic analysis was then performed using DESeq2 ( Love et al., 2014 ) to analyze for differences between conditions. Results were filtered for only those genes with FDR\u22640.05 and fold changes more t"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""e \u2018split into object\u2019 function. To represent the phagocytosed beads, the numbers of beads within IBA1 surfaces were counted. Using in-house developed Python software, cells were grouped as having 0, 0 to 1, 1 to 2, 2 to 3, or >3 beads per cell. The percentage of cells in each group was multiplied by the c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:BJFF.6"": [""methods""], ""cell_lines:XF"": [""methods""], ""cell_lines:OSW"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
37996843,10.1186/s12883-023-03429-7,Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey.,BMC Neurol,2023,2102,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Plexiform neurofibromas (PN) are complex, benign nerve-sheath tumours that occur in 30-50% of patients with neurofibromatosis type 1 (NF1), a rare, genetic disorder. PN are associated with substantial, heterogeneous morbidities that impact health-related quality of life (HRQoL), includi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Plexiform neurofibromas (PN) are complex, benign nerve-sheath tumours that occur in 30-50% of patients with neurofibromatosis type 1 (NF1), a ra"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38008284,10.1016/j.jmoldx.2023.11.005,Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions.,J Mol Diagn,2024,1604,5268,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Study cohort The study cohort consisted of couples considering PND because of NF1, who were referred to the Cochin Hospital (Assistance Publique - H\u00f4pitaux de Paris, APHP, Paris, France). Databases from NF1 molecular PND at the Coc"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Study cohort The study cohort consisted of couples considering PND because of NF1, who were referred to the Cochin Hospital (Assistance Publique - H\u00f4pitaux de Pa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""mega, Charbonni\u00e8res-les-Bains, France) on EDTA blood samples according to the manufacturer\u2019s instructions. DNA concentrations were quantified using a NanoDrop 1000 Spectrophotometer v3.8 (Thermo Fisher Scientific, Courtaboeuf, France). Targeted NGS For the identification of pathogenic variants in probands, "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:NanoDrop"": [""methods""]}",False
38009710,10.1002/jclp.23623,"Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.",J Clin Psychol,2024,1566,105,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: We conducted mixed-effects models to assess whether these mechanisms uniquely mediated outcomes."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
38057084,10.1265/ehpm.23-00221,Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.,Environ Health Prev Med,2023,1910,6338,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ractable Diseases of Japan\u201d containing clinical and personal records (\u201cMedical Certificates of Designated Intractable Diseases\u201d) of all patients with NF1 following approval of the study protocol. To examine the association between the severity of symptoms and QoL, multinominal logistic regression analy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods The Japanese Ministry of Health, Labour and Welfare provided the \u201cNational Database of Designated Intractable Diseases of Japan\u201d containing clinical and personal records "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ratios (ORs) and 95% confidence intervals (CIs) were calculated. P < 0.05 was considered statistically significant. All analyses were performed using SPSS version 25 (IBM, Chicago, IL, USA)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
38086379,10.1016/j.xcrm.2023.101309,Econazole selectively induces cell death in NF1-homozygous mutant tumor cells.,Cell Rep Med,2023,598,17132,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""CellProfiler"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" 9661S; RRID: AB_2341188 Cleaved PARP Cell Signaling 9541S; RRID: AB_331426 GAP43 Abcam ab75810; RRID: AB_1310252 Ki67 Abcam ab16667; RRID: AB_302459 NF1 Bethyl Laboratories A300-140A; RRID: AB_2149790 P75 Abcam ab8874; RRID: AB_306827 Phospho-ERK Cell Signaling 9101S; RRID: AB_331646 Total-ERK Cell Si"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""STAR\u2605Methods Key resources table \n \n REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies AP2 Abcam ab61; RRID: AB_305292 BIM Cell Signaling 2933S; RRID: AB_1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""-3\u2033 This paper N/A SgRNA GAP2 5\u2032 GCTAACATGTTGCCAATCAG-3\u2032 This paper N/A Software and algorithms ImageJ Schneider et\u00a0al. 33 https://imagej.nih.gov/ij/ CellProfiler Stirling et\u00a0al. 34 https://cellprofiler.org Resource availability Lead contact Further information and requests for resources and reagents should be "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""STAR\u2605Methods Key resources table \n \n REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies AP2 Abcam ab61; RRID: AB_305292 BIM Cell Signaling 2933S; RRID: AB_1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""A-3\u2033 This paper N/A sgRNA GAP1 5\u2032 TCCATGCAGACTCTCTTCCG-3\u2033 This paper N/A SgRNA GAP2 5\u2032 GCTAACATGTTGCCAATCAG-3\u2032 This paper N/A Software and algorithms ImageJ Schneider et\u00a0al. 33 https://imagej.nih.gov/ij/ CellProfiler Stirling et\u00a0al. 34 https://cellprofiler.org Resource availability Lead contact Further in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,Medicine (Baltimore),2023,1973,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""limma"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:limma"": {""context"": ""The mRNA-miRNA modulatory network was generated via the miRTarBase database. Differentially expressed genes (DEGs) were identified via the R package \""limma\"" in both datasets, and hub genes were screened via intersection of common DEGs, candidate hub genes from the PPI axis, and candidate hub genes from t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 2 (NF2)-related vestibular schwannoma (NF2-VS) is a rare genetic disorder that results in bilateral acoustic neuromas. However, the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:limma"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,Clin Cancer Res,2024,1949,241,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Experimental Design: Here we resolve gene expression profiles in PNSTs across the neurofibroma-to-MPNST continuum in NF1 patients and mouse models, revealing early molecular features associated with neurofibroma evolution and transformation."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental Design: Here we resolve gene expression profiles in PNSTs across the neurofibroma-to-MPNST continuum in NF1 patients and mouse models, reveali"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,Cancers (Basel),2023,0,8625,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""HTS dataset produced by Ferrer et al. [ 15 ], which reported pharmacologic and genomic profiling of plexiform neurofibroma-derived Schwann cells from NF1 patients and control nerve cells. Proliferation assays were used to screen a panel of 1912 small molecules (the MIPE 4.0 library [ 17 ]) against immo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Cell Lines, Data Access, and Extraction  To assess our analysis algorithm and identify promising targets, we analyzed an HTS dat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
38140900,10.1177/17407745231205577,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,Clin Trials,2024,3128,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND/AIMS: Individuals with neurofibromatosis 1 may experience changes in their appearance due to physical manifestations of the disorders and/or trea"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
38170419,10.1007/s11136-023-03574-z,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,Qual Life Res,2024,1658,0,0,1,1,2,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:XF"": {""context"": ""of each condition. METHODS: Data from 860 children, ages 8-17, with a diagnosis of epilepsy, pNF (neurofibromatosis type 1 associated neurofibroma plexform), MD (muscular dystrophy), cancer, or skin conditions recruited from three projects were analyzed. Children with epilepsy, pNF and MD (sample-1) c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""PURPOSE: To develop the PROMIS Pediatric Stigma (PPS) and Skin (PPS-Skin) by constructing a common metric for measuring stigma in children with various c"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:XF"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,Heliyon,2024,2023,7233,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods A semi-automatic segmentation technique based on mean magnetic resonance imaging (MRI) intensity thresholding (SSTMean) was developed"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": "" ms, TE\u00a0=\u00a0[60\u2212221] ms, and slice number\u00a0=\u00a0[34\u201383]. 2.3 Segmentation technique The SSTMean method consisted of 4 main steps that were implemented in a Matlab script (Version 9.9.0, Natick, MA). (1) Selection of the region-of-interest (ROI): This process was initiated by loading MRI image files (in PNG form"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:MATLAB"": [""methods""]}",False
38175707,10.1172/jci.insight.168826,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,JCI Insight,2024,1568,16547,0,3,9,12,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c"", ""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""BWA"", ""GraphPad Prism"", ""STAR"", ""NanoDrop"", ""clusterProfiler"", ""DESeq2"", ""ImageJ"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Patients, cNFs, and tumor processing. Patients with NF1 diagnosed according to standard diagnostic criteria ( 52 ) provided tumor samples after giving written informed consent. Immediately after excision, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1+/-"": {""context"": ""thousands of cNFs, which greatly affect their quality of life. cNF growth is driven by the proliferation of NF1-/- SCs and their interaction with the NF1+/- microenvironment. We analyzed the crosstalk between human cNF-derived SCs and fibroblasts (FBs), identifying an expression signature specific to the "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""animal_models:Nf1-/-"": {""context"": ""eurofibromatosis type 1 (NF1) may develop thousands of cNFs, which greatly affect their quality of life. cNF growth is driven by the proliferation of NF1-/- SCs and their interaction with the NF1+/- microenvironment. We analyzed the crosstalk between human cNF-derived SCs and fibroblasts (FBs), identifyin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Patients, cNFs, and tumor processing. Patients with NF1 diagnosed according to standard diagnostic criteria ( 52 ) provided tumor samples after giving written informed consent"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""sing other Gpr68 activators or cAMP analogs/adenylyl cyclase activators in combination with selumetinib. Interestingly, whereas primary SC cultures restarted their proliferation after treatment with selumetinib alone was stopped, the combination of ogerin-selumetinib elicited a permanent halt on SC expa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:BWA"": {""context"": ""it and sequenced in a HiSeq instrument (Illumina) at Centro Nacional de Analisis Genomicos (Barcelona, Spain). Sequencing reads were then mapped with bwa mem ( 55 ) against GRCh38. We called variants with strelka2 ( 56 ) and annotated them with annovar ( 57 ). RNA-Seq analysis. RNA-Seq libraries were p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s were counted per time point and treatment. Statistics. Data were analyzed and graphically represented using Microsoft Office Excel spreadsheets and GraphPad Prism (version 9.4.1). Quantitative data are shown as the mean \u00b1 SEM of 3 independent experiments. Bioinformatic analysis of RNA-Seq is described in  RNA-S"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""EV simplyRNA Purification Kit (Promega), following the manufacturer\u2019s instructions, in the Maxwell 16 Instrument (Promega). RNA was quantified with a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific). Quality was assessed with a Bioanalyzer 2200 TapeStation (Agilent). NF1 genetic analysis. NF1  ger"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""iltered out genes with fewer than 5 counts in more than 2 samples and used DESeq2 ( 60 ) to perform differential expression analysis. We finally used clusterProfiler ( 61 ) to determine Gene Ontology and KEGG pathway enrichment from differentially expressed genes (adjusted  P  < 0.05). Heatmaps were created using "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""s into R and summarized them to gene level using tximport ( 59 ). We then filtered out genes with fewer than 5 counts in more than 2 samples and used DESeq2 ( 60 ) to perform differential expression analysis. We finally used clusterProfiler ( 61 ) to determine Gene Ontology and KEGG pathway enrichment fro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "".05). For neurofibromasphere analysis, disaggregation index and raw integrity density (RawIntDen) from each fluorescent channel were calculated using ImageJ (NIH) software. Disaggregation index was calculated by measuring disaggregated spheroid area normalized by spheroid area at 72 hours of treatment and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""counterpart revealed the transcriptional changes due to heterotypic interactions. RNA-Seq data from real and in silico mixed samples was aligned with Salmon v1.8.0 ( 58 ) against the reference genome and transcriptome (refMRNA and hg38 genome from UCSC) ( 58 ). We imported transcript-level estimates into "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""abstract""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
38187038,,Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.,Am J Cancer Res,2023,2129,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""There is a demonstrated need for new chemotherapy options in pediatric oncology, as pediatric solid tumors continue to plateau at 60% with event-free surv"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,Cancers (Basel),2023,869,14033,0,3,2,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""eriments and stored at \u221280 \u00b0C. Ac-DEVD-AMC used in caspase assays was purchased from BD Biosciences (San Diego, CA, USA). 2.2. Cell Culture The human NF1 MPNST cell line S462TY was the gift of N. Ratner (University of Cincinnati College of Medicine, Cincinnati, OH, USA). It was derived from a xenograft"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""at \u221280 \u00b0C. Ac-DEVD-AMC used in caspase assays was purchased from BD Biosciences (San Diego, CA, USA). 2.2. Cell Culture The human NF1 MPNST cell line S462TY was the gift of N. Ratner (University of Cincinnati College of Medicine, Cincinnati, OH, USA). It was derived from a xenograft of S462 cells that g"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Chemicals Lovastatin (Sigma-Aldrich, St. Louis, MO, USA) was prepared in dimethyl sulfoxide (DMSO) for cell culture experiments "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""spensions of 700 S462TY cells, 300 iSC cells, or 1000 A549 cells were plated in 60 mm culture dishes ~18\u201324 h prior to treatment. The MPNST cell line ST88-14 was obtained from T. Glover (University of Michigan, Ann Arbor, MI, USA). Adherent cultures of ST88-14 cells were maintained in RPMI 1640 (Invitrogen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ith 3 to 5 concentrations of  IG 2  at a fixed concentration of lovastatin. In vivo S462TY sciatic nerve tumor xenograft data were analyzed using IBM SPSS Statistics software version 29.0.1.0 (IBM, Armonk, NY, USA). The data were checked for homogeneity of variances using Levine\u2019s test. The combination "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:ST88-14"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,Int J Mol Sci,2023,1488,8810,0,4,7,11,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""StringTie"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""clusterProfiler"", ""FastQC"", ""FlowJo""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""supplemented with DMEM and 10% fetal bovine serum in a humid incubator at 37 \u00b0C with 5% CO 2 . All MPNST cell lines, except STS26T, were derived from NF1 patients. STS26T is a sporadic MPNST with no known NF1 mutation [ 45 ]. Normal human Schwann cells (HSC) (ScienCell Research Laboratories, Carlsbad, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Cell Culture The S462TY cell line was a kind gift from Dr. Timothy Cripe (Nationwide Children\u2019s Hospital Columbus, Columbus, OH,"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""4. Materials and Methods 4.1. Cell Culture The S462TY cell line was a kind gift from Dr. Timothy Cripe (Nationwide Children\u2019s Hospital Columbus, Columbus, OH, USA) [ 43 ]. The MPNST cell lines STS26T, "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": "" calculated by 2 \u2212\u0394\u0394CT . \u0394\u0394CT was determined by \u0394CT [FT895 treated] \u2212 \u0394CT [DMSO control]. 4.4. Metabolism Assay MPNST cells were plated in a Seahorse XFe24 microplate (Agilent Technologies, Santa Clara, CA, USA) and allowed to adhere overnight. An XFe24 FluxPack sensor cartridge (Agilent Technologies,"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""TY cell line was a kind gift from Dr. Timothy Cripe (Nationwide Children\u2019s Hospital Columbus, Columbus, OH, USA) [ 43 ]. The MPNST cell lines STS26T, T265, and ST8814 have been reported before [ 44 ] and were gifted by Dr. Nancy Ratner (Cincinnati Children\u2019s Hospital, Cincinnati, OH, USA). The cultures "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:StringTie"": {""context"": "" was checked with FASTQC. To align the reads, we employed HISAT2 version 2.2.1 [ 46 ] against the GRCh38 human genome. Read counts were normalized by StringTie version 2.2.1 [ 47 ]. Differential expression analysis was analyzed by DEGseq version 1.48.0 ( https://bioconductor.org/packages/devel/bioc/manuals/D"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""tistics and Data Analysis All the experimental values were presented as the mean \u00b1 SEM (standard error of the mean). The analysis was performed using GraphPad Prism version 9. Statistical analysis was performed using the Student\u2019s  t -test. A  p -value of less than 0.05 was considered to be statistically signific"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""nded mRNA Kit. RNA sequencing was carried out on a NovaSeq 6000 system, and the read quality was checked with FASTQC. To align the reads, we employed HISAT2 version 2.2.1 [ 46 ] against the GRCh38 human genome. Read counts were normalized by StringTie version 2.2.1 [ 47 ]. Differential expression analysis"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""/manuals/DEGseq/man/DEGseq.pdf , accessed on 19 November 2023). For the examination of transcriptional gene set enrichment, the GSEA KEGG method with ClusterProfiler version 4.2.2 [ 48 ] was applied. We also conducted protein\u2013protein interaction analysis using STRING version 11.5 ( https://string-db.org/ , accesse"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""ere prepared by the Illumina Truseq Stranded mRNA Kit. RNA sequencing was carried out on a NovaSeq 6000 system, and the read quality was checked with FASTQC. To align the reads, we employed HISAT2 version 2.2.1 [ 46 ] against the GRCh38 human genome. Read counts were normalized by StringTie version 2.2.1 "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""8 nm laser and detected by the FITC channel in FACSverse Flow Cytometry (BD Biosciences, Franklin Lakes, NJ, USA). The data were analyzed by v10.8 of FlowJo\u2122 software. 4.3. Mitochondrial DNA Copy Number Genomic DNA was extracted using the Genomic DNA Kit (Geneaid Biotech Ltd., Taoyuan, Taiwan) and quantif"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:XF"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:StringTie"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,Mol Metab,2024,2810,22365,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {""iNF-07E"": ""2e2c2957-fb99-49a9-adb0-7348ebc3d076""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""msigdbr"", ""clusterProfiler"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We employed two ER+  NF1 -deficient breast cancer models: (1) an  NF1 -deficient MCF7 breast cancer cell line to model sporadic breast cancer, and (2) three distinct,  Nf1 -d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""the transcriptional effect of  NF1  deficiency on global and metabolism-related transcription. We measured cellular energetics using Agilent Seahorse XF-96 Glyco Stress Test and Mito Stress Test assays. We performed stable isotope labeling and measured [U\u2013 13 C]-glucose and [U\u2013 13 C]-glutamine metabol"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We employed two ER+  NF1 -deficient breast cancer models: (1) an  NF1 -deficient MCF7 breast cancer cell line to model sporadic breast cancer, and (2) three distinct,  "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""antibodies:iNF-07E"": {""context"": ""expression. Western blot analysis of total neurofibromin protein. Immunoblotting was carried out using antibodies against neurofibromin (H12, Bethyl, iNF-07E) and \u03b2-tubulin (n\u00a0=\u00a03+, 1 representative biological replicate shown). G)  NF1  deficiency increases RAS and AKT/PI3K pathway signaling. Western blot "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""te. Cell proliferation was measured via cell confluency and doublings per day were calculated via the equation: Doublings per day\u00a0= (final confluency/starting confluency)/assay duration (2 days). 2.5 3-dimensional culture of cells on matrigel MCF7 cells were plated into 8-well chamber slides (Thermo Fis"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:msigdbr"": {""context"": ""erse strand alignments, and principal component analysis was computed using iDEP 9.1. Fold change was calculated using normalized counts per million. Msigdbr [ 48 ] and clusterProfiler [ 49 ] packages were used to perform Gene Set Enrichment Analysis (GSEA) using 10,000 permutations and genes ranked by fol"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""nts, and principal component analysis was computed using iDEP 9.1. Fold change was calculated using normalized counts per million. Msigdbr [ 48 ] and clusterProfiler [ 49 ] packages were used to perform Gene Set Enrichment Analysis (GSEA) using 10,000 permutations and genes ranked by fold change. For the metabolis"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""antibodies:iNF-07E"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:msigdbr"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""]}",False
38229454,10.1002/acn3.51995,Estrogen-induced glial IL-1 mediates extrinsic retinal ganglion cell vulnerability in murine Nf1 optic glioma.,Ann Clin Transl Neurol,2024,411,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Optic pathway gliomas (OPGs) arising in children with neurofibromatosis type 1 (NF1) can cause retinal ganglion cell (RGC) dysfunction and vision loss, which occurs more frequently in girls. While our previous studies demonstrated th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Optic pathway gliomas (OPGs) arising in children with neurofibromatosis type 1 (NF1) can cause retinal ganglion cell (RGC) dysfunction and vision loss, which occurs more frequently "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38258905,10.1172/jci.insight.171275,Schwann cells modulate nociception in neurofibromatosis 1.,JCI Insight,2024,1017,14108,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""Seurat"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" (Rosa26-LSL-hM3Dq) (Jackson Laboratory) to obtain a line that allows for DREADD-dependent modulation of SC activity. In other studies, to knock out  Nf1  in SCs and SCP, we crossed the Dhh-Cre mouse to a Nf1 fl/fl  (Jackson Laboratory) line to create the DhhCre Nf1 fl/fl  mouse model of NF1 ( 40 ). Si"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Animals. Male and female mice between 1 and 7 months of age were used in all studies. All transgenic mice used in these studies were bred in house. Mice expressing a Gq-coupled DREADD specifically in SCs were used"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ercentage change, where 2-fold change = 100% change. Primers used are listed in  Supplemental Table 1 . Statistics. All data sets were analyzed using GraphPad Prism statistical software. Data are represented as mean \u00b1 SEM. Significance was defined as  P  \u2264 0.05. For behavioral analyses, 1- or 2-way ANOVA with Tuk"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""mak bundles was calculated and compared between genotypes. scRNA-Seq. CellChat ( http://www.cellchat.org , version 1.6.0) objects were created from 4 Seurat ( https://satijalab.org/seurat , version 3.1.2) objects \u2014 2- and 7-month-old WT mouse DRG controls, 2-month-old mouse neurofibroma pretumor (DhhCre N"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""]}",False
38308315,10.1186/s40478-024-01735-w,Brain injury drives optic glioma formation through neuron-glia signaling.,Acta Neuropathol Commun,2024,1125,10148,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""DESeq2"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""-h light/dark cycle in a barrier facility with ad libitum access to food and water. Several lines of mice were used for these experiments, including  Nf1 ; hGFAP-Cre mice ( flox/flox Nf1 +  mice with somatic  / + Nf1  gene inactivation in neuroglial progenitors [ 7 ]),  Nf1 flox/mut ; GFAP-Cre ( Nf1 OP"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Mice All experiments were performed under an active and approved Animal Studies Committee protocol at Washington University School of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""easurements determined as previously reported [ 16 ]. At least 5 mice per group were used in all experiments. Quantification and statistical analysis GraphPad Prism software was used for data analysis. To determine differences between two groups, a two-tailed Student\u2019s\u00a0 t \u00a0test was used, whereas multiple comparis"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""e counts were normalized by median normalization. Differential genetic analysis was performed for differences between crush and control samples using DESeq2, excluding features with average coverage\u2009<\u20091. Differential genetic analysis results were filtered to include only genes with  p -value\u2009\u2264\u20090.05 and fo"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""olated optic nerves were photographed using a Leica S9D with a\u00a0Flexicam C3 camera, and their volumes calculated as previously described [ 16 ]. Using ImageJ (version 10.1), four diameter measurements were taken to estimate the thickness of each optic nerve, beginning at the chiasm (D 0 ), at 150\u00a0\u00b5m (D 150"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38318960,10.1002/ajmg.a.63543,The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.,Am J Med Genet A,2024,1393,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The neurofibromatoses (NFs) are a set of incurable genetic disorders that predispose individuals to nervous system tumors. Although many patients experience a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
38321701,10.1177/17407745231217279,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,Clin Trials,2024,2283,5333,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The Response Evaluation in Neurofibromatosis and Schwannomatosis Patient-Reported Outcomes Communication Subgroup systematically evaluated patient-reported"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
38336988,10.1038/s41388-024-02958-w,Simultaneous inhibition of PI3K and PAK in preclinical models of neurofibromatosis type 2-related schwannomatosis.,Oncogene,2024,1320,10143,0,0,4,4,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials & methods Cell culture Primary human fetal Schwann cells (SC), HS11, and HS13 were acquired from SciencCell Research Laboratories (Carlsbad, CA, "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""wo sections per sample were used for each protein target, with a minimum of 4 ROIs imaged per section to account for tissue heterogeneity. Statistics GraphPad Prism Version 7.04 was used for statistical analysis. One-way analysis of variance (ANOVA) was used to compare IVIS radiance fold change and tumor size bet"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""isualized using the Jess System (Biotechne), densitometry was measured in two replicate spots and normalized to the mean of six reference spots using ImageJ Software (NIH, Bethesda, MD, USA). Calculations were carried out using Prism 9 Software (GraphPad, Boston, MA, USA). Pharmacokinetic studies Male and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""and treated with DMSO (0.001%) or pictilisib (2.5\u2009\u03bcM) for 6\u2009h. This time was selected based on previous Incucyte data and coincided with MTC-10 cells started to round up and detach. Cells were lysed and procedure was performed according to the Proteome Profiler Human or Mouse Apoptosis Array Kit (Cat No"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
38339230,10.3390/cancers16030477,Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.,Cancers (Basel),2024,60,6510,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Review Committee (IACUC). Validation of mouse strains and selection of alleles of interest were performed by genotyping, as previously described for  Nf1  [ FLOX 49 ],  PlpCre  [ ERT2 50 ], and  cag-catEGFP  [ 51 ] alleles. The mouse genotypes used were  PlpCre ;  ERT2 Nf1  (henceforth  FLOX/+ ),  pNf1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Animals All mouse studies were approved by the University of Texas Rio Grande Valley Institutional Animal Care and Use Review Co"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ntibodies, images were collected using a Leica 2500SPE confocal microscope. Automated and manual (for NG2 staining) cell counting was performed using ImageJ and the ITCN plugin. Specifically, an area/region of interest of 1 mm 2  (Arbitrary Units; AU) was established for all confocal images and the total "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
38360927,10.1038/s41467-024-45618-z,Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors.,Nat Commun,2024,1213,22190,0,2,9,11,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""BWA"", ""STAR"", ""MATLAB"", ""SAMtools"", ""NanoDrop"", ""FastQC"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""/19 and G0270/18. Myf5 Cre  and Acta1 86 Cre  mice were obtained from Carmen Birchmeier (Max Delbr\u00fcck Center for Molecular Medicine Berlin, Germany), Nf1 36 flox  mice were obtained from The Jackson Laboratory (Nf1tm1Par/J), and Rosa26 87 mTmG  mice were obtained from Andreas Kispert (Medizinische Hoch"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Animals and animal study approval All animal procedures conducted within this study have been conducted in accordance with FELASA and ARRIVE guidelines and were approved by the re"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""nology # 9202; 1:1000). Blots images were analyzed and relative protein level was calculated using the gray value measurement tool in ImageJ. SeahorseXF metabolic flux analysis Seahorse XF96 extracellular flux analyzer (Agilent) was used to measure the ECAR and OCR. The cartridge sensor was hydrated w"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""y FastQC software. ChIP-seq reads (Illumina 2\u2009\u00d7\u200975 base paired-end) were mapped to the mouse reference genome ( mm9 ) using the default parameters of BWA MEM aligner using bwa v0.7.15 . BAM files were filtered using samtools rmdup 91 . Only unique mapped reads were used for the downstream analyses. MAC"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ed by sequencing with an Illumina HiSeq 4000 system in PE75bp mode. 45\u201372 million fragments were acquired in each sample. Mapping was performed using STAR 2.4.2a software with mouse genome (mm9). Read counts were generated with R Studio function Summarize Overlaps and normalized to RPKM based on the num"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": "" enzyme expr ession in all controls and Esample is the enzyme expression in the individual sample. Metabolic capacities were determined as described. MATLAB R2020b was used for running simulations and generating graphs of respective outputs. 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\us"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": "") were mapped to the mouse reference genome ( mm9 ) using the default parameters of BWA MEM aligner using bwa v0.7.15 . BAM files were filtered using samtools rmdup 91 . Only unique mapped reads were used for the downstream analyses. MACS2 92  version 2.1.2 93  was used to call peaks at 5% FDR and annotated"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""Prep DNA / RNA / Protein Mini Kit (Qiagen) and used as one sample, and two samples were used for each genotype. Sample quality was measured using the Nanodrop 2000. The low-input MeDIP protocol  was used for library preparation. 80\u2009ng of genomic DNA were fragmented to around 170\u2009bp followed by End Pair and "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""braries were purchased from Eurofins Scientific and are listed in Supplementary Table\u00a0 3 . ChIP-seq data analysis Sequencing quality was evaluated by FastQC software. ChIP-seq reads (Illumina 2\u2009\u00d7\u200975 base paired-end) were mapped to the mouse reference genome ( mm9 ) using the default parameters of BWA MEM "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": "" function Summarize Overlaps and normalized to RPKM based on the number of uniquely mapped reads. Differential expression analysis was performed with DESeq2 using default settings. Genes with an absolute fold change\u2009\u2265\u20092 and adjusted  p -value\u2009\u2009\u2264\u20090.01 were used as significantly differentially expressed. GS"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""nti-acetyl-Histone H4 (Lys16) (Millipore # 07-329; 1:500) (see also Supplementary Table\u00a0 1 ). Relative fluorescence intensity (RFI) was measured with ImageJ software; at least 200 cells per biological sample and experiment were analyzed. Immunolabeling of tissue sections Mouse hind limbs were dissected an"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38366576,10.1093/jpepsy/jsae006,Perceived transition readiness among adolescents and young adults with neurofibromatosis type 1 and plexiform neurofibromas: a cross-sectional descriptive study.,J Pediatr Psychol,2024,1799,294,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods AYAs (aged 16\u201324) enrolled in existing studies related to NF1 were eligible. AYAs and their parents completed measures of transition readiness (Transition Readiness Assessment Questionnaire version 4 [TRAQ-4]), "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods AYAs (aged 16\u201324) enrolled in existing studies related to NF1 were eligible. AYAs and their parents completed measures of transition readiness (Transition Readiness Assess"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38372904,10.1007/s11060-024-04596-4,Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.,J Neurooncol,2024,1787,5693,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The trial enrolled 12 NF2 patients with progressive VS. Participants received oral everolimus daily for 52 weeks. Brain imaging was obtained quarterly. As p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" using RAD001 (everolimus) as an Investigational New Drug (IND #111195) in NF2. Drug administration and safety Adult participants (18 and older) were started on everolimus at 10\u00a0mg/day while adolescents aged 16\u201317 were started on 3\u00a0mg/day. All participants could receive study drug once daily continuousl"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
38387803,10.1016/j.jneumeth.2024.110082,Development of a vestibular schwannoma tumor slice model for pharmacological testing.,J Neurosci Methods,2024,1755,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""BACKGROUND: Our goal was to develop a 3D tumor slice model, replicating the individual tumor microenvironment and for individual pharmaceutical testing in v"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
38402381,10.1186/s13023-024-03078-0,Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.,Orphanet J Rare Dis,2024,1496,3894,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Study population We identified NF1 patients by using the database of the Public Health Primary Care system and the database from the Leon main Hospital (Complejo Asistencial Universita"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Study population We identified NF1 patients by using the database of the Public Health Primary Care system and the database from the Leon main Hospital (Complejo Asistencial Universitario de Leon) by looking for the following items: \u201c Neur"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""cant effect of the disease. Individual results of Skindex-29 are available in Supplementary File  1 . Data analysis Data analysis was performed using SPSS for Windows v.26.0 software (SPSS Inc. Chicago, IL USA). We used non-parametric tests due to the limited number of patients and the non-normal distri"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
38409461,10.1007/s11060-024-04610-9,Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.,J Neurooncol,2024,1936,447,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods: Secondary analysis of a fully-powered RCT of a mind-body program (Relaxation Response Resiliency Program for NF; 3RP-NF) versus an educational program (Health"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
38458648,10.26508/lsa.202302229,C5aR plus MEK inhibition durably targets the tumor milieu and reveals tumor cell phagocytosis.,Life Sci Alliance,2024,65,14699,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Mouse husbandry All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at Cincinnati Ch"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""e were housed in temperature- and humidity-controlled facilities with free access to food and water on a 12-h light\u2013dark cycle. Mouse lines used are  Nf1  ( fl/fl Zhu et al, 2001 ) and  DhhCr e ( Jaegle et al, 2003 ). The  DhhCre  allele was maintained on the male;  DhhCre;Nf1  mice were crossed to fl/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ge analsysis and random coefficient model analysis were completed as described in  Wu et al (2012) . All other statistical analyses were conducted in GraphPad Prism. Significance was set at  P  \u2264 0.05. Statistical tests and any posthoc tests used for each experiment are given in figure legends. Error bars represe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""l. Macrophages were identified using CD172a reactivity, and mean intensity of CFSE within identified macrophages was measured using Cell Profiler and ImageJ software. Nucleated Schwann cells were excluded from analysis. In vitro phagocytosis assay with isolated tumor cells PNF from mice used to prepare BM"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38475852,10.1186/s13023-024-03093-1,Pilot study of the effectiveness of a telehealth group for improving peer relationships for adolescents with neurofibromatosis type 1.,Orphanet J Rare Dis,2024,669,19443,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Participants Participants were 19 adolescents with NF1 with social skills difficulties and at least one caregiver from each family. Demographic information, sample characteristics, and pre-test (i.e., bas"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Participants Participants were 19 adolescents with NF1 with social skills difficulties and at least one caregiver from each family. D"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""h ASD [ 35 ]. Higher scores represent greater knowledge of the PEERS\u00ae social skills curriculum. Statistical analysis The data were analyzed using IBM SPSS for Windows, version 28. A post-hoc power analysis was conducted using GPower 3.1 ( n \u2009=\u200919) [ 60 ]. Under a typical one-tailed 0.05 criterion of sta"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
38480916,10.1038/s41388-024-03000-9,p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.,Oncogene,2024,1468,19947,0,1,10,11,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""Fiji"", ""clusterProfiler"", ""FastQC"", ""limma"", ""FlowJo"", ""pheatmap"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ctivation, waterfall, and site-specific expression plots were created using ggplot2 (v 3.3.0) in R (v 3.6.3). Lentiviral transduction To generate the NF1-MET;sgP53 cell line, the pLentiCRISPRv2 vector (Addgene #52961) [ 89 ] was digested with BsmBI and dephosphorylated with CIP (New England BioLabs) fo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Cell culture and drugs Mouse-derived MPNST cell lines described previously [ 34 ] were cultured at 37\u2009\u00b0C in a humidified atmosphere in 5% CO 2  in low pH DMEM (T"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""rially diluted drug (4.6\u2009nM\u201310\u2009\u03bcM) for 72\u2009h, cell viability was measured by ATPlite Luminescence Assay (PerkinElmer), and IC 50  was calculated using GraphPad Prism 7. The rcorr function in the Hmisc (v4.4-1) package was used to generate spearman correlations of IC 50 . The ggplot2 (v 3.3.0) and ggpubr (v 0.2.5) "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""eans (v 1.4.5) packages and plotted using the ggplot2 (v 3.3.0) package in R (v 3.6.3). Western blotting Cells were grown overnight followed by serum starving overnight for a final confluency of 90%, and then treated with drug and/or stimulated with 10% serum or 100\u2009ng/mL HGF or EGF as indicated. Cell l"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""solution was 1024\u2009\u00d7\u20091024 of z-slices covering the entirety of cell thickness. PMT levels were set using controls with 403 and 561 solid-state lasers. FIJI was used to generate maximum intensity projection TIFF images. RNA sequencing Cells were plated in a 6-well plate, grown in 10% FBS overnight, and th"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""n adjusted using the BH method; adjusted  P -values less than 0.05 were considered significant. Gene ontology enrichment analyses were done using the clusterProfiler R package v3.14.3 using the function \u2018goseq\u2019 with KEGG ontologies. Heatmaps were generated from library-size normalized counts centered across genes "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""/projects/trim_galore/ ). Bases with a quality score less than 20 were also removed from the ends of reads. Trimmed data were quality controlled with FastQC v0.11.7 [ 93 ] and then mapped with STAR v2.5.2b to the mm10 genome using the default settings [ 94 ]. Raw gene counts (minimum of 30\u2009M counts per sa"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": "" [ 25 ] A total of 98 protein sites passed quality control metrics and were used for analysis. Differential expression was performed using R package \u201climma\u201d [ 88 ] and R (v 3.6.0). For differential activation analysis,  P -values for delta-delta differences in limma fold changes were generated in R (v 3."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ve cells that were either GFP+ or RFP+ using a CytoFLEX S flow cytometer with CytExpert v2.4 software (Beckman Coulter). Analysis was performed using FlowJo v10.7 software (BD Life Sciences). Single cells were identified using SSC vs FSC, followed by SSC area vs height. Live cells (DAPI negative) were ide"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""ing the function \u2018goseq\u2019 with KEGG ontologies. Heatmaps were generated from library-size normalized counts centered across genes (z-scores) using the pheatmap package v1.0.12. Apoptosis assay NF1-MET and NF1-MET;sgP53 cells were plated in a 6-well plate, grown in 10% FBS overnight, and then treated with 20\u2009"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""g transformed and pairwise comparisons of beta regressions were done using the betareg (v 3.1-3) and emmeans (v 1.4.5) packages and plotted using the ggplot2 (v 3.3.0) package in R (v 3.6.3). Emmeans and ggplot2 were also used for comparison of doubling times. For human MPNST cell lines, the IC 50  was det"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:pheatmap"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,Front Cell Dev Biol,2024,106,9063,0,6,3,9,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {""Anti-Neurofibromin Antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b"", ""Neurofibromin antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b"", ""anti-Neurofibromin Antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b"", ""Anti-Neurofibromin antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2 Materials and methods 2.1 Pluripotent stem cell reprogramming and culture \n NF1 -1 and  NF1 -2 hiPSC lines were reprogrammed using OSKM episomal technique by Phenocell from two patient-derived fibroblasts carrying  NF1  mutations"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2 Materials and methods 2.1 Pluripotent stem cell reprogramming and culture \n NF1 -1 and  NF1 -2 hiPSC lines were reprogrammed using OSKM episomal technique "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": "") control hiPSC line used for Crispr/Cas9 engineering corresponds to the  WT -1 line. HiPSCs were maintained and expanded with the StemMACS\u2122 iPS-Brew XF medium (Miltenyi Biotec) on Matrigel \u00ae  hESC-qualified Matrix (Corning)-coated culture dishes. Cultures were changed every 2\u00a0days and passaged every "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-Neurofibromin Antibody"": {""context"": ""-Blot Turbo Transfert system (Bio-Rad), blocked with Odyssey blocking buffer (OBB) containing 0.1% Tween-20, and incubated overnight with the primary anti-neurofibromin antibody (abcam, ab17963, 1/1000) diluted in the OBB containing 0.1% Tween-20. The membrane was then incubated for 1\u00a0h with the corresponding IRDye secondary "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Neurofibromin antibody"": {""context"": "" Turbo Transfert system (Bio-Rad), blocked with Odyssey blocking buffer (OBB) containing 0.1% Tween-20, and incubated overnight with the primary anti-neurofibromin antibody (abcam, ab17963, 1/1000) diluted in the OBB containing 0.1% Tween-20. The membrane was then incubated for 1\u00a0h with the corresponding IRDye secondary "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:anti-Neurofibromin Antibody"": {""context"": ""-Blot Turbo Transfert system (Bio-Rad), blocked with Odyssey blocking buffer (OBB) containing 0.1% Tween-20, and incubated overnight with the primary anti-neurofibromin antibody (abcam, ab17963, 1/1000) diluted in the OBB containing 0.1% Tween-20. The membrane was then incubated for 1\u00a0h with the corresponding IRDye secondary "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-Neurofibromin antibody"": {""context"": ""-Blot Turbo Transfert system (Bio-Rad), blocked with Odyssey blocking buffer (OBB) containing 0.1% Tween-20, and incubated overnight with the primary anti-neurofibromin antibody (abcam, ab17963, 1/1000) diluted in the OBB containing 0.1% Tween-20. The membrane was then incubated for 1\u00a0h with the corresponding IRDye secondary "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ssion level was calculated with the 2-delta delta Ct method and normalized to 18S expression. 2.13 Statistical analysis All data were processed using GraphPad Prism 9 \u00ae . Data were analyzed using the non-parametric Mann\u2013Whitney test for side-by-side comparison.  p- values \u22640.05 were considered significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ng with the isotypic antibody was performed as a control. Analysis was performed on a MACSQuant \u00ae  system (Miltenyi Biotec). Data were analyzed using FlowJo software (FlowJo LLC). 2.8 Protein extraction and Western blot analysis Total proteins were extracted in RIPA lysis buffer (Sigma) containing 1% prot"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""antibodies:Anti-Neurofibromin Antibody"": [""methods""], ""antibodies:Neurofibromin antibody"": [""methods""], ""antibodies:anti-Neurofibromin Antibody"": [""methods""], ""antibodies:Anti-Neurofibromin antibody"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
38493052,10.1016/j.abd.2023.08.011,Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.,An Bras Dermatol,2024,1764,3600,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods This is a descriptive cross-sectional study. Data were collected from 101 individuals with NF1 using the Brazilian version of the Impact of NF1 on Quality of Life Questionnaire (INF1-QoL), a form with information on sociodemographic characteris"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods This is a descriptive cross-sectional study. Data were collected from 101 individuals with NF1 using the Brazilian version of the Impact of NF1 on Quality of Life Qu"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",J Patient Rep Outcomes,2024,1922,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Half of the patients with Neurofibromatosis type 1 (NF1) develop one or more tumours called plexiform neurofibromas, which can have a significant impact on Quality of Life (QoL). The PlexiQoL questionnaire"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Half of the patients with Neurofibromatosis type 1 (NF1) develop one or more tumours called plexiform neurofibromas, which can have a significan"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,J Clin Invest,2024,1067,9944,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""H. DNA lysates were then neutralized at room temperature with 1 M Tris-HCl (pH 7). To genotype  cisNP  mice, the following primers were used for the  Nf1  allele: 5940 (5\u2032-GTATTGAATTGAAGCACCTTTGTTTGG-3\u2032), 5941 (5\u2032-GCGTGTTCGAATTCGCCAATG-3\u2032), and 5942 (5\u2032-CTGCCCAAGGCTCCCCCAG-3\u2032), generating a 194 bp band"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Sex as a biological variable Our study examined male and female humans and mice, and similar findings are reported for both sexes. Mice Mouse colonies were maintained in a b"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""lturing H358 cells (shared by the Kate O\u2019Donnell laboratory at UT Southwestern) were KRAS mutant human lung cancer cells that expressed PD-L1 ( 47 ). S462 cells were human NF1\u2013related MPNST cells (SCC414, MilliporeSigma). The  cis MPNST cell line was generated in the laboratory by harvesting tumors from"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ferent fields of each sample were imaged. These fields were selected randomly, avoiding the tumor borders. The target cell type was counted using the ImageJ Cell Counter extension (NIH), and the average number of cells per square millimeter was calculated. It should be noted that in the control treatments"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38521834,10.1038/s41598-024-57401-7,The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.,Sci Rep,2024,1546,9874,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods The study was conducted as an extension of the Erfurt Neurofibromatosis Database Research (NF registry), which contains disease data "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" whereas higher scores on the OPD-SQS indicate impairments in personality functioning. 26 Statistical analyses Data analyses were performed using IBM SPSS (version 20). Since single values were missing from the questionnaires, the mean substitution method was applied. Isolated single missing values in t"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
38585724,10.1101/2024.03.25.585959,Pharmacogenomic synthetic lethal screens reveal hidden vulnerabilities and new therapeutic approaches for treatment of NF1-associated tumors.,bioRxiv,2024,153,10205,0,2,8,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""StringTie"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""STAR"", ""Trimmomatic"", ""FlowJo"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""out this study. Cell line authentication was performed at the University of Arizona Genetics Core against established reference lines. Generation of  NF1- deficient cell lines. We received immortalized human Schwann cell (SC) lines (iHSCs) from Dr. Margaret Wallace (University of Florida, Gainesville)."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Tissue culture. Immortalized human Schwann cell lines were maintained and passaged at 37\u00b0C with 5% CO 2  in DMEM high glucose media s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": "" media supplemented with 10% FBS and penicillin/streptomycin. If antibiotic selection was needed, puromycin was used at 500 \u03bcg/ml as indicated below. S462-TY cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin at 37\u00b0C and 5% CO 2 . Mycoplasma detection was routinely perf"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:StringTie"": {""context"": ""s: Quality trimming via Trimmomatic (v0.33) , alignment via HISAT2 (v2.1.0) 38  to the GRCh38 Ensembl assembly 39 , and gene count quantification via StringTie(v1.3.4d) 40 . Differential expression analysis was performed using R Statistical Software(v4.3.1) 41 , tidyverse(v2.0.0) 42  DESeq2(v1.42.0) 43  Path"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""lated by fluorescence of experimental wells in percent of unexposed control wells with blank values subtracted. Data were analyzed in Prism software (Graphpad Prism) and dose-response curves generated using nonlinear regression log(inhibitor) vs. response-variable slope model. Each point represents mean \u00b1 SD. Com"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""ovaSeq 6000 next generation sequencer. RNAseq Analysis. RNAseq data was analyzed as follows: Quality trimming via Trimmomatic (v0.33) , alignment via HISAT2 (v2.1.0) 38  to the GRCh38 Ensembl assembly 39 , and gene count quantification via StringTie(v1.3.4d) 40 . Differential expression analysis was perfo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""d. After incubation with drug(s) or vehicle for 48 hrs, cells were incubated with alamarBlue (Thermo Fisher) reagent and fluorescence read on a CLARIOstar microplate reader (BMG LABTECH). Cell viability was calculated by fluorescence of experimental wells in percent of unexposed control wells with blank"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""lyzer and sequenced on an Illumina NovaSeq 6000 next generation sequencer. RNAseq Analysis. RNAseq data was analyzed as follows: Quality trimming via Trimmomatic (v0.33) , alignment via HISAT2 (v2.1.0) 38  to the GRCh38 Ensembl assembly 39 , and gene count quantification via StringTie(v1.3.4d) 40 . Differentia"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""Staining Solution before being run through the CytoFLEX flow cytometer (Beckman Coulter). Cell cycle stage was determined with the Cell Cycle tool in FlowJo V10.7.1 Software (BD Life Sciences) using the Watson (Pragmatic) model. In vivo  models and drug testing. For the MPNST cell line xenograft model, S4"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""tification via StringTie(v1.3.4d) 40 . Differential expression analysis was performed using R Statistical Software(v4.3.1) 41 , tidyverse(v2.0.0) 42  DESeq2(v1.42.0) 43  Pathway analysis was performed using Gene Analytics(v) 44 . The data discussed in this publication have been deposited in NCBI\u2019s Gene Ex"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""computational_tools:StringTie"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:DESeq2"": [""methods""]}",False
38595983,10.1016/j.omton.2024.200783,Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.,Mol Ther Oncol,2024,875,12176,0,2,7,9,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""StringTie"", ""R"", ""HISAT2"", ""Fiji"", ""Trimmomatic"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""m Peggy Wallace (University of Florida); primary human Schwann cells (pHSC) were purchased from ScienCell Research Laboratories. C57BL/6J mice on an  Nf1 +/\u2212 ; Trp53 \n +/\u2212 NPCis  background develop MPNST-like syngeneic tumors (JW16, JW18, and JW23), and were kindly provided by Karlyne Reilly, PhD (Cent"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell lines Human MPNST cell lines STS26T, ST88\u201314, S462, and S462-TY were provided by Nancy Ratner (Cincinnati Children\u2019s); 2-002 MP3"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""Materials and methods Cell lines Human MPNST cell lines STS26T, ST88\u201314, S462, and S462-TY were provided by Nancy Ratner (Cincinnati Children\u2019s); 2-002 MP3, JHU 2\u2013079, and JHU 2\u2013103 were provided by Christine Pratilas (Johns Ho"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:StringTie"": {""context"": ""ase pair read length was performed by the University of Minnesota Genomics Center. Quality control, read alignment with HISAT2, and read mapping with Stringtie were performed with support from the Minnesota Supercomputing Institute. Differential gene expression experiments were performed in R Statistical Sof"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""40 million read depth and 75 base pair read length was performed by the University of Minnesota Genomics Center. Quality control, read alignment with HISAT2, and read mapping with Stringtie were performed with support from the Minnesota Supercomputing Institute. Differential gene expression experiments we"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""ing 10% buffered formalin (10\u00a0min), stained with 1% crystal violet in 70% ethanol (20\u00a0min), washed, air-dried, and imaged. Images were analyzed using FIJI ImageJ software. Animal models All  in\u00a0vivo  procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""ncing was performed by Azenta Life Sciences. Sequence reads were trimmed to remove possible adapter sequences and nucleotides with poor quality using Trimmomatic v.0.38. The trimmed reads were aligned to the reference genomes using the Illumina Dragen Bio-IT Platform. Somatic variants were called using the Ill"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": "" with support from the Minnesota Supercomputing Institute. Differential gene expression experiments were performed in R Statistical Software with the DESEQ2 package. 55 , 56 , 57 , 58 Syngeneic model whole exome sequencing and prediction of transcribed variants Genomic DNA of each JW cell line was extract"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""0% buffered formalin (10\u00a0min), stained with 1% crystal violet in 70% ethanol (20\u00a0min), washed, air-dried, and imaged. Images were analyzed using FIJI ImageJ software. Animal models All  in\u00a0vivo  procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Minnes"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""computational_tools:StringTie"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,PLoS One,2024,1619,6546,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In Neurofibromatosis type 1 (NF1), peripheral nerve sheaths tumors are common, with cutaneous neurofibromas resulting in significant aesthetic, painful and functional problems requir"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and methods Study collective and sample acquisition A total of 20 patients were enrolled at the Department of Oral and Maxillofacial Surgery at t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38607967,10.1093/neuonc/noae054,NF1 mutation-driven neuronal hyperexcitability sets a threshold for tumorigenesis and therapeutic targeting of murine optic glioma.,Neuro Oncol,2024,1929,442,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We leverage a collection of  Nf1- mutant mice that spontaneously develop OPGs to alter both germline and retinal neuron-specific midkine expression.  Nf1- mutant mice harboring sever"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We leverage a collection of  Nf1- mutant mice that spontaneously develop OPGs to alter both germline and retinal neuron-specific midkine expression.  Nf1- mut"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38654147,10.1186/s12872-024-03878-z,Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.,BMC Cardiovasc Disord,2024,1196,4440,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""BWA"", ""GATK"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Following clinical assessment, WES was used to identify genetic variants in a family with a son suffering from NF1. No symptomatic manifestations were observed in other family members. In the studied family,  in silico  and segregation analysis were applied to sur"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Following clinical assessment, WES was used to identify genetic variants in a family with a son suffering from NF1. No symptomatic manifestations were observed in other family members. In the studied family,  in silic"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""and Research Center, Iran University of Medical Sciences, Tehran, Iran with a complaint of chest pain and arrhythmias. The patient\u2019s cardiac symptoms started at 16 years old, and dark spots were observed on his body at 2 years old. He was the second child of non-consanguineous healthy parents (Fig.\u00a0 1 A"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""sed to align the reads to the reference genome (NCBI, hg19) [ 11 ]. Single-nucleotide polymorphisms and insertions and/or deletions were called using GATK, v.4.1.4.1 [ 12 ]. All the determined variants were annotated by ANNOVAR [ 13 ]. Frequency databases, consisting of Iranome ( http://www.iranome.ir )"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""rogen (Amsterdam, Netherlands) on the Illumina HiSeq 6000. Raw data were analyzed by Rajaie Cardiovascular Medical and Research Center, Tehran, Iran. BWA, v.07.17, was used to align the reads to the reference genome (NCBI, hg19) [ 11 ]. Single-nucleotide polymorphisms and insertions and/or deletions we"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""]}",False
38691597,10.1126/sciadv.adk4946,Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1.,Sci Adv,2024,539,8923,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Ex vivo cNF explant analysis Ex vivo assays were used to determine the activity of NFX-179 Topical Gel in penetrating skin and suppre"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""ester Inc. (Rochester, NY), and The Education & Research Foundation Inc. (Lynchburg, VA). Persons aged 18 years or older with a clinical diagnosis of NF1 and with at least six cNFs that met study criteria were eligible for the study. Eligible cNFs had the following characteristics: were dome-shaped and"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
38712289,10.1101/2024.04.23.590787,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2.,bioRxiv,2024,293,7980,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Material and Methods Zebrafish lines: Zebrafish ( Danio rerio ) were maintained at 28\u00b0C, with adults on a 14-hour light/10-hour dark cycle. All zebrafish w"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,Mol Cancer Ther,2024,1740,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tible to developing low-grade glioma and less commonly high-grade glioma. These gliomas exhibit loss of the neurofibromin gene [neurofibromin type 1 (NF1)], and 10% to 15% of sporadic high-grade gliomas have somatic NF1 alterations. Loss of NF1 leads to hyperactive RAS signaling, creating opportunity g"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1, an autosomal dominant neurogenetic and tumor predisposition syndrome, are susceptible to developing low-grade glioma and less co"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38721358,10.1093/noajnl/vdae036,Effect of food on selumetinib pharmacokinetics and gastrointestinal tolerability in adolescents with neurofibromatosis type 1-related plexiform neurofibromas.,Neurooncol Adv,2024,848,11172,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""iple doses were taken with a low-fat meal compared with a fasted state. Eligible participants were adolescents aged\u2005\u2265\u200512 to\u2005<\u200518 years diagnosed with NF1 (per National Institutes of Health Consensus Development Conference Statement 1988)  and inoperable PN. Participants who had prior treatment with a M"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Eligible participants aged \u2265 12 to\u00a0< 18 years took 25\u00a0mg/m 2  selumetinib BID with a low-fat meal (T1) for 28 days, followed by a 7-day washout, and then administ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38722890,10.1371/journal.pone.0303138,NF-B1 deficiency promotes macrophage-derived adrenal tumors but decreases neurofibromas in HTLV-I LTR-Tax transgenic mice.,PLoS One,2024,1625,3029,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Animals Nfkb1 -/-  and  Tax +  mice have been described before [ 28 , 29 ].  Nfkb1 -/-  mice were originally purchased from Jackson L"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,J Patient Rep Outcomes,2024,1680,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Almost all patients with Neurofibromatosis type 1 (NF1) develop cutaneous neurofibroma (cNF), benign dermal tumours that have a large impact on the patient's Quality of Life (QoL). The French cNF-Skindex "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Almost all patients with Neurofibromatosis type 1 (NF1) develop cutaneous neurofibroma (cNF), benign dermal tumours that have a large impact on "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
38816530,10.1038/s41593-024-01654-y,Nf1 mutation disrupts activity-dependent oligodendroglial plasticity and motor learning in mice.,Nat Neurosci,2024,1356,20803,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""MATLAB"", ""Fiji"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""midity ranging from 30% to 70%. Littermates (4\u201324\u2009weeks of age) were used without selection for sexes. No obvious sex-dependent effect was observed.  Nf1 WT  ( Nf1 ,  fl/fl Nf1  or  fl/+ Nf1 ) and heterozygous  +/+ Nf1 -mutant ( Nf1  or  fl/mut Nf1 ) mice were generated previously +/mut  and bred with "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Mice All mice were used in accordance with an approved Institutional Animal Care and Use Committee protocol at Stanford University and Washington University. All mice "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""al circling behavior when the blue light was on. During stimulation sessions, light was administered for 30\u2009min, and mice were perfused 3\u2009h after the start of the stimulation session. To label the dividing cells, all mice were injected i.p. with EdU (40\u2009mg\u2009kg \u22121 ) for all the stimulation sessions. Immun"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""nce of the wheels. Further hardware specifications are available upon request. Logged data from the Arduino-based monitoring system were processed in Matlab. The rotation of individual wheel rungs across the sensor path (rung intercepts) was identified via Matlab\u2019s \u2018findpeaks\u2019 function. The data were then"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""Cxcl10 -C2 (ACDbio 408921-C2) and Mm- Sox9  (ACDbio 401051). Images were taken using a Zeiss 800 and Zeiss 980 confocal microscope and analyzed using Fiji (v 2.3.0/1.53q). To measure  Ttr  area, the threshold was adjusted to  Ttr  fluorescence signal. To get consistent data, the same threshold value was"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""search 712-605-150). Images were taken using a Zeiss Axio Imager M2, a Zeiss LSM 700 or a Zeiss 980 scanning confocal microscope and quantified using ImageJ (v 2.0.0). Fluorescence in situ hybridization To obtain fresh frozen brain samples for RNAscope, mice were intracardially perfused with PBS. The brai"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,PLoS One,2024,1516,5974,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""al Care standards. All mouse strains were maintained in a room with 12/12 (day/night) light cycle with a temperature of 70-72\u00b0F. NPcis and Hoxb7-cre  Nf1 \n f/f  mice were rederived on C57bl/6 background. Genotyping was performed by PCR as reported elsewhere [ 14 ,  21 ]. The investigators were not blin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Mice All mice were housed in the Animal Care Facility at the Universit\u00e9 de Sherbrooke. We follow the principles of laboratory animal care (NIH publication No. 86\u201323, r"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""M as the demodification solution (20 min, 95\u00b0C) as previously done [ 24 ]. The resulting column-based purified total RNA extract was quantified using Nanodrop and 150 ng from each sample were submitted to a reverse transcription reaction using Roche Transcriptor \u2122  and N6 random primers. Finally, cDNA was d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:NanoDrop"": [""methods""]}",False
38913608,10.1371/journal.pone.0304778,Dietary intervention rescues a bone porosity phenotype in a murine model of Neurofibromatosis Type 1 (NF1).,PLoS One,2024,1578,8065,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1Prx1-/-"": ""3a66bcb2-e137-4471-8cee-29dd9655b276""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""Salmon"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Animal ethics and husbandry Prx-Cre  transgenic mice [ 15 ] supplied by Jackson Laboratory (Bar Harbor, ME, USA) and  Nf1  mice [ flox/flox 16 ] supplied by the National Cancer Institute (Bethesda, MD, USA) were crossbred to generate  Nf1 Prx1 -/-  mice after two generat"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1Prx1-/-"": {""context"": "" NF1 deficiency has been reported to affect genes involved with lipid metabolism. Bone specimens were analyzed from wild type control mice as well as Nf1Prx1-/- (limb-targeted Nf1 knockout mice) fed standard chow versus a range of modified chows hypothesized to influence lipid metabolism. Mice were fed from 4"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and methods Animal ethics and husbandry Prx-Cre  transgenic mice [ 15 ] supplied by Jackson Laboratory (Bar Harbor, ME, USA) and  Nf1  mice [ flo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" were performed on the datasets to identify differences between each group and the  Nf1 Prx1 -/-  standard control group. All tests were performed on GraphPad Prism 9 (GraphPad Software, San Diego, USA) with a p<0.05 considered statistically significant. Blinding of genotype and/or treatment was infeasible during"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" standard AIN93M rodent chow, or one of six other AIN93M-modified diets altered to reduce LCFA intake and improve lipid metabolism ( Fig 1 ). Feeding started at 4 weeks. Cages of  Nf1 Prx1 -/-  mice were randomly assigned to the dietary treatment groups. Female WT littermates (n = 8) were fed standard A"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""parameters associated with closed and open intracortical pores were analyzed for NF1 based on protocols supplied by Bruker microCT Systems (Dr Phil L Salmon) MN058 \u201cOsteocyte and blood vessel analysis in cortical bone\u201d, MN010 \u201c3D visualization of open and closed porosity\u201d, MN011 \u201cAdvanced Porosity Analysi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1Prx1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
38923593,10.1111/1346-8138.17276,The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.,J Dermatol,2024,1941,4856,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2 METHODS A cross\u2010sectional cohort study examined the health and QoL of adults with NF1 attending a clinical genetics and dermatology clinic in Australia. Laser treatments and surgical excisions of primarily cNFs are performed at this cl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2 METHODS A cross\u2010sectional cohort study examined the health and QoL of adults with NF1 attending a clinical genetics and dermatology clinic in Australia. Laser tre"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""an of comparable questions between the surveys.  40 \n p \u2010values of <0.05 were considered statistically significant. All analyses were performed using SPSS, version 27.0 (IBM Corp.)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,Pharmaceuticals (Basel),2024,500,12192,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""tional guidelines for the care and use of animals. The study was approved by the Nemours Institutional Committee for the Care and Use of Animals. The NF1 mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and bred at Nemours. The triple mutant line from the vendor carries Trp53, Nf1,"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods The materials and methods section describes the radiosynthesis and quality control of L-[ 18 F]FETrp, the in vitro evaluation of [ 18"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,PLoS One,2024,1989,7311,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Children (3\u20136 years) with NF1, with and without known OPG and children with sporadic OPG (S-OPG) resident in the Stockholm area, were invited and followed in a prospective study d"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Children (3\u20136 years) with NF1, with and without known OPG and children with sporadic OPG (S-OPG) resident in the Stockholm area, were invited and followed i"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""n first reliable VA and VF examination and between first reliable OCT examinations. The Generalized Linear Mixed Models (GLMM) of statistical package SPSS (ver.26) was used to compare the groups. The dependent variables were the VA, GC-IPL, pRNFL and VFI. The fixed factors were OPG group, age, the rando"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ptoms), age at OPG diagnosis, MRI findings (initial location and extension of the tumor as well as radiologic progression or regression), criteria to start treatment (visual decline or other), treatment regime (surgery, chemotherapy) as well as age at treatments and additional information such as cognit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,J Cell Sci,2024,1172,24215,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {""Anti-NF1"": ""535891d9-4608-48eb-9e61-01201533a5bc""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R"", ""STAR"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""it is considered to be a human glioblastoma cell line of unknown origin ( Allen et al., 2016 ). In the context of this work, U87-MG cells serve as an NF1-deficient tumor cell line model, due to elevated proteasome-mediated degradation of the NF1 protein ( McGillicuddy et al., 2009 ). U87-MG cells have "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Reagents Y102 was originally purchased from Maybridge (NRB04162SC). Subsequent stocks of Y102, along with JW-1, all Y102 analogs, and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": "" , which were prepared fresh in DMEM (Corning Life Sciences) plus 10% fetal bovine serum (FBS) (Life Technologies). Cell culture U87-MG, U251-MG, and sNF96.2 cells were purchased from ATCC. ipnNF95.11C and ipNF95.11b \u2018C\u2019 cells were kindly provided by Peggy Wallace, University of Florida, USA and are availa"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1"": {""context"": ""n using a 3\u20138% NuPAGE gel (Invitrogen). Protein was transferred to a nitrocellulose membrane, blocked with 5% nonfat dry milk in TBST and probed with anti-NF1 (D7R7D) rabbit monoclonal (cat. no 14623, Cell Signaling Technology, 1:1000, overnight at 4\u00b0C), anti-PARP (46D11) rabbit monoclonal (cat. no 9532, Ce"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ng Harbor Protocols  https://cshprotocols.cshlp.org/content/2016/11/pdb.rec090589.full?sid=65431fb9-2fc5-4685-bbe6-85343665fa93 ) containing compound starting at 100\u2005\u00b5M, followed by 2-fold serial dilutions to generate a 10-point range of concentrations in quadruplicate; one column was treated with equiv"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""en Dynamics Series 120 Q X-Cite Fluorescence Illuminator, and AxioVision SE64 Rel. 4.9.1 software. Image processing was performed with Fiji, built on ImageJ2. MV-151 proteasome active site inhibition assay U87-MG cells were plated at 500,000 cells/well in six-well plates and allowed to adhere overnight (F"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""m camera, a Lumen Dynamics Series 120 Q X-Cite Fluorescence Illuminator, and AxioVision SE64 Rel. 4.9.1 software. Image processing was performed with Fiji, built on ImageJ2. MV-151 proteasome active site inhibition assay U87-MG cells were plated at 500,000 cells/well in six-well plates and allowed to ad"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF96.2"": [""methods""], ""antibodies:Anti-NF1"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,Cancers (Basel),2024,320,8088,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rom Abcam (Cambridge, MA, USA). 2.2. Cells and Cell Maintenance The following immortalized human plexiform neurofibroma cell lines (hereafter called pNF1 cells) described in [ 36 ] were used: ipNF95.11b C, ipNF95.11b C-RFP, and ipNF 05.5. ipNF95.11b C gifted from Dr. Margaret Wallace (University of Flo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Reagents Reduced growth factor reconstituted basement membrane (rBM; Cultrex TM ) and Collagen I (high concentration; rat tail) "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""aluated either by one-way ANOVA, followed by Tukey\u2019s post hoc test to correct for multiple comparisons, or by Student\u2019s  t -test for two groups using GraphPad Prism version 8.0.1 for Windows, GraphPad Software (Boston, MA, USA). For all studies,  p  \u2264 0.05 was considered statistically significant. 2.11. Patents T"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""r the stained filters were mounted on slides, invaded cells were visualized using a Nikon Eclipse Ti-S microscope (Tokyo, Japan) and quantified using ImageJ software (NIH, Bethesda, MD, USA). Images of seven random fields per insert were acquired, and three independent experiments were carried out. 2.8. 3"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
39106942,10.1016/j.expneurol.2024.114914,Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model.,Exp Neurol,2024,1485,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a human genetic disorder caused by variants in the NF1 gene. Plexiform neurofibromas, one of many NF1 manifestations, are benign peripheral nerve"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a human genetic disorder caused by variants in the NF1 gene. Plexiform neurofibromas, one of many NF1 manifestations, ar"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39149363,10.1101/2024.08.08.607070,Neurofibromin deficiency alters the patterning and prioritization of motor behaviors in a state-dependent manner.,bioRxiv,2024,694,7398,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""MATLAB"", ""Fiji"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ard protocols. Behavioral assays were performed using 3-8 days old flies. Except where indicated, males were used (to prevent egg accumulation). The  nf1  mutation was backcrossed 6 generations into the wCS10 genetic background. The Nf1 RNAi line was obtained from the Vienna  P1 Drosophila  RNAi Center"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Drosophila  maintenance Flies were raised on cornmeal/agar food medium, housed in incubators at 25 \u00b0C, 60% relative humidity, and kep"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""aphed in aggregate or by individual body parts, as appropriate. Ethograms were generated with a custom Python script and heat maps were plotted using GraphPad Prism. Stimulus-evoked grooming was performed as previously described [ 20 ]. Each fly was coated in Reactive Yellow 86 dust and transferred to an open fie"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""rator and recorded at 7.5 frames per second, 1616 x 1240 with lossless Motion JPEG 2000 compression. 5-min videos were recorded at several intervals, starting at: 0, 30, 60, and 150 min following introduction into the open field arena. Grooming was manually scored via frame-by-frame analysis, recording "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""alized to the median value of the dust coverage at time 0. Open field locomotion tracking Locomotion was tracked (in videos collected as above) using MATLAB with DLTdv8 [ 73 ]. Accuracy of the tracking was visually confirmed and any errors in the xy position tracking were manually corrected. Total distanc"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""oup of 10 flies was starved for 150 minutes prior to providing food for the experiment. Total feeding was measured in a 30-min window and analyzed in Fiji. Immunohistochemistry Five to seven-day-old adult brains were dissected in 1% paraformaldehyde in S2 medium and processed as previously described [ 7"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""d bout duration was calculated. Grooming was graphed in aggregate or by individual body parts, as appropriate. Ethograms were generated with a custom Python script and heat maps were plotted using GraphPad Prism. Stimulus-evoked grooming was performed as previously described [ 20 ]. Each fly was coated in"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
39196570,10.1001/jamadermatol.2024.2912,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.,JAMA Dermatol,2024,2492,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rgeoning interest in therapeutic development for cutaneous neurofibromas (cNFs), a major cause of morbidity in persons with neurofibromatosis type 1 (NF1). To determine meaningful clinical trial outcomes, deeper understanding is needed regarding how cNFs are associated with quality of life (QoL). Howev"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""IMPORTANCE: There is a burgeoning interest in therapeutic development for cutaneous neurofibromas (cNFs), a major cause of morbidity in persons with neurof"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39198186,10.1265/ehpm.24-00158,Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan.,Environ Health Prev Med,2024,1763,5017,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods The Japanese Ministry of Health, Labour and Welfare provided access to the \u201cNational Database of Designated Intractable Diseases of Japan\u201d containing the \u201cMedical Certifi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ratios (ORs) and 95% confidence intervals (CIs) were calculated. P < 0.05 was considered statistically significant. All analyses were performed using SPSS version 25 (IBM, Chicago, IL, USA)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
39201967,10.3390/children11081033,"Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.",Children (Basel),2024,1455,4117,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2. Materials and Methods 2.1. Subjects and Procedure The participants were children and adolescents diagnosed with NF1, recruited at the Pediatric Neurofibromatosis Referral Centre of the University of Campania \u201cLuigi Vanvitelli\u201d. Eligibility criteria included the fol"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Subjects and Procedure The participants were children and adolescents diagnosed with NF1, recruited at the Pediatric Neurofibrom"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""and parent report) and the severity and visibility of NF1, Spearman\u2019s correlational analysis was conducted. The analyses were conducted utilizing IBM SPSS-20, with the critical alpha level set at 0.05."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,Skin Res Technol,2024,1848,4870,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods We compared the Vectra\u2010H1, LifeViz\u2010Micro and Cherry\u2010Imaging systems. A total of 58 cNFs from 13 participants with NF1 were selected for imaging and analysis. The primary endpoint was accuracy as measured by comparison of measurements between imaging systems. Secondar"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods We compared the Vectra\u2010H1, LifeViz\u2010Micro and Cherry\u2010Imaging systems. A total of 58 cNFs from 13 participants with NF1 were selected f"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" (E, F) 3D model analysis using Vectra software. Scale bars represent 10\u00a0mm. 2.4 Statistical assessment Statistical analyses were conducted using IBM SPSS Statistics (version 27.01). Friedman tests and Dunn\u2013Bonferroni post hoc tests were performed to assess accuracy by comparing measurements of cNF leng"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
39234078,10.3389/fpubh.2024.1398803,"Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.",Front Public Health,2024,1920,13682,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We conducted an online cross-sectional survey employing the China Cloud Platform for Rare Diseases, with 223 caregivers of NF1 pediatric patients (patients under 18), and 226 adult patients. Economic burden was estimated using direct and indirect costs related to NF1 in 2021,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We conducted an online cross-sectional survey employing the China Cloud Platform for Rare Diseases, with 223 caregivers of NF1 pediatric patients (patients under 18), and 226 "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,J Mol Neurosci,2024,1811,4478,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Method Online Data Retrieval The standard protein sequence of NF1 was obtained from UniProt (UniprotKB  P21359 , ENSG00000196712). The missense mutations were collected from UniProt (UniProt ID UP51795) as well as f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Method Online Data Retrieval The standard protein sequence of NF1 was obtained from UniProt (UniprotKB  P21359 , ENSG00000196712). The missen"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,Int J Mol Sci,2024,1188,5009,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ples [ 57 , 58 ]. The list of genes in the literature was created by conducting a bibliographical search on PubMed, using the MESH terms \u201cMPNST\u201d and \u201cNF1\u201d. Papers mentioning the most frequently mutated genes were selected; in addition, extensive research was carried out on the  Supplementary Materials "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Sample Collection and DNA Extraction Four samples were collected from the same patient, including three tumor samples (a primary"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""umor, a lung metastasis and a skin metastasis) and one benign sample (selected from the benign area of plexiform neurofibroma). The gDNA was purified starting from formalin-fixed paraffin-embedded (FFPE) samples obtained at surgical resection, using the Magcore DNA FFPE One-Step Kit (Code 405). Fragment"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": "" alterations in the number of copies, the CNV calling was also performed using the CNVKit version 0.9.11 [ 55 ]. The output was then visualized using ggplot2 v3.5.1 [ 56 ] ( https://ggplot2.tidyverse.org ). 4.4. Driver-Gene Identification and Kaplan\u2014Meier Analysis We downloaded data from the TCGA-SARC from"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,Dis Model Mech,2024,1249,9308,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Zebrafish lines Zebrafish ( Danio rerio ) were maintained at 28\u00b0C, with adults on a 14\u2005h light/10\u2005h dark cycle. All zebrafish work co"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""crest cells and pLLn SCs ( Fig.\u00a0S1L,\u00a0M ) were performed using ImageJ cell counter feature by manually labeling the cells. The data were plotted using GraphPad Prism software. CRISPR-Cas9 strategy gRNAs for zebrafish  nf2a  and  nf2b  ( Table\u00a0S1 ) were designed using  CHOP-CHOP . gRNAs targeting zebrafish  nf2a/b "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "".\u00a04H ), Schwann cell hyperplasia ( Fig.\u00a05J,K ), and  nf2b  HCR signal in cranial neural crest cells and pLLn SCs ( Fig.\u00a0S1L,\u00a0M ) were performed using ImageJ cell counter feature by manually labeling the cells. The data were plotted using GraphPad Prism software. CRISPR-Cas9 strategy gRNAs for zebrafish  n"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
39518076,10.3390/cancers16213639,Leveraging Neural Crest-Derived Tumors to Identify NF1 Cancer Stem Cell Signatures.,Cancers (Basel),2024,281,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disorder that predisposes individuals to develop benign and malignant tumors of the nerve sheath. Understanding the signatures of cance"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a genetic disorder that predisposes individuals to develop benign and malignant tumors of the nerve sheath. Understandin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39521772,10.1038/s41540-024-00464-z,Automatic construction of Petri net models for computational simulations of molecular interaction network.,NPJ Syst Biol Appl,2024,1049,22327,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" were generated in the form of list objects by the function \u201cconvert_graph_to_graphml\u201d from GINtoSPN. To simulate the loss of function effects of the NF1 gene, we deleted the transition nodes that were catalyzed by NF1 and all the related arcs. Similar to the normal human skin fibroblast cells, we gene"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Basic concepts of Petri nets Petri nets are a mathematical tool used to model and simulate the behaviors of systems. Typical Petri nets consisted of places, transitions, an"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" finite set of places. m T \u2009=\u2009{ t 1 ,  t 2 , \u2026  t } is a finite set of transitions. n I \u2009=\u2009{ i 1 ,  i 2 , \u2026  i } is a finite set of input arcs, whose starting and ending nodes  k u  and  v  follow:  u \n \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsf"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
39539654,10.3389/fneur.2024.1432196,Quality of life of patients with neurofibromatosis 1-Physical disability does not necessarily result in poor mental health.,Front Neurol,2024,1486,2503,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Patients and methods We conducted a prospective analysis of 89 NF1 patients between January 2016 and March 2018. Data sourced from local records including demographic information, employment status, education level, "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Patients and methods We conducted a prospective analysis of 89 NF1 patients between January 2016 and March 2018. Data sourced from local records including demographic information, employme"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""on of values (Mann-Whitney Test, Kruskal-Vallis-test). The significance level was defined as  P  < 0.05. Statistical analysis was performed using the SPSS \u00ae  statistical software (IBM Company, SPSS Inc. Chicago Illinois)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
39601046,10.1080/17501911.2024.2430170,Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.,Epigenomics,2024,408,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on nerve tissues. NF1 is the most prevalent form, identified by neurofibromas and skin changes. NF1 is the most prevalent neurofibromatosis disorder, distinct from the rar"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis (NF) is identified as genetic disorder characterized by multiple tumors on nerve tissues. NF1 is the most prevalent form, identified by "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,Neurooncol Adv,2024,1115,11204,0,7,10,17,"{""cell_lines"": {""sNF02.2"": ""b72d99fd-ee1e-42ec-92b6-9f89e375cce1"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""JH-2-002"": ""1bc84ef2-208f-4f0e-8045-6be47fd968de"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""hTERT NF1 ipNF95.6"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""STAR"", ""clusterProfiler"", ""limma"", ""Trimmomatic"", ""FlowJo"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We engineered  NF1 -deficient iHSCs with loss of function  SUZ12  or  EED  mutations. RNA sequencing revealed 1327 differentially expressed genes to define PRC2-"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF02.2"": {""context"": ""SPR Edits analysis tool ( 16 https://ice.synthego.com ). We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC) with loss of function  NF1  mutations. Other MPNST cell lines and patient-derived xenografts (PDX) were"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""mutations. Other MPNST cell lines and patient-derived xenografts (PDX) were kindly provided by Dr Nancy Ratner (Cincinnati Children\u2019s Hospital) (26T, S462TY, ST88-14, MPNST724), the Characterized Cell Line Core Facility (MD Anderson) (MPNST007), and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:JH-2-002"": {""context"": ""he Characterized Cell Line Core Facility (MD Anderson) (MPNST007), and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL, JH-2-003 CL, JH-2-002 CL).  Cell lines and media are listed in  17\u201319 Supplementary Table S1 . Sample Preparation and RNA-seq Cell pellets of 3-4 million cells were collec"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""rence of CRISPR Edits analysis tool ( 16 https://ice.synthego.com ). We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC) with loss of function  NF1  mutations. Other MPNST cell lines and patient-derived xenograft"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""s. Other MPNST cell lines and patient-derived xenografts (PDX) were kindly provided by Dr Nancy Ratner (Cincinnati Children\u2019s Hospital) (26T, S462TY, ST88-14, MPNST724), the Characterized Cell Line Core Facility (MD Anderson) (MPNST007), and Dr Christine Pratilas (Johns Hopkins) (JH-2-055 CL, JH-2-079c CL,"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Methods We engineered  NF1 -deficient iHSCs with loss of function  SUZ12  or  EED  mutations. RNA sequencing revealed 1327 differentially expressed genes to define PRC2-regulat"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:hTERT NF1 ipNF95.6"": {""context"": ""dated using Western blotting and Synthego\u2019s Inference of CRISPR Edits analysis tool ( 16 https://ice.synthego.com ). We also utilized immortalized PN hTERT NF1 ipNF95.6 (iPNF) and MPNST cell lines (sNF96.2 and sNF02.2) from American Type Culture Collection (ATCC) with loss of function  NF1  mutations. Other MPNST cel"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""lm.nih.gov/geo/query/acc.cgi?acc=GSE263107 ) was trimmed and aligned with Trimmomatic and HISAT2 to the human genome (hg38). Reads were counted using featureCounts.  Differentially expressed genes were identified using DESeq2. 20  Inclusion criteria for differentially expressed genes were an absolute fold change"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""iferation Assay In 6-well plates, 20000 GOF cells were plated in duplicate. Cell counts were taken daily with a Countess for 5 days and plotted using GraphPad Prism software. Two-way ANOVA was used to determine significant differences in cell count between gene statuses. Quantitative RT-PCR RNA was extracted usin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""lysis and Pathway Analysis RNA-seq data ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263107 ) was trimmed and aligned with Trimmomatic and HISAT2 to the human genome (hg38). Reads were counted using featureCounts.  Differentially expressed genes were identified using DESeq2. 20  Inclusion crite"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" Strand Synthesis Kit (Invitrogen). Reverse transcription, qPCR reactions, and analysis were performed as previously described.  The dye used was FastStart SYBR Green Master (Sigma-Aldrich). qPCR reaction was performed on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad). Primer sequences are liste"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": "" less than 0.05. Pathway analysis was performed using EnrichR and gene set enrichment analysis (GSEA) as previously described with the R package,  21 clusterProfiler .  Significantly enriched pathways scored a  22\u201324 P -value less than .05 and FDR less than 0.25. Transcriptome files for patient samples were provid"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""filtering, normalization, and statistical testing were performed as previously described.  Differential methylation of probes was identified with  25 limma . Filtering and normalization were performed using  minfi . Average methylation of each gene was constructed using an average of beta values of each "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""e Expression Analysis and Pathway Analysis RNA-seq data ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE263107 ) was trimmed and aligned with Trimmomatic and HISAT2 to the human genome (hg38). Reads were counted using featureCounts.  Differentially expressed genes were identified using DESeq2. 20  Incl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""gen). Data were acquired using a CytoFLEX flow cytometer (Beckman Coulter) and 10\u2005000 single cells were analyzed per sample. Data were analyzed using FlowJo."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""with Trimmomatic and HISAT2 to the human genome (hg38). Reads were counted using featureCounts.  Differentially expressed genes were identified using DESeq2. 20  Inclusion criteria for differentially expressed genes were an absolute fold change of normalized read counts in pairwise comparison greater than"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF02.2"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:JH-2-002"": [""methods""], ""cell_lines:sNF96.2"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:NF1"": [""methods""], ""cell_lines:hTERT NF1 ipNF95.6"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:DESeq2"": [""methods""]}",False
39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,Genet Med Open,2024,1213,4648,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GATK"", ""BWA"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Prospectively, 134 patients presenting with a skin condition suspected of being genetic in origin were offered the next-generation variant exon screenin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""erage above 95%) and the sequencing Q30 accuracy was \u226590%. SNVs/indel variants and SNPs were called using version 3.8 of the Genome Analysis Toolkit (GATK). Annotation databases utilized included (1) human population databases, such as gnomAD ( http://gnomad.broadinstitute.org/ ), the 1000 Genome Projec"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""ncing data. For analysis of SNVs/indels and CNVs, FASTQ files were first aligned to the human reference genome (hg19) by the Burrows-Wheeler Aligner (bwa-0.7.15), and PCR duplications that cause bias in copy-number analysis were filtered out using Sambamba (v0.6.6) ( 17 https://github.com/biod/sambamba"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""]}",False
39731295,10.1093/neuonc/noae282,"Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumor.",Neuro Oncol,2025,1815,5210,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We examined the action mechanism of PRG-N-01, a candidate molecule for NF2-SWN, through the direct binding assay and mass spectrometry. For in vitro anti-proliferative experiments, primary"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""nalysis Statistical differences were assessed using the Student\u2019s  t -test or 1-way ANOVAs combined with the Dunnett\u2019s test for multiple comparisons (GraphPad Prism software, version 9.5.1).  P -values\u2005<\u2005.05 were considered significant."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
39749698,10.3892/ijo.2024.5716,SUCLG1 promotes aerobic respiration and progression in plexiform neurofibroma.,Int J Oncol,2025,1403,14810,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibromas (PNFs) are benign tumors that affect 20\u201150% of patients with type I neurofibromatosis (NF1). PNF carries a risk of malignancy. There is no effective cure for PNF. Its onset may be associated with genetic and metabolic abnormalities, but the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and methods Tissue collection and cell culture A total of three pairs of PNF and normal human skin tissue and four pairs of serum samples were ob"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""nd the concentration of the samples was calculated. Metabolic energy assay A total of 8 ml of 5\u00d710 4 /ml virus-infected cell suspension was plated on XF96 cell culture plates (Agilent Technologies, Inc.) and cultured at 37\u00b0C overnight. The probe plate was hydrated with XF Calibrant and placed in a non"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""se XFe96 Analyzer was used to measure oxygen consumption rate and extracellular acidification rate. Statistical analysis The data were analyzed using GraphPad Prism 9.4.1 (Dotmatics, Inc.). Data are presented as the mean and standard deviation, after three independent experimental replications. One-way ANOVA and "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""n (Sparkjade ECL plus, ED0016-B; Sparkjade) and ChemiDoc Imaging System (Bio-Rad Laboratories, Inc.) was used to quantify the expression of proteins. ImageJ 1.53e (National Institutes of Health) analyses the greyscale values and performs calculations. Immunofluorescence staining Tissues were fixed with 4%"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ng Solution (1:9 ratio) at 25\u00b0C for 30 min in the dark before loading into CytoFLEX S (Beckman Coulter, Inc.) for detection. Data were analyzed using FlowJo 10.8.1 (BD Biosciences). Transmission electron microscopy After washing with PBS, the virus-infected cells were pre-fixed with 3% glutaraldehyde at 4"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
39762421,10.1038/s41591-024-03361-4,Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.,Nat Med,2025,1529,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PNs). To evaluate whether similar outcomes were possible in adult patients, in whom PN growth is generally s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The MEK inhibitor selumetinib induces objective responses and provides clinical benefit in children with neurofibromatosis type 1 (NF1) and inoperable plexiform neurof"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39786423,10.1158/1078-0432.CCR-24-2807,"Triple Combination of MEK, BET, and CDK Inhibitors Significantly Reduces Human Malignant Peripheral Nerve Sheath Tumors in Mouse Models.",Clin Cancer Res,2025,1788,9492,0,7,7,14,"{""cell_lines"": {""NMS-2"": ""83512f26-8cc3-48db-8f66-1b490a943eb1"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""90-8"": ""0f404e70-2acf-4877-bcd5-6da81d9fa41e"", ""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""STS-26T"": ""9a7997c9-9399-47ed-b44b-5b717be89ba3""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""NanoDrop"", ""Salmon"", ""DESeq2"", ""pheatmap""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ingle agents and 147 pairwise co-treatments. Best combinations were validated in nine MPNST cell lines, and three were tested in one sporadic and one NF1-associated patient-derived orthotopic xenograft (PDOX) MPNST mouse model. A final combination of the three inhibitor classes was tested in the same P"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental Design: We performed a high-throughput screening in 3 MPNST cell lines testing 14 MEK inhibitors (MEKi), 11 cyclin-dependent kinase 4/6 inhibi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NMS-2"": {""context"": ""62 (RRID: CVCL_1Y70; ref.  24 ), sNF96.2 (RRID: CVCL_K281; ref.  25 ), ST88-14 (RRID: CVCL_8916; ref.  26 ), NF90-8 (RRID: CVCL_1B47; ref.  27 ), and NMS-2 (RRID: CVCL_4662; refs.  15 ,  28 ). The human foreskin fibroblast (HFF-1) cell line (Banco de C\u00e9lulas do Rio de Janeiro Cat. #0275, RRID: CVCL_3285)"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": "" cell lines (NF1-08, NF1-09, NF1-18B, and SP-10) were established in our lab (data not shown; ref.  12 ), whereas five were obtained from other labs: S462 (RRID: CVCL_1Y70; ref.  24 ), sNF96.2 (RRID: CVCL_K281; ref.  25 ), ST88-14 (RRID: CVCL_8916; ref.  26 ), NF90-8 (RRID: CVCL_1B47; ref.  27 ), and NM"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:90-8"": {""context"": "" five were obtained from other labs: S462 (RRID: CVCL_1Y70; ref.  24 ), sNF96.2 (RRID: CVCL_K281; ref.  25 ), ST88-14 (RRID: CVCL_8916; ref.  26 ), NF90-8 (RRID: CVCL_1B47; ref.  27 ), and NMS-2 (RRID: CVCL_4662; refs.  15 ,  28 ). The human foreskin fibroblast (HFF-1) cell line (Banco de C\u00e9lulas do Rio"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""B, and SP-10) were established in our lab (data not shown; ref.  12 ), whereas five were obtained from other labs: S462 (RRID: CVCL_1Y70; ref.  24 ), sNF96.2 (RRID: CVCL_K281; ref.  25 ), ST88-14 (RRID: CVCL_8916; ref.  26 ), NF90-8 (RRID: CVCL_1B47; ref.  27 ), and NMS-2 (RRID: CVCL_4662; refs.  15 ,  28 "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""lab (data not shown; ref.  12 ), whereas five were obtained from other labs: S462 (RRID: CVCL_1Y70; ref.  24 ), sNF96.2 (RRID: CVCL_K281; ref.  25 ), ST88-14 (RRID: CVCL_8916; ref.  26 ), NF90-8 (RRID: CVCL_1B47; ref.  27 ), and NMS-2 (RRID: CVCL_4662; refs.  15 ,  28 ). The human foreskin fibroblast (HFF-"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:STS-26T"": {""context"": ""roteins to tubulin, vinculin, or GAPDH. RNA extraction and RT-qPCR analysis Between 80,000 and 140,000 cells of six cell lines (S462, NF1-18B, SP-10, STS-26T, Sch-2, and NF1-09) were seeded in six-well plates and incubated overnight. Cells were either untreated, treated with I-BET151, or treated with ARRY-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ative expression. Primer sequences are provided in Supplementary Table S3B. Data analysis and representation were performed using Microsoft Excel and GraphPad Prism (version 7.03; RRID: SCR_002798). RNA sequencing The RNA sequencing (RNA-seq) library was prepared at BGI using DNBSEQ standard protocols. Data were "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" targeting MEK, CDK, or BRD4 (BET) were screened in S462, NF1-08, and NF1-09 cell lines. Briefly, compounds were tested in an 11-point dose-response (starting at a stock concentration of 10 mmol/L, until the maximum concentration of 46 \u00b5mol/L), and cell viability was measured using CellTiter-Glo (CTG) a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""d and RNA isolated using TRI Reagent and ethanol. Total RNA was extracted with the Direct-zol RNA MiniPrep kit (Zymo Research) and quantified using a NanoDrop 1000 (RRID: SCR_016517) spectrophotometer. RNA (0.5 \u00b5g) was reverse-transcribed using SuperScript III (Life Technologies). RT-qPCR was performed with"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""; RRID: SCR_002798). RNA sequencing The RNA sequencing (RNA-seq) library was prepared at BGI using DNBSEQ standard protocols. Data were aligned using Salmon v1.8.0 (RRID: SCR_017036; ref.  33 ) against the UCSC refMrna and hg38 genome. Transcript-level estimates were imported into R (R v4.3.0 Bioconductor"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""nt analysis (PCA) plot was generated. Differentially expressed genes in PRC2-inactivated MPNST cell lines treated with I-BET151 were identified using DESeq2 (RRID: SCR_015687; ref.  35 ) with the Wald test and apeglm (RRID: SCR_015687; ref.  36 ). Genes with an adjusted  P  value <0.05 were considered dif"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""peglm (RRID: SCR_015687; ref.  36 ). Genes with an adjusted  P  value <0.05 were considered differentially expressed. Heatmaps were created using the pheatmap package. The code used for generating the different bioinformatic analyses performed can be found at:  https://github.com/miriammagallon/RNA-seq_Sara"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NMS-2"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:90-8"": [""methods""], ""cell_lines:sNF96.2"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:STS-26T"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:Salmon"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:pheatmap"": [""methods""]}",False
39804140,10.1158/2767-9764.CRC-24-0386,"Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.",Cancer Res Commun,2025,2217,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ABSTRACT: NF1 encodes the multifunctional tumor suppressor protein, neurofibromin, which is best known for its causative role in neurofibromatosis type 1 and in re"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""ABSTRACT: NF1 encodes the multifunctional tumor suppressor protein, neurofibromin, which is best known for its causative role in neurofibromatosis type 1 a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,Sci Rep,2025,737,11538,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Patients and methods The diagnosis of NF2-related schwannomatosis was confirmed in all patients by clinical evaluation using the upda"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""ately to gain a comprehensive impression. Statistical analysis Statistical evaluation was performed using the Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.). The significance level was set to a  p-value\u2009\u2264\u20090.05  for all analyses. To obtain a size reference for the measured and "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
39840093,10.3389/fphar.2024.1454418,Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: insights from FAERS.,Front Pharmacol,2024,1365,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a rare neurogenetic disorder with limited treatment options. Selumetinib, a MEK1/2 inhibitor, has emerged as a promising therapy for inoperable N"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Neurofibromatosis type 1 (NF1) is a rare neurogenetic disorder with limited treatment options. Selumetinib, a MEK1/2 inhibitor, has emerged as a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39840811,10.1002/pro.70042,Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.,Protein Sci,2025,328,5997,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""5 MATERIALS AND METHODS 5.1 Modeling of  NF1  in complex with  GRD \n GTP \u2010bound K\u2010 Ras4B \n The crystal structure of wild\u2010type K\u2010Ras4B (GMPPNP\u2010bound) in complex with the GRD of NF1 (PDB ID: 6OB2)"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""5 MATERIALS AND METHODS 5.1 Modeling of  NF1  in complex with  GRD \n GTP \u2010bound K\u2010 Ras4B \n The crystal structure of wild\u2010type K\u2010Ras4B (GMPPNP\u2010bound) in compl"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,JAMIA Open,2025,1946,13006,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods EHR-derived data from pediatric subjects with a confirmed clinical diagnosis of NF1 were used to create 10 unique comorbidities code-derived feature sets by incorporating dimensionality reduction techniques using raw International Cl"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods EHR-derived data from pediatric subjects with a confirmed clinical diagnosis of NF1 were used to create 10 unique comorbidities code-"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""fic ICD10-CM codes were filtered out to prevent leakage of the outcome variable into the set of predictor variables. All feature sets were created by starting with the base ICD10-CM dataset (ICD10-1), removing the ICD10-CM codes corresponding specifically to the outcome variable, then mapping the remain"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
39857943,10.3390/cancers17020161,UBR5 in Tumor Biology: Exploring Mechanisms of Immune Regulation and Possible Therapeutic Implications in MPNST.,Cancers (Basel),2025,1917,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""response to therapy. The primary treatment remains surgical resection with negative margins. Nonetheless, in the setting of neurofibromatosis type 1 (NF1), the five-year survival rate is at 20-50%, with recurrence occurring in up to 50% of individuals. For patients with metastatic and unresectable dise"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a rare but aggressive soft-tissue sarcoma characterized by poor response to therapy. The primary treatment remai"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,NPJ Digit Med,2025,1135,7047,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ere carefully reviewed by a board-certified radiologist and a doctor within the plastic and reconstructive surgery department, both with expertise in NF1. Manual image segmentation and annotation Ground truth for the ROI region was manually established in all selected images. This task was completed by"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Study design and participants This multicenter study used MRI image sets from seven hospitals in China, including Shanghai Ninth People\u2019s Hospital, Shanghai Jiaotong Univ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""evelopment U-Net, a convolutional neural network (CNN), was utilized to perform automatic segmentation . The runtime environment for our model was on Python 3.7.1, and the model structure is illustrated in Fig.  30 3 . Among all included images, a batch consisted of 4 randomly selected slices. Each time, "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Python"": [""methods""]}",False
39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",BMC Chem,2025,303,10540,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Instrumentation A multi-mode microplate reader (Spectramax \u00ae  M5: Molecular Devices, California, USA) was used to measure the UV-VIS "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""rom Sigma-Aldrich (St. Louis, Missouri, USA). A 96-Microwell transparent plates used in the photometric assay application were sourced from Corning/Costar, Inc. (Cambridge, USA). Solvents and other chemicals were obtained from Sigma-Aldrich and Thermo Fischer Scientific (Waltham, Massachusetts, USA). Pr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,Sci Rep,2025,1802,17383,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {""Neurofibromin antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""GATK"", ""BWA"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Cell lines : ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace . To create an isogenic  28 NF1  null cell line, we utilized CRISPR Cas9 targeting of  NF1 exon 2  to create inactivating indels in  46 NF1  on both alleles  (Supplemental Fig.\u00a01 ) "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell lines : ipn97.4 immortalized human Schwann cells were obtained from Peggy Wallace . To create an isogenic  28 NF1  null cell lin"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""cDNA (WT) and variant tagged m Nf1  (G848R, R1276Q, R1809C, and delM992) in  NF1 null ipn97.4 human Schwann cells. Using previously generated data in HEK293 cells, we used empty vector (EV) controls to filter out non-specific PPIs . All lists from each individual pull down were compiled ( 29 Supplemental "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Neurofibromin antibody"": {""context"": "" 2\u00a0h. The gels were transferred onto a polyvinylidene difluoride (PVDF) membrane at 85\u00a0V for 2\u00a0h. Blots were probed overnight at 4\u00a0\u00b0C with either the neurofibromin antibody (Cell Signaling Technologies Cat. #: 14623\u00a0S; Danvers, MA, USA), or one of the selected antibodies for validation (details in  Supplemental Table 22 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": ""BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied to get more accurate base quality scores, which will in turn impro"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""s ToolKit (version 4.6.0) following their Best Practices Guidelines . In brief, BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""mmed sequence reads were further analyzed using Broad\u2019s Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines . In brief, BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle. Duplicate reads were removed with Pic"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""antibodies:Neurofibromin antibody"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:BWA"": [""methods""]}",False
39921490,10.1002/advs.202410909,NF2 is Essential for Human Endoderm Development.,Adv Sci (Weinh),2025,838,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Vertebrate embryogenesis requires the precisely timed specification of 3 germ cell layers- ectoderm, mesoderm, and endoderm- which give rise to tissues a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
39948669,10.1186/s13023-025-03590-x,How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.,Orphanet J Rare Dis,2025,1889,7712,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Data from a nationwide cross-sectional survey from Nov 2022 to Jan 2023 was used. A total of 154 caregivers for underage NF1 patients who completed the EQ-5D-Y proxy version, PedsQL 4.0 Generic Core Scales (PedsQL GCS) proxy version, and Zarit Burden Interview (ZBI-22) were"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Data from a nationwide cross-sectional survey from Nov 2022 to Jan 2023 was used. A total of 154 caregivers for underage NF1 patients who completed the EQ-5D"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
39952425,10.1016/j.exer.2025.110279,Sex-dependent variations of retinal function and architecture in a neurofibromatosis type I mouse model with normal vision.,Exp Eye Res,2025,195,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We aimed to characterize the structure and function of the early visual system of the neurofibromatosis type 1 (NF1) mouse model, a syndromic model of autism spectrum disorders (ASD). We used Nf1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We aimed to characterize the structure and function of the early visual system of the neurofibromatosis type 1 (NF1) mouse model, a syndromic model of autism spectrum"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39965929,10.1523/JNEUROSCI.1531-24.2025,Neurofibromin Deficiency Alters the Patterning and Prioritization of Motor Behaviors in a State-Dependent Manner.,J Neurosci,2025,654,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Genetic disorders such as neurofibromatosis type 1 (Nf1) increase vulnerability to cognitive and behavioral disorders, such as autism spectrum disorder and attention-deficit/hyperactivity disorder. Nf1 res"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Genetic disorders such as neurofibromatosis type 1 (Nf1) increase vulnerability to cognitive and behavioral disorders, such as autism spectrum disorder and attenti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,Sci Rep,2025,1339,8548,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Based on our initial trials with a dataset of 10 images, we determined that 150 MRI images were required for a ground truth data set to achieve the desired AI acc"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
39980445,10.1093/neuonc/noaf047,A molecular array for 10-second diagnosis of common spinal tumor types with picosecond infrared laser mass spectrometry.,Neuro Oncol,2025,1822,2534,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Through a retrospective study of  n \u2005=\u2005319 patient specimens, verified where appropriate by learning curve analysis to be sufficient for statistically si"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,CNS Neurosci Ther,2025,1142,4761,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2 Materials and Methods 2.1 Preparation of Meningeal Cells From Cas9 Transgenic Mice Twenty mice of Rosa26\u2010LSL\u2010Cas9 knockin were purchased from Jackson Labor"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
40000831,10.1038/s41588-025-02097-2,Cancer-independent somatic mutation of the wild-type NF1 allele in normal tissues in neurofibromatosis type 1.,Nat Genet,2025,1011,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ng on 479 tissue biopsies from a child with neurofibromatosis type 1, a multisystem cancer-predisposing syndrome mediated by constitutive monoallelic NF1 inactivation. We identified multiple independent NF1 driver variants in histologically normal tissues, but not in 610 biopsies from two nonpredispose"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Cancer predisposition syndromes mediated by recessive cancer genes generate tumors via somatic variants (second hits) in the unaffected allele. Second hits "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40025071,10.1038/s41420-025-02367-2,Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor.,Cell Death Discov,2025,1311,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Malignant peripheral nerve sheath tumor (MPNST) is a soft tissue sarcoma commonly associated with the tumor-predisposition disorder neurofibromatosis 1. The extrac"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,Acta Neuropathol Commun,2025,1964,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) and schwannomatosis (SWN) are rare genetic disorders with distinct genetic etiologies. Both syndromes are predominantly characterized by the develop"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) and schwannomatosis (SWN) are rare genetic disorders with distinct genetic etiologies. Both syndromes are predominantly cha"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40034205,10.1016/j.omtn.2025.102475,The evolving landscape of NF gene therapy: Hurdles and opportunities.,Mol Ther Nucleic Acids,2025,1092,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1)- and NF2-related schwannomatosis are rare autosomal dominant monogenic disorders characterized by a predisposition for nerve-associated tumors. Curr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1)- and NF2-related schwannomatosis are rare autosomal dominant monogenic disorders characterized by a predisposition for nerv"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40063513,10.1158/1078-0432.CCR-24-3029,DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.,Clin Cancer Res,2025,1988,196,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Experimental design: Here we perform an integrated analysis of multiple, independent datasets obtained from human NF1 patients to gain critical insight into PNST evolution and MPNST heterogeneity."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Experimental design: Here we perform an integrated analysis of multiple, independent datasets obtained from human NF1 patients to gain critical insight int"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
40075752,10.3390/cancers17050905,Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation.,Cancers (Basel),2025,228,6356,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""(Proteome Profiler Mouse XL Cytokine Array, R&D Systems, Minneapolis, MN, USA). In brief, protein lysates were prepared from the paraspinal tumors of Nf1 f/f ; DhhCre mouse neurofibromas, which exhibited a global deletion of either GM-CSFR-\u03b1 or GM-CSFR-\u03b2c. The arrays were conducted according to the ins"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Mice GM-CSFR-\u03b1 and the GM-CSFR \u03b2 c  knockout mice on a C57BL/6 background were a kind gift from Bruce C. Trapnell (CCHMC). Mouse"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""multiple comparisons as appropriate. A  p -value < 0.05 is considered significant. Generation of graphs and statistical analyses were performed using GraphPad Prism v.10."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""d and dorsal root ganglia (DRG) in 7-month-old mice. Image snapshots of dissected spinal cords with the attached nerves were taken and analyzed using ImageJ. (V.1.53k). A DRG with a diameter >1 mm, measured parallel to the spinal axis, was defined as a tumor. 2.3. Immunofluorescence (IF) and Immunohistoch"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""2, Biolegend), and several others. Samples were analyzed with the Aurora cell multiparametric flow analyzer (Cytek Biosciences, Fremont, CA, USA) and FlowJO_V10 or SpectroFlo 3.3.0 software. 2.5. Mouse Cytokine Array Analysis Mouse cytokine protein expressions were quantified using a mouse cytokine array "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
40087579,10.1186/s11689-025-09599-4,Disrupted visual attention relates to cognitive development in infants with Neurofibromatosis Type 1.,J Neurodev Disord,2025,1946,9192,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We report data from 28 infants with NF1 tested longitudinally at 5, 10 and 14\u00a0months compared to cohorts of 29 typical likelihood infants (with no history of NF1 or ASD and/or ADHD), and 12"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We report data from 28 infants with NF1 tested longitudinally at 5, 10 and 14\u00a0months compared to cohorts of 29 typical likelihood infants (with no history"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" stimulus (PS) presented pseudo-randomly at one side of the screen, at distance of\u2009~\u200920\u00b0 of visual angle (at a viewing distance of 60\u00a0cm). Each trial started with the onset of a central stimulus (CS), a cartoon image of an analogue clock accompanied by an alerting sound. After a 200\u00a0ms period had elapse"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
40127956,10.1101/gad.352629.125,Cognition and behavior in neurofibromatosis type 1: report and perspective from the Cognition and Behavior in NF1 (CABIN) Task Force.,Genes Dev,2025,239,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) are prone to the evolution of neurodevelopmental symptomatology including motor delays, learning disabilities, autism, and attention deficits. Cause"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Individuals with neurofibromatosis type 1 (NF1) are prone to the evolution of neurodevelopmental symptomatology including motor delays, learning disabilities, autism, and "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40128216,10.1038/s41598-025-94517-w,The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors.,Sci Rep,2025,1347,6516,0,4,15,19,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""bedtools"", ""featureCounts"", ""R"", ""STAR"", ""SAMtools"", ""Fiji"", ""clusterProfiler"", ""Trimmomatic"", ""FlowJo"", ""DESeq2"", ""ImageJ"", ""ComplexHeatmap"", ""bowtie2"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""sly shared by Dr. Jeffrey Field. The JH-2\u2013002, JH-2\u2013031, JH-2-079c, and JH-2\u2013103 patient-derived MPNST cell lines   originated from the Johns Hopkins NF1 biospecimen repository 53  and were shared under Material Transfer Agreement from Johns Hopkins University. Other cell lines were cultured in high gl"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell culture The S462 and MPNST724 cell lines were graciously provided by Dr. Raphael Pollock. Additionally, the ST88-14, T265, 90\u20138,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""Materials and methods Cell culture The S462 and MPNST724 cell lines were graciously provided by Dr. Raphael Pollock. Additionally, the ST88-14, T265, 90\u20138, and STS26T cell lines were generously shared by Dr. Jeffrey Field. The JH-2\u2013002, JH-2\u2013031, JH-2-079c, and JH-2\u2013103 patient-derived MPNST"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""Materials and methods Cell culture The S462 and MPNST724 cell lines were graciously provided by Dr. Raphael Pollock. Additionally, the ST88-14, T265, 90\u20138, and STS26T cell lines were generously"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""Materials and methods Cell culture The S462 and MPNST724 cell lines were graciously provided by Dr. Raphael Pollock. Additionally, the ST88-14, T265, 90\u20138, and STS26T cell lines were generously shared by Dr. Jeffrey Field. The JH-2\u2013002, JH-2\u2013031, JH-2-079c, and JH-2\u2013103 patient-derived MPNST cell "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": "" done by Azenta Life Sciences and reads were trimmed using the fastp command in fastp v.0.23.4. Reads were aligned with GRCh38 reference genome using bowtie2 v.2.4.2. Sam files were filtered to retain the mapped reads only and converted to BAM files using Samtools v.1.12. Bed and Bedgraph files were creat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bedtools"": {""context"": "". Sam files were filtered to retain the mapped reads only and converted to BAM files using Samtools v.1.12. Bed and Bedgraph files were created using Bedtools v.2.31.0. Peaks were called using Macs2 v.2.2.7.1 with the nomodel, and nolambda options. Bam files were normalized using RPKM to create BigWig files"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""ing Trimmomatic v.0.36. Reads were mapped to the GRCh38 reference genome using STAR aligner v.2.5.2b. Unique gene hit counts were calculated by using featureCounts from the Subread package v.1.5.2. Counts were used for differential analysis using DESeq2. The Wald test was used to generate p-values and log2 fold "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""Life Sciences. Reads were trimmed and low-quality reads were removed using Trimmomatic v.0.36. Reads were mapped to the GRCh38 reference genome using STAR aligner v.2.5.2b. Unique gene hit counts were calculated by using featureCounts from the Subread package v.1.5.2. Counts were used for differential a"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""as done using ggrepel. GO Plots were generated using the enrichGO and dotplot commands in clusterProfiler v4.12.0  56 . Motif analysis was done using Samtools v.1.12 and homer v.4.1 using the findmotif.pl command searching for motifs within -400 to 100\u00a0bp of TSS. 57 Kaplan Meier survival curves Kaplan Meier"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""using the Nikon Eclipse E400 microscope and SPOT Advanced software. Five images at 20X were captured for each membrane. Image analysis was done using Fiji ImageJ using the method previously described . A total of three biological replicates were done with three technical replicates done for each experim"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""1. Volcano plots were generated using ggplot2 and labeling was done using ggrepel. GO Plots were generated using the enrichGO and dotplot commands in clusterProfiler v4.12.0  56 . Motif analysis was done using Samtools v.1.12 and homer v.4.1 using the findmotif.pl command searching for motifs within -400 to 100\u00a0bp"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""us Mini Kit (Qiagen). RNA-seq Library was prepared and sequenced by Azenta Life Sciences. Reads were trimmed and low-quality reads were removed using Trimmomatic v.0.36. Reads were mapped to the GRCh38 reference genome using STAR aligner v.2.5.2b. Unique gene hit counts were calculated by using featureCounts f"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""sciences) according to the manufacturer\u2019s recommendations. Flow cytometry data was analyzed using SpectroFlo (v2.2) provided by Cytek Biosciences and FlowJo software (v10.10). RNA extraction S462, T265, MPNST724, and STS26T cells were treated for 24\u00a0h with 1\u00a0\u03bcM Corin or DMSO control treatment. RNA was ext"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": "".2b. Unique gene hit counts were calculated by using featureCounts from the Subread package v.1.5.2. Counts were used for differential analysis using DESeq2. The Wald test was used to generate p-values and log2 fold changes. Genes with an adjusted p-value\u2009<\u20090.05 and absolute log2 fold change\u2009>\u20091 were call"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" the Nikon Eclipse E400 microscope and SPOT Advanced software. Five images at 20X were captured for each membrane. Image analysis was done using Fiji ImageJ using the method previously described . A total of three biological replicates were done with three technical replicates done for each experiment. 58"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": ""change\u2009>\u20091 were called as differentially expressed genes for each comparison. Heatmap and hierarchical clustering for the RNA-seq was generated using ComplexHeatmap v.2.20.0  . PCA analysis was done using ggfortify v.4.4.1. Volcano plots were generated using ggplot2 and labeling was done using ggrepel. GO Plots w"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": "" done by Azenta Life Sciences and reads were trimmed using the fastp command in fastp v.0.23.4. Reads were aligned with GRCh38 reference genome using bowtie2 v.2.4.2. Sam files were filtered to retain the mapped reads only and converted to BAM files using Samtools v.1.12. Bed and Bedgraph files were create"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""ring for the RNA-seq was generated using ComplexHeatmap v.2.20.0  . PCA analysis was done using ggfortify v.4.4.1. Volcano plots were generated using ggplot2 and labeling was done using ggrepel. GO Plots were generated using the enrichGO and dotplot commands in clusterProfiler v4.12.0  56 . Motif analysis "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:bedtools"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:ComplexHeatmap"": [""methods""], ""computational_tools:bowtie2"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
40140675,10.1038/s41467-025-57586-z,Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma.,Nat Commun,2025,1140,14341,0,1,6,7,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""NanoDrop"", ""scanpy"", ""ImageJ"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Ethics Research performed in this study complies with all relevant ethical regulations: Approved by the Health Research Authority (HRA) and Health and Care Re"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""ssion of known cell types and states. Single-cell metrics for each population were extracted for each ROI, and used to calculate cell abundance. 82 Maxfuse IMC and scRNA-seq integration We accessed a publicly available (Gene Expression Omnibus  GSE216783 ) single-cell RNA sequencing (scRNA-seq) datase"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" arrangement of spatial clusters within ROIs, indicating neighbourhood enrichment between clusters. Statistics Statistical tests were performed using GraphPad Prism (v9.5.1). Data distribution was assessed by Shapiro-Wilk normality test. Differences in cell abundances between two groups (Antoni A versus Antoni B;"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""hey did not require chelating polymer due to the intercalative nature of cisplatin. Final concentrations of conjugated antibodies were determined via Nanodrop (Thermofisher), followed by reconstitution with Antibody Stabilisation Solution (Candor Bioscience, Germany), and stored at 4  71 o C. IMC staining S"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scanpy"": {""context"": ""ageJ. Single-cell analyses of IMC data The single-cell expression data was interrogated in Python using packages devised to analyse single-cell data (Scanpy v1.9.3 ) and spatial data (Squidpy v1.2.3 77  and ATHENA v0.1.0 78 ). Mean cell intensity of each marker was normalised to the 99.9 79 th  percentile"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""lides were imaged with a 3D Histech Pannoramic P25020X using a 20\u00d7 objective in brightfield and fluorescence (for DAPI) and analysed using QuPath and ImageJ. Single-cell analyses of IMC data The single-cell expression data was interrogated in Python using packages devised to analyse single-cell data (Scan"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""nd fluorescence (for DAPI) and analysed using QuPath and ImageJ. Single-cell analyses of IMC data The single-cell expression data was interrogated in Python using packages devised to analyse single-cell data (Scanpy v1.9.3 ) and spatial data (Squidpy v1.2.3 77  and ATHENA v0.1.0 78 ). Mean cell intensity "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:scanpy"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
40168468,10.2106/JBJS.24.01007,Molecular Evidence Supporting MEK Inhibitor Therapy in NF1 Pseudarthrosis.,J Bone Joint Surg Am,2025,1427,5400,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods: Primary cells cultured from control bone or fracture pseudarthroses from children with NF1 were treated with vehicle or with the MEK inhibitors trametinib or selumetinib. Gene expression was evaluated with use of transcriptome sequencing (R"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: Primary cells cultured from control bone or fracture pseudarthroses from children with NF1 were treated with vehicle or with the MEK inhibitors trametin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" S1). Target specificity was confirmed on a melting curve analysis. Statistical analyses were performed using a 1-way analysis of variance (ANOVA) in GraphPad Prism. Western Blotting Protein was extracted from primary cells using radioimmunoprecipitation assay (RIPA) buffer with Halt protease inhibitor cocktail ("", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""uencing on an Illumina NovaSeq X Plus generating paired-end 150-bp reads. Sequence reads were mapped to the human reference genome (hg38) with use of STAR (version 2.7.8) . Alignments were filtered to remove duplicates, singleton reads, and unaligned reads. Gene expression was quantified using the Ensem"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""g the Ensembl database (EMBL-EBI; release 109). The expression levels of protein-coding transcripts were normalized using the median ratio method for DESeq2 analysis 26 . Significant differences were determined using DESeq2. All analyses were conducted using Partek Flow software. Differentially expressed "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ding to the recommendation of the manufacturer. Images were acquired using an Odyssey CLx system (LI-COR Biotech). Quantification was performed using ImageJ software (National Institutes of Health) and is represented as the mean and standard error of the mean (SEM). The statistical analysis (1-way ANOVA) "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40169570,10.1038/s41467-025-57077-1,A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations.,Nat Commun,2025,1148,18175,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s across all samples was calculated in PLINK 54  using a minimum PI_HAT cutoff of 0.09375 to capture out to 3rd degree relationships. None of the  55 NF1  PV carriers that we identified were 3 rd  degree relatives or closer. PMBB variant annotation The genetic variants in PMBB exome sequencing data wer"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Informed consent All patients signed informed consent forms for inclusion in the respective biobanks that our data were drawn from. For the recall study in"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""e. Only variants affecting the NCBI RefSeq canonical  NF1  transcript ( NM_001042492.2 ) were considered. Copy number variants (CNVs) were annotated, starting with the same exome sequencing data as described above, using version 1.3 of the CLAMMS pipeline . Standard quality control measures were taken b"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
40188079,10.1186/s13287-025-04281-x,"Interactions among Merlin, Arkadia, and SKOR2 mediate NF2-associated human Schwann cell proliferation.",Stem Cell Res Ther,2025,1311,11178,0,1,2,3,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Herein, we utilized a human induced pluripotent stem cell (hiPSC)-based Schwann cell (SC) model to investigate the role of Merlin in human SCs. SCs were "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""ere normalized with Renilla readouts prior to the statistical analysis. Lentivirus generation and infection Lentivirus were generated by transfecting HEK293T cells (Takara) with lentiviral plasmids using the Lenti-vpak packaging kit (Origene) following the manufacturer instruction. Lentiviral plasmids car"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" overtime on 1, 4, and 7 days of culture in 24 well plates. Cell number was counted based on DAPI staining in 8 different samples per cell line using ImageJ. Cell cycle analysis Cells were plated in 24 well plates. Cells underwent 24\u00a0h in the culture medium containing 0.1% FBS followed by 24\u00a0h in the medi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",G3 (Bethesda),2025,1824,10295,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""NanoDrop"", ""bowtie"", ""R"", ""bowtie2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:XF"": {""context"": ""re quantified with the Quant-iT TM  PicoGreenTM dsDNA and Qubit TM  dsDNA High Sensitivity kits (ThermoFisher Scientific, Waltham, MA, USA) used for Oxford Nanopore and Pacific biosciences (PacBio) runs, respectively. The concentrations (A260/A280) and purity (A260/A230) of DNA were determined using a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Herd maintenance The animal protocols related to this work were approved by the Institutional Animal Care and Use Committee at the Un"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""2022-02 ( Shumate and Salzberg 2021 ). Gene diversity analysis The draft WMS TM  genome and annotation files produced here were interrogated for the  NF1  (neurofibromin) and  AHR  (aryl hydrocarbon receptor) genes. For each putative WMS TM  gene, we extracted the entire annotated gene sequence and ali"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""rd Nanopore and Pacific biosciences (PacBio) runs, respectively. The concentrations (A260/A280) and purity (A260/A230) of DNA were determined using a NanoDrop TM  One spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA). Finally, the sizing and quality of diluted samples were assessed using the Fem"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""ide polymorphism (SNP) genotypes ( et al . 2014 Glaubitz  ). Briefly, demultiplexed reads were aligned to the WMS et al . 2014 TM  draft genome using Bowtie2 ( Langmead and Salzberg 2012 ). The Tassel pipeline was then used to identify potential tags in the aligned SAM files compared to the WMS TM  refere"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": ""ide polymorphism (SNP) genotypes ( et al . 2014 Glaubitz  ). Briefly, demultiplexed reads were aligned to the WMS et al . 2014 TM  draft genome using Bowtie2 ( Langmead and Salzberg 2012 ). The Tassel pipeline was then used to identify potential tags in the aligned SAM files compared to the WMS TM  referen"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:XF"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:bowtie2"": [""methods""]}",False
40214469,10.3390/cells14070515,Galectin-1 Inhibition as a Strategy for Malignant Peripheral Nerve Sheath Tumor Treatment.,Cells,2025,1304,11413,0,2,3,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""DESeq2"", ""limma"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an inherited disorder that predisposes individuals to malignant peripheral nerve sheath tumors (MPNSTs), a highly aggressive sarcoma with limited"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Cell Lines The cell lines used in this study include MPNST-derived cell lines NF02.2 and NF96.2, as well as HEK293T. These cells"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""2. Materials and Methods 2.1. Cell Lines The cell lines used in this study include MPNST-derived cell lines NF02.2 and NF96.2, as well as HEK293T. These cells were cultured in DMEM containing 10% fetal bovine serum and 1% penicillin/streptomycin, and maintained in a 5% CO 2  atmosphere at 37 \u00b0"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""ere identified using a 1.5-fold change threshold and a significance level of  p  < 0.05. For normalization, raw RNA-seq data were processed using the DESeq2 package to account for sequencing depth and library size. The data were normalized to ensure comparability across samples. Volcano plots were generat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""titute.org/gsea/index.jsp , accessed on 27 February 2022), following previously established protocols [ 24 ]. Genes were ranked according to shrunken limma log2 fold changes, and the GSEA tool was run in \u201cpre-ranked\u201d mode with all default settings. 2.12. Statistics Analysis In vitro experiments were perf"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:limma"": [""methods""]}",False
40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,Genome Med,2025,1254,17605,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Here, we prospectively profile by single-cell full-length transcriptomics tumors from 22 patients with  NF2 -related schwannomatosis, non- NF2 -related s"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,Hum Mutat,2023,94,5354,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ording to standard diagnostic protocols. 2.2. Patient Assessment and Selection of Variants for Testing The Erasmus MC Department of Clinical Genetics NF1/LS cohort consists of >4900 index cases suspected of NF1 or LS based on the international clinical diagnostic criteria [ 25 ] for whom DNA has been s"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Editorial Policies and Ethical Considerations Informed consent was provided by all subjects, as required by the institutional re"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
40240141,10.1101/gad.352508.124,IRX2 and NPTX1 differential regulation of -catenin underlies MEK-mediated proliferation in human neuroglial cells.,Genes Dev,2025,77,7238,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""BJFF.6"": ""8a213a9d-392b-4746-8f59-c12f753d9217""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Human induced pluripotent stem cell culture and differentiation NF1 patient homozygous and heterozygous germline  NF1  gene (transcri"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Materials and methods Human induced pluripotent stem cell culture and differentiation NF1 patient homozygous and heterozygous germline  NF1  gene (transcript ID  NM_000267 ) mutations (c.2041C > T; c.6513T > A) were CRISPR/Cas9-engineered "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:BJFF.6"": {""context"": ""t ID  NM_000267 ) mutations (c.2041C > T; c.6513T > A) were CRISPR/Cas9-engineered into a single commercially available male control human iPSC line (BJFF.6) by the Washington University Genome Engineering and iPSC Core Facility (GEiC) ( Anastasaki et al. 2022 ). Homozygous mutations were confirmed by NGS"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" a minimum of three independently generated biological replicates. Quantification and statistical analysis All statistical tests were performed using GraphPad Prism 10 software, two-tailed Student's  t -tests, one-way analysis of variance (ANOVA) with Bonferroni posttest correction, or two-way ANOVA using GraphPa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:BJFF.6"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
40279245,10.1016/j.celrep.2025.115625,Loss of neurofibromin induces inflammatory macrophage phenotypic switch and retinal neovascularization via GLUT1 activation.,Cell Rep,2025,814,22319,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""10CM"": ""423cc0f3-8a43-4e10-a9a4-d529aa78f022"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ological variable Both male and female mice were used for all  in vitro  and  in vivo  studies. Tissue samples from both male and female persons with NF1 were analyzed. Sex was not considered as a biologic variable for any studies. Cells Murine bone marrow-derived macrophages (BMDM), and human THP-1-de"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials availability This study did not generate new materials or unique reagents. STAR\u2605METHODS EXPERIMENTAL MODEL AND STUDY PARTICIPANT DETAILS Sex as a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:10CM"": {""context"": ""CSF (20 ng/mL) and 1% penicillin/streptomycin). After thoroughly being pipetted to obtain a single cell suspension, the bone marrow was plated on 3 \u00d7 10cm petri dishes (uncoated). This was determined to be day 1. On day 3, the media was removed from the plates and replaced with fresh differentiation med"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""omycin (ThermoFisher Scientific) was replaced for 3 days. Selected cells were cultured and  40 NF1  knockdown was confirmed by Western blot. Seahorse XF glycolysis stress test Cellular bioenergetics were measured using an XF96 analyzer (Agilent Seahorse XF Technology, Santa Clara, CA). Macrophages (tr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ukey\u2019s or Sidak\u2019s or Dunnette\u2019s post hoc test for multiple comparisons and two-tailed Student\u2019s t-test was used to compare pairs of data groups using GraphPad Prism. In all figures, data are expressed as mean \u00b1 SD values. Figures representing  in vitro  technical replicates are presented as mean \u00b1 SEM values; (* "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""Pearson\u2019s correlation coefficient for co-localization of F4/80 with CD86 or CD206 was calculated using Just Another Colocalization plugin (JA-CoP) in ImageJ software. Flow cytometry Cells were stained according to the protocol described previously by Zaidi et al.  Briefly, retinas from  48 Nf1 f/f  and  N"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""Materials availability This study did not generate new materials or unique reagents. STAR\u2605METHODS EXPERIMENTAL MODEL AND STUDY PARTICIPANT DETAILS Sex as a biological variable Both male and female mice were used for all  in vitro  and  in "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:10CM"": [""methods""], ""cell_lines:XF"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
40291747,10.1101/2024.09.11.612546,High-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells.,bioRxiv,2025,276,12479,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""CellProfiler"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods: Cell Lines We derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We started by isolating sin"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: Cell Lines We derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We sta"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""pplementary Figure 6 ). Poor-quality images included large smudges and/or debris, out-of-focus organelles, and over-saturated organelles. We utilized CellProfiler\u2019s image quality metrics to decide two image quality features best distinguished between poor and good quality images: Power Log Log Slope (to represe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We started by isolating single-cell clones of the parental line by sorting with the BD FACSAria III (BD Biosciences). From a monoclonal derived cell line (wh"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
40299482,10.3390/biomedicines13040907,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,Biomedicines,2025,0,3156,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""bromatosis type 1 were as follows: Being between 2 and 12 years of age. Having a definite diagnosis of neurofibromatosis type 1. Individuals with non-NF1-related neurological diagnoses (i.e., epilepsy secondary to a known unrelated etiology, neurodegenerative disorders, neuropsychiatric diseases uncomm"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Study Population In the following observational case\u2013control study, 50 children affected by neurofibromatosis type 1 and admitte"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
40304934,10.1186/s41687-025-00877-2,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,J Patient Rep Outcomes,2025,2726,3321,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods For this multi-site, qualitative study, 56 individuals (26 children, 6\u201316 years; 30 adults, 18\u201368 years) with NF1 and pNF participated in a focus group and/or individual interview about pain intensity and pain interference (concept elicitation) and also provided "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods For this multi-site, qualitative study, 56 individuals (26 children, 6\u201316 years; 30 adults, 18\u201368 years) with NF1 and pNF participated in a focus group a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
40342626,10.1097/PR9.0000000000001285,Clinical characterization of neuropathic pain and small fiber impairment in neurofibromatosis.,Pain Rep,2025,1502,10125,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods: In this case-control study, we enrolled 51 patients who fulfilled the diagnostic criteria for neurofibromatosis type 1 (NF1), NF2-related schwannomatosis (SWN-NF2), and schwannomatosis-not otherwise specified (SWN-NOS). Patients completed validated questionnaires for pain "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: In this case-control study, we enrolled 51 patients who fulfilled the diagnostic criteria for neurofibromatosis type 1 (NF1), NF2-related schwannomatosis (SWN-NF2), and"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" role of generalized small fiber dysfunction in the context of neuropathic pain. 28 2.5. Statistical analysis We conducted statistical analyses using SPSS 26 software (IBM, Ehningen, Germany). The main outcome variables of the study were SFI, assessed by IENFD, CCM parameters, QST, and pain scores. Data"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""]}",False
40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,Cureus,2025,1639,2850,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Following institutional board review approval, a retrospective chart review was conducted of all patients presenting with cranial men"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""rating characteristic (ROC) curve was conducted to evaluate the predictive ability of the proposed model. All statistics and models were conducted in Python version 3.10 (Python Software Foundation, Wilmington, Delaware, US)."", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Python"": [""methods""]}",False
40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,Br J Cancer,2025,1379,11154,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene Ontology (GO)"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods We collected 15 cNFs from four NF1 individuals and used mass spectrometry to compare the tumor tissue with the skin overlying each tumor. Data were analyzed based on Gene On"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,Eur Radiol Exp,2025,2147,6849,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods This prospective study included 20 NF1 patients (8 with neuropathic pain) and 28 healthy controls. Magnetic resonance imaging (MRI) scans of lumbosacral DRG (L5\u2009+\u2009S1) were performed using "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods This prospective study included 20 NF1 patients (8 with neuropathic pain) and 28 healthy controls. Magnetic resonance imaging (MRI) scans of lumbosacral DRG "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""dation for Statistical Computing 2024: R: A language for Data Analysis and Graphics, version 4.4.1, retrieved from:  https://www.r-project.org/ ) and GraphPad Prism (GraphPad Prism version 9.4.0, GraphPad Software). For descriptive statistics, all data is given as median (interquartile range) or number ( n ) (per"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": "". The slice orientation was aligned paracoronal through the DRG of the lumbar 5 (L5) and sacral 1 (S1) levels. Image postprocessing was performed via MATLAB (The MathWorks, Inc., 2024: MATLAB, version R2024a Update 3, retrieved from  https://www.mathworks.com/ ) using a custom-built script [ 25 ,  26 ]. M"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
40460210,10.2478/acph-2025-0013,Development of two different eco-friendly label-free platforms for analysis of selumetinib.,Acta Pharm,2025,310,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Selumetinib (SEL) is a recently approved medication for paediatric patients who have neurofibromatosis type 1. It is the first approved therapy for this rare, debilitating, a"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
40501799,10.1101/2025.05.30.657071,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning and increases cAMP-PKA signaling in a zebrafish model of Neurofibromatosis type 1.,bioRxiv,2025,124,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurogenetic disorder caused by loss of function mutations in the gene neurofibromin 1 ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurogenetic disorder caused by loss of function mutations in the gene neurofibromin 1 ("", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,Cancers (Basel),2025,550,27394,0,1,4,5,"{""cell_lines"": {""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""FlowJo"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Monoclonal Ab (mAb) Generation Immunogens for mouse immunization and substrates for downstream hybridoma selection were prepared"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""SPR Knockout MCF7 Cell Line Preparation MCF7 cells (1 \u00d7 10 6 ) were transfected with 1 \u00b5g of a 12:1 DNA ratio of the pCMV-T7-(FZ) SpCas9-BPNLS(SV40)-3xFLAG-P2A-Puro-R plasmid (modified from RTW3027, Addgene #139987) and a plasmid (derived from BPK1520, Addgene #65777) with a sgRNA targeting exon 5 of "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""finite plate reader according to the manufacturer\u2019s specification to determine cell death. The IC50s for each of the cell lines were determined using GraphPad Prism v8.3 (nonlinear regression and dose\u2013response curve fitting) and plotted against the % fold change of PRIMAB reading from baseline and at 1 h of treat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""tal BCLX-L]) were used. Acceptance for upper and lower limits were as described above. Event-free survival (EFS) was established as the time from the start of treatment to the occurrence of primary refractory disease, relapse, or death. Relapse was determined to occur when more than 5% blasts in the bon"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""on a Canto 2 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) as mean fluorescence intensities (MFI) in the selected gates. FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data. For analysis, both the MFI and the \u201cpriming ratio\u201d (PRIMAB MFI divided by co"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,JID Innov,2025,1626,4856,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Instruments to measure cNF stiffness We tested 2 different instruments for their ability to accurately and reproducibly measure cNF s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
40540562,10.1126/sciadv.adu0772,TGF-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.,Sci Adv,2025,581,20583,0,1,8,9,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""STAR"", ""DESeq2"", ""FastQC"", ""scanpy"", ""Salmon""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""MATERIALS AND METHODS Experimental animals Nf1 ; flox/flox PostnCre  mice were used for in vivo studies, with genotypes confirmed by polymerase chain reaction (PCR) as previously described ( + ,  "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Experimental animals Nf1 ; flox/flox PostnCre  mice were used for in vivo studies, with genotypes confirmed by polymerase chain react"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""rker genes and UMAP plots of  57 LAMB1  and  NID1  expression were generated in scanpy. Statistical analysis Statistical analyses were performed with GraphPad Prism v9.2 software (GraphPad, La Jolla, CA) or using the ggpubr package in R using the stat_compare_means() function. Unpaired Welch\u2019s  t  tests or one-wa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": "" were aligned to the human reference assembly (GRCh38) using the CellRanger pipeline v3.1.0 ( ). 54 The filtered feature-barcode matrix was passed to Seurat v4.0 ( ) for downstream analysis in R. Cells with <400 or\u00a0>3000 features were filtered to exclude empty droplets and doublets, respectively. Low-qual"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""sing a KAPA Stranded RNA-Seq Kit (Roche) with 10 cycles of amplification. FastQC-passed reads were aligned to the mouse reference genome (mm10) using STAR 2.4.2a ( \u2212 ), and reads were translated to transcriptome coordinates using Salmon 0.60 ( 50 ). Isoform data were collated to single-gene IDs using bi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""ne values were filtered to include only those with 10 or more reads in at least one sample. Differential gene expression analysis was conducted using DESeq2 ( 51 ) on counts data, while log 52 2  ( x \u00a0+\u00a04)\u2013transformed counts per million data were used for bar plot visualizations. Log 2  fold change ratios"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""2100. Total RNA (800 ng) was used as an input for cDNA library preparation using a KAPA Stranded RNA-Seq Kit (Roche) with 10 cycles of amplification. FastQC-passed reads were aligned to the mouse reference genome (mm10) using STAR 2.4.2a ( \u2212 ), and reads were translated to transcriptome coordinates using "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scanpy"": {""context"": ""d, non-PCR duplicates with valid barcodes and unique molecular identifiers were filtered to generate a gene-barcode matrix for downstream analysis in scanpy. Low-quality cells with less than 200 genes, genes expressed in less than three cells, and outlier cells with less than the 2nd percentile or greater"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""-passed reads were aligned to the mouse reference genome (mm10) using STAR 2.4.2a ( \u2212 ), and reads were translated to transcriptome coordinates using Salmon 0.60 ( 50 ). Isoform data were collated to single-gene IDs using biomaRt, and abundance estimates were upper quartile normalized. Gene values were fi"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:scanpy"": [""methods""], ""computational_tools:Salmon"": [""methods""]}",False
40563570,10.3390/cancers17121920,The RXR Agonist MSU-42011 Reduces Tumor Burden in a Murine Preclinical NF1-Deficient Model.,Cancers (Basel),2025,0,14915,0,1,6,7,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""NanoDrop"", ""FlowJo"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""9% purity) and bexarotene (>99% purity) were purchased from LC Laboratories (Woburn, MA, USA). 2.2. Cell Culture 2.2.1. Culture of Human Immortalized NF1 \u2212/\u2212  Schwann Cells, Murine Nf1-Related MPNSTs, and Murine Lewis Lung Carcinoma Cells (LL2) Human immortalized normal Schwann cells (ipn02.3 2\u03bb), non-"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Drugs MSU-42011 was synthesized (>95% purity) as described [ 30 ]. Selumetinib (>99% purity) and bexarotene (>99% purity) were p"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""strate (GE Healthcare, Chicago, IL, USA), and protein levels were quantified using ImageJ 5.2 (NIH, RRID:SCR_003070) and statistically analyzed using GraphPad Prism v10 (RRID:SCR_002798). 2.6. Cell Viability Human immortalized NF1 \u2212/\u2212  Schwann cells and primary murine Nf1 \u2212/\u2212  DNSCs were plated at a density of 15"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""CD16/CD32 antibody (Biolegend) to reduce antibody binding to Fc receptors. Cells were analyzed using Cytek Aurora and FlowJo v10.0.7r2 software (Tree Star). The gating strategy used is shown in  Figure S2 . 2.11. Triglyceride Assay Triglyceride levels in plasma were quantified using the Triglyceride Qua"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""ated cells was isolated with TRIzol (Invitrogen, Waltham, MA, USA), both per the manufacturer\u2019s instructions. RNA purity and quality were assessed by Nanodrop. Two micrograms of RNA were reverse transcribed to cDNA with the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific), following o"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ntific), and 5 \u03bcg/mL anti-mouse CD16/CD32 antibody (Biolegend) to reduce antibody binding to Fc receptors. Cells were analyzed using Cytek Aurora and FlowJo v10.0.7r2 software (Tree Star). The gating strategy used is shown in  Figure S2 . 2.11. Triglyceride Assay Triglyceride levels in plasma were quantif"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ignaling), a signal was detected using the ECL Western Blotting Substrate (GE Healthcare, Chicago, IL, USA), and protein levels were quantified using ImageJ 5.2 (NIH, RRID:SCR_003070) and statistically analyzed using GraphPad Prism v10 (RRID:SCR_002798). 2.6. Cell Viability Human immortalized NF1 \u2212/\u2212  Sch"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40567456,10.1016/j.ynirp.2025.100258,Non-invasive brain stimulation reorganises effective connectivity during a working memory task in individuals with Neurofibromatosis Type 1.,Neuroimage Rep,2025,2086,19185,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Eighteen adolescents with Neurofibromatosis Type 1 (NF1) completed a single-blind sham-controlled cross-over randomised tDCS trial (with the anode at F3 and cathode at Cz). Dynamic causal modelling was use"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Eighteen adolescents with Neurofibromatosis Type 1 (NF1) completed a single-blind sham-controlled cross-over randomised tDCS trial (with the anode at F3 and cathode at Cz). Dynamic"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""d cerebrospinal fluid (CSF) using SPM8 ( http://www.fil.ion.ucl.ac.uk/spm/ ). Voxel registration was performed using custom-made scripts developed in MATLAB by Dr. Nia Goulden, which can be accessed at  http://biu.bangor.ac.uk/projects.php.en . The scripts generated a mask for voxel location by combining "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:MATLAB"": [""methods""]}",False
40585258,10.21203/rs.3.rs-6865989/v1,Single-cell tumor microenvironment profiling informs a circulating proteome test for the interception of malignant transformation in NF1 nerve sheath tumors.,Res Sq,2025,1280,18223,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""Seurat"", ""STAR"", ""Cell Ranger"", ""infercnv""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""METHODS NF1 patients for scRNAseq Informed consent was obtained from all patients (or their legal guardians if the patients were minors). The collection of patie"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""METHODS NF1 patients for scRNAseq Informed consent was obtained from all patients (or their legal guardians if the patients were minors). The collection of patient tumor samp"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": "" and estimated doublets were removed before a count matrix was generated by merging the count matrices of all 114 capture lanes from 55 NF1 tumors in Seurat v4.0.4 63  for downstream integration and analysis. 63 , 64 Data integration and annotation for single cell populations in NF1 tumors After normaliza"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""g the embedded software Bcl2fastq v2.20.0. The demultiplexed fastq files were aligned to human genome GRCh37 in Cell Ranger v6.0.0 using the embedded STAR v2.7.2a. The generated count matrix from each capture lane was next corrected using SoupX  to correct the ambient RNA contamination in the data with "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""ing data analysis of NF1 nerve tumors Quality control and pre-processing Raw sequencing data after base calling using RTA v3.9.2 was demultiplexed in Cell Ranger v6.0.0 using the embedded software Bcl2fastq v2.20.0. The demultiplexed fastq files were aligned to human genome GRCh37 in Cell Ranger v6.0.0 using t"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:infercnv"": {""context"": ""ly set to the lower or upper limit for visualization purposes. Inference of copy number variation The gene expression matrix was used in the software inferCNV ( https://github.com/broadinstitute/inferCNV ) to predict copy number variations (CNV) in cells. Cells in the clusters that belong to the immune cell"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:infercnv"": [""methods""]}",False
40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",Proc Natl Acad Sci U S A,2025,3,16149,0,3,5,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""HISAT2"", ""FastQC"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" All constructs were validated by Sanger sequencing of the protospacer region. The following protospacers were used: sgNTC (GTGCACCCGGCTAGGACCGG), sg NF1 -1 (GGGATCCTTTCCACGGCCCG), sg NF1 -2 (GGTGGGGAGACGGCGCTAGT), sg PTPN11 -1 (GGAGGAACATGACATCGCGG), sg PTPN11 -2 (GGCAAGGAGCGGGTCCGTCG), sg SOS2 -1 (GC"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""als and Methods CRISPRi Cell Line Generation. Lentivirus containing pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene) was produced from transfected HEK293T cells with packaging vectors (pMD2.G #12259, Addgene, and pCMV-dR8.91, Trono Lab) following the manufacturer\u2019s protocol (#MIR6605, Mirus) as previou"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": "" at least 5 d. Cell Culture, Cell Viability Assays, and In Vitro Pharmacology. Patient-derived iPN, neurofibroma (NF95.11b), or human MPNST (JH002-2, ST88-14) cell lines were obtained from the Neurofibromatosis Therapeutic Acceleration Program or American Type Culture Collection. Mouse MPNST cell lines (JW"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods CRISPRi Cell Line Generation. Lentivirus containing pMH0001 (UCOE-SFFV-dCas9-BFP-KRAB, #85969, Addgene) was produced from transfected"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""www.bioinformatics.babraham.ac.uk/projects/fastqc/ ) as previously reported ( 6 ). Reads were mapped to the appropriate reference genome (hg19) using HISAT2 with default parameters ( 32 ). Transcript abundance estimation in transcripts per million (TPM) and differential expression analysis were performed "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""on an Illumina HiSeq 2500 or NovaSeq to a minimum depth of 25 M reads per sample at Medgenome, Inc. Quality control of FASTQ files was performed with FASTQC, and after trimming of adapter sequences, reads were filtered to remove bases that did not have an average quality score of 20 within a sliding windo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""default parameters ( 32 ). Transcript abundance estimation in transcripts per million (TPM) and differential expression analysis were performed using DESeq2 ( 33 ). Differentially expressed transcripts with an adjusted  P -value < 0.1 were identified and filtered based on an expression cutoff (TPM > 1) an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""175, 1:1000 dilution), SHP2 (Cell Signaling Technologies, #3397, 1:1,000 dilution), and SOS2 (Santa Cruz, sc-393667). Quantification was performed in ImageJ (NIH) using the relative densitometry between phosphorylated and total protein abundance from immunoblotting. qRTPCR. RNA was extracted from cell lin"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""cell_lines:HEK293"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""computational_tools:R"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,J Clin Invest,2025,1362,23794,0,4,3,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {""Neurofibromin antibody"": ""3e92d170-96f1-4be4-985c-d2ac15f5af6b""}, ""animal_models"": {""Nf1+/-"": ""d27fd7b0-ed8f-4ee2-a8d9-26748c12518c""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Sex as a biological variable Male  Nf1  mice were utilized for these studies due to their well-documented neurobehavioral phenotype ( +/\u2013 15 ). While our findings are likely applicable to "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1+/-"": {""context"": "" increased neurofibromin levels, suppressed Ras-dependent ERK phosphorylation, and corrected social learning deficits and impulsive behaviors in male Nf1+/- mice. Our results demonstrate that preventing the degradation of neurofibromin is a feasible and effective approach to ameliorate the neurodevelopmen"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Sex as a biological variable Male  Nf1  mice were utilized for these studies due to their well-documented neurobehavioral phenotype ( +/\u2013 15 ). While our findings are likely"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""ealing temperatures were 56\u00b0C and 59\u00b0C, respectively. For  Fbxw11  genotyping, primer F and reverse primer ttR were used (826 bp). fl/fl Cell culture HEK293T cells (American Type Culture Collection [ATCC], CRL-3216), HeLa cells (ATCC CCL-2), MEFs (generated in our laboratory), and human fibroblasts (ATCC,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Neurofibromin antibody"": {""context"": ""nd the bound material was eluted with Laemmi sample buffer. The relative levels of ubiquitylated neurofibromin were determined by immunoblotting with neurofibromin antibody (ab238142, Abcam) or ubiquitin antibody (no. 3933, Cell Signaling Technology). NanoBiT luciferase assays for GRDiso1/GRD1so2-FBXW11 interactions GRD1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""Western blot and in vitro assay experiments were performed at least in triplicate, and representative results are shown. Analysis was performed using GraphPad Prism version 5.0d (GraphPad Software). A  P  value of less than 0.05 was considered statistically significant unless stated otherwise. Baseline behavioral"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""s were taken (\u00d7200), and neurofibromin-immunoreactive (NF1-ir) cells and pERK-immunoreactive (pERK-ir) cells were counted by a blinded observer using ImageJ software (NIH). GFP-ir cells were used to quantify the injection targets. Neurofibromin staining. The primary antibody used was rabbit anti\u2013neurofibr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1+/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""antibodies:Neurofibromin antibody"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40617948,10.1038/s41598-025-07318-6,Unraveling novel variants in the NF1 gene and investigating potential therapeutic strategies.,Sci Rep,2025,1464,3232,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""Picard"", ""ComplexHeatmap"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Study design and population This study retrospectively analyzed 16 families with patients diagnosed with NF1 by genetic testing at Henan Provincial People\u2019s Hospital from February 2018 to October 2024. Peripheral blood of these family members was collected f"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Study design and population This study retrospectively analyzed 16 families with patients diagnosed with NF1 by genetic testing at He"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": "" mapped to the human reference genome (hg19) using Burrows-Wheeler Aligner (version 0.7.17) after quality control. Duplicated reads were processed by Picard (version 1.128). Genome Analysis Toolkit (version 3.5) and ANNOVAR were used to identify and annotate variants according to the information from the "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": ""sition. The group information of gender, neurofibromin domains, variant consequence, pathogenicity, and inheritance manner was drawn by the R package ComplexHeatmap using R (version 4.2.1). Retrospective analysis of clinical trials in the last 20\u00a0years \u201cClinic trials\u201d of \""neurofibromatosis type 1\"" were retrieved "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:Picard"": [""methods""], ""computational_tools:ComplexHeatmap"": [""methods""]}",False
40653509,10.1038/s41598-025-09751-z,Rare variants modulating phenotype in NF1 carriers.,Sci Rep,2025,1246,7049,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""BWA""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ly, over a period of three years. These patients were referred for various clinical reasons and were found to carry a pathogenic or likely pathogenic NF1 variant. The 32 patients included in our study were identified based on the presence of a pathogenic or likely pathogenic  NF1  mutation rather than "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Study design This study was conducted on a cohort of patients attending the Medical Genetics Unit in Siena, Italy, over a period of three years. These patients were referred for various clinical rea"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""equencing was conducted using the Illumina NovaSeq6000 System, and reads were aligned to the hg19 reference genome using the Burrows-Wheeler Aligner (BWA) with a mean target coverage depth of 100. The variant calling was performed using the Illumina DRAGEN Enrichment BaseSpace App and we consider PASS "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:BWA"": [""methods""]}",False
40661612,10.1101/2024.12.14.628525,High-Throughput Targeted Drug Screening for NF1-associated High-Grade Gliomas with ATRX Deficiency.,bioRxiv,2025,1540,7078,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR"", ""RStudio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""51 ATRX \u2212/2.02 , knockouts were utilized as previously generated in our study ( Yuan et al., 2022 ). NF-1 associated high grade glioma cell line, JHH-NF1-GBM1, previously stablished in our lab ( Yuan et al., 2022 ) was grown in DMEM/F12 containing 2mM GlutaMax (Gibco \u2122  #35050061), 1X B27 supplement (G"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Cell lines and culture conditions U251, initially derived from an adult glioblastoma patient, was purchased from the American Type Cu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""590. Fluorescence data were normalized to DMSO-treated controls, and cell viability was calculated. Nonlinear regression analysis was conducted using GraphPad Prism to generate dose-response curves and determine IC50 values for each compound. Comparisons of IC50 values were made across cell lines to assess compou"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""erformed according to the manufacturer\u2019s protocol and fluorescence was measured at excitation/emission wavelengths of 560 nm/590 nm using a BMG CLARIOstar multimode microplate reader. Cell viability for each well was calculated using the following formula:\n C e l l V i a b i l i t y = Fluorescence of tr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": "" C e l l V i a b i l i t y = Fluorescence of treated well Fluorescence of control well Control well represents the cells treated with vehicle (DMSO). RStudio was used for further data processing and visualization. Cell viability assay and IC50 determination To evaluate cell viability and determine the IC50"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:RStudio"": [""methods""]}",False
40666364,10.1101/2025.06.23.25328558,NF1-specific growth charts for head circumference over the first three years of life.,medRxiv,2025,1807,11131,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ethods: Using electronic health records from the Children\u2019s Hospital of Philadelphia, we collected head circumference measurements from children with NF1 and a community control cohort seen at scheduled well-child visits. We compared head circumference normed using Center for Disease Control (CDC) grow"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: Using electronic health records from the Children\u2019s Hospital of Philadelphia, we collected head circumference measurements from children with NF1 and a community "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" deviate systematically from CDC norms . Second, for neonatal head circumferences in premature infants, CDC growth charts are suboptimal because they start at birth and are not corrected for gestational age. To address these limitations, we also computed separate growth charts using the NF1 and well-chi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,Acta Neuropathol Commun,2025,1244,15407,0,1,7,8,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""STAR"", ""Cell Ranger"", ""scDblFinder"", ""RStudio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""e lines were used and genotyped as described in the original publications:  Prss56 Cre/Cre ,  R26 tdTom/tdTom ;  Prss56 Cre/Cre ,  R26 tdTom/tdTom ,  Nf1 flox/flox ;  Nf1 flox/flox ;  Nf1 +/\u2212 ; and B6D2F1 ( https://janvier-labs.com/en/fiche_produit/b6d2f1-mouse/ ). We bred  Prss56 Cre/Cre ,  R26 tdTom/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Animals The following mouse lines were used and genotyped as described in the original publications:  Prss56 Cre/Cre ,  R26 tdTom/tdT"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""es, and automatically processed for the proportion of tomato\u2009+\u2009SCs and MBP\u2009+\u2009myelinating SCs using specific Image J macros. Results were processed in GraphPad Prism 10 software and presented as mean +/- SEM. Skin processing for single cell RNA sequencing 3-hour dissociation protocol Animals were anesthetized, sha"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""ta set, which corresponded to one biological replicate from one experimental condition, was analyzed individually from its raw count matrix using the Seurat V3 package [ 29 ]. Cells with less than 2 6  UMIs or less than 600 genes were filtered out. Doublet cells were removed using the scDblFinder tool and"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" male mice, kept alone since weaning, were injected intraperitoneally with EdU at a dose of 20\u00a0\u00b5g/g of body weight twice a day for 4 consecutive days starting on postnatal day P45 and harvested 72\u00a0h later. Five  Nf1 -KO and four control mice were sacrificed, and their skin was dissected and fixed for 2\u00a0"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""uencing libraries, each of which was sequenced on a Nextseq500 Illumina flow cell. Bioinformatic analyses BCL files were processed using 10x Genomics Cell Ranger 7.0.1. Reads were mapped to a custom mouse transcriptome based on the GRCm39 release 108 transcriptome, to which we added sequences such as  tdTomato"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scDblFinder"": {""context"": ""rix using the Seurat V3 package [ 29 ]. Cells with less than 2 6  UMIs or less than 600 genes were filtered out. Doublet cells were removed using the scDblFinder tool and scds in hybrid mode. Then, cells with more than 20% of UMI related to mitochondrial genes or more than 40% related to ribosomal genes were f"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": ""ned two pipelines using Nextflow [ 10 ] and Singularity containerization [ 17 ]. Count matrices were processed from raw matrices to the figures using RStudio and Rmarkdown in order to generate fully traceable notebook for each analysis. To ensure version stability, a singularity container containing R vers"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:scDblFinder"": [""methods""], ""computational_tools:RStudio"": [""methods""]}",False
40707701,10.1038/s44321-025-00276-6,Pyrimidine addiction: an Achilles' heel of NF2-altered mesothelioma.,EMBO Mol Med,2025,376,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Therapeutic options for patients with mesothelioma remain scarce and five-year survival is a meager ten percent. According to data from three large studie"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
40713507,10.1186/s11689-025-09624-6,Distinct early development trajectories in Nf1() and Tsc2() mouse models of autism.,J Neurodev Disord,2025,1240,7383,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""elopmental milestones and maternal separation-induced ultrasonic vocalizations (USVs) in two genetic animal models of ASD, neurofibromatosis type 1 ( Nf1 \u00b1 ) and tuberous sclerosis complex 2 ( Tsc2 \u00b1 ). Methods Here, we studied the behavioral development and communication skills during the infancy of m"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Here, we performed a detailed analysis of neonatal developmental milestones and maternal separation-induced ultrasonic vocalizations (USVs) in two geneti"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""-USV interval duration, mean frequency and slope (frequency variation over time) were also analyzed. Statistical analyses All data was analyzed using GraphPad Prism version 8.0.1 (GraphPad Software, California, USA). Outliers were identified as values outside the mean \u00b1\u20093SD interval and were excluded. One- or two"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""c container, padded with tissue paper to help maintain body temperature. The pup was acclimated to the box for 2\u00a0min, after which the sound recording started with the condenser microphone placed 28 cm above the container's bottom and lasted 5\u00a0min. At the end of the test, the pup was returned to its home"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""2 points, 16-bit format, sampling frequency 250 kHz, time resolution 1\u00a0ms, frequency resolution 488 Hz, overlap 50%. USVs were further analyzed using MATLAB toolbox DeepSqueak version 2.6.1., which allowed the extraction of individual mouse USV calls by applying the Mouse Call_Network_V2 neural network, w"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:MATLAB"": [""methods""]}",False
40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,Cancers (Basel),2025,0,4083,0,1,2,3,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""the Medical College of Wisconsin. pNF tumors were generated in nude mice by transplanting tumor cells harvested from dorsal root ganglia with  DhhCre;Nf1  configuration. Following harvest, tumors were enzymatically dissociated into a single-cell suspension, and 5 \u00d7 10 f/f ;Luciferase 4  cells were inje"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""liper at Day 18 and calculated by \u00bd \u00d7 length \u00d7 width 2 . 2.4. Statistical Analyses All graph generation and statistical analyses were conducted using GraphPad Prism (v10.4.0; GraphPad Software, San Diego, CA, USA). Results are presented as mean \u00b1 standard error of the mean (SEM) of three independent biological re"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Drug Screen Analysis and Combination Prediction Drug screen data and pNF cell lines expression data were downloaded from the NFd"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:R"": [""methods""]}",False
40724874,10.3390/ijms26146628,Preclinical Evaluation of Repurposed Antimalarial Artemisinins for the Treatment of Malignant Peripheral Nerve Sheath Tumors.,Int J Mol Sci,2025,1446,6318,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Cell Culture Cells used in this study were maintained at 37 \u00b0C/5% CO 2  in DMEM supplemented with fetal bovine serum (10%, GemCe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": "" Children\u2019s Hospital (Cincinatti, OH, USA)). Immortalized Schwann cells (iHSC-1\u03bb and iHSC-2\u03bb), ipNF95.11bC (plexiform neurofibroma), and ipnNF95.11c (NF1 patient-matched Schwann cells) were kindly gifted from Margaret Wallace (University of Florida (Gainesville, FL, USA)). Cells were split twice weekly"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": "" Francisco, CA, USA), penicillin (penicillin (250 units mL \u22121 ), streptomycin (250 \u03bcg mL \u22121 ), and L-glutamine (2 mmol/L) (Gibco, Waltham, MA, USA)). S462TY and STS26T were kindly provided by Nancy Ratner (University of Cincinnati\u2014Cincinnati Children\u2019s Hospital (Cincinatti, OH, USA)). Immortalized Schwa"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""r was sterilized and used within one hour of preparation. 4.8. Statistical Analysis IC 50  values were calculated via least squares methodology using GraphPad Prism 9 software (Version 10.2.3, San Diego, CA, USA). Statistical significance between IC 50  and cell viability assays were determined using two-tailed S"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:S462"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,JMIR Hum Factors,2025,2765,9393,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Interviews examined for the following themes: (1) shortcomings of the currently used linear analysis, (2) utility of 3D visualizations, (3) features of an "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
40756144,10.1016/j.jposna.2025.100202,Molecular Basis of Fracture Pseudarthrosis Associated with Neurofibromatosis Type 1.,J Pediatr Soc North Am,2025,218,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""UNLABELLED: Neurofibromatosis Type 1 (NF1) is a tumor-predisposition syndrome caused by heterozygous mutations in the  KEY CONCEPTS: (1)Fracture pseudarthrosis in patients with NF1 is caused "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""UNLABELLED: Neurofibromatosis Type 1 (NF1) is a tumor-predisposition syndrome caused by heterozygous mutations in the  KEY CONCEPTS: (1)Fracture pseudarthrosis in pat"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40766628,10.1101/2025.07.25.666841,Metabolic and behavioral effects of neurofibromin result from differential recruitment of MAPK and mTOR signaling.,bioRxiv,2025,54,8665,0,2,4,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR"", ""Fiji""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Drosophila maintenance Flies were raised on  Drosophila  cornmeal/agar food medium according to standard protocols and housed at 25 \u00b0"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Drosophila  cornmeal/agar food medium according to standard protocols and housed at 25 \u00b0C, 60% relative humidity, on a 12:12 h light:dark cycle. The  nf1  mutation was backcrossed six generations into the control genetic background wCS10. RNAi lines were obtained from the Vienna  P1 Drosophila  RNAi Ce"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""er blotting with pERK/\u03b2-tubulin, then reblocked in 5% BSA and incubated with ERK/\u03b2-tubulin antibodies overnight. Images were captured with an Odyssey XF Imaging System (LI-COR). Immunohistochemistry and imaging Five to ten-day-old adult flies were dissected fixed in 1% paraformaldehyde in in Schneider"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": "" groups; controls lacking one or both of the drivers and effectors were run in key control experiments. Statistics and graphing were carried out with Graphpad Prism, version 10.1.1."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""os were recorded 30 min following the introduction into the open-field arena. Grooming was manually scored via frame-by-frame analysis, recording the start and stop frame for each grooming bout. Grooming was calculated as the percent of total time grooming during the 5-minute video. Metabolic analysis C"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": ""t 25 \u00b0C for 1 h. Images were captured every 15 min with PhenoCapture 3.3. The liquid meniscus level was measured in each respirometer after 3 h using Fiji 2.0. Where appropriate, data were normalized to the mean of the control genotypes. Quantitative polymerase chain reaction (qPCR) Heads were collected"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:XF"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""]}",False
40769067,10.1016/j.jns.2025.123643,Serum miRNAs as biomarkers in Neurofibromatosis 1: New promising findings.,J Neurol Sci,2025,1863,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""OBJECTIVE: Neurofibromatosis type 1 (NF1) is a neurocutaneous genetic disorder caused by dominant mutations in the NF1 gene and characterized by increased susceptibility to develop benign an"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""OBJECTIVE: Neurofibromatosis type 1 (NF1) is a neurocutaneous genetic disorder caused by dominant mutations in the NF1 gene and characterized by increased susceptibi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40802118,10.1007/s11060-025-05197-5,Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.,J Neurooncol,2025,1661,6526,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""SPSS"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods This retrospective study collected data from 70 patients (aged 3\u2009\u2212\u200918 years) with NF1 and symptomatic inoperable PNs treated with selumetinib as part of compassionate use at 11 Italian centers between October 2018 and October 2024. Ass"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods This retrospective study collected data from 70 patients (aged 3\u2009\u2212\u200918 years) with NF1 and symptomatic inoperable PNs treated with selumetinib as part of com"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""erapy, surgery, previous pharmacotherapies, the duration of selumetinib therapy, and the occurrence of AEs). Statistical analysis was performed using SPSS software (IBM SPSS Statistics for Windows, version 20; IBM Corp., Armonk, NY, USA). The p-value associated with the Pearson correlation was corrected"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ographic information; age at NF1 and PN diagnosis; anatomical location of PNs; history of surgical resection or biopsy before selumetinib initiation; start and end dates of selumetinib therapy; symptoms and clinical indications for treatment; PN volume at baseline and at predefined intervals (every 6 cy"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
40842566,10.3389/fncel.2025.1624817,Translocator protein deficiency blocks the ferroptosis of malignant peripheral nerve sheath tumors through glutathione peroxidase 4.,Front Cell Neurosci,2025,1435,7101,0,1,2,3,"{""cell_lines"": {""sNF96.2"": ""c9a87975-378b-4930-8fda-e5896c42c86c""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods TSPO expression was analyzed in adjacent non-tumor tissues, benign neurofibromas, and malignant tissues using real-time PCR, western blotting, immunohistochemi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:sNF96.2"": {""context"": ""34-01). Clinical trial number: not applicable. Cell culture The human plexiform neurofibroma cell line ipNF05.5 (RRID: CVCL_UI71) and MPNST cell line sNF96.2 (RRID: CVCL_K281), purchased from the American Type Culture Collection (Manassas, VA, United States), were cultured in DMEM (Gibco) and RPMI 1640 (Gi"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""licitly indicated otherwise, all experimental procedures were independently replicated three times. Statistical analyses were conducted utilizing the GraphPad Prism software (version 8.0), a widely recognized and validated tool in the field of data analysis. The experimental data are presented as the mean \u00b1 stand"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:sNF96.2"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,Front Radiol,2025,1528,5480,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Ten patients with NF2-SWN, totaling 17 tumors, underwent high-resolution MRI scans with varying voxel sizes on different MRI machines at Yale New Haven Hospital. Tumors were segmented using both"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""e performed using R (R Core Team), and visualization of volume differences, Dice similarity coefficients, and Hausdorff distances was conducted using ggplot2 and tidyverse ( 10 ,  11 ) for comparative analysis."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ggplot2"": [""methods""]}",False
40843672,10.3390/epigenomes9030030,Epigenetic Mechanisms in Neurofibromatosis Types 1 and 2.,Epigenomes,2025,646,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""omes, known as phakomatoses, encompass a diverse group of congenital conditions affecting the nervous system and skin, with neurofibromatosis type 1 (NF1) and neurofibromatosis type 2 (NF2) among the most clinically significant. Both disorders are inherited in an autosomal dominant manner. NF1 presents"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurocutaneous syndromes, known as phakomatoses, encompass a diverse group of congenital conditions affecting the nervous system and skin, with neurofibro"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,Cells,2025,983,7673,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""unoResearch (West Grove, PA, USA), respectively. 2.2. Cells and Cell Maintenance The following immortalized human plexiform neurofibroma cell lines ( Nf1 \u2212/\u2212 ; hereafter called pNF1 cells) described in [ 23 ] were used: ipNF95.11b C and ipNF05.5 purchased from ATCC. Primary fibroblasts ( Nf1 +/\u2212 , here"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Reagents and Antibodies Reconstituted basement membrane (rBM; Cultrex TM  with reduced growth factor) and high-concentration col"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""s were captured using an inverted Stellaris 5 confocal microscope (Leica Microsystems). Fluorescence intensity of P-glycoprotein was quantified using ImageJ 1.54g software (National Institutes of Health, Bethesda, MD, USA). 2.9. 3D MTT Assay 3D MTT assay was used to assess cell growth and viability as pre"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""]}",False
40877908,10.1186/s13046-025-03525-1,TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells.,J Exp Clin Cancer Res,2025,1763,17630,0,2,9,11,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""OSW"": ""7a62af66-384d-419b-b8ac-f4d381b85942""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""featureCounts"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""SAMtools"", ""FastQC"", ""Trimmomatic"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods We have studied the phenotypic changes elicited by a MPNST cell-conditioned medium in macrophages with or without TRAP1, and their subsequent ability to support MPNST cell growth and migration and endothelial cell angiogenesis. Materials an"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""ll line is a murine MPNST cell line derived from tumors established by autologous transplantation of skin-derived precursor cells (SKPs) lacking both Nf1 and p53. Such SKPs have been demonstrated to consistently give rise to tumors with all the histological hallmarks of human MPNSTs [ 36 ]. NPCIS and c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:OSW"": {""context"": ""d atmosphere containing 5% CO\u2082. Cell lines were routinely checked for the presence of mycoplasma. To prepare macrophage differentiation medium (DM), Roswell Park Memorial Institute (RPMI) 1640 medium was supplemented with 10% heat-inactivated FBS, 0.1 mM P/S, 25 mM HEPES pH 7.4 and with 20% of L929 con"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:featureCounts"": {""context"": ""Q quality score\u2009<\u200920 using Samtools [ 39 ]. The Sequence Alignment/Map format and SAMtools [ 39 ]. Raw counts were obtained from filtered reads using featureCounts [ 40 ]. Subsequently, differential expression analysis was performed using [ 41 ], retaining only genes with a corrected  p -value\u2009<\u20090.05. For subseq"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""t\u2019s  t  tests. In the case of more than two groups, one-way analysis of variance (ANOVA) was performed. Statistical significance was determined using GraphPad Prism (version 5). Results with a  p \u2009value lower than 0.05 were considered significant; * P \u2009<\u20090.05, ** P \u2009<\u20090.01; *** P \u2009<\u20090.001, **** P \u2009<\u20090.0001 compar"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""t Sequence Data ( http://www.bioinformatics.babraham.ac.uk/projects/fastqc/ ). Passing filtered reads were mapped to the mouse reference (mm10) using HISAT2 with default parameters. Mapped reads were filtered excluding unpaired mate/pair reads and reads with a MAPQ quality score\u2009<\u200920 using Samtools [ 39 ]"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""0) using HISAT2 with default parameters. Mapped reads were filtered excluding unpaired mate/pair reads and reads with a MAPQ quality score\u2009<\u200920 using Samtools [ 39 ]. The Sequence Alignment/Map format and SAMtools [ 39 ]. Raw counts were obtained from filtered reads using featureCounts [ 40 ]. Subsequently,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""proach averaged on 4 bases and keeping only sequences with average quality evaluated with phred value\u2009>\u200920. Optimal quality was checked employing the FastQC tool (Andrews, S. (n.d.). FastQC A Quality Control tool for High Throughput Sequence Data ( http://www.bioinformatics.babraham.ac.uk/projects/fastqc/"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""cing was performed on NextSeq500 ILLUMINA instrument to produce at least 10\u00a0million of reads (75\u00a0bp SE) for sample. Raw reads were preprocessed using Trimmomatic [ 38 ], (10.1093/bioinformatics/btu170), removing adapter sequences using the Illuminaclip step and employing a sliding window approach averaged on 4"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""hical purposes, normalized counts were extracted from the DESeq object, as well as variance-stabilized values obtained using the vst command from the DESeq2 package. Obtained differentially expressed genes were filtered employing a previously published pipeline [ 32 ] to identify secreted factors. Moreove"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" crystal violet in PBS, 61135 Sigma Aldrich) dropwise to the edge of each well. After 4 h at RT, colonies were immediately scanned and analyzed using ImageJ software to measure the parameter \u201cintegrated density\u201d. Boyden chamber assays To perform Boyden chamber assays, bone marrow-derived macrophages (BMDM"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""cell_lines:OSW"": [""methods""], ""computational_tools:featureCounts"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,Hum Genomics,2025,1758,8134,0,2,1,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""XF"": ""c2a2dca4-ebcc-4c8e-94c8-c867beaca9ab""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Data availability All data produced in the present work are contained in the manuscript Databases ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 available at:  https://ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh37/archive_2.0/2024/clinv"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Data availability All data produced in the present work are contained in the manuscript Databases ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:XF"": {""context"": ""ms (SIFT, SIFT4G, Polyphen2-HDIV, Polyphen2-HVAR, LRT, MutationTaster2, MutationAssessor, FATHMM, MetaSVM, MetaLR, PROVEAN, FATHMM-MKL coding, FATHMM-XF coding, fitCons, M-CAP, PrimateAI, DEOGEN2, BayesDel no AF, BayesDel add AF, ClinPred, and LIST-S2). In order to assess the frequencies of the varian"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:XF"": [""methods""]}",False
40896930,10.1016/j.clinph.2025.2110992,High resolution nerve ultrasound in neurofibromatosis type 1: a prospective and descriptive study.,Clin Neurophysiol,2025,658,6491,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2. Methods 2.1. Study Design Sixty adult patients with NF1 participated in the previously published cross-sectional explorative study on HRUS [ 9 ]. The baseline study visit included clinical examination, NCS"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Methods 2.1. Study Design Sixty adult patients with NF1 participated in the previously published cross-sectional explorative study on HRUS [ 9 ]. The baseline study visit included clinical examination, NCSs an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
40977920,10.62347/EBRY4326,Cell-free DNA fragmentomics: a universal framework for early cancer detection and monitoring.,Am J Clin Exp Immunol,2025,2179,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Cell-free DNA (cfDNA) fragmentomics has emerged as a powerful and noninvasive approach for cancer detection, characterization, and monitoring. By analyzing g"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
40992926,10.26508/lsa.202503359,"Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas.",Life Sci Alliance,2025,1151,15782,0,1,5,6,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""Cell Ranger"", ""FlowJo""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": "" ensuring they had continuous access to food and water. The facility\u2019s light\u2013dark cycle was set to 12 h. The mouse strains used in this research were Nf1fl/fl and DhhCre ( Wu et al, 2012 ). For breeding purposes, we kept the DhhCre allele in males and crossed DhhCre;Nf1fl/+ mice with Nf1fl/fl mice to p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Mice and husbandry The experimental protocols followed in this study received approval from the Institutional Animal Care and Use Com"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ge analysis and random coefficients model analysis were completed as described in  Wu et al (2012) . All other statistical analyses were conducted in GraphPad Prism. Significance was set at  P  \u2264 0.05. Statistical tests (one-way or two-way ANOVA, with Tukey\u2019s post hoc test) were as in figure legends. Error bars r"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": "" were aligned to the mm10 mouse genome using the Cell Ranger pipeline (version 6.0) with default parameters. Downstream analyses were performed using Seurat (version 4.1.1,  https://satijalab.org/seurat/ ). Data normalization, dimensionality reduction, clustering, and integration were performed using the "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""l concentration for droplet-based scRNA-seq. The 10X Genomics scRNA-seq (3\u2032 v3.1 chemistry) libraries were aligned to the mm10 mouse genome using the Cell Ranger pipeline (version 6.0) with default parameters. Downstream analyses were performed using Seurat (version 4.1.1,  https://satijalab.org/seurat/ ). Dat"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ibody panels ( Fig S3G ). Fcs files from individual mice were downsampled and concatenated to include the same number of events for each tumor, using FlowJo software. UMAP analysis was performed in FlowJo with default settings of nearest neighbors of 15 and minimum distance. Data were scaled before genera"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
41001496,10.1101/2025.09.16.25335916,T1w/T2w ratio suggests reduced intracortical myelin content in youth with RASopathies.,medRxiv,2025,1599,8220,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods In this prospective study, 112 children (86 RASopathies, 26 typical developing (TD), aged 6\u201317 years) completed T1w and T2w MRI scans and NIH Toolbox cognitive "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,Mol Cell Oncol,2025,107,10424,0,3,4,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""T265"": ""6419dd0d-1937-4ecf-bf01-876632ae0f54""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""Python"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor syndrome caused by pathogenic variants in the"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cells used in this study were previously describ"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cells used"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:T265"": {""context"": ""Methods Cell lines Human T265, S462, and NSF1 cell lines of malignant peripheral nerve sheath tumors (MPNSTs) being associated with neurofibromatosis type 1, and BRGN control cell"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""yence, Neu-Isenburg, Germany). Data analysis, statistics, and bioinformatic database analysis NGS data analysis and heat map creation were done using GraphPad Prism software (GraphPad Software, Boston, USA) version 9.5.0. Tests for the presence of a circadian rhythm were performed by Cosinor analysis based on est"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ere incubated for another 24\u00a0h. Then, a serum shock was induced with 10% FBS-containing medium. After that the cells were lysed at six-hour intervals starting at zero and ending at 48\u00a0h ( Figure 1 ). For sample collection, cells were washed two times with 1\u2009mL of 4\u00b0C cold Phosphate Buffered Saline (PBS,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""reely available online tool ( 44 https://cosinor.online/app/cosinor.php ). In addition, numerical and graphical analysis was done using the CosinorPy Python package.  To determine the most suitable period length, a \u201cgrid-search\u201d approach is employed, where the parameter T is systematically varied between "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:S462"": [""methods""], ""cell_lines:T265"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,Nat Commun,2025,1220,15499,0,13,2,15,"{""cell_lines"": {""3PNF_SiPSsv_MM_11"": ""1cc872fc-6a95-4722-a598-bf60bb124b82"", ""JH-2-002"": ""1bc84ef2-208f-4f0e-8045-6be47fd968de"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb"", ""SW480"": ""2b79f24b-7362-4687-8c66-03bcb6a26ab3"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""JH-2-031"": ""4241b7ff-c08e-4c6d-b2c1-9de9ac91f72b""}, ""antibodies"": {""Rabbit Anti-NF1 Antibody"": ""b527f06d-69bf-4641-a962-4efe8a648dff"", ""Anti-NF1"": ""535891d9-4608-48eb-9e61-01201533a5bc"", ""NF1 Antibody"": ""78c68cff-46d0-40cd-ae01-4d7bb5fa9d4e"", ""Anti-NF1 antibody"": ""535891d9-4608-48eb-9e61-01201533a5bc"", ""Anti-NF1 Antibody"": ""535891d9-4608-48eb-9e61-01201533a5bc"", ""NF1 antibody"": ""78c68cff-46d0-40cd-ae01-4d7bb5fa9d4e""}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""of Medicine 15 . ST88-14 and S462 cells were authenticated by Short Tandem Repeat (STR) profiling at the JHU Genetic Resources Core Facility. The  46 NF1 -deficient LN229 glioma cell line was kindly provided by Karisa Schreck of the Johns Hopkins University . A549, HCC4006, SW480, HCT116, MCF7 and 143B"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Ethics Methods used in all experiments including the animal studies were in accordance with standards set by the Johns Hopkins University (JHU) and the Animal Care and Use Committee "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:3PNF_SiPSsv_MM_11"": {""context"": "" its isogenic  47 NF1  iPSC generated by CRISPR (NF1 \u2212/\u2212 \u2212/\u2212  edited FiPS Ctrl1-SV4F-7, D12, Sex: XY), as well as the pNF-derived  NF1 \u2212/\u2212  iPSC 3MM (3PNF_SiPSsv_MM_11, Sex: XX), were obtained from the Spanish Stem Cell Biobank ( https://www.isciii.es/es/servicios/biobancos/banco-nacional-lineas-celulares/lineas-ips"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:JH-2-002"": {""context"": ""1  fibroblasts following the protocol established by Mazuelas et al. +/-  The neurofibromaspheres were implanted in the sciatic nerve of NSG mice. 29 JH-2-002 and JH-2-031 patient-derived xenografts (PDX) were obtained from the Johns Hopkins NF1 biospecimen repository, and were passaged as subcutaneous tumo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""nn cell line ipn023\u03bb, were generated by the Wallace\u2019s lab , and obtained from American Type Culture Collection (ATCC). Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel at the Indiana University School of Medicine 15 . ST88-14 and S462 cel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""mal Schwann cell line ipn023\u03bb, were generated by the Wallace\u2019s lab , and obtained from American Type Culture Collection (ATCC). Human MPNST cell line ST88-14, S462 and a patient-derived xenoline RHT92 were kindly provided by Melissa L. Fishel at the Indiana University School of Medicine 15 . ST88-14 and S4"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:SW480"": {""context"": ""s Core Facility. The  46 NF1 -deficient LN229 glioma cell line was kindly provided by Karisa Schreck of the Johns Hopkins University . A549, HCC4006, SW480, HCT116, MCF7 and 143B cell lines were obtained from ATCC. 2V6.11 cells were purchased from Cytion Cell Lines Services LLC. All the aforementioned ce"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:JH-2-031"": {""context"": ""s following the protocol established by Mazuelas et al. +/-  The neurofibromaspheres were implanted in the sciatic nerve of NSG mice. 29 JH-2-002 and JH-2-031 patient-derived xenografts (PDX) were obtained from the Johns Hopkins NF1 biospecimen repository, and were passaged as subcutaneous tumors in NSG mic"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Rabbit Anti-NF1 Antibody"": {""context"": ""s/banco-nacional-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1/2 (p44/4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1"": {""context"": ""-nacional-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:NF1 Antibody"": {""context"": ""onal-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1/2 (p44/4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1 antibody"": {""context"": ""-nacional-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1/2 (p44/4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:Anti-NF1 Antibody"": {""context"": ""-nacional-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1/2 (p44/4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""antibodies:NF1 antibody"": {""context"": ""onal-lineas-celulares/lineas-ips ), and were cultured and differentiated to NC and SC as reported previously . 19 Reagents and antibodies Rabbit anti-NF1 antibody (A300-140A) was purchased from Bethyl Laboratories. The rabbit anti-phospho-ERK1/2 (p44/42 MAPK) (Thr202/Tyr204) antibody (#9101), anti-ERK1/2 (p44/4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""l for the assay. Statistics and reproducibility The results are presented as a mean value plus or minus the standard deviation. Data were analyzed by GraphPad Prism 8.0. The  p -values were determined by a Student\u2019s  t  test. A  p -value under 0.05 was accepted as statistically significant. Sample sizes were chos"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:3PNF_SiPSsv_MM_11"": [""methods""], ""cell_lines:JH-2-002"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:SW480"": [""methods""], ""cell_lines:JH-2-031"": [""methods""], ""antibodies:Rabbit Anti-NF1 Antibody"": [""methods""], ""antibodies:Anti-NF1"": [""methods""], ""antibodies:NF1 Antibody"": [""methods""], ""antibodies:Anti-NF1 antibody"": [""methods""], ""antibodies:Anti-NF1 Antibody"": [""methods""], ""antibodies:NF1 antibody"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""]}",False
41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,Mol Med,2025,1929,2834,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ckdown were used to perform gain/loss-of-function experiments to explore the effect of reconstituting the GTPase-activating protein-related domain of NF1 or knockdown of A/B/CRAF kinases on ERK signaling output and MPNST cell growth. Colony formation, cell proliferation and live cells imaging assays we"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Conditional gene expression, CRISPR-CAS9, and shRNA-mediated knockdown were used to perform gain/loss-of-function experiments to explore the effect of reconstituting the G"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""umor xenograft fragments from seed mice were implanted subcutaneously close to the sciatic nerves, into study mice (n\u2009=\u20097\u20138/ arm). Drug treatment was started when tumor size reached roughly 120\u2013200 mm 3 , around five weeks after tumor implantation. Mice were randomized into treatment groups using the ra"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,Mol Cancer Ther,2026,1707,14104,0,4,8,12,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""S462"": ""b2fb9f7e-ea11-404f-8c0c-c9dc36367f2d"", ""HSC1\u03bb"": ""a0193c87-8813-4841-92e7-ee5095bd94fe"", ""ST88-14"": ""202c110b-a5f1-49ab-acdc-e6e33a1c29bb""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""StringTie"", ""R"", ""GraphPad Prism"", ""HISAT2"", ""STAR"", ""Trimmomatic"", ""FlowJo"", ""DESeq2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""erence lines using short tandem repeat profiling. All assays were conducted on cells 1 to 3 passages after thawing from banked stocks. Generation of  NF1- deficient cell lines We received iHSCs from Dr. Margaret Wallace (University of Florida). These are wild-type human SCs immortalized using the human"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and Methods Tissue culture iHSC lines were maintained and passaged at 37\u00b0C with 5% CO 2  in DMEM high-glucose media supplemented with 10% FBS and"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:ST88-14"": {""context"": ""ells which when sequenced did not have mutations at the guide target site in  NF1 . HSC1\u03bb is the parental cell line and serves as a positive control. ST88-14 is an established  NF1- deficient MPNST cell line.  C, NF1- deficient human SCs form significantly more colonies in soft agar under low-serum conditi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:S462"": {""context"": ""media supplemented with 10% FBS and penicillin/streptomycin. If antibiotic selection was needed, puromycin was used at 500 \u00b5g/mL, as indicated below. S462-TY cells were cultured in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin at 37\u00b0C with 5% CO 2 .  Mycoplasma  detection was routinely p"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:HSC1\u03bb"": {""context"": ""ples come from isogenic sister clones to the  +/+ NF1- deficient cells which when sequenced did not have mutations at the guide target site in  NF1 . HSC1\u03bb is the parental cell line and serves as a positive control. ST88-14 is an established  NF1- deficient MPNST cell line.  C, NF1- deficient human SCs f"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:StringTie"": {""context"": ""via Trimmomatic (v0.33; ref.  40 ), alignment via HISAT2 (v2.1.0; ref.  41 ) to the GRCh38 Ensembl assembly ( 42 ), and gene count quantification via StringTie (v1.3.4d; ref.  43 ). Differential expression analysis was performed using R statistical software (v4.3.1; ref.  44 ), tidyverse (v2.0.0; ref.  45 ),"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""d by fluorescence of experimental wells in the percent of unexposed control wells with blank values subtracted. Data were analyzed in Prism software (GraphPad Prism), and dose\u2013response curves were generated using a nonlinear regression log(inhibitor) vs. response\u2013variable slope model. Each point represents the me"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:HISAT2"": {""context"": ""). RNA sequencing analysis RNA sequencing (RNA-seq) data were analyzed as follows: quality trimming via Trimmomatic (v0.33; ref.  40 ), alignment via HISAT2 (v2.1.0; ref.  41 ) to the GRCh38 Ensembl assembly ( 42 ), and gene count quantification via StringTie (v1.3.4d; ref.  43 ). Differential expression "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""n with drug(s) or vehicle for 48 hours, cells were incubated with alamarBlue (Thermo Fisher Scientific) reagent, and fluorescence was read on a CLARIOstar microplate reader (BMG Labtech). Cell viability was calculated by fluorescence of experimental wells in the percent of unexposed control wells with b"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""00 next-generation sequencer (RRID: SCR_016387). RNA sequencing analysis RNA sequencing (RNA-seq) data were analyzed as follows: quality trimming via Trimmomatic (v0.33; ref.  40 ), alignment via HISAT2 (v2.1.0; ref.  41 ) to the GRCh38 Ensembl assembly ( 42 ), and gene count quantification via StringTie (v1.3"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""efore being run through a Beckman Coulter CytoFLEX Flow Cytometer (RRID: SCR_019627). The cell-cycle stage was determined with the Cell Cycle tool in FlowJo v10.7.1 software (BD Life Sciences) using the Watson (pragmatic) model. RAS\u2013GTP level determination RAS\u2013GTP levels were determined in S462-TY in resp"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""3.4d; ref.  43 ). Differential expression analysis was performed using R statistical software (v4.3.1; ref.  44 ), tidyverse (v2.0.0; ref.  45 ), and DESeq2 (v1.42.0; ref.  46 ). Pathway analysis was performed using GeneAnalytics(v; ref.  47 ). The data discussed in this publication have been deposited in"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:ST88-14"": [""methods""], ""cell_lines:S462"": [""methods""], ""cell_lines:HSC1\u03bb"": [""methods""], ""computational_tools:StringTie"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:HISAT2"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:DESeq2"": [""methods""]}",False
41053414,10.1038/s41698-025-01078-2,Natural history of SPP1 signaling in NF1 tumors.,NPJ Precis Oncol,2025,1091,5942,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""monocle"", ""Monocle3"", ""scDblFinder""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Bulk RNA sequencing analysis and solid sarcoma survival analysis The bulk sequencing data from 54 different NF1 tumors were originally generated by the NF Therapeutic Acceleration Program. The whole dataset is standardized by CBioPortal , and SPP1 expression wa"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Bulk RNA sequencing analysis and solid sarcoma survival analysis The bulk sequencing data from 54 different NF1 tumors were originally generated by the NF T"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""l AUA7457 by the Institutional Animal Care and Use Committee of the Medical College of Wisconsin. Log-rank-based survival analysis was performed with GraphPad Prism v10. +/- Single-cell RNA sequencing analysis Human PN and MPNST scRNA-seq datasets were downloaded from GEO ( GSE179043 ). Mouse PN scRNA-seq dataset"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""sis Human PN and MPNST scRNA-seq datasets were downloaded from GEO ( GSE179043 ). Mouse PN scRNA-seq datasets were downloaded from GEO ( GSE181985 ). Seurat (version 5.1.0) was used for quality control, normalization, dimensionality reduction, and clustering . Cells with fewer than 250 UMIs and genes expr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""hat objects were merged and then used for quantitative comparative analysis. 67 scRNA-seq pseudotime analysis Pseudotime analysis was performed using Monocle3 (version 1.3.7) . Seurat (version 5.1.0) 68  was used for quality control, normalization, dimensionality reduction, clustering, and clusters were vi"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Monocle3"": {""context"": ""hat objects were merged and then used for quantitative comparative analysis. 67 scRNA-seq pseudotime analysis Pseudotime analysis was performed using Monocle3 (version 1.3.7) . Seurat (version 5.1.0) 68  was used for quality control, normalization, dimensionality reduction, clustering, and clusters were vis"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scDblFinder"": {""context"": "", and clustering . Cells with fewer than 250 UMIs and genes expressed in fewer than 10 cells were filtered out. Doublet detection was performed using scDblFinder (version 1.18.0) 64  with default parameters using the cluster-agnostic method. Doublets were filtered out, and cells with over 20% mitochondrial gen"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:Monocle3"": [""methods""], ""computational_tools:scDblFinder"": [""methods""]}",False
41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,Curr Oncol,2025,239,7976,0,0,3,3,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""FlowJo"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Patients The study protocols received approval from Beijing Tiantan Hospital\u2019s institutional review boards, and written consent "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""p  values less than 0.05 were considered to indicate statistical significance. Data are expressed as the Mean \u00b1 SD, and analyses were performed using GraphPad Prism (version 9.5.0)."", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""h corresponding isotype controls. Flow cytometry analysis was conducted using a (BD Biosciences, San Jose, CA, USA), and the data were processed with FlowJo software (version X10.0.7). 2.7. Detection of Intracellular ROS Generation For the detection of intracellular ROS levels, ROS-sensitive probe DCFH-DA"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:FlowJo"": [""methods""]}",False
41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,Orphanet J Rare Dis,2025,834,1429,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Review methodology This narrative review integrates clinical and technical dimensions of AI applications in NF1-associated glial tumors. The methodolog"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""Review methodology This narrative review integrates clinical and technical dimensions of AI applications in NF1-associated glial tumors. The methodology was designed to address the heterogeneity of AI approaches across pathology, imaging, and molecular diagnost"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""]}",False
41211508,10.1016/j.jmsacl.2025.10.002,Ambient ionization mass spectrometry in brain cancer diagnosis.,J Mass Spectrom Adv Clin Lab,2025,4239,8215,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Brain cancer diagnosis using other AIMS methods In addition to DESI-MS, other AIMS techniques have been explored for brain cancer diagnosis. Notably, RE"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
41223283,10.1126/sciadv.adt9210,Glial-to-mesenchymal transition of tumor Schwann cells drives the genetic burden in MPNSTs from neurofibromatosis type 1 mouse model.,Sci Adv,2025,605,16067,0,1,23,24,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""TinGa"", ""bwa-mem2"", ""slingshot"", ""msigdbr"", ""clusterProfiler"", ""FastQC"", ""Cell Ranger"", ""RStudio"", ""Picard"", ""BWA"", ""CellProfiler"", ""SAMtools"", ""R"", ""destiny"", ""GATK"", ""Seurat"", ""NanoDrop"", ""EaCoN"", ""infercnv"", ""ImageJ"", ""OMERO"", ""ComplexHeatmap"", ""scDblFinder""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""- and humidity-controlled vivarium on a 12-hour dark-light cycle with free access to food and water. We bred  Prss56 ,  Cre/Cre Rosa26 ,  tdTom/tdTom Nf1  mice with the  fl/fl Nf1  or  fl/fl Nf1  mice to obtain  +/\u2212 Prss56 ,  Cre/+ Rosa26 ,  tdTom/+ Nf1  or  fl/fl Prss56 ,  Cre/+ Rosa26 ,  tdTom/+ Nf1 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Animals Only male mice were considered in this study. Sex was not considered as a biological variable. Male mice used in this study w"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TinGa"": {""context"": ""PNST atlas All PCA\u2014harmony tSNE Human PNST atlas Tumor cells FastMNN UMAP Trajectory inference was made using two distinct methods: slingshot ( ) and TinGa ( 14 ), using cells from the pNF datasets as trajectory root. For the functional analysis, the TCs were divided into three subsets using  38 k -means"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bwa-mem2"": {""context"": ""ntamination with FastQ_Screen v0.15.3, and results were aggregated with multiQC v1.13. Mapping against the murine genome UCSC mm10 was performed with bwa-mem2 v.2.2.1 with default parameters, except for \u201c-A 2 -E 1.\u201d Mapped reads QC was performed using samtools stats/flagstat/idxstats v1.18, and coverage was"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:slingshot"": {""context"": ""astMNN UMAP Human PNST atlas All PCA\u2014harmony tSNE Human PNST atlas Tumor cells FastMNN UMAP Trajectory inference was made using two distinct methods: slingshot ( ) and TinGa ( 14 ), using cells from the pNF datasets as trajectory root. For the functional analysis, the TCs were divided into three subsets usin"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:msigdbr"": {""context"": ""conducted using Seurat::FindMarkers. Heatmaps were made using the ComplexHeatmap package ( ). Functional enrichment analyses were conducted using the msigdbr package ( 39 https://CRAN.R-project.org/package=msigdbr ) for the gene set database, and clusterProfiler package for the analyses ( ). 40 Whole-exome"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""ctional enrichment analyses were conducted using the msigdbr package ( 39 https://CRAN.R-project.org/package=msigdbr ) for the gene set database, and clusterProfiler package for the analyses ( ). 40 Whole-exome sequencing Raw sequences were demultiplexed to FASTQ, taking care of UMIs, with bcl2fastq v2.20.0.422 us"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:FastQC"": {""context"": ""ameters. Raw reads were trimmed for bad quality bases, adapter content, and polymere tracks using fastp v0.23.2. General reads QC were assessed using fastqc v0.12.1, sample contamination with FastQ_Screen v0.15.3, and results were aggregated with multiQC v1.13. Mapping against the murine genome UCSC mm10 "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": ""equencing libraries that were each sequenced on one flow cell Nextseq500 Illumina. Bioinformatic analysis BCL files were processed using 10x Genomics Cell Ranger software (version 2 or 3). For mouse PNSTs, reads were mapped onto a custom mouse transcriptome based on GRCm38 transcriptome, in which we added tdTo"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": ""uent analyses. Publicly available scRNA-Seq datasets from human PNSTs were downloaded as filtered count matrices. Count matrices were processed using RStudio and R Markdown to generate fully traceable notebooks, including the figures included in this article. To ensure version stability, a Singularity cont"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Picard"": {""context"": "" mosdepth v0.2.6. Deduplication of reads because of UMIs was performed using umi_tools v1.1.2. PCR and optical duplicate marking were performed using Picard tools v2.23.5. Somatic variant calling was performed using the GATK mutect2 v4.2.6.1 with recommended guidelines ( ). Variant annotation and filterin"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""ntamination with FastQ_Screen v0.15.3, and results were aggregated with multiQC v1.13. Mapping against the murine genome UCSC mm10 was performed with bwa-mem2 v.2.2.1 with default parameters, except for \u201c-A 2 -E 1.\u201d Mapped reads QC was performed using samtools stats/flagstat/idxstats v1.18, and coverag"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""f view were acquired per well, using the 20\u00d7 objective (0.45 numerical aperture). Images were imported into an OMERO Plus database and analyzed using CellProfiler. Data were normalized to DMSO control wells (16 per plate) within the same plate. Two independent experiments were performed for both the primary scr"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": "" the murine genome UCSC mm10 was performed with bwa-mem2 v.2.2.1 with default parameters, except for \u201c-A 2 -E 1.\u201d Mapped reads QC was performed using samtools stats/flagstat/idxstats v1.18, and coverage was assessed using mosdepth v0.2.6. Deduplication of reads because of UMIs was performed using umi_tools "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:destiny"": {""context"": "" and harmony ( ) or FastMNN ( 35 ) was used to remove batch effect. Cell projections were made using Seurat::RunUMAP, Seurat::RunTSNE, or DM from the destiny package ( 36 ). Batch-effect correction and projection methods are summarized in  37 Table 1 . Table 1. Batch-effect correction method and projection"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": "" using umi_tools v1.1.2. PCR and optical duplicate marking were performed using Picard tools v2.23.5. Somatic variant calling was performed using the GATK mutect2 v4.2.6.1 with recommended guidelines ( ). Variant annotation and filtering were performed using snpEff/snpSift v4.3.1t ( 41 ). Copy number an"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""tory and duplicated on Zenodo (see the \u201cData and materials availability\u201d section). From the count matrices, datasets were analyzed individually using Seurat V3 package ( ). Cells having less than exp(6) (403) Unique Molecular Identifiers (UMI) or less than 600 genes were filtered out. Doublets were remove"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""qRT-PCR Total RNAs were isolated using the RNAqueous-micro kit (Ambion). After deoxyribonuclease treatment, concentration of RNA was determined using NanoDrop and QuBit technology. cDNA was synthesized using the Maxima First Strand cDNA Synthesis Kit, and qRT-PCR was performed using the Maxima SYBER green/R"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:EaCoN"": {""context"": "". Variant annotation and filtering were performed using snpEff/snpSift v4.3.1t ( 41 ). Copy number analysis of tumor/normal pairs was performed using EaCoN v0.2.8 using the ASCAT2 segmentation method, with default parameters ( 42 ). 43 TC culture Cells dissociated from mouse MPNST were frozen in 90% FBS/"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:infercnv"": {""context"": "" or in table S7 for the Fb dataset. 34 The same annotation procedure was applied to the human datasets, with an additional analysis of CNVs using the infercnv package to assess the annotation of TCs, using macrophages as reference. Individual datasets were merged to generate combined datasets. For the human"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""ere counterstained with Hoechst (Life Technologies). Images were acquired on Zeiss LSM 900 confocal microscope and then processed and assembled using ImageJ and Photoshop. Sample processing and single-cell RNA sequencing Mice were euthanized via isoflurane inhalation and perfused with PBS to remove circul"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:OMERO"": {""context"": ""Healthcare Life Sciences). Six fields of view were acquired per well, using the 20\u00d7 objective (0.45 numerical aperture). Images were imported into an OMERO Plus database and analyzed using CellProfiler. Data were normalized to DMSO control wells (16 per plate) within the same plate. Two independent exper"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ComplexHeatmap"": {""context"": ""tats base package, on the batch-effect corrected space. Differential expression was conducted using Seurat::FindMarkers. Heatmaps were made using the ComplexHeatmap package ( ). Functional enrichment analyses were conducted using the msigdbr package ( 39 https://CRAN.R-project.org/package=msigdbr ) for the gene s"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scDblFinder"": {""context"": ""( ). Cells having less than exp(6) (403) Unique Molecular Identifiers (UMI) or less than 600 genes were filtered out. Doublets were removed using the scDblFinder tool ( 32 ) and scds in hybrid mode ( 33 ). Then, cells having more than 50% of UMI related to mitochondrial genes or more than 30% related to riboso"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:TinGa"": [""methods""], ""computational_tools:bwa-mem2"": [""methods""], ""computational_tools:slingshot"": [""methods""], ""computational_tools:msigdbr"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:FastQC"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:RStudio"": [""methods""], ""computational_tools:Picard"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:SAMtools"": [""methods""], ""computational_tools:destiny"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:EaCoN"": [""methods""], ""computational_tools:infercnv"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:OMERO"": [""methods""], ""computational_tools:ComplexHeatmap"": [""methods""], ""computational_tools:scDblFinder"": [""methods""]}",False
41293003,10.1101/2025.11.15.688608,Variable Schwann cell merlin inactivation is targetable with TEAD1 inhibition in schwannomas.,bioRxiv,2025,218,33121,0,0,15,15,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bedtools"", ""R"", ""BWA"", ""GraphPad Prism"", ""velocyto"", ""scVelo"", ""Seurat"", ""STAR"", ""clusterProfiler"", ""Trimmomatic"", ""Cell Ranger"", ""infercnv"", ""scanpy"", ""Python"", ""RStudio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Experimental model and subject details Human subjects Annotated surgical samples were obtained from non-consecutive patients (n = 15) that underwent surger"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bedtools"": {""context"": ""ere filtered using adapter trimming program Trimmomatic, followed by alignment using BWA. Next, normalized bigwig files were created and scaled using BEDTools.  DeepTools was used to generate gene-body meta-profiles from bigWig files and to calculate genome-wide IP enrichment. Peaks were annotated relative "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:BWA"": {""context"": ""lyzed using the Galaxy ChIP-seq pipeline. Briefly, raw QC reads were filtered using adapter trimming program Trimmomatic, followed by alignment using BWA. Next, normalized bigwig files were created and scaled using BEDTools.  DeepTools was used to generate gene-body meta-profiles from bigWig files and "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""one/two-way ANOVAs where appropriate. P values < 0.05 two-tailed were considered statistically significant. Statistical analyses were performed using GraphPad Prism 9.0 (GraphPad Software, La Jolla, California), or appropriate python packages. Primary Cell Culture Clinical tissue samples were collected asepticall"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:velocyto"": {""context"": ""alculate RNA velocities using the unfiltered expression matrix from 10x Cell Ranger software, and ratios of spliced to unspliced mRNA calculated from velocyto. 78  The CellRank 44  python package was used to compute a transition matrix, initial and terminal states, cell lineage fate probabilities, and linea"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scVelo"": {""context"": "" similarity within versus between VS 77 nf2  and VS spo  samples across cell types. For RNA velocity and lineage tracing analysis, the python package scvelo  was used to calculate RNA velocities using the unfiltered expression matrix from 10x Cell Ranger software, and ratios of spliced to unspliced mRNA c"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""l Ranger-arc count function. Single cell/nuclei RNA and multiome analysis Filtered and raw .h5 files from Cell Ranger were processed in RStudio using Seurat v5.0.1.  Cell Free RNA contamination and doublets was estimated and removed using the SoupX 66  and DoubletFinder 67  R packages. For quality control"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ted and refined by motif enrichment, peak accessibility, and correlation with target gene expression. Motif enrichment was performed using the hg38 cisTarget databases (hg38_screen_v10_clust) together with motif-to-gene annotations (motifs-v10nr_clust-nr.hgnc). Finally, gene regulon activity was quantif"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""elled after cross-referencing with existing literature using the FindAllMarkers() function and based on gene-set enrichment analysis (GSEA) using the clusterProfiler 73  R-package and GSEApy 74  python package. Cell-cell communication networks were identified using the CellChat 75  R package. 76 snRNAseq data was "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""ycles (Illumina # 20024904). Data was analyzed using the Galaxy ChIP-seq pipeline. Briefly, raw QC reads were filtered using adapter trimming program Trimmomatic, followed by alignment using BWA. Next, normalized bigwig files were created and scaled using BEDTools.  DeepTools was used to generate gene-body met"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": "" Kits v2.5 with 150 cycles (Illumina # 20024907). Sequencing reads were demultiplexed and aligned to the hg38 reference genome using the 10X Genomics Cell Ranger software (arc v2.0.1) mkfastq function with default settings, and counts were generated using the Cell Ranger-arc count function. Single cell/nuclei "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:infercnv"": {""context"": ""ase scores were determined using the CellCycleScoring() function in Seurat. 69 Copy number variants (CNVs) were first identified using the R-packages InferCNV  with endothelial cells, macrophages, neutrophils, and pericytes marked as reference cells. In parallel, CONICSmat 70  was used to produce UMAP plots"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:scanpy"": {""context"": ""greater than 0 and an adjusted p-value less than 0.05 were used to create a merlin depletion score (MDS) using the tl.rank_genes_groups() function in Scanpy. 71  MDS class was determined for Schwann cells based merlin depletion score quartiles: +\u03c3 > 2\u03c3 > \u2212\u03c3 as merlin-depleted (Schwann 72 mer\u2212 ), merlin-in"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""iterature using the FindAllMarkers() function and based on gene-set enrichment analysis (GSEA) using the clusterProfiler 73  R-package and GSEApy 74  python package. Cell-cell communication networks were identified using the CellChat 75  R package. 76 snRNAseq data was visualized using the Scanpy python p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": "" using the Cell Ranger-arc count function. Single cell/nuclei RNA and multiome analysis Filtered and raw .h5 files from Cell Ranger were processed in RStudio using Seurat v5.0.1.  Cell Free RNA contamination and doublets was estimated and removed using the SoupX 66  and DoubletFinder 67  R packages. For qu"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bedtools"": [""methods""], ""computational_tools:BWA"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:velocyto"": [""methods""], ""computational_tools:scVelo"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:infercnv"": [""methods""], ""computational_tools:scanpy"": [""methods""], ""computational_tools:Python"": [""methods""], ""computational_tools:RStudio"": [""methods""]}",False
41294711,10.3390/curroncol32110649,Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening.,Curr Oncol,2025,93,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a complex, multisystem, genetic disorder caused by germline"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a complex, multisystem, genetic disorder caused by germline"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41397954,10.1038/s41413-025-00492-3,Pharmacological inhibition of RAS pathway alleviates spine deformity in a mouse model of neurofibromatosis type 1.,Bone Res,2025,841,13457,0,1,6,7,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""clusterProfiler"", ""Cell Ranger"", ""RStudio""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods Mice C57BL/6,  R26tdTomato  ( R26 ), tdTom \n 45 Nf1  ( flox Nf1 ),  fl Nf1 -knock out ( Nf1 ) -  were obtained from Jackson Laboratory (Bar Harbor, ME).  46 Prss56  mice were provided by Piotr Topilko."", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Mice C57BL/6,  R26tdTomato  ( R26 ), tdTom \n 45 Nf1  ( flox Nf1 ),  fl Nf1 -knock out ( Nf1 ) -  were obtained from Jackson Laboratory (Bar Harbor, ME).  46 Prss56  m"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""tatistical analyses Data are reported as mean \u00b1 standard deviation with  n  representing mice or vertebrae. Statistical analyses were performed using GraphPad Prism. Statistical comparisons used for two groups were Mann-Whitney test, for \u22653 groups were one-way/two-way ANOVA with Tukey\u2019s multiple comparisons post-"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": "" the mm10 mouse genome following the Cell Ranger count pipeline. Single-cell RNA sequencing analyses Single-cell RNAseq analyses were performed using Seurat 5.0.3 and Rstudio v.2023.12.1\u2009+\u2009402. Filtering and clustering using Seurat Aligned scRNAseq datasets were corrected for ambient RNA using SoupX v1.6."", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""at\u2019s FindMarkers function. Genes upregulated in the mutant with adj.  P \u2009<\u20090.05 and log 2 FC\u2009>\u20090.5 were selected to do a gene ontology analysis using clusterProfiler (v4.10.1). MAPK pathway activation and proliferation score Scores were calculated based on the average expression of the list of genes from the 2024 "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Cell Ranger"": {""context"": "" manufacturer\u2019s instructions. Sequencing was performed using Nextseq550 (Illumina) followed by reads alignment on the mm10 mouse genome following the Cell Ranger count pipeline. Single-cell RNA sequencing analyses Single-cell RNAseq analyses were performed using Seurat 5.0.3 and Rstudio v.2023.12.1\u2009+\u2009402. Filt"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:RStudio"": {""context"": ""enome following the Cell Ranger count pipeline. Single-cell RNA sequencing analyses Single-cell RNAseq analyses were performed using Seurat 5.0.3 and Rstudio v.2023.12.1\u2009+\u2009402. Filtering and clustering using Seurat Aligned scRNAseq datasets were corrected for ambient RNA using SoupX v1.6.2 and the genes ex"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:Cell Ranger"": [""methods""], ""computational_tools:RStudio"": [""methods""]}",False
41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,PLoS Genet,2025,1556,19165,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""se (ADPKD) cases were identified using ICD-10 codes Q61.2 and Q61.3; Marfan syndrome cases were identified using Q87.4; and neurofibromatosis type 1 (NF1) cases were identified using Q85.0. For each disease, individuals carrying any of these codes were assigned to the corresponding disease cohort. Cont"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods UK Biobank 200K dataset and genotype data quality control We utilized the UK Biobank 200K dataset [ 4 , 50 ] in our analysis. To miti"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
41437121,10.1186/s40478-025-02176-9,The tumour immune microenvironment is enriched but suppressed in vestibular schwannoma compared to meningioma: therapeutic implications for NF2-related schwannomatosis.,Acta Neuropathol Commun,2025,2043,6116,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""DESeq2"", ""limma"", ""scanpy"", ""Python""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Affymetrix microarray data For controls, VS, and meningioma samples, publicly available Affymetrix microarray data from  GSE54934  we"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""crophages, VS T cells or VS macrophages was generated per single cell RNA-seq sample, with PCA computed, and pseudo-bulk DEG analysis completed using DESeq2 package applying the Wald test with Benjamini\u2013Hochberg FDR adjustment with significance when  p \u2009<\u20090.05 with fold change of\u2009\u2264\u2009-2 or\u2009\u2265\u20092. Ingenuity pa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": ""quent annotation using the U219 array database \u2018pd.hugene.1.0.st.v1\u2019 [ 7 ,  29 ]. Differential gene expression analysis was conducted in R using the \u2018limma\u2019 package with empirical Bayes to analyse six groups: control vestibular and eighth cranial nerve  n \u2009=\u20092, VS tissue (sporadic  n \u2009=\u200928 and  NF2 -SWN "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:scanpy"": {""context"": "" Supplementary Table\u00a01 and can be found in the GEO repositories and associated publications [ 4 ,  10 ]. Data were pre-processed using python package Scanpy to compute per-cell and per-gene quality control to remove cells of poor quality and doublets, leaving mitochondrial genes in the data to help identi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""is described in Supplementary Table\u00a01 and can be found in the GEO repositories and associated publications [ 4 ,  10 ]. Data were pre-processed using python package Scanpy to compute per-cell and per-gene quality control to remove cells of poor quality and doublets, leaving mitochondrial genes in the data"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:scanpy"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,Sci Rep,2025,647,9935,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Disease animal model and ethical considerations The Postn-Cre transgenic and conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs at Indiana University Schoo"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""ness\u2009=\u20090.2\u00a0mm; matrix\u2009=\u2009200\u2009\u00d7\u2009150; RARE factor\u2009=\u20094; bandwidth\u2009=\u200978\u00a0kHz; averages\u2009=\u200912; 5\u00a0min, 32\u00a0s) was acquired. 52 MRI images were transferred into MATLAB with Aedes software for manual segmentation of DRG schwannomas at bilateral lumbar levels L1\u2013L6 by two independent raters (JLS and YS, Fig.\u00a0 3 B,C), "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:MATLAB"": [""methods""]}",False
41446112,10.64898/2025.12.15.694380,Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice.,bioRxiv,2025,484,23871,0,0,6,6,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""CellProfiler"", ""STAR"", ""Fiji"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials Availability The  Mapk1  mouse model is available upon request to the lead contact. A172V METHODS EXPERIMENTAL MODEL DETAILS Mice All experiments"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""ash for 10 minutes in TBS. Signals were visualized on the Odyssey CLx (LI-COR) using ImageStudio Ver 5.2 (LI-COR). Data was analyzed through Fiji and GraphPad Prism 10.1.2. If applicable, the PVDF membrane was stripped in Restore Western Blot Stripping Buffer (Thermo Fisher Scientific), followed by 30 minutes at "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""100%) for 5 minutes each. Slides are then put into two washes of xylene for 5 minutes each and cover slipped with DPX mountant media (Sigma-Aldrich). CellProfiler (ver 4.2.8) was used to quantify the images. Heart Immunohistochemistry: Histological analysis was conducted on formalin-fixed tissues, paraffin-embe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""d using Anymaze software (Stoelting Company, Wood Dale, IL). There were 3 phases of the experiment: training, acquisition, and reversal learning. The starting quadrant was rotated in acquisition and reversal phases so no mouse started in the same quadrant on consecutive trials. Distance, speed, latency,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Fiji"": {""context"": "" by one wash for 10 minutes in TBS. Signals were visualized on the Odyssey CLx (LI-COR) using ImageStudio Ver 5.2 (LI-COR). Data was analyzed through Fiji and GraphPad Prism 10.1.2. If applicable, the PVDF membrane was stripped in Restore Western Blot Stripping Buffer (Thermo Fisher Scientific), followe"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""5) and a fold change cutoff of |1.5|. The following packages were used for subsequent downstream analysis:  ReactomePA  (Reactome Pathway analysis),  ggplot2  (bargraphs and volcano plot),  ggpubr  (stats on bargraphs), and  ssGSEA2  (post-translational modification-signature enrichment analysis or PTM-SEA"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:Fiji"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
41463204,10.3390/cancers17243955,The Pathogenesis of the Neurofibroma-to-Sarcoma Transition in Neurofibromatosis Type I: From Molecular Profiles to Diagnostic Applications.,Cancers (Basel),2025,351,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) predisposes to a spectrum of peripheral nerve sheath tumors, ranging from benign plexiform neurofibromas (PN) to atypical neurofibromatous neoplasms"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) predisposes to a spectrum of peripheral nerve sheath tumors, ranging from benign plexiform neurofibromas (PN) to atypical n"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,Neurology,2026,1825,579,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ethods: Using electronic health records from the Children\u2019s Hospital of Philadelphia, we collected head circumference measurements from children with NF1 and a community control cohort seen at scheduled well-child visits. We compared head circumference normed using Centers for Disease Control (CDC) gro"", ""confidence"": 0.7999999999999999, ""is_development"": true, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: Using electronic health records from the Children\u2019s Hospital of Philadelphia, we collected head circumference measurements from children with NF1 and a community "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
41480763,10.1172/JCI194395,NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress.,J Clin Invest,2026,1279,26186,0,0,10,10,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""TopHat"", ""monocle"", ""STAR"", ""Seurat"", ""clusterProfiler"", ""HTSeq"", ""Monocle3"", ""DESeq2"", ""ImageJ""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. For experiments involving human pancreatic tissues, the sex of organ donors is reported in  Supplemental Table 1  and was not considered as a b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""PTN cells were cultured in CM for 4 days to allow organoid formation. On day 4, the organoids were exposed to low-nutrient medium for 1 day to induce starvation responses. A control group was maintained in fresh complete nutrient medium. Half of the medium (~200 \u03bcL) from each well was collected, and FIT"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""encing analysis using the Illumina HiSeq 3000 or NovaSeq 6000 System. Raw sequencing data were aligned to the reference genome GRCh38 or GRCm38 using TopHat 2.1.1. Gene expression reads were quantified using HTSeq 0.11.1. For tumor tissue samples, in order to separate human and mouse transcripts, the raw "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:monocle"": {""context"": ""scores of a list of gene signatures were calculated using the \u201cAddModuleScore\u201d command in Seurat. Single-cell trajectory analysis was performed using Monocle3 v.1.3.4 in R software with the default setting. The Seurat object containing all organoid cells were passed into Monocle3 to infer their cell-type t"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""le with the sample preparation protocol. The reference genomes GRCh38 and GRCm38 were used for alignment. The subsequent analysis was performed using Seurat v.5.0.1 in R software. A quality control step was performed to remove low-quality cells, including possible cell debris (nFeature <200), cell doublet"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:clusterProfiler"": {""context"": ""core of the transformed/normalized read count as indicated in each figure. Overrepresentation analysis for the lists of genes was performed using the clusterProfiler 4.4.4 package in R with default settings. A significant enrichment was considered with a multiple test\u2013adjusted  P  value of less than 0.05. scRNA-Se"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:HTSeq"": {""context"": ""000 System. Raw sequencing data were aligned to the reference genome GRCh38 or GRCm38 using TopHat 2.1.1. Gene expression reads were quantified using HTSeq 0.11.1. For tumor tissue samples, in order to separate human and mouse transcripts, the raw reads were aligned to a concatenated human and mouse geno"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Monocle3"": {""context"": ""scores of a list of gene signatures were calculated using the \u201cAddModuleScore\u201d command in Seurat. Single-cell trajectory analysis was performed using Monocle3 v.1.3.4 in R software with the default setting. The Seurat object containing all organoid cells were passed into Monocle3 to infer their cell-type tr"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""gned to both the human and mouse genome ( 56 ). Differential expression analysis of the read counts from aligned RNA-Seq data was performed using the DESeq2 1.36.0 package in R software. A prefiltering process was applied for each analysis to remove genes with a low read count, i.e., we only retained gene"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" were captured using a Leica DMI6000 B microscope and compatible software (Leica Microsystems). Fluorescence signal intensities were quantified using ImageJ v1.5g software (NIH). The following primary and secondary antibodies were used: mouse anti\u2013human STEM121 (Takara Bio, Y40410, dilution 1:200); mouse "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods"", ""abstract""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:monocle"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:clusterProfiler"": [""methods""], ""computational_tools:HTSeq"": [""methods""], ""computational_tools:Monocle3"": [""methods""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
41480769,10.1172/JCI200909,Merlin's disappearing act: NF2 loss conjures pancreatic cancer survival in the hostile tumor microenvironment.,J Clin Invest,2026,753,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Pancreatic cancer cells \""live on the edge,\"" starved of nutrients, compressed by abundant stiff stroma, and deprived of oxygen. In this issue, Xu et al. lev"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""Pancreatic cancer cells \""live on the edge,\"" starved of nutrients, compressed by abundant stiff stroma, and deprived of oxygen. In this issue, Xu et al. leveraged human pancreas organoid-based CRISPR"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
41487565,10.3389/fonc.2025.1724278,Context-specific targeting of focal adhesion kinase in brain tumors: lessons from glioblastoma and neurofibromatosis type 2-mutant meningioma.,Front Oncol,2025,388,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Focal adhesion kinase (FAK) has long been explored as a therapeutic target in glioblastoma (GBM) based on its overexpression and involvement in invasive signaling. However, clinical trials have cons"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
41496278,10.1016/j.scr.2025.103904,Simultaneous reprogramming and gene correction to generate six iPSC lines and isogenic controls from individuals with neurofibromatosis type 1.,Stem Cell Res,2026,716,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder that affects\u00a0\u223c\u00a01: 2700 individuals (Lee et al., 2023) however the underlying pathogenic mechanisms are poorly under"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurodevelopmental disorder that affects\u00a0\u223c\u00a01: 2700 individuals (Lee et al., 2023) however the underlying pathogenic me"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41496346,10.1016/j.biopha.2025.118947,"Midkine as a therapeutic node in NF1-driven neurooncology: Biology, biomarkers, and translational strategies.",Biomed Pharmacother,2026,1431,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) produces a permissive neuro\u2011oncologic milieu by disabling neurofibromin's GTPase\u2011activating control over RAS, thereby exaggerating RAF-MEK-ERK and P"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) produces a permissive neuro\u2011oncologic milieu by disabling neurofibromin's GTPase\u2011activating control over RAS, thereby exagg"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41533509,10.1016/j.celrep.2025.116822,Microenvironmental TGF- is an early driver of NF1-associated tumor formation.,Cell Rep,2026,108,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome characterized by neurofibromas, Nf1"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common tumor predisposition syndrome characterized by neurofibromas, Nf1"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41545416,10.1038/s41540-026-00647-w,Asthma-mediated control of optic glioma growth via T cell-microglia interactions: A mathematical model.,NPJ Syst Biol Appl,2026,1245,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Optic glioma, a slow-growing tumor, is associated with Neurofibromatosis type 1 (NF1) mutations and increased midkine (MDK) production. A connection between asthma and optic glioma has previously been observed, but the mechanisms are "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Optic glioma, a slow-growing tumor, is associated with Neurofibromatosis type 1 (NF1) mutations and increased midkine (MDK) production. A connection between asthma and optic"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,PLoS One,2026,1433,21282,0,20,10,30,"{""cell_lines"": {""icNF98.4d"": ""882101e0-1207-4323-a354-6d5a642e6ca3"", ""icNF00.10a"": ""ad2e271b-55ac-44ae-b39d-f1a6d76e1dc3"", ""icNF09.5"": ""a9638c45-74f3-4d0d-8bac-67631503f437"", ""cNF97.2a"": ""d390b3f3-fea7-46d2-9bb7-dc72d59b2ccc"", ""cNF98.4c"": ""df513bb8-697a-4cac-ae6c-5aca6113ac24"", ""icNF97.5"": ""3003d963-fb4b-44e0-9b4c-97c5df6d6661"", ""cNF97.2b"": ""b4987f0a-67ec-4f13-96f1-9443aac6e5ac"", ""icNF99.1"": ""27004264-d872-493f-8668-ec4d2425cdc2"", ""icNF18.1a"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""icNF98.4c"": ""df513bb8-697a-4cac-ae6c-5aca6113ac24"", ""icNF97.2a"": ""a731535e-f7a6-4c6e-b0db-7f0d0979e69f"", ""icNF97.2b"": ""a731535e-f7a6-4c6e-b0db-7f0d0979e69f"", ""cNF00.10a"": ""ad2e271b-55ac-44ae-b39d-f1a6d76e1dc3"", ""28cNF"": ""5a466cdc-5eaa-45a5-87b1-ba9cac6d7d21"", ""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31"", ""icNF93.1a"": ""dcf74355-dce9-4eac-bfda-00984a4e7f3c"", ""cNF98.4d"": ""882101e0-1207-4323-a354-6d5a642e6ca3"", ""icNF04.9a"": ""c5b9e065-6855-4a11-bceb-681d8e82ae5e"", ""cNF04.9a"": ""c5b9e065-6855-4a11-bceb-681d8e82ae5e"", ""i28cNF"": ""8e9ec3f3-5622-4f8f-a02c-34d8777c82b6""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bedtools"", ""R"", ""GATK"", ""STAR"", ""edgeR"", ""limma"", ""Salmon"", ""ImageJ"", ""pheatmap"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and methods Subjects. This study utilized data from a total of 14 de-identified cell lines from 10 individuals with NF1, and one who was too young to meet diagnostic criteria. For 8 of these individuals (11 cell lines), written consent had been previously obtained unde"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Subjects. This study utilized data from a total of 14 de-identified cell lines from 10 individuals with NF1, and one who was too youn"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:icNF98.4d"": {""context"": ""A, in-frame) icNF98.4c* M sessile c.6641+1G\u2009>T r.6580\u20136641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) loss of heterozygosity (LOH) \u2013 allele deletion icNF98.4d* M sessile c.6641+1G\u2009>T r.6580_6641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cuta"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF00.10a"": {""context"": ""gosity (LOH) \u2013 allele deletion icNF98.4d* M sessile c.6641+1G\u2009>T r.6580_6641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cutaneous c.5798C\u2009>\u2009A p.Ser1933Ter c.5968C\u2009>\u2009G p.Leu1990Val icNF04.9a* F globular c.7328_7343del p.Thr2443LysfsTer20 c.5205+"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF09.5"": {""context"": ""oesn\u2019t meet diagnostic criteria for NF1, and the only germline mutation we can find seemed to be a silent variant via direct sequencing; icNF18.1 and icNF09.5 (same patient) - icNF18.1 is mostly heterozygous and the somatic mutation is in low frequency, we were unable to observe a second NF1 hit on icNF09.5"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF97.2a"": {""context"": ""., 2018 (Neurology 91 (Suppl 1):S5-S13). Cell line name Sex CNF lesion type** Germline NF1 variant (NM_0000267.3) Somatic NF1 variant (NM_0000267.3) icNF97.2a* F sessile c.233del p.Asn78IlefsTer6 c.1929del p.Thr639Thrfs47 icNF97.2b* F globular c.233delA p.Asn78IlefsTer6 c.1392+\u20092delTA p.Ser421_Pro464del (sk"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF98.4c"": {""context"": ""cell lines with details on their histologic, NF1 variant, passage and staining properties. Final row includes data on a subcloned heterozygous line (icNF98.4c). * indicates cell lines that were included in genomic profiling experiments. Excluded cell lines were not genomically profiled for the following rea"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF97.5"": {""context"": ""ndicates cell lines that were included in genomic profiling experiments. Excluded cell lines were not genomically profiled for the following reasons: icNF97.5 \u2013 the patient doesn\u2019t meet diagnostic criteria for NF1, and the only germline mutation we can find seemed to be a silent variant via direct sequencin"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF97.2b"": {""context"": ""pe** Germline NF1 variant (NM_0000267.3) Somatic NF1 variant (NM_0000267.3) icNF97.2a* F sessile c.233del p.Asn78IlefsTer6 c.1929del p.Thr639Thrfs47 icNF97.2b* F globular c.233delA p.Asn78IlefsTer6 c.1392+\u20092delTA p.Ser421_Pro464del (skip exon 12 in mRNA, in-frame) icNF98.4c* M sessile c.6641+1G\u2009>T r.6580\u201366"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF99.1"": {""context"": ""0T\u2009>\u2009C p.Trp784Arg none detected (= heterozygous?) icNF97.5 M flat or sub-cutaneous c.8160G\u2009>\u2009C p.Thr2720\u2009=\u2009 (silent) none detected (= heterozygous?) icNF99.1 F globular c.1246C\u2009>\u2009T p.Arg416Ter c.6888G\u2009>\u2009A p.Trp2296Ter low level (mostly heterozygous?) i18cNF F not available DNA-level mutation is unclear, co"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF18.1a"": {""context"": ""5del p.Val1718_Lys1735del (cryptic splice losing last 18 codons of exon 36) i28cNF* F not available c.3233C\u2009>\u2009G p.Ser1078Ter c.3158C\u2009>\u2009G p.Ser1053Ter icNF18.1a F pedunculated c.4084C\u2009>\u2009T p.Arg1362Ter (strong NMD) low level of c.92A\u2009>\u2009G p.His31Arg (mostly heterozygous) icNF09.5 F pedunculated c.4084C\u2009>\u2009T p.Ar"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF98.4c"": {""context"": "" cell lines with details on their histologic, NF1 variant, passage and staining properties. Final row includes data on a subcloned heterozygous line (icNF98.4c). * indicates cell lines that were included in genomic profiling experiments. Excluded cell lines were not genomically profiled for the following rea"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF97.2a"": {""context"": ""l., 2018 (Neurology 91 (Suppl 1):S5-S13). Cell line name Sex CNF lesion type** Germline NF1 variant (NM_0000267.3) Somatic NF1 variant (NM_0000267.3) icNF97.2a* F sessile c.233del p.Asn78IlefsTer6 c.1929del p.Thr639Thrfs47 icNF97.2b* F globular c.233delA p.Asn78IlefsTer6 c.1392+\u20092delTA p.Ser421_Pro464del (sk"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF97.2b"": {""context"": ""ype** Germline NF1 variant (NM_0000267.3) Somatic NF1 variant (NM_0000267.3) icNF97.2a* F sessile c.233del p.Asn78IlefsTer6 c.1929del p.Thr639Thrfs47 icNF97.2b* F globular c.233delA p.Asn78IlefsTer6 c.1392+\u20092delTA p.Ser421_Pro464del (skip exon 12 in mRNA, in-frame) icNF98.4c* M sessile c.6641+1G\u2009>T r.6580\u201366"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF00.10a"": {""context"": ""osity (LOH) \u2013 allele deletion icNF98.4d* M sessile c.6641+1G\u2009>T r.6580_6641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cutaneous c.5798C\u2009>\u2009A p.Ser1933Ter c.5968C\u2009>\u2009G p.Leu1990Val icNF04.9a* F globular c.7328_7343del p.Thr2443LysfsTer20 c.5205+"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:28cNF"": {""context"": ""waiving consent, which occurred on multiple occasions between August 1, 2018, and August 17, 2023. The three other additional lines (i18cNF, i21cNF, i28cNF) were from NF1 cNFs obtained and cultured with approval of the Clinical Research Ethics Committee of Germans Trias i Pujol Hospital, Badalona (Barcel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF93.1a"": {""context"": "".1 is mostly heterozygous and the somatic mutation is in low frequency, we were unable to observe a second NF1 hit on icNF09.5 via direct sequencing; icNF93.1a - heterozygous and unable to observe a second NF1 hit via direct sequencing. ** morphology defined per rubric from Ortonne et al., 2018 (Neurology 91"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF98.4d"": {""context"": "", in-frame) icNF98.4c* M sessile c.6641+1G\u2009>T r.6580\u20136641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) loss of heterozygosity (LOH) \u2013 allele deletion icNF98.4d* M sessile c.6641+1G\u2009>T r.6580_6641del p.Ala2194ArgfsTer5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cuta"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:icNF04.9a"": {""context"": ""r5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cutaneous c.5798C\u2009>\u2009A p.Ser1933Ter c.5968C\u2009>\u2009G p.Leu1990Val icNF04.9a* F globular c.7328_7343del p.Thr2443LysfsTer20 c.5205+2T\u2009>\u2009G r.5151_5205del p.Val1718_Lys1735del (cryptic splice losing last 18 codons of exon 36) i2"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:cNF04.9a"": {""context"": ""5 (skip exon 43 in RNA) c.6253del p.Val2085LeufsTer4 icNF00.10a* M flat, or possibly sub-cutaneous c.5798C\u2009>\u2009A p.Ser1933Ter c.5968C\u2009>\u2009G p.Leu1990Val icNF04.9a* F globular c.7328_7343del p.Thr2443LysfsTer20 c.5205+2T\u2009>\u2009G r.5151_5205del p.Val1718_Lys1735del (cryptic splice losing last 18 codons of exon 36) i2"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""cell_lines:i28cNF"": {""context"": "" waiving consent, which occurred on multiple occasions between August 1, 2018, and August 17, 2023. The three other additional lines (i18cNF, i21cNF, i28cNF) were from NF1 cNFs obtained and cultured with approval of the Clinical Research Ethics Committee of Germans Trias i Pujol Hospital, Badalona (Barcel"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:bedtools"": {""context"": ""ome data only) [ 38 ]. Filtered variant (vcf) files for each cell line identified by DeepVariant were compared using the \u201cjaccard\u201d function from the \u201cbedtools\u201d software package [ 39 ]. The Jaccard indices were calculated in a pairwise manner ( i.e. , all cell lines compared to all other cell lines), followe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GATK"": {""context"": ""e Ion S5 sequencer per manufacturer\u2019s instructions. Variant calling of the germline samples was performed using The Genome Analysis Toolkit ( https://gatk.broadinstitute.org ) and IonTorrent Variant Caller (TVC,  https://github.com/domibel/IonTorrent-VariantCaller ), while somatic variant calling was pe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""plots to compare the CNAs to the gene counts [ 41 , 42 ]. The genes in the gene expression data were mapped to the appropriate chromosome and genomic start location using the BiomaRt R package [ 43 , 44 ]. The CNA values and gene counts were log10 transformed to make smaller changes easier to observe in"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:edgeR"": {""context"": ""\u201d The normalized counts were adjusted for heteroscedasticity using the \u201cvoom\u201d function then analyzed by fitting a generalized linear model (limma and edgeR packages) to identify differentially expressed genes between the sample groups [ 49 \u2013 54 ]. \u201cPheatmap\u201d was used for hierarchical clustering of the di"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:limma"": {""context"": "" \u201cggplot2.\u201d The normalized counts were adjusted for heteroscedasticity using the \u201cvoom\u201d function then analyzed by fitting a generalized linear model (limma and edgeR packages) to identify differentially expressed genes between the sample groups [ 49 \u2013 54 ]. \u201cPheatmap\u201d was used for hierarchical clustering"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Salmon"": {""context"": ""ormed and underlying software versions can be found in the nf-core/rnaseq documentation ( https://nf-co.re/rnaseq/3.5 ). The pipeline was run in STAR-Salmon mode, which uses STAR for alignment (GRCh38, NCBI build), and Salmon for quantification of transcripts and genes. The pairwise Euclidean distances be"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""substrate from Bio-Rad (Cat. #: 170\u20135061; Hercules, California) per the manufacturer\u2019s protocols. Western blot band intensities were quantitated with ImageJ software. Neurofibromin (when present) was normalized to beta actin of that sample. Comparison of neurofibromin, p-ERK, and ERK levels across blots w"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:pheatmap"": {""context"": ""s compared to all other cell lines), followed by hierarchical clustering of the resulting matrix of Jaccard indices, plotting the results with the R \u201cpheatmap\u201d package ( https://cran.r-project.org/web/packages/pheatmap/index.html ). For the lollipop analysis,  NF1  variants were extracted from the annotated"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""the normalized log transformed counts (log counts per million) was performed using the \u201cprcomp\u201d function of the \u201cstats\u201d package and visualized using \u201cggplot2.\u201d The normalized counts were adjusted for heteroscedasticity using the \u201cvoom\u201d function then analyzed by fitting a generalized linear model (limma and"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:icNF98.4d"": [""methods""], ""cell_lines:icNF00.10a"": [""methods""], ""cell_lines:icNF09.5"": [""methods""], ""cell_lines:cNF97.2a"": [""methods""], ""cell_lines:cNF98.4c"": [""methods""], ""cell_lines:icNF97.5"": [""methods""], ""cell_lines:cNF97.2b"": [""methods""], ""cell_lines:icNF99.1"": [""methods""], ""cell_lines:icNF18.1a"": [""methods""], ""cell_lines:icNF98.4c"": [""methods""], ""cell_lines:icNF97.2a"": [""methods""], ""cell_lines:icNF97.2b"": [""methods""], ""cell_lines:cNF00.10a"": [""methods""], ""cell_lines:28cNF"": [""methods""], ""cell_lines:icNF93.1a"": [""methods""], ""cell_lines:cNF98.4d"": [""methods""], ""cell_lines:icNF04.9a"": [""methods""], ""cell_lines:cNF04.9a"": [""methods""], ""cell_lines:i28cNF"": [""methods""], ""computational_tools:bedtools"": [""methods""], ""computational_tools:GATK"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:edgeR"": [""methods""], ""computational_tools:limma"": [""methods""], ""computational_tools:Salmon"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:pheatmap"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
41570527,10.1016/j.psj.2026.106375,Novel insights into the regulation of NF2/SWH signaling in granulosa cells of prehierarchical follicle development in hen ovary.,Poult Sci,2026,1977,19658,0,0,5,5,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""STAR"", ""FlowJo"", ""SPSS""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and methods Ethics statement All procedures executed in chickens were approved by the Institutional Animal Care and Use Committee (IACUC) of Jili"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""as mean \u00b1 SEM and bars with superscript symbols that indicate the significant difference compared with control groups at **  P  < 0.01, *  P  < 0.05. GraphPad Prism version 8 (GraphPad Prism, CA, USA) was applied to form statistical graphs based on the results. Appendix Supplementary materials \n \n Supplementary I"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""GCCATAGTCA 281 MYC KU981087.1 F: ATCAGCAACAACCGAAAATG R: GTCACGCAGGGCAAAGAAAC 132 GDF9 AY566700.2 F: CTATTGCTGCATTCACTGGC R: CCTTGGTGGCGTACATCTTA 269 STAR NM_204686.2 F: GTCCCTCGCAGACCAAGT R: TCCCTACTGTTAGCCCTGA 196 CYP11A1 NM_001001756.1 F: GTGGACACGACTTCCATGACT R: GAGAGTCTCCTTGATGGCGG 174 BCL-2 NM_205"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:FlowJo"": {""context"": ""ic cells comprises the number of cells in the right upper quadrant (Q1-UR) and number of cells in the right lower quadrant (Q1-LR) and analyzed using FlowJo v7.6 software (Stanford University, Stanford, CA, USA). Each experiment was carried out at least three times. ROS detection Reactive Oxygen Species A"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": ""CTAGTCAGCTGAAGACTTTAAT-3\u2032, which was synthesized by Genepharma (Shanghai, China). Statistical analysis Statistical analysis was carried out using the SPSS12.0 software package. The data were collected and analyzed with a one-way ANOVA followed by Tukey\u2019s multiple-comparison test when more than two group"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:FlowJo"": [""methods""], ""computational_tools:SPSS"": [""methods""]}",False
41580779,10.1186/s12935-025-04165-3,HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2.,Cancer Cell Int,2026,1718,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) represent the most severe complication of neurofibromatosis type 1 (NF1), with limited therapeutic options and poor prognosis. High-mobility group box 1 (HMGB1) is a chromatin-associated protein implicated in various canc"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Malignant peripheral nerve sheath tumors (MPNSTs) represent the most severe complication of neurofibromatosis type 1 (NF1), with limited therape"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41582719,10.1242/dmm.052509,Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning in a zebrafish model of Neurofibromatosis.,Dis Model Mech,2026,1351,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurogenetic disorder caused by loss of function mutations in the gene neurofibromin 1 (NF1). NF1 encodes neurofibromin, a multifunctional tumo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a neurogenetic disorder caused by loss of function mutations in the gene neurofibromin 1 (NF1). NF1 encodes neurofibromi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,Acta Neuropathol,2026,2283,10773,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""slingshot"", ""Seurat"", ""STAR"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Ethical approval & cohort Our study was approved by the responsible ethical committee of Ludwig-Maximilians-University of Munich (reference: project number 25-065"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:NF1"": {""context"": ""single-cell transcriptomic analyses were performed using custom R scripts, which are available on GitHub ( https://github.com/ngr-path/Analysis_R_FAP_NF1_MPNST ). Statistical analysis Continuous data are given as mean\u2009\u00b1\u2009standard deviation or median and range, where appropriate. Comparisons were perform"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""e-body imaging was acquired at 60\u00a0min post administration with 6\u20138 bed positions and an emission time of 2\u00a0min each. Data were decay-corrected to the starting time of each individual scan. PET imaging was accompanied by whole-body auxiliary CT (35 mAs, 120\u00a0keV, a 512\u2009\u00d7\u2009512 matrix, 5-mm slice thickness, "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:slingshot"": {""context"": ""rker expression  (FAP, SLC2A1, SLC2A3)  were visualized by UMAP and DotPlot. To explore differentiation trajectories among tumor clusters, we applied Slingshot [ 39 ] (Version: 2.12.0) ( slingshot.html ) on UMAP embeddings. Bulk, spatial, and single-cell transcriptomic analyses were performed using custom R "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""NSTs), two hybrid peripheral nerve sheath tumors (HPNSTs), one plexiform neurofibroma, and one NF2-associated neuropathy. We processed the data using Seurat [ 36 ,  37 ] (Version: 5.3.0,  https://satijalab.org/seurat/ ) in R (Version: 4.4.0). For each sample, we retained spatial spots with\u2009>\u200950 detected g"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:NF1"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:slingshot"": [""methods""], ""computational_tools:Seurat"": [""methods""]}",False
41598414,10.3390/jcm15020475,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,J Clin Med,2026,0,2580,0,1,1,2,"{""animal_models"": {}, ""antibodies"": {}, ""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""animal_models"": [], ""antibodies"": [], ""cell_lines"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""on and Exclusion Criteria The inclusion criteria for this study involved obtaining informed consent from participants and confirming the diagnosis of NF1 based on the current criteria published by Legius et al. in 2021 [ 10 ], followed by molecular genetic analysis of the NF1 gene in all patients. Excl"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2. Materials and Methods 2.1. Inclusion and Exclusion Criteria The inclusion criteria for this study involved obtaining informed consent from participants and"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods""], ""computational_tools:R"": [""methods""]}",False
41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,Cureus,2025,1939,6689,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""d remotely; therefore, participants resided in multiple locations across the United States. Recruitment and data collection procedures Recruitment of NF1 patients, referred to hereafter as the \u201cpatient group,\u201d involved sending a mass email announcement through the Children\u2019s Tumor Foundation (CTF) regi"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods The methods and findings for the current study have not been previously presented or published. The study was conducted between June "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""eratively until the team concluded that data saturation had been achieved (that is, no new information emerged in subsequent interviews) [ 22 - 24 ]. Starting with an initial set of codes based on the domains in the Interview Guide, the coding team independently coded all transcripts and then reviewed t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,Sci Adv,2026,373,27721,0,0,7,7,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""GraphPad Prism"", ""Seurat"", ""MATLAB"", ""msigdbr"", ""ImageJ"", ""ggplot2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""MATERIALS AND METHODS Study approval All animal studies were conducted at the Indiana University School of Medicine in accordance with the Institutional An"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""lgorithm as negative (0; blue), weakly positive (1+; yellow), moderately positive (2+; orange), or strongly positive (3+; red). Data were exported to GraphPad Prism for statistical analysis as described below. 87 Immunohistochemical staining Five-micrometer-thick tissue sections were deparaffinized, hydrated, and"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Seurat"": {""context"": ""Gene Expression Omnibus (GEO) under the accession number GSE250061. The filtered_bc_matrix.h5 files were read into R using the Read10X_h5 function in Seurat (version 4.0.2, RRID:SCR_016341). Seurat objects were created for each dataset with a minimum of three cells and 200 features per cell. Violin plots "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": ""10-dB steps, and presented at 21/s with a closed-field system) were amplified, filtered (3 Hz to 3 kHz), averaged, and stored for offline analysis in MATLAB (MathWorks, Natick, MA, USA). ABR waveforms were high-pass filtered using a cutoff of 200 Hz to remove slow oscillations and emphasize characteristic"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:msigdbr"": {""context"": ""pes based on the expression of known marker genes ( 95 ). 96 GSEAs comparing MET+ and MET \u2013  SCs were performed using the following packages: Seurat, msigdbr (version 7.4.1, RRID:SCR_022870), ggplot2 (version 3.3.5, RRID: SCR_014601), gridExtra (version 2.3), and enrichplot (version 1.14.0) ( ,  97 ). From"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" Sensitivity Substrate 34095), and images were collected on a Bio-Rad ChemiDoc. Arbitrary densitometry units were calculated and quantified using the ImageJ software [National Institutes of Health (NIH), version 1.53], with signals normalized to the corresponding loading control and expressed relative to "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ggplot2"": {""context"": ""r genes ( 95 ). 96 GSEAs comparing MET+ and MET \u2013  SCs were performed using the following packages: Seurat, msigdbr (version 7.4.1, RRID:SCR_022870), ggplot2 (version 3.3.5, RRID: SCR_014601), gridExtra (version 2.3), and enrichplot (version 1.14.0) ( ,  97 ). From the cell-type\u2013annotated Seurat object gen"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:Seurat"": [""methods""], ""computational_tools:MATLAB"": [""methods""], ""computational_tools:msigdbr"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:ggplot2"": [""methods""]}",False
41631643,10.1002/hbm.70464,Disrupted Frontoparietal Dynamics in Neurofibromatosis Type 1: Reduced Sensitivity and Atypical Modulation During Working Memory.,Hum Brain Mapp,2026,2294,17177,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""MATLAB""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""2 Methods 2.1 \n NF1  Participants The adolescents aged 11\u201317\u2009years were recruited via the Northern UK NF\u2014National Institute of Health, with (i) diagnostic criteria [Nati"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""2 Methods 2.1 \n NF1  Participants The adolescents aged 11\u201317\u2009years were recruited via the Northern UK NF\u2014National Institute of Health, with (i) diagnostic criteria [National "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:MATLAB"": {""context"": "" Image Processing Image processing was done using SPM12 (Wellcome Department of Imaging Neuroscience, London;  http://www.fil.ion.ucl.ac.uk/spm ) and MATLAB R2023a. Dual echo images were extracted and averaged using in\u2010house MATLAB code developed by Halai et\u00a0al.\u00a0( 2014 ) (DEToolbox). First, functional ima"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:MATLAB"": [""methods""]}",False
41659661,10.64898/2026.01.26.701794,"Mechanical Stiffening Promotes Growth, Invasion, and Mitogen-Activated Protein Kinase Kinase (MEK) Inhibitor Resistance in 3D Plexiform Neurofibroma Cultures.",bioRxiv,2026,113,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Plexiform neurofibromas with neurofibromatosis type I (pNF1s) are benign peripheral nerve sheath tumors caused by"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Plexiform neurofibromas with neurofibromatosis type I (pNF1s) are benign peripheral nerve sheath tumors caused by"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
6093111,10.1073/pnas.81.21.6681,Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies.,Proc Natl Acad Sci U S A,1984,795,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The nerve growth factor (NGF) receptor was characterized by using a new series of anti-receptor monoclonal antibodies (MAbs). These MAbs (i) showed significa"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
6417334,10.1136/jmg.20.5.334,Linkage analysis of neurofibromatosis (von Recklinghausen disease).,J Med Genet,1983,1027,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Linkage analysis of 28 genetic markers was undertaken in 108 subjects from 11 families with well-documented, classic, peripheral neurofibromatosis. Fifty-four persons were affected in "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
6451216,10.1042/bj1880677,An enzyme activity in normal and ataxia telangiectasia cell lines which is involved in the repair of gamma-irradiation-induced DNA damage.,Biochem J,1980,786,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""An enzyme that enhances the activity of DNA polymerase I (EC 2.7.7.7) for gamma-irradiated calf thymus DNA was demonstrated in cellular extracts of normal human fibroblasts and lymphoid-cell lines. Thi"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
7474134,10.1128/JVI.69.11.7138-7146.1995,Frequent disruption of the Nf1 gene by a novel murine AIDS virus-related provirus in BXH-2 murine myeloid lymphomas.,J Virol,1995,1360,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Evi-2, a common site of viral integration in BXH-2 myeloid lymphomas, is located within a large intron of the Nf1 tumor suppressor gene. Viral integration at Evi-2 appears to induce disease by disrupting normal Nf1 expression. During our attempts to characterize "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Evi-2, a common site of viral integration in BXH-2 myeloid lymphomas, is located within a large intron of the Nf1 tumor suppressor gene. Viral integration at Evi-2 appears to in"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7485407,,NF2 gene analysis distinguishes hemangiopericytoma from meningioma.,Am J Pathol,1995,1241,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The histogenesis of dural-based or \""central\"" hemangiopericytomas (cHPCs) remains controversial. Some authors consider these tumors variants of meningiomas while others consi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
7499408,10.1074/jbc.270.48.28834,"Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NF1) gene product, in cell-free systems.",J Biol Chem,1995,1572,7670,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The neurofibromatosis type 1 (NF1) gene encodes a protein, neurofibromin, containing GTPase-activating protein-related domain (GRD) that stimulates intrinsic GTPase activity of Ras pr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and methods We performed a comprehensive search of PubMed, Web of Science, Ovid, the Cochrane Library and Embase databases from the drugs\u2019 incept"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s independently assessed each study under five main headings for the risk of bias. Statistical analyses All statistical analyses were performed using GraphPad Prism software (version 6.0; GraphPad Software, Inc., La Jolla, CA, USA). Fisher\u2019s exact or chi-square tests were used to compare the frequencies of AEs am"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""stical significance was considered at  P <0.05. Supplementary materials Table S1 Nine-point NOS scores for the NRCTs Study Selection (maximum of four stars)\n Comparability (maximum of two stars)\n Outcome (maximum of three stars)\n Representativeness of the exposed cohort Selection of the nonexposed cohor"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
7505343,10.1002/jnr.490360212,"Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation.",J Neurosci Res,1993,1666,10308,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""ImageJ"", ""Python"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""percent of aligned fibers by dividing the among of fibers that deviated less than 20\u00b0 from the neutral axis [ 26 ]. Schwann cell culture Immortalized NF1 patient derived Schwann cell (NF SC, NF-/-) line, ipNF 95.11b and Wild type Schwann cell (WT SC, NF+/+) line, ipn 02.8 were utilized for all experime"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods HA hydrogels Hyaluronic acid (HA) hydrogels were made using previously described methods using 3% methacrylated HA and 0.05% I2959 photoinitiator [ 25 ]. Bri"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" were made during slow focus to obtain clear images. Images were captured at 10k and 15k magnifications. Fiber diameter and angle were measured using ImageJ (v1.53a) with at least 200 fibers per fiber type. Fiber diameter was measured manually. The angle tool was used to measure the orientation of the fib"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:Python"": {""context"": ""ugh the stimulation chamber (Voltage Out) were captured from Channel 1 and Channel 2 of an oscilloscope (Rigol) connected to a Raspberry Pi running a Python script to store the data in near real time through the USB port connection. The plates were UV sterilized before the hydration to prevent contaminati"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:Python"": [""methods""]}",False
7570581,10.1620/tjem.175.225,"Evidence for the presence of two amino-terminal isoforms of neurofibromin, a gene product responsible for neurofibromatosis type 1.",Tohoku J Exp Med,1995,1466,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder, primarily affecting cells of neural crest origin, and is characterized by caf\u00e9-au-lait skin spots, multiple"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common autosomal dominant disorder, primarily affecting cells of neural crest origin, and is characterized by caf\u00e9-au-"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7609078,10.1128/JVI.69.8.5095-5102.1995,Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.,J Virol,1995,1584,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""15% of BXH-2 myeloid leukemias harbor proviral integrations at the Evi-2 common viral integration site. Evi-2 is located within a large intron of the Nf1 tumor suppressor gene, raising the possibility that proviral integration at Evi-2 predisposes mice to myeloid tumor development by disrupting Nf1 exp"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Approximately 15% of BXH-2 myeloid leukemias harbor proviral integrations at the Evi-2 common viral integration site. Evi-2 is located within a large intr"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7671302,10.1016/0092-8674(95)90470-0,Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons.,Cell,1995,977,3723,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Mutations at the neurofibromatosis 1 (NF1) locus in humans and mice result in abnormal growth of neural crest-derived cells, including melanocytes and Schwann cells. We have exploited a targe"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Methods Sequencing All study participants signed written informed consent. Blood samples were collected for research purposes after receiving approval from the different local ethics"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
7686513,10.1016/0014-5793(93)81094-g,An exon-trapping system with a newly constructed trapping vector pEXT2; its application to the proximal region of the human chromosome 21 long arm.,FEBS Lett,1993,529,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""applied the system to the cosmid clones located on human chromosome 21p11-q21, and identified two fragments highly homologous to neurofibromatosis 1 (NF1) gene and a clearly transcribed fragment hybridized with approximately 1.6 kb RNA from human brain and human glioblastoma A172 cell."", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have developed an exon-trapping system with a newly constructed trapping vector containing multiple cloning sites (designated pEXT2). The system revealed high sensitivity for "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7706208,10.1093/oxfordjournals.jbchem.a124664,An exon 8-spliced out transcript of neurofibromatosis 2 gene is constitutively expressed in various human tissues.,J Biochem,1994,700,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We succeeded in cloning the exon 8-spliced out transcript of neurofibromatosis 2 (NF2) gene in human glioma cell lines. We then investigated the expression of the spliced out form in various human ti"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
7717450,,Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.,Am J Pathol,1995,1288,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""There is evidence from cytogenetic and loss of heterozygosity studies for the involvement of a tumor suppressor gene on chromosome 22 in the formation of "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
7903272,10.1007/BF00420953,An EcoRI RFLP in the 5' region of the human NF1 gene.,Hum Genet,1993,363,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Von Recklinghausen neurofibromatosis or type 1 neurofibromatosis (NF1), is one of the most common autosomal dominant disorders. NF1 is characterized by neurofibromas, caf\u00e9-au-lait spots and Lisch nodules of the iris. Th"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Von Recklinghausen neurofibromatosis or type 1 neurofibromatosis (NF1), is one of the most common autosomal dominant disorders. NF1 is characterized by neu"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7911002,,Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.,Am J Hum Genet,1994,1463,0,0,0,2,2,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The gene for the hereditary disorder neurofibromatosis type 2 (NF2), which predisposes for benign CNS tumors such as vestibular schwannomas and meningiomas, has b"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""ted tumors the NF2 gene functions as a recessive tumor-suppressor gene. The mutations detected resulted mostly in frameshifts, predicting truncations starting within the N-terminal half of the putative protein."", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
7947085,10.1038/bjc.1994.404,"Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction.",Br J Cancer,1994,1221,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""hether these loci are indeed the targets for alteration in colorectal cancer. In addition, we have assayed two other tumour-suppressor genes, WT1 and NF1, to see whether they play a role in colorectal carcinogenesis. The putative metastasis-suppressor gene, NM23, was also investigated since there have "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We report here the use of multiplex fluorescent polymerase chain reaction (PCR) for quantitative allele loss detection using microsatellites with 2-5 base"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7949098,,Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras.,Blood,1994,1462,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""type 1 (NF-1) are at increased risk of developing malignant myeloid disorders and their bone marrows frequently show loss of the normal allele of the NF1 tumor-suppressor gene. NF1 encodes a protein called neurofibromin, which accelerates guanosine triphosphate (GTP) hydrolysis on the p21ras (Ras) fami"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Children with neurofibromatosis, type 1 (NF-1) are at increased risk of developing malignant myeloid disorders and their bone marrows frequently show loss o"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
7959746,10.1006/geno.1994.1328,DNA sequences in the promoter region of the NF1 gene are highly conserved between human and mouse.,Genomics,1994,1079,0,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The gene for type 1 neurofibromatosis (NF1) is most highly expressed in brain and spinal cord, although low levels of mRNA can be found in nearly all tissues. As a first step in investigating "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The gene for type 1 neurofibromatosis (NF1) is most highly expressed in brain and spinal cord, although low levels of mRNA can be found in nearly all tissues. As "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": "" regulation of NF1 gene expression, we have cloned and sequenced the promoter regions of the human and mouse NF1 genes and mapped the transcriptional start sites in both species. We report here that the 5' ends of the human and murine NF1 genes are highly conserved. While no discernable TATA or CCAAT bo"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
7977647,,Characterization of naturally occurring cutaneous neurofibromatosis in Holstein cattle. A disorder resembling neurofibromatosis type 1 in humans.,Am J Pathol,1994,1040,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ws in a Holstein dairy herd developed cutaneous neurofibromatosis. This unique condition was investigated and compared with neurofibromatosis type 1 (NF1) in humans. All cutaneous lesions but one were consistent with neurofibromas in noncutaneous sites in cattle and neurofibromas in patients with NF1. "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis in cattle is typically a noncutaneous disease. A small group of cows in a Holstein dairy herd developed cutaneous neurofibromatosis. Thi"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8051082,,Cloning and characterization of a novel epidermal cell surface antigen (ESA).,J Biol Chem,1994,1338,14006,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Materials and Methods Plant Material Transgenic  A. thaliana  lines  AtFlot2-GFP  with the p35S::AtFlot2:GFP construct that stably produces the Flot2-GFP p"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
8089100,,An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).,J Biol Chem,1994,1671,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""-length NF2 and its N-terminal half (NF2-N, residues 9-359) have been expressed in v-Ha-Ras-transformed NIH/3T3 cells. Like neurofibromatosis type 1 (NF1) fragments (Nur-E-Kamal, M. S. A., Varga, M., and Maruta, H. (1993) J. Biol. Chem. 268, 22331-22337), full-length NF2 can reverse the Ras-induced mal"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Previously, we have cloned a candidate for the 595-amino acid neurofibromatosis type 2 tumor suppressor called NF2 or Merlin, with striking sequence sim"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8105688,,Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping.,Am J Hum Genet,1993,1481,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""s of linkage disequilibrium for gene mapping, we compared physical distances and linkage disequilibrium among eight RFLPs in the neurofibromatosis 1 (NF1) region. Seven of the polymorphisms span most of the NF1 gene, while the remaining polymorphism lies approximately 70 kb 3' to a stop codon in exon 4"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""To test the usefulness of linkage disequilibrium for gene mapping, we compared physical distances and linkage disequilibrium among eight RFLPs in the neurofibromatosis 1 (NF1) region. Seven of th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8176268,10.1111/1523-1747.ep12379925,Localization of neurofibromin to keratinocytes and melanocytes in developing rat and human skin.,J Invest Dermatol,1994,1285,6755,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""performed according to Abel et al. . using a single dose of DMBA (25\u2009\u03bcg) and a bi-weekly schedule for TPA (4\u2009\u03bcg) over 23 weeks. The  22 PLP CreERT2;  Nf1 f/\u2212 ;  ROSA -LacZ mice  was conditionally activated with a single subcutaneous dose of 4-hydroxytamoxifen (40\u2009\u03bcg) dissolved in 100% ethanol on the fi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods Animal studies All mice were housed in the Animal Care Facility at the University of Texas Southwestern Medical Center, and all procedures were approved by Institutional Animal "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""]}",False
8176761,10.1002/jnr.490370312,Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.,J Neurosci Res,1994,1410,0,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin, the protein product of the neurofibromatosis type 1 (NF1) gene, has two alternate isoforms which are generated by alternative splicing of two exons. One of these isoforms containing exon 48a is expressed at"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin, the protein product of the neurofibromatosis type 1 (NF1) gene, has two alternate isoforms which are generated by alternative splicing of t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""ed p21-ras protein. Using this model system, we demonstrate that differentiating C2C12 cells upregulate the expression of NF1 mRNA by 2 days of serum starvation concomitant with increased expression of nicotinic acetylcholine receptor mRNA. This upregulation of mRNA expression paralleled an increase in "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
8226742,,The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype.,J Biol Chem,1993,1910,15890,0,1,4,5,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""BWA"", ""R"", ""STAR"", ""SAMtools""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ze analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) to distinguish between MPNST and PN in patients with NF1. Following in silico enrichment for short cfDNA fragments and copy number analysis to estimate the fraction of plasma cfDNA originating from tumor (t"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods and findings This multi-institutional study from the National Cancer Institute and Washington University in St. Louis used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WG"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""The NF91 is, so far, the smallest among the tumor suppressor proteins that show the anti-v-Ha-Ras action in vivo. Thus, the NF91 appears to be a good starting material from which a smaller and more potent v-Ha-Ras antagonist could be devised to be used as a potential cure for the human cancers caused by"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:BWA"": {""context"": ""emultiplexed, and raw reads were quality filtered using fastp v.0.2. Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17. Aligned reads were deduplicated with Samtools v.1.7, then downsampled to 10 million read pairs (WGS coverage approximately 0.6\u00d7), or separa"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SAMtools"": {""context"": ""sing fastp v.0.2. Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17. Aligned reads were deduplicated with Samtools v.1.7, then downsampled to 10 million read pairs (WGS coverage approximately 0.6\u00d7), or separately for comparison purposes to 5 million read pairs (WG"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""abstract""], ""computational_tools:BWA"": [""methods""], ""computational_tools:SAMtools"": [""methods""]}",False
8226805,,Purification of a novel ras GTPase-activating protein from rat brain.,J Biol Chem,1993,1242,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""GTPase-activating protein (GAP) and neurofibromin, a gene product of neurofibromatosis type I gene, have been identified as factors that stimulate GTPase activity of ras "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
8264632,10.1128/mcb.14.1.641-645.1994,Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function.,Mol Cell Biol,1994,1006,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""The NF1 gene, which is altered in patients with type 1 neurofibromatosis, has been postulated to function as a tumor suppressor gene. The NF1 protein product"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The NF1 gene, which is altered in patients with type 1 neurofibromatosis, has been postulated to function as a tumor suppressor gene. The NF1 protein product neurofibromin stimul"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8320697,10.1136/jmg.30.5.363,A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.,J Med Genet,1993,1456,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common, autosomal dominant genetic disorder with a variety of highly variable symptoms including cutaneous manifestations (such as caf\u00e9 au lait"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1) is a common, autosomal dominant genetic disorder with a variety of highly variable symptoms including cutaneous manifestati"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8328449,,An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.,Am J Hum Genet,1993,1516,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis (NF) type 1 (NF1) is notable for its variable expression. To determine whether variation in expression has an inherited component, we examined 175 individuals in 48 N"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis (NF) type 1 (NF1) is notable for its variable expression. To determine whether variation in expression has an inherited component, we ex"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8332934,10.1007/BF01233074,Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules.,Somat Cell Mol Genet,1993,1073,12479,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""CellProfiler"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Methods: Cell Lines We derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We started by isolating sin"", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Methods: Cell Lines We derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We sta"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:CellProfiler"": {""context"": ""pplementary Figure 6 ). Poor-quality images included large smudges and/or debris, out-of-focus organelles, and over-saturated organelles. We utilized CellProfiler\u2019s image quality metrics to decide two image quality features best distinguished between poor and good quality images: Power Log Log Slope (to represe"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""derived an isogenic  NF1  wildtype ( NF1 +/+ ) and  NF1  null ( NF1 \u2212/\u2212 ) cell line from the hTERT-immortalized human Schwann cell line ipn02.3\u03bb.  We started by isolating single-cell clones of the parental line by sorting with the BD FACSAria III (BD Biosciences). From a monoclonal derived cell line (wh"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:CellProfiler"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
8335107,10.1016/0014-5793(93)80165-q,Differential contribution of M(r) 120 kDa rasGTPase-activating protein and neurofibromatosis type 1 gene product during the transition from growth phase to arrested state in human fibroblasts accompanied by a unique rasGTPase-activating activity.,FEBS Lett,1993,930,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""rasGTPase-activating protein (p120GAP) molecules per cell decreases to half its original levels, the amount of neurofibromatosis type 1 gene product (NF1, a neurofibromin) remains constant during the transition. The contribution of p120GAP to the total rasGTPase-activating (rasGA) activity in growing c"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Using octyl glucoside-solubilized cell extracts from human fibroblasts during growth phase to G0/G1 arrest state, we found that while the number of M(r) 120 kDa rasGTPase-activating protein (p1"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8341688,10.1073/pnas.90.14.6706,Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.,Proc Natl Acad Sci U S A,1993,1649,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""NF1 was first identified as the gene responsible for the pathogenesis of the human genetic disorder neurofibromatosis type 1. cDNA cloning revealed that "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""NF1 was first identified as the gene responsible for the pathogenesis of the human genetic disorder neurofibromatosis type 1. cDNA cloning revealed that its puta"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8417346,10.1128/mcb.13.1.487-495.1993,"A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity.",Mol Cell Biol,1993,1707,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""-activating protein (GAP), yeast Ira1p and Ira2p (inhibitory regulators of the RAS-cyclic AMP pathway), and neurofibromin, the protein encoded by the NF1 gene. Yeast expression experiments have confirmed that a 381-amino-acid segment of neurofibromin, dubbed the GAP-related domain (GRD), can function a"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Sequence analysis has shown significant homology between the catalytic regions of the mammalian ras GTPase-activating protein (GAP), yeast Ira1p and Ira2p (inhibitory regulators of the RAS-cyclic AMP pathway), and neurofib"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8455625,10.1128/mcb.13.4.2497-2503.1993,Differential regulation of cellular activities by GTPase-activating protein and NF1.,Mol Cell Biol,1993,1787,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""gaps) which increase the GTPase activity of wild-type (wt) Ras but not activated Ras in vitro have been identified: type I and type II GAP and type I NF1. Mutations of wt Ras resulting in lowered intrinsic GTPase activity or loss of response to cellular Ras-gap proteins are thought to be the primary re"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""The regulation of the GTPase activity of the Ras proteins is thought to be a key element of signal transduction. Ras proteins have intrinsic GTPase activit"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8544190,10.1136/jmg.32.9.706,Characterisation of germline mutations in the neurofibromatosis type 1 (NF1) gene.,J Med Genet,1995,866,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 is one of the most common inherited disorders with an incidence of 1 in 3000. The search for NF1 mutations has been hampered by the overall size of the gene, the large number of exons, and the high mutation rate. To date, fewer than 90 mutations "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 is one of the most common inherited disorders with an incidence of 1 in 3000. The search for NF1 mutations has been hampered by t"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,Development,1995,953,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""To identify cell type(s) that might contribute to nerve sheath tumors (neurofibromas) in patients with neurofibromatosis type 1, we generated cell cultures containing neurons. Schwann cells a"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
8602361,10.1093/nar/24.3.478,The neurofibromatosis type I messenger RNA undergoes base-modification RNA editing.,Nucleic Acids Res,1996,765,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""functional mooring sequence, known to be required for apolipoprotein B (apoB) mRNA editing, exists in the mRNA encoding the neurofibromatosis type I (NF1) tumor suppressor. Editing of NF1 mRNA modifies cytidine in an arginine codon (CGA) at nucleotide 2914 to a uridine (UGA), creating an in frame trans"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""A functional mooring sequence, known to be required for apolipoprotein B (apoB) mRNA editing, exists in the mRNA encoding the neurofibromatosis type I (NF1) tumor supp"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8612763,10.1016/0014-5793(96)00137-8,Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase.,FEBS Lett,1996,847,10562,0,1,3,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""DESeq2"", ""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Script RT Reagent Kit with gDNA Eraser (TaKaRa, Japan). Real-time quantitative PCR detection was performed to determine the mRNA expression levels of NF1, ALP, Runx2, Osx and Col1a1 with FastStart Universal SYBR Green Master (Rox) on a LightCycler \u00ae  480 II Real-Time PCR System (Roche, Mannheim, German"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""4. Materials and Methods Reagents. Icariin reagents (purity >99%) were purchased from the National Institute for the Control of Pharmaceutical and Biological "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:DESeq2"": {""context"": ""oled. After RNA-seq library construction, paired-end sequencing of the library was performed on HiSeq XTen sequencers (Illumina, San Diego, CA, USA). DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples. Genes were considered to be significantly different"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""aKaRa, Japan). Real-time quantitative PCR detection was performed to determine the mRNA expression levels of NF1, ALP, Runx2, Osx and Col1a1 with FastStart Universal SYBR Green Master (Rox) on a LightCycler \u00ae  480 II Real-Time PCR System (Roche, Mannheim, Germany). The conditions were 95 \u00b0C for 5 min, 9"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:DESeq2"": [""methods""], ""computational_tools:STAR"": [""methods""]}",False
8621451,10.1074/jbc.271.10.5819,A naturally occurring T14A11 tract blocks nucleosome formation over the human neurofibromatosis type 1 (NF1)-Alu element.,J Biol Chem,1996,1897,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The nature of chromatin organization over Alu repetitive elements is of interest with respect to the maintenance of their transcriptional silencing as well as "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
8627811,10.1128/JVI.70.5.3280-3285.1996,Repression of the NF1 gene by Tax may expain the development of neurofibromas in human T-lymphotropic virus type 1 transgenic mice.,J Virol,1996,907,0,0,1,2,3,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""In familial neurofibromatosis type 1 (NF1), individuals with a germ line-transmitted NF1 mutation develop multiple neurofibromas. To explain the observation that transgenic mice expressing th"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""In familial neurofibromatosis type 1 (NF1), individuals with a germ line-transmitted NF1 mutation develop multiple neurofibromas. To explain the observation that tran"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}, ""computational_tools:STAR"": {""context"": ""the Tax trans-regulator can functionally repress NF1 gene expression through a cis-acting element located immediately upstream of its transcriptional start site, thereby allowing the development of benign neurofibromas without the need for direct mutations in NF1. We propose that such a mechanism would "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""], ""computational_tools:STAR"": [""abstract""]}",False
8659521,,Genotyping of PCR-based polymorphisms and linkage-disequilibrium analysis at the NF1 locus.,Am J Hum Genet,1996,1122,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Six polymorphisms across the NF1 gene have been adapted for genotyping through application of PCR-based assays. Three exon-based polymorphisms--at positions 702, 2034, and 10647 in t"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Six polymorphisms across the NF1 gene have been adapted for genotyping through application of PCR-based assays. Three exon-based polymorphisms--at positions 702,"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8751853,,Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.,Am J Hum Genet,1996,1891,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Neurofibromatosis 2 (NF2) features bilateral vestibular schwannomas, other benign neural tumors, and cataracts. Patients in some families develop many tum"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
8825042,10.1136/jmg.33.1.2,Molecular genetics of neurofibromatosis type 1 (NF1).,J Med Genet,1996,1574,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1), also called von Recklinghausen disease or peripheral neurofibromatosis, is a common autosomal dominant disorder characterised by multiple neurofibr"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1), also called von Recklinghausen disease or peripheral neurofibromatosis, is a common autosomal dominant disorder characteri"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
8892969,10.1006/excr.1996.0297,NF1 mRNA isoform expression in PC12 cells: modulation by extrinsic factors.,Exp Cell Res,1996,1082,11035,0,1,9,10,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""bowtie"", ""R"", ""TopHat"", ""STAR"", ""NanoDrop"", ""Trimmomatic"", ""ImageJ"", ""SPSS"", ""bowtie2""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ith 5% of CO 2  in DMEM medium supplemented with 1X N2 (Calbiochem) and 10\u00a0ng/mL bFGF (Invitrogen). Primary Schwann cells previously isolated from an NF1 patient nerve biopsy, were thawed and cultured on Poly-L-Lysine (0.1\u00a0mg/mL) and laminin (4\u00a0\u00b5g/mL) coated plates in Schwann Cell Media (SCM)\u2009+\u2009forskol"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:R"": {""context"": ""Materials and methods Cell culture PC12 cells (ATCC CRL-1721) were grown on Collagen IV-coated dishes (25\u00a0\u03bcg/ml) and maintained in RPMI 1640 medium, supple"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie"": {""context"": ""rm with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the counts matrix was processed "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:TopHat"": {""context"": ""he Illumina HiSeq 2000 platform with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": "" extraction was performed using Maxwell 16 LEV simplyRNA Purification Kit (Promega) according to manufacturer\u2019s instructions. Libraries were prepared starting from 200\u00a0ng of RNA per sample with the TruSeq stranded mRNA Illumina procedure. Libraries were quantified using the KAPA library quantitation kit"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:NanoDrop"": {""context"": ""antification and reverse transcription (RT) Total RNA was extracted using Tripure Isolation Reagent (Roche). Quality and quantity were assessed using NanoDrop spectrophotometer and gel electrophoresis analysis. For an accurate quantification, size and integrity of the RNA was determined with Bioanalyzer (RN"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:Trimmomatic"": {""context"": ""it for Illumina GA and sequenced on the Illumina HiSeq 2000 platform with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": ""entiated cells over total cells in the field. Neurite extension was measured by determining the length of at least 10\u201320 neurites per field using the ImageJ  (versions 1.45\u00a0s and 1.8.0_172;  72 https://imagej.nih.gov/ij/download.html ) plugin NeuronJ . Neurite thickness was analyzed using ImageJ 73  (vers"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:SPSS"": {""context"": "" assuming equal variances. An event was considered significant with a  P  value\u2009<\u20090.05. The statistical analysis was performed using PASW Statistics (SPSS Inc. Released 2009. PASW Statistics for Windows, Version 18.0. Chicago: SPSS Inc.;  http://www.spss.com.hk/statistics/ ), while graphical representat"", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:bowtie2"": {""context"": ""rm with 2\u2009\u00d7\u2009100 reads, 4 samples per lane. Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2 against the  Rattus norvergicus  reference genome Rnor 6.0. The reads overlapping every known gene were counted and the counts matrix was processed i"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:bowtie"": [""methods""], ""computational_tools:TopHat"": [""methods""], ""computational_tools:STAR"": [""methods""], ""computational_tools:NanoDrop"": [""methods""], ""computational_tools:Trimmomatic"": [""methods""], ""computational_tools:ImageJ"": [""methods""], ""computational_tools:SPSS"": [""methods""], ""computational_tools:bowtie2"": [""methods""]}",False
8982875,10.1093/oxfordjournals.jbchem.a021498,Differential tissue-specific expression of neurofibromin isoform mRNAs in rat.,J Biochem,1996,1162,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""We have cloned the full-length cDNA encoding the rat homolog of type I neurofibromin isoform, a protein product of a gene linked to neurofibromatosis type 1. Rat type I neurofibromin isoform is compos"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9001241,10.1128/MCB.17.2.862,Nf1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: reversion of some phenotypes by an inhibitor of farnesyl protein transferase.,Mol Cell Biol,1997,1243,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have developed a potential model of Schwann cell tumor formation in neurofibromatosis type 1 (NF1). We show that mouse Schwann cells heterozygous or null at Nf1 display angiogenic and invasive properties, mimicking the behavior of Schwann cells fr"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have developed a potential model of Schwann cell tumor formation in neurofibromatosis type 1 (NF1). We show that mouse Schwann cells heterozygous or null at Nf1 display angiogenic and invasive properties,"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9036924,10.1111/1523-1747.ep12286456,Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors.,J Invest Dermatol,1997,1337,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Among the symptoms that characterize neurofibromatosis type 1 (NF1) are pigmentation anomalies such as cafe au lait spots. It has been suggested that the reduction of the neurofibromin level in the epidermis of NF1 p"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Among the symptoms that characterize neurofibromatosis type 1 (NF1) are pigmentation anomalies such as cafe au lait spots. It has been suggested that the reduction of the neurofi"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9078372,,Neurocristopathy resembling neurofibromatosis type 1 in an NGF-SV40 transgenic line.,Genes Cells,1996,1279,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""ecifically causes the development of either neurofibromas or neurofibrosarcomas similar to those found in the human disease neurofibromatosis type 1 (NF1). These tumours are completely penetrant and appear after a mean latency of about 8 months. In contrast to the previously reported neurofibromatosis "", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""BACKGROUND: Animal models of carcinogenesis have been produced in transgenic mice by directing the expression of oncogenes such as SV40 T antigen and myc to"", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9136014,10.1093/genetics/146.1.245,Isolation of mutations in the Drosophila homologues of the human Neurofibromatosis 2 and yeast CDC42 genes using a simple and efficient reverse-genetic method.,Genetics,1997,1106,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Reverse genetic analysis in Drosophila has been greatly aided by a growing collection of lethal P transposable element insertions that provide molecula"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9171370,10.1101/gad.11.10.1253,The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation.,Genes Dev,1997,1380,14946,0,1,3,4,"{""cell_lines"": {""HEK293"": ""7b6dcc42-3c32-4008-8b2c-309aa01b17be""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""GraphPad Prism"", ""ImageJ"", ""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods Sex as a biological variable. Our study examined male and female animals, and similar findings are reported for both sexes. Generation of Nf2-cKO mice. The animals were main"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""cell_lines:HEK293"": {""context"": ""mental Table 2 . For lentivirus packaging, the second-generation packaging plasmids (psPAX2 and pMD2.G) and lentivirus vector were cotransfected into HEK293T cells (3101HUMGNHu17, BMCR) using the Lipofectamine 8000 transfection reagent (Beyotime, C0533) following manufacturer\u2019s instructions as described ("", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""computational_tools:GraphPad Prism"": {""context"": ""s, 1-way or 2-way ANOVA was performed. A  P  value less than 0.05 was considered statistically significant. Statistical analyses were performed using GraphPad Prism 9 (GraphPad Software). Study approval. All the animal experiments were approved by the animal committee of Zhejiang Sci-Tech University (201911001). "", ""confidence"": 0.95, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:ImageJ"": {""context"": "" embryo collection. EdU staining was performed based on the BeyoClick EdU-594 (C0078S, Beyotime). The Edu +  osteoprogenitor cells were counted using ImageJ (NIH) for data analysis. EdU +  cells were calculated from 3 samples using ImageJ. Apoptosis assay. The apoptosis was determined by TUNEL labeling as"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""], ""cell_lines:HEK293"": [""methods""], ""computational_tools:GraphPad Prism"": [""methods""], ""computational_tools:ImageJ"": [""methods""]}",False
9222967,10.1136/jmg.34.7.579,Four frameshift mutations in neurofibromatosis type 1 caused by small insertions.,J Med Genet,1997,725,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""We have been using heteroduplex analysis to assay individual exons within the NF1 gene in an effort to identify disease causing constitutional mutations in neurofibromatosis type 1 patients. Here we report the identification and ch"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""We have been using heteroduplex analysis to assay individual exons within the NF1 gene in an effort to identify disease causing constitutional mutations in neurofibromatosis "", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9391890,10.1136/jmg.34.11.934,Misleading linkage results in an NF2 presymptomatic test owing to mosaicism.,J Med Genet,1997,1014,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""A two generation family with neurofibromatosis type 2 (NF2) is presented in which a family member requested presymptomatic molecular diagnosis. Since the consult"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9399891,10.1086/301633,Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.,Am J Hum Genet,1997,1022,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Patients with multiple schwannomas without vestibular schwannomas have been postulated to compose a distinct subclass of neurofibromatosis (NF), termed \""schwannomatosis.\"" To compare the molecular-genetic"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9430655,10.1074/jbc.273.3.1273,"NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.",J Biol Chem,1998,1125,10754,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""4. Materials and Methods 4.1. Cloning, Expression and Purification of the FERM-Domain from Human Ezrin The  E. coli  codon-optimized gene for the human ezrin "", ""confidence"": 0.85, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
9458162,10.1111/j.1750-3639.1998.tb00129.x,A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes.,Brain Pathol,1998,1677,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""The specific analysis of gene transcripts is of increasing importance for studies in molecular pathology. Competitive RT-PCR with mutagenized exogenous competitor templates has evolv"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9516485,10.1074/jbc.273.13.7757,"Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli.",J Biol Chem,1998,1372,4564,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods 850 high-grade/progressive meningiomas, including 441 WHO grade 2 and 176 WHO grade 3 meningiomas and 220 progressive WHO grade 1 meningiomas, were tested as par"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
9553042,10.1101/gad.12.8.1121,Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors.,Genes Dev,1998,1113,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""A role for the membrane/cytoskeleton interface in the development and progression of cancer is established, yet poorly understood. The neurofibromatosis "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9560242,10.1073/pnas.95.9.5139,A role for Pak protein kinases in Schwann cell transformation.,Proc Natl Acad Sci U S A,1998,1396,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by loss of the NF1 gene, is characterized clinically by neurofibromas and more rarely by neurofibrosarc"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromatosis type 1 (NF1), a common autosomal dominant disorder caused by loss of the NF1 gene, is characterized clinically by neurofibromas and more"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9607929,10.1084/jem.187.11.1893,Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.,J Exp Med,1998,1967,6687,0,2,2,4,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {""Nf1-/-"": ""b705a9f5-84ef-404e-9fe4-d499550298b3""}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R"", ""STAR""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Materials and Methods Isolation of Fetal Hematopoietic Cells. Heterozygous  Nf1 \n +/\u2212  mice were mated to produce  Nf1 \n \u2212/\u2212  embryos. Pregnant  Nf1 \n +/\u2212  females were killed by cervical dislocation on day 13.5 of gestation and "", ""confidence"": 0.75, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""methods""}, ""animal_models:Nf1-/-"": {""context"": ""out mice spontaneously develop a myeloid disorder that resembles JCML. Both human and murine leukemias show loss of the normal allele. JCML cells and Nf1-/- hematopoietic cells isolated from fetal livers selectively form abnormally high numbers of colonies derived from granulocyte-macrophage progenitors i"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Materials and Methods Isolation of Fetal Hematopoietic Cells. Heterozygous  Nf1 \n +/\u2212  mice were mated to produce  Nf1 \n \u2212/\u2212  embryos. Pregnant  Nf1 \n +/\u2212 "", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}, ""computational_tools:STAR"": {""context"": ""ing: anti-B220, anti-CD3\u03b5, anti\u2013Gr-1, and anti\u2013Mac 1 all conjugated to FITC ( PharMingen ). They were then separated by FACS \u00ae  using a dual laser FACStar PLUS \u00ae  equipped with an argon and a krypton laser ( Becton Dickinson , Mountain View, CA). Hematopoietic Progenitor Colony Growth. Recombinant GM-CS"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""cell_lines:NF1"": [""methods"", ""abstract""], ""animal_models:Nf1-/-"": [""abstract""], ""computational_tools:R"": [""methods"", ""abstract""], ""computational_tools:STAR"": [""methods""]}",False
9687500,10.1093/emboj/17.15.4313,Structural analysis of the GAP-related domain from neurofibromin and its implications.,EMBO J,1998,1583,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis of neurofibromatosis type 1 (NF1), one of the most frequent genetic disorders in man. It a"", ""confidence"": 0.7, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Neurofibromin is the product of the NF1 gene, whose alteration is responsible for the pathogenesis of neurofibromatosis type 1 (NF1), one of the most freq"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
9703963,10.1006/bbrc.1998.9009,Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.,Biochem Biophys Res Commun,1998,1073,7394,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Methods DNA constructs We used our previously described Nf2/merlin construct, residues 1\u2013339  [11] , which was cloned into the pGEX-2T expression vector (GE Life Scienc"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""methods""}}","{""computational_tools:R"": [""methods"", ""abstract""]}",False
9707592,10.1073/pnas.95.17.10015,Mutation frequency declines during spermatogenesis in young mice but increases in old mice.,Proc Natl Acad Sci U S A,1998,1347,0,0,0,1,1,"{""cell_lines"": {}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""computational_tools:R"": {""context"": ""Five percent of live-born human offspring will have a genetic disorder. Of these, 20% are because of germ-line de novo mutations. Several genetic diseases, su"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""computational_tools:R"": [""abstract""]}",False
9878702,10.1016/s0006-8993(98)01133-0,Region-specific astrogliosis in brains of mice heterozygous for mutations in the neurofibromatosis type 1 (Nf1) tumor suppressor.,Brain Res,1999,1282,0,0,1,1,2,"{""cell_lines"": {""NF1"": ""1a8a362e-e3be-4bc3-be7e-d0a0865b9c31""}, ""antibodies"": {}, ""animal_models"": {}, ""genetic_reagents"": {}, ""computational_tools"": {}, ""advanced_cellular_models"": {}, ""patient_derived_models"": {}, ""clinical_assessment_tools"": {}}","{""cell_lines"": [], ""antibodies"": [], ""animal_models"": [], ""genetic_reagents"": [], ""computational_tools"": [""R""], ""advanced_cellular_models"": [], ""patient_derived_models"": [], ""clinical_assessment_tools"": []}","{""cell_lines:NF1"": {""context"": ""Brains from human neurofibromatosis type 1 (NF1) patients show increased expression of glial fibrillary acidic protein (GFAP), consistent with activation of astrocytes (M.L. Nordlund, T.A. Rizvi, C"", ""confidence"": 0.7999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": false, ""section"": ""abstract""}, ""computational_tools:R"": {""context"": ""Brains from human neurofibromatosis type 1 (NF1) patients show increased expression of glial fibrillary acidic protein (GFAP), consistent with activatio"", ""confidence"": 0.8999999999999999, ""is_development"": false, ""is_generic"": false, ""is_established"": true, ""section"": ""abstract""}}","{""cell_lines:NF1"": [""abstract""], ""computational_tools:R"": [""abstract""]}",False
